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 ABSTRACT 
Major depressive disorder (MDD) is a disabling condition with a high frequency of 
recurrence and non-recovery, resulting in serious morbidity and mortality (Kessler & Bromet, 
2013; Stotland, 2012; Alonso et al., 2013). Depressive patients are said to report persistent 
symptoms and long-term disability despite high primary care utilization and medicines, and this 
notion is challenging the efficacy of existing models of care (Stirling et al., 2001; Ambresin et 
al., 2015). Despite increased numbers of issued prescriptions, the prevalence of depression 
remains static (Ambresin et al. 2015; Baxter et al., 2014; Wittchen et al., 2011), or demonstrates 
progressive course (Mojtabai et al. 2016; Hidaka, 2012). This striking polarity of findings opens 
space for further research. Former studies designed to promote medications for the treatment of 
depression generated rather discouraging findings (Aikens et al., 2008; Kutcher et al. 2002; 
Brook et al. 2005; Pampallona et al., 2004; Katon et al., 2001). It seems imperative to undertake 
a careful analysis of reasons, for which the low effectiveness of treatment may result from its 
low utilization. A better understanding of individual views on antidepressants may help improve 
adherence as well as patient-centeredness in depression care and suggest innovative, more 
effective intervention strategies. 
Purpose of the study: This review summarises patients’ accounts of experiences with drug 
therapy in depressive disorder. Perceptions of mood-stabilizing drugs have been explored with 
the aim to unravel negative treatment decisions. Individual and common beliefs that lead to 
refusal of antidepresant treatment as well as challenges experienced during initially accepted and 
initiated treatment have been identified and explained. 
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Methods: With the help of Arksey and O’Malley’s scoping review methodology as a guide, 
several databases were searched: MEDLINE through PubMed, Scopus, PsycNET and Google 
Scholar. In addition, bibliographies and references of relevant studies were searched online. 
As a result, 41 qualitative research papers remained the core of this work. Design triangulation 
was used to examine the consistency and reliability of qualitative data with 71 quantitative and 
mixed-methods studies. Concepts emerging from summarized findings are presented in a 
thematic analysis. The research was conducted in a manner that will allow this review to be 
replicable.  
Findings: Utilization of antidepressants continues to raise concerns. Existing scholarly 
evidence concerning attitudes and people’s behavior in relation to mood-stabilizing drugs 
uncovered a rich spectrum of ethical, racial, cultural and emotional underpinnings of medical 
treatment. There were accounts of patients who both accepted and refused drug treatment in the 
process of acceptance or denial of their depressive condition. Pattern of ignorant or dismissive 
behaviors observed in health care professionals was the cause of major frustration.  
Conclusions: depressive patients either fully refuse the medicines or they do not adhere 
to recommended treatment. The analysed studies provide evidence that adherence to 
antidepressants is a complex health behavior that is mediated by multiple factors based on 
patients’ cultural, religious and ethical beliefs. The most serious reasons for non-compliance are 
adverse side effects and frustration experienced due to lack of efficacy of drug treatment and 
absence of permanent cure after prolonged use of medications. A major concern is the quick 
diagnostic procedure based on patient’s self-report and the ease of prescribing antidepressants 
viewed by patients as unnecessary and harmful. Complains about lack of continuous medical 
support indicate an urgent need of revision of existing mental-health services and regulations.   
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Not the least of the reasons for studying illness meanings, therefore, is that 
such investigation can help the patient, the family, and also the practitioner: 
certainly, not every time, perhaps not even routinely, but often enough to make a 







CHAPTER 1. INTRODUCTION 
“[N]ot only are we well or ill, but also, we act or refuse to act, 
and we can choose to act one way rather than another. 
And thus we – women and men –  
must take responsibility for doing things or not doing them. 
It makes a difference, and we need to take note of that difference”   
Amartya Sen, Development as Freedom, 2000, p.190 
 
 
Few diseases are found to be as troublesome as depression (Sapolsky, video). The World 
Health Organization (WHO) predicts depression to become the leading cause of global disease 
burden in 2030 (http://apps.who.int/gb/ebwha/pdf_files/EB130/B130_9-en.pdf). The large 
number of people suffering from depression contribute to the overall economic deficit by large 
health care expenditures and production losses. Concerning is not only the economic loss 
resulting from unemployment, low work performance, absenteeism and premature death, but first 
and foremost, it is the overall health and individual well-being which is put on risk. Generally, 
one in five people are believed to suffer from a depressive episode at some point in their lives 
(Kessler et al., 2009). Frequently misdiagnosed and in many instances undertreated, depressive 
condition often takes a chronic and recurrent course, leading to increased disability, premature 
mortality (Lepine & Briley, 2011), and contributes to the global economic burden. Symptoms of 
depression often show an episodic pattern and may resolve without medical treatment; but the 
majority of affected individuals experiences multiple episodes or residual symptoms, and some 
cases take a long-lasting course (Hollon et al., 2002). The severity of illness can differ from 
“mild disruptions of normal mood to disorders of psychotic intensity” (Hollon et al, 2002; 
Murray & Lopez, 1997). The burden of unipolar depression is intensified as a result of multiple 
relapses and the chronic character of the illness (Berwian et al. 2017). More than 50% of people 
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affected by one episode of depression are said to experience another one, and the majority of 
them will not be able to escape further episodes (American Psychiatric Association, 2000).  
Medicines are found to demonstrate high efficiency in the maintenance of functional 
activity in depressive patients (McDonald et al., 2002). The intake of antidepressants is also 
believed to improve self-rated health and life satisfaction. Mood-stabilizers have proven utility 
not only in treating acute episodes of depression, but also in reducing the risk of relapse (Geddes 
et al. 2003; Kaymaz et al. 2008; Donovan et al. 2010), and preventing relapses presents as an 
essential component of treatment in depressive illness. Regretfully, lack of satisfying evidence 
about significant improvement challenges the belief in efficacy of recommended therapies. 
While the ultimate goal, such as symptomatic remission, is the only desired and acceptable 
treatment outcome (McIntyre & O’Donovan, 2004), only 30–40 % of individuals diagnosed with 
depression are estimated to be reaching full symptom relief after successful treatment with first-
line antidepressants (Kessler et al, 2013; Bortolato et al, 2016). Many patients never reach 
premorbid levels of psychosocial functioning, such that a significant number of patients suffers 
from residual symptoms (Kessler et al, 2013; Bortolato et al, 2016).  
The effort to understand why depressed patients have poor medical care outcomes 
despite available treatment options may help to determine the extent to which negative results in 
treatment might be linked to low adherence to treatment recommendations (DiMatteo et al. 
2000). During the past 3 decades, patient noncompliance has been of concern in attempts to 
understand limitations in the process of medical care delivery (DiMatteo et al. 2000). The 
benefit of effective treatment is particularily important in primary care and the phenomenon of 
non-adherence is not exclusive to depression. Challenges to efficient utilization of effective 
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treatments in chronic illnesses have been brought to light by multiple studies (DiMatteo et al., 
2000; Brown & Bussel, 2011; Gadkari & McHorney, 2012; Burra et al., 2007). 
Patient preferences regarding treatment conditions, type of treatment, or relationship with 
the physician, are found to have a major influence on therapy outcomes (Winter and Barber, 
2013; van Grieken et al. 2014). Controversies exist: some studies indicate higher levels of 
nonadherence among patients who explain their depression with interpersonal causes (Brown et 
al., 2001), while contradictory research demonstrates the best clinical outcomes in individuals 
who perceive their depressive symptoms in nonbiological terms (Sullivan et al., 2003). Also, the 
disorder itself is believed to be a frequent reason for refusal of medications and noncompliance 
to treatment (Marazziti et al., 2010).  
Treatment guidelines for Major Depression state that it is imperative to collaborate with 
patients in decision making about therapy and attend to their concerns, preferences and choices 
(American Psychiatric Association (APA), 2010 in: van Grieken 2014). “With increasing 
numbers of effective self-administered treatments, the need is apparent for better understanding 
and management of nonadherence” (Mc. Donald et al, 2002). Gibson, Cartwright and Read 
(2014) summarized and examined existing research on treatment preferences and individual 
attitudes toward antidepressants. By constructing a patient centered perspective, they discovered 
a range of ambivalent feelings about medication use.  Many individuals discontinue treatment 
rapidly (Olfson et al., 2006) or adhere partially (Hunot et al., 2007) because of the adverse 
effects; some relapse despite regular treatment while others do not relapse despite 
discontinuation. Also, it is scientifically proven that not all patients will respond to a particular 
antidepressant treatment with experiencing the same side effects (e.g. Rush et al., 2006). In 
addition, there are also suggestions that antidepressant treatment itself possibly provokes relapses 
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after discontinuation through perturbational effects on neuromodulatory systems (Andrews et al. 
2011). Finally, patients need to learn how to assess a treatment effect appropriately; if not, they 
will use their own measures, e.g. may interpret depressive symptoms as side effects of the 
medication (Dowell & Hudson, 1997). Since treatment preferences result from treatment 
knowledge, research should further explore the role of educational strategies in motivating 
depressed patients to actively seek the most effective therapy and adhere to it (Dwight-Johnson 
et al., 2000). McDonald et al. (2002) imply that full benefits of medication treatment cannot be 
accurately assessed at current levels of adherence; therefore, more studies of innovative 
approaches are needed in order to assist patients to follow prescriptions. They also claim that 
existing methods of improving medication adherence in chronic diseases are “mostly complex, 
labor-intensive, and not predicably effective” (McDonald et al, 2002). In consideration of 
inconsistencies in research findings, this thesis sought to clarify the role of patient’s individual 
perception on use of mood-regulating prescription drugs. This review is a major task undertaken 
by a single person, leading to the discovery of relevant opinions, recorded verbatim or reflected 
upon by other scholars. The addition of quantitative data to the extensively analysed qualitative 
reports is believed to strengthen the results and create a greater understanding of the 
phenomenon. The review succeeded in identifying relatively large numbers of patients both 
accepting and refusing the antidepressant therapy and revealed mechanisms that support or 
hinder medication adherence. It may serve the purpose of identifying meaningful ways of 
educating the public about symptom detection and treatment motivation. Detecting ways to 
motivate people to be in charge of their own well-being and become more approving of 
potentially effective treatment options as well as enhance compliance, could lead to significant 
cost savings in public health care and improve general mental health condition.  
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CHAPTER 2. BACKGROUND ON DEPRESSION 
2.1. What is Depression? 
“There are few diseases out there that are as bad as depression. It is crippling.  
It is pervasive. It wipes out any capacity for joy, hope or pleasure.  
Cancer victims will often express gratitude for their disease. It woke them up, gave them 
a new perspective, helped them rebuild important relationships and get to the meaning of life. 
This is not depression.  
Depression destroys perspective, undermines relationships, and steals joy.  




It is a commonly occurring, serious, recurrent disorder linked to diminished role 
functioning and quality of life, medical morbidity, and mortality (Spijker et al., 2004; Üstün et 
al., 2004). It is generally understood in terms of “a low”; and speaking of the emotional 
condition, people usually describe feelings of sadness, emptiness, and hoplessness. It is often 
associated with self-blame or self-deprecation; awareness of the future is impaired (Chapman 
and Gavrin, 1999). Women are said to more likely have major depression than men, and the 
average age for clinical depression to set in is 32 years old. Men are reluctant to admit to 
symptoms of depression, because these symptoms are not the culturally approved idioms for 
men.  
The condition is said not to be a disease sensu stricto as its etiology and mechanisms have 
not yet been fully unraveled (Dantzer et al., 2011). It is perceived as a disparate and 
heterogeneous disorder with a varying and modifiable course, with an unpredictable response to 
treatment, and no explicit mechanism (Belmaker, 2008). Depression induces a far-reaching 
social and economic burden and negatively impacts people’s lives (Papakostas and Ionescu, 
2015). Individuals tormented by depressive prodroms generally refer to experiencing dysphoria 
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and anhedonia1 and a variety of emotional and behavioral symptoms including, but not limited 
to, deviant sleep pattern, poor appetite or overeating, feelings of worthlessness, and intrusive 
thoughts of death (www.ncbi.nlm.nih.gov). In addition, cognitive and executive dysfunctions are 
present in depression, along with fatigue, tiredness and somatic pain (Fava, 2003; Targum & 
Fava, 2011). The ICD-10 and DSM-5 diagnostic criteria link ‘reduced concentration and 
attention’ and ‘diminished ability to think’ with Major Depressive Disorder (MDD) (Bortolato et 
al., 2016). Inflammation is also an important etiologic factor, and thus a potential 
pharmacological target in depression treatment (Kaster et al., 2016).  
Existing studies suggest that a poor prognosis in depression outcome could be linked with 
patient family history and personal traits, younger age of onset and disease characteristics (longer 
duration of depressive episodes), but also with the type of treatment and medical service 
characteristics (e.g., underdetection, undertreatment, limited treatment effectiveness) (van 
Grieken, 2014; Hölzel et al., 2011 and Cantrell et al., 2006). Researchers try to explore why 
depression continues to be overlooked or misdiagnosed, and, in frequent cases of comorbidity, 
simply not identified (McIntyre et al., 2005). In recent times, there have been hefty debates about 
the efficacy of antidepressants (Fountoulakis & Möller, 2011; Kirsch et al., 2008) and 
widespread concern about whether they are being overprescribed (Jureidini & Tonkin, 2006) or 
have harmful effects (Middleton & Moncrieff, 2011). Moreover, some studies openly question 
the efficacy of antidepressive drugs and compare them with placebo (Moncrieff & Kirsch, 2005; 
Moncrieff & Cohen, 2006).  
                                                 
1  dysphoria is general state of sadness that includes restlessness, lack of energy, anxiety, and vague irritation; 




The International Classification of Diseases 10 (World Health Organization, 1992) 
characterizes depression by three core symptoms: “low mood, anhedonia and low energy levels. 
Other symptoms include reduced concentration and self-esteem, ideas of self-harm, disturbed 
sleep and diminished appetite, which must persist for 2-weeks minimum”. Variation in 
symptomatology distinguishes between mild, moderate and severe depression. In regards to 
management, antidepressants are recommended as first-line treatment for moderate and severe 
depression, whereas ‘watchful-waiting’, exercise and problem solving are recommended for mild 
depression (www.ncbi.nlm.nih.gov; Anderson et al. 2008). According to the DSM-5 criteria, “the 
diagnosis of major depressive disorder can be made in the presense of a distinct change of mood, 
characterized by sadness or irritability and accompanied by at least several psychophysiological 
changes, such as disturbances in sleep, appetite, or sexual desire; loss of the ability to experience 
pleasure in work or with friends; spells of crying; suicidal thoughts; and slowing of speech and 
action. These changes have to be noticeable for minimum of 2 weeks and interfere considerably 
with work and family relations” (APA 2013). For an appropriate diagnosis of a major depressive 
episode, patients need to demonstrate 5 of 9 symptoms during the same 2-week period. Of the 
following 9 symptoms, a diagnosis of MD must also include either the first or second symptom: 
1) depressed mood; 2) loss of interest or pleasure (anhedonia); 3) significant weight loss or gain, 
or increase or decrease in appetite: 4) insomnia or hyposomnia; 5) psychomotor agitation or 
retardation; 6) fatigue or loss of energy; 7) feelings of worthlessness (Keller et al., 1998), 
diminished ability to think or concentrate, or indecisiveness, and 9) suicidal ideation. DSM-5 
formulates it as “the presense of a distinct change of mood, characterized by sadness or 
irritability and accompanied by at least several psychophysiological changes, such as 
disturbances in sleep, appetite, or sexual desire; loss of the ability to experience pleasure in work 
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or with friends; spells of crying and suicidal thoughts” (DSM-5). Cognitive symptoms are an 
emerging clinical focus in patients with major depressive disorder (Bortolato et al., 2016). 
Deficits in executive function, memory, attention, and processing speed, as well as negative 
cognitive bias, can contribute to low mood symptoms and reduced occupational and social 
functioning (Bortolato et al. 2016). Both patient reports and objective measures demonstrate that 
cognitive symptoms are common in patients with depression. Cognitive dysfunction may be 
present even before the first depressive episode and may remain after mood symptoms have 
remitted (www.science.gov)  
Depression ‘profoundly and fundamentally’ changes perception of, and interaction with, 
the environment and “pervasively impacts elementary and complex neurocognitive processes 
which play a role in these” (Roiser et al., 2012). Furthermore, the effect of depression on 
cognitive function determines daily function in the long term and also influences the degree to 
which patients are capable of psychotherapy and psychotherapeutic improvement (Roiser et al., 
2012; Bortolato et al., 2016). Persistent cognitive dysfunction decreases coping capacities and 
influences therapeutic compliance and cooperation (Castaneda et al., 2008). Focus on cognitive 
symptoms in depression remained for a long time only secondary to mood symptoms, yet 
impairment of executive functions, varying from symptoms affecting basic neurocognition 
through concentration and memory problems and inability to control recurring negative thoughts, 
dysfunctional attitudes and maladaptive schemata, form an important part of depressive 
symptomatology (Marazziti et al., 2010). The ICD and DSM describe cognitive impairment 
during depression only in general, but there are studies that explore a wide spectrum of cognitive 
dysfunctions also during the acute phase of depression. Executive functions, verbal and visual 
short and long-term memory as well as psychomotor skills and attention, have been found to 
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negatively affect patients with depression in multiple studies (Hammar & Ardal, 2009; Marazziti 
et al., 2010; Roiser et al., 2012; Castaneda et al., 2008; Austin et al., 2001).  
 Despite a vibrant and ever-changing depression research (Beck & Alford, 2009), the 
illness is increasingly becoming the leading cause of disability worldwide, and it is an alarming 
fact that deserves focused clinical and research attention (Beck & Alford, 2009). The belief that 
“more human suffering has resulted from depression than from any other single disease affecting 
humankind” (Kline, 1964), challenges cohorts of specialists worldwide, inviting them to conduct 
more effective studies in order to find better answers regarding its phenomena. 
Fava (2003) found that eight of ten people experiencing an initial episode of major 
depressive disorder will suffer at least one additional episode during their lifetime (i.e. a 
recurrent major depressive disorder). In some patients, the episodes may be separated by many 
symptom-free years of normal functioning (Fava, 2016). For others, the episodes become 
increasingly frequent (Panel, 1993), what appears to be the more prevalent, both in psychiatric 
and primary care settings (Fava 1999; Fava & Kendler 2000; Ormel et al., 1993). 
Longer duration of episodes and a history of previous depressive episodes have been 
found to increase the vulnerability to psychosocial stressors (Kendler et al., 2000), when the self-
concept changes, and cognitive skills and coping strategies become weaker (Coyne et al., 1998). 
While a number of patients may recover from depressive episodes, the majority become chronic 
(Keller et al., 1998). Partial remission between episodes, and not full recovery, appears to be 
most common and is associated with ‘residual disability’ (Fava, 1999). As a result, for most 
people, depression is a lifelong episodic disorder with multiple recurrences, averaging one 
episode in every 5-year period (Fava & Kendler, 2000) with adverse economic, interpersonal and 
medical consequences (e.g. work impairment, family dysfunction, co-morbidity) (Judd, 1997). 
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Major depressive disorder (MDD) represents the classic condition in the group of Depressive 
Disorders. It is characterized by discrete episodes of at least 2 weeks’ duration or longer, 
involving clear-cut changes in affect, cognition, and neurovegetative functions and inter-episode 
remissions. A diagnosis based on a single episode is possible, although the disorder is recurrent 
in the majority of cases. During a mild episode of MDD, a person feels persistent sadness and a 
diminished interest in previously enjoyable activities. Insomnia, fatigue, and trouble 
concentrating negatively influence their daily routine, but the individual still manages to function 
with some extra effort. A moderate episode in MDD brings constant sadness and anhedonia. The 
person experiences some difficulty in every day life and abnormal sleep pattern, has trouble 
concentrating, and sometimes thinks about harming himself (or herself). During a severe episode 
an individual feels overwhelmed with persistent sadness and functioning in daily life is impaired.  
The person sometimes loses touch with reality and wants to harm or kill himself (or herself). 
(http://www.who.int/healthinfo/global_burden_disease/GlobalDALYmethods_2000_2015.pdf?u
a=1). Clinical studies show that a substantial proportion of people who seek treatment for major 
depression have a chronic-recurrent course of illness (Hardeveld et al., 2010; Torpey & Klein, 
2008). Major Depressive Disorder appears as a highly heterogeneous category what leads to 
problems in classification and in specificity of treatment (Paris, 2014). A small percentage of 
patients with major depression demonstrate manic episodes consisting of hyperactivity, euphoria, 
and an increase in pleasure seeking (Belmaker & Agam, 2008).  
The boundaries to the chronic variant of depression are redefined in DSM-5: a newly 
introduced category of ‘persistent depression’ combines chronic major depressive episodes and 
dysthymia into one category; the minimum required duration of symptoms in this new diagnosis 
is 2 years. Major depression lasting more than 2 years shifts into this new category and no longer 
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belongs to the category of major depression. A more chronic form of depression, persistent 
depressive disorder (dysthymia) occurs when the mood disturbance continues for at least 2 years 
in adults. Studies found that the majority of depressive patients suffer from a persistent condition 
rather than from an episodic illness (Klein & Santiago, 2003).  
 
2.2. Depression Burden 
2.2.1. Prevalence and Incidence 
The World Health Organization’ global estimate for 2004 showed that major depression 
caused disability for 65.5 million people worldwide (World Health Organization. Global Burden 
of Disease Study: 2004 Updates. Geneva, Switzerland, World health Organization; 2008). The 
condition is chronic and its recurrent nature is receiving increasing attention (Fava et al., 2003; 
Judd, 1997). Beck (2009) stated that “[d]epression is second only to schizophrenia in first and 
second admissions to mental hospitals in the United States, and it has been estimated that the 
prevalence of depression outside of the hospitals is five times greater than that of schizophrenia”. 
The NIMH estimates report that in the United States, 16 million adults had at least one major 
depressive episode in 2012. That’s 6.9 percent of the population. According to the World Health 
Organization (WHO), 350 million people worldwide suffer from depression. It is a leading cause 
of disability. Depressive disorders are said to be highly prevalent in the United States (Olfson et 
al., 2002). Studies suggest that the 1-year prevalence of major depression in the adult population 
is between 5.0% and 10.3%. Cross-national epidemiologic research further suggests that major 
depression is common in Europe, Canada, New Zealand, and, to a lesser extent, Taiwan and 
Korea (Olfson et al., 2002). Depression is often chronic, recurrent, and responsible for a large 
number of suicide attempts (Burcusa & Iacono, 2007). 
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In Canada, the lifetime prevalence of Major Depressive Episode (MDE) is 12.2% as 
determined by the Canadian Community Health Survey, Mental Health and Wellbeing (CCHS 
1.2) national survey conducted in 2002 (Patten, 2009). Similar values have been reported by a 
methodologically comparable European study (Patten, 2009). Higher past values had been 
reported in the US: 16–18% (Kessler et al., 1994). Lifetime prevalence estimates may 
substantially underestimate the true population values (Kessler et al., 1997).  The lifetime 
incidence of depression in the United States is said to be more than 12% in men and 20% in 
women (Kessler et al., 2003). Epidemiological studies link gender, age, and marital status with 
depression and women are said to have a two-fold increased risk of major depression compared 
to men (Van de Velde et al., 2010), individuals who are separated or divorced have significantly 
higher rates of major depression than the currently married (Weissman et al., 1996). This 
evidence, however, mainly reflects studies conducted in highly developed countries. The limited 
data available from low-middle income countries suggest that the age pattern might either be 
non-monotonic or reversed compared to other countries, with depression increasing with age 
(Kessler et al., 2010). Within high-income countries, the ratio ranged from ≤30% in France, 
Germany, Italy, and the Netherlands to >40% in the US and Israel. Within low-middle income 
countries, the lowest ratios were in Colombia (46.7%) and South Africa (49.6%) and the highest 
(57–58%) in São Paulo, Shenzhen, and Ukraine. Consistent with these results, the 30-day 
prevalence estimate was somewhat lower in high income (1.8%) than low-middle income (2.6%) 
countries (Kessler et al., 2013).  
A Canadian study by Remick (2002) confirms that mood disorders, and thus depression, 
are among the most common indispositions that bring patients to doctors. It is believed that 
almost 20% of adults will have a mood disorder requiring treatment during their lifetime, and 
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about 8% of adults will have a major depressive disorder during their lives (Murphy et al., 2000). 
The individual rate of depression prevalence in patients with physical disorders is about two- to 
three-fold higher than in the general population (6.6%) (Kessler et al., 2005). With respect to 
specific physical diseases, rates of depression vary according to methodological issues including 
the differential use of estimated time points and assessment scales (Kang et al., 2015). The 
individual rate of depression prevalence in patients with physical disorders is about two- to three-
fold higher than in the general population (6.6%) (Kessler et al., 2005).   
 
2.2.2. Economic Cost of Depression 
  In 2008, the direct costs (i.e., hospital care, physician care and drug expenditures) 
associated with mental illness were estimated at approximately $8 billion in Canada 
(Government of Canada). Indirect expences associated with mental illness, including costs of 
disability claims, social and judicial expenditures, lost educational potential and lost or limited 
productivity at work due to absenteeism and presenteeism, are much higher than direct costs 
(Lim & Dewa, 2008; Sanderson et al., 2007). According to the WHO, "more working days are 
lost as a result of mental disorders than physical conditions" (WHO 1998). It has been suggested 
that workplace impairment may contribute to more than 60 % of the MDD-related economic 
burden (Katon and Ciechanowski, 2002). Several studies attempted to estimate the annual salary-
equivalent human capital value of overall lost work performance. These estimates were in the 
range $30.1 billion (Stewart et al., 2003) to $51.5 billion (Greenberg et al., 2003). 
 The economic cost of depression introduced through global statistics mainly refers to the 
economic burden on healthcare systems and society, but we cannot disregard the fact that it also 
pertains to patient well-being (Berto et al., 2000). Report issued by the Pharmaceutical Research 
and Manufacturers Association (PhRMA) where prevalence and cost of disease were compared 
14 
 
for several major chronic diseases, including Alzheimer’s, asthma, cancer, depression, 
osteoporosis, hypertension, schizophrenia, found depression to be one of the most serious 
diseases, ranked third by prevalence and sixth in terms of economic burden (Berto et al., 2000). 
Moreover, “in terms of the average cost per patient, depression imposes a societal burden that is 
larger than other chronic conditions such as hypertension, rheumatoid arthritis, asthma and 
osteoporosis” (Berto et al., 2000). Depressed individuals’ ability to fit into society is estimated to 
be worse than in patients with other chronic diseases (Kessler & Bromet, 2013).  
 It is important to consider patients’ perceptions on their quality of life: people who suffer 
from depression usually experience as much or even more limitations in multiple aspects of their 
daily functioning and well-being as is associated with most medical conditions (Berto et al., 
2000; Martin et al., 2005). Individuals living with untreated mental illness face an increased risk 
of suffering from co-morbid chronic medical conditions (Colton & Manderscheid, 2006). Among 
the 20.7 million adults in the U.S. who experienced a substance use disorder, 8.4 million (40.7%) 
had a co-occurring mental illness (U.S. Department of Health and Human Services). 
Approximately 1 in 5 adults in the U.S., 43.7 million, or 18.6%, experience mental illness in a 
given year (National Institute of Mental Health). According to the World Health Organization 
(WHO, 2010), major depression carries the heaviest burden of disability among mental and 
behavioral disorders (US National Institute of Mental Health). Depressive illness is continuously 
defined as an under-recognized, underreported and undertreated condition (Koenig et al., 1997).  
 
2.2.3. Poor Life Performance in Individuals with Depressive Disorders 
Depression comes in different forms and shows an episodic pattern. Major depressive 
disorder, known for its severity, constrains the ability to work, study, and to enjoy once 
pleasurable activities (anhedonia). A deep, long-lasting sadness, anxiety, or emptiness are the 
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characteristic moods, as well as feelings of hopelessness, overwhelming pessimism, guilt and 
worthlessness; loss of interest in hobbies and sex, persistent fatigue, difficulty concentrating, 
remembering, or making decisions, changes in sleep pattern and appetite, suicidal ideation and 
chronic physical pain and discomfort, which do not respond to regular treatment such as 
headaches, digestive problems, etc. (Wrobel, 2007). Dysthymia is a chronic although less severe 
and less disabling, form of depression, but is also a condition that makes it difficult to enjoy life, 
function well, or feel good over the long-term. Individuals with dysthymic disorder may also 
experience major depressive episodes at some time in their lives (Wrobel, 2007). MDD was one 
of two- with the other being Bi-polar disorder (BPD)- mental disorders most often rated severely 
impairing in both developed and developing countries. None of physical disorders considered as 
severe conditions (cancer, diabetes, and heart disease) have impairment levels as high as those 
for MDD or BPD (Kessler and Bromet, 2013).  
2.2.3.1 Education 
Several studies show early-onset mental disorders associated with a high number of 
school drop-outs (Breslau et al., 2008). MDD is associated with a greater potential risk of failure 
to complete secondary education in developed countries; however, these adverse effects are 
believed to be weaker in lower-income countries (Kessler & Bromet, 2013). 
2.2.3.2 Family Life 
It has long been known that marital dissatisfaction and hostility are strongly related to 
depressive symptoms (Whisman 1999). “Considerable research documents that both perpetration 
of, and victimization by, physical violence in marital relationships are significantly associated 
with depression” (Stith et al., 2004). A growing body of research has more recently suggested 
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that spousal violence and child neglect/maltreatment might be consequences of pre-existing 
mental disorders (Kessler et al., 2001).  
2.2.3.3 Work  
A number of epidemiological surveys in the US have estimated the workplace costs of 
either MDE or MDD on absenteeism and low work performance (often referred to 
as presenteeism) (Lerner & Henke, 2008). Studies found that MDE and MDD significantly 
predicted overall lost work performance. Research analyses have also documented high-risk 
associations between unemployment rates and suicide (Jones, 1991). Although depression is 
known to be associated with unemployment, research on this association has emphasized the 
impact of job loss on depression rather than depression as a risk factor for job loss (Dooley et al., 
1996). A recent analysis from the WMH surveys documented the latter association by showing 
that history of mental disorders as of the age of completing schooling predicted current (at the 
time of interview) unemployment and work disability (Kawakami et al., 2012). 
 
2.2.4. Suicidal Ideation 
Hollon et al. (2002) claim that depression is a leading cause of suicide. Suicidal ideation 
is said to occur frequently as one of the common symptoms of the disorder (Paykel & Priest, 
1992). Major depressive episode is known as the most common current psychiatric diagnosis 
among suicide victims and attempters (56-87%), thus a successful acute and long-term treatment 
will drastically reduce the risk of suicidal ideation (Rihmer et al., 2012). People 65 years and 
older are found to be committing suicide at a higher rate than the national average (Senior 
Health). High risks of suicide have been found in men between age 20 and 30, over age 50 years 
and especially very old men and in women between age 40 and 60 with affective illness, poor 
impulse control, history of previous suicide attempt(s) (believed to be most relevant factor), 
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family history of suicidal ideation, positive family history of early-onset affective disorder, 
alcohol abuse, broken marital status (single, divorced or widowed) as well as sudden change in 
socioeconomic status (loss of job, financial problems, undesired retirement), and finally, lack of 
support (Blumenthal 1990; Appleby 1992; Nordstrom et al., 1995; Angst ,1999; Bostwick and 
Pankratz, 2000; Möller, 2003). There is no specific, acutely acting “anti-suicidal” medication 
known, but some clinicians successfully combine antidepressants with antipsychotics or 
benzodiazepines (Furukawa et al., 2001).  
In recent decades, epidemiological studies have discovered a dual phenomen: a reduction 
in the numbers of suicides and increased prescriptions of antidepressants. At the same time, an 
ongoing debate about antidepressants potentially increasing the risk of suicidal behaviour leads 
to differentiated findings: studies exist, which suggest that treatment with SSRIs and other 
antidepressant drug classes may increase the risk of suicidality (suicidal attempts) in some 
patients (Möller, 2006). This risk is said to be higher in the initial phase of treatment (Jick et 
al. 2004). Simon and colleagues (2006) showed that the risk of suicide is highest in the month 
preceding treatment with antidepressants. However, Khan et al. (2000) compared the incidence 
of suicide and suicide attempts with several of the “newer” antidepressants and placebo and did 
not find statistically significant differences.  
 
2.3. Depression Management 
“When practice guidelines are followed, patient outcomes are quite good” 
(Goldman et al., 1999) 
 
 Research findings indicate that in 2012, depression was estimated to affect 350 million 
people (Marcus et al., 2012), and is predicted to be the second leading cause of disability 
worldwide by 2020 (second to ischemic heart disease) (Murray & Lopez, 1996). The demand for 
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reducing the burden of mental health has become a raising global concern (Marcus et al., 2012). 
World Health Assembly urged the WHO and its member states to take immediate actions in this 
direction (WHO, 2012). The importance of the doctor–patient relationship in general practice 
care, the engagement of patients in management decisions, and the role of self-management goes 
in the direction of ‘patient centredness’ (Williamson, 2014). Ideally, the management of 
depression should start with the bio-psychosocial model of assessment and continue with 
successful treatment (drugs, psychological, social), until mental issues have been sucessfully 
addressed (Hegarty et al., 2009). The available pharmacology is said to be offerring very 
effective forms of treatment (Andrews et al., 2011); however, in general, rather negative attitudes 
towards antidepressants (Olfson, 2002) are believed to significantly influence poor adherence to 
treatment (Consumer Reports, 2013, Hollon et al., 2002). At the same time, pharmacology alone 
is rather rarely offering a complete solution for depression (Whybrow, 2015). In chronic 
conditions, treatment with antidepressants and psychotherapy in accordance with current 
depression guidelines is suggested to be most efficacious (Ramasubbu et al., 2012).  
 This review aims to detect and to share the research findings about the ways people tend 
to manage their depressive symptoms with or without medications. As lay beliefs seemingly 
portray depression as a ‘sick self’-image (Kihlstrom & Kihlstrom, 1999), with an apparent fear 
of being labeled and stigmatized as mentally ill, the majority of people tend to be in denial of 
their symptoms, trying to avoid the painful realization (Lieberman, 2013). Doctors, patients, and 
their families must gain a deeper understanding of the illness and a broader knowledge of 
existing and preferred treatment options (Whybrow, 2015, p.285). The need and importance of 
new directions in research in this area should not be underestimated and patient perspectives 
should be considered and validated in new studies. To quote Whybrow (2015), “with the 
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advances in pharmacology and general knowledge about the nature of […] severe depression, it 
is possible for patients to educate themselves about their illness and to help manage it, much as 
diabetes or asthma can be managed” (p. 288). 
 
2.3.1. Course of Depression and Phases of Treatment  
 The chart below illustrates a course of an episode of mood disorder and the associated 
phases of treatment that best illustrate a drug treatment (Kupfer, 1991). The acute phase marks 
the period from the start of treatment until the reduction of symptoms becomes noticeable. 
Response to treatment would be then defined as a significant reduction in symptom severity 
(typically 50%), such that the patient no longer meets criteria for the disorder (Frank, Prien et al., 
1991). Remission is the desired and ultimate outcome of treatment, defined as a ‘reduction of 
symptom intensity to a level within the range of a never-ill population’. Remission is associated 
with a lower risk of relapse that a response to treatment (Paykel et al., 1995). Relapse refers to 
the return of symptoms associated with the treated episode (Frank, Prien, et al., 1991). Treatment 
may suppress symptoms early on, but these symptoms are likely to reemerge if treatment is 
discontinued before the underlying episode has been resolved. Ending treatment too early is 
analogous to discontinuing an antibiotic as soon as a fever breaks but before the underlying 




Fig. 1. Phases of treatment and the five “Rs” of depression: response, remission, relapse, 
recovery, and recurrence. The solid line represents the course of a prototypical episode of 
depression, the dotted line represents normalization that occurs if the oncoming episode is 
prevented, and the dashed lines represent the return of symptoms associated with relapse and 
recurrence. Adapted from “Long-Term Treatment of Depression,” by D.J. Kupfer, 1991, Journal of Clinical 





CHAPTER 3. METHODOLOGY 
3.1. Study Rationale 
 
The high global prevalence of depression and the seemingly never-ending need for 
improving efficacy of therapies shows potential for continuous research. The impact of 
depressive disorder on our society cannot be overemphasised; especially, since the existing 
ways to fight depression are not optimal (Frazer et al., 2005). A growing scholarly evidence 
continues to demonstrate the dichotomy between a rich variety of available treatment options 
and the disorder of vast dimensions. There is a reported dramatic increase in the incidence and 
severity of depression, although it is a matter of debate how much of these statistics reflects an 
increase in the actual incidence of depression, and how much should be assigned to biasing 
factors such as reduced stigma, better diagnosis, diagnostic procedures, and drug industry 
pressures (Borch-Jacobson, 2002; Shorter, 1997; Torrey and Miller, 2001). Yet the belief that 
antidepressants are overprescribed is quite prevalent (Spence, 2013). For example, prescribing 
of antidepressants in the UK has more than doubled over the last decade (Anderson & Roy, 
2013). Especially the newer antidepressants are considered to have a higher clinical efficacy, 
together with a milder side-effect profile, lower lethality, and increased social acceptance (Khan 
et al., 2002; Kirsch et al., 2002; Thase, 2002). Numerous studies report that the use of 
antidepressants, and especially of the selective serotonin reuptake inhibitors (SSRIs), has 
dramatically increased in recent years, although new analyses suggest that their efficacy for 
depression may be significantly less than formerly believed (Khan et al., 2002; Kirsch and 
Antonuccio, 2002; Kirsch et al., 2002; Thase, 2002). I recommend caution in the application of 
the term “use” within the context of utilization of mood-stabilizing drugs. It can be misleading, 
because it does not precisely reflect the intake of the medicines, but rather indicates the amount 
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of issued prescriptions which can be both filled or disregarded. According to the WHO report, 
the global measures of treatment utilization in depression are alarming: worldwide, not even 
half of people suffering from the illness, and in many countries, less than 10%, receive 
treatments http://www.who.int/mediacentre/factsheets/fs369/en/).  
It is suggested that the majority of people with prescribed antidepressants do not adhere 
to recommended treatment (Farinde, 2013). If the potential offered to reduce heavy burden of 
depression is not properly managed, the issue is becoming bigger than individual choices; it 
translates into unsused therapeutic means as well as financial, societal and environmental losses 
coming from overproduction of psychotropic drugs and tons of unwanted medications ending in 
waste disposal. Multiple studies found that negative beliefs and views lead directly to non-
treatment or under-treatment in depression. Public views and media create the depression 
paradigm that has quite significant influence on individual treatment choices. Also, people’s 
beliefs and patients’ relationships with their physicians are found to play major roles in 
medication adherence. Refusal of medical treatment might occur due to beliefs that adverse side 
effects of medications outweigh the benefits, or due to many other cultural, social and religious 
reasons, still, the patient assumes the central role in making final decisions about the course of 
his/her illness. There is a great need to explore patients’ views and their life experiences of 
medication use vs. non-use. My aim is to introduce the depressive patient and his/her reasoning 
within the treatment process. By exploring the mechanisms of refusal and non-adherence to 
medications, I argue that the task of fighting depression is presented by research in a such a 
manner that leaves no doubt about patients’ individual responsibility for treatment outcomes. 
“The term adherence is intended to be non-judgmental, a statement of fact rather than of blame 
of the prescriber, patient, or treatment. Compliance and concordance are synonyms for 
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adherence” (McDonald et al., 2002). Nonetheless, what I have discovered, yet what has not 
been stressed before, is the following: the task to treat one’s own depression, carried out by the 
said patient, can become so overwhelming that almost impossible to complete. Moreover, and 
regardless of reasons provided, the patient who is non-adherent to therapy will sooner or later, 
but almost always, lose the battle. We should not only be talking about patients’ non-adherence 
to treatment; we should be reflecting on what makes this non-compliance to persist and see if 
anything can be done to intervene. The urge of raising public awareness of both, the depressive 
symptoms and consequences of leaving them untreated, is thought to be the message send 
across by this work. The results I have summarized in this review are strongly supported by 
research findings, and also fit within my own personal experience. According to Holliday 
(2007) the voice and person of the researcher as writer not only become a major ingredient of 
the written study, but have to be evident for the meaning to become clear (Holliday, 2007). The 
essence of qualitative writing is very different from an analysis in quantitative studies. 
Qualitative writing develops like an unfolding story in which the arguments gradually make 
sense, not only of the collected data, but of the total entity, and in this case, the medication 
adherence in depression treatment. This review is an interactive process in which I have tried to 
untangle and make reflexive sense of my own presence and role in depression research.  
 
3.2. Aims and Scope of the Study (adapted version of definitions of purpose of scoping 
studies (Levac’s, Colquhoun’s & O’Brien’s, 2010) and methodological framework’s elements 
proposed by Arksey and O’Malley, 2005: 
- Extract, summarize and present research findings regarding drug treatment in depression 
based on views of people living with depression; 
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- Outline what is already known about adherence and non-adherence to pharmacological 
treatment in depression;  
- Identify the most serious reasons for non-adherence to medical treatment in depressive 
disorders. 
 
I was made aware that the subject of this study is very broad, therefore both qualitative 
and quantitative studies would be needed to provide valuable answers to the formulated research 
goals (Seeds, 2015). This caused the revision of the initial aim to include only qualitative data. 
The inclusion of quantitative studies in addition to qualitative findings made the assessment of 
the methodological quality of the papers complicated. Still, the search method, data extraction, 
synthesis and evaluation of results were implemented as systematically as possible. 
Arksey and O’Malley’s scoping review framework outlines a five stage approach with 
each stage discussed and explained. Adaptations were driven by an intention to develop a 
feasible approach for reviewing a vast body of literature. 
The initial idea to check out as broad selection of existing qualitative and quantitative 
studies as possible, with the inclusion of reviews and grey literature, as recommended by Gibson 
et al. (2014), lead to the discovery of a very large amount of data to be extracted by one person 
within the limited time of thesis completion, and had to be revisited. 
 
3.3. Design  
According to Arksey and O’Malley, scoping review methodology is particularly useful 
for examining a broadly covered topic to comprehensively and systematically map the literature 
and identify key concepts, theories, evidence, or research gaps (Arksey and O’Malley, 2005). 
Unlike systematic reviews or meta-analyses, scoping reviews do not narrow the parameters of 
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the review to research trials and they do not require quality assessment (Enns et al., 2016). 
Nonetheless, this type of review is rigorous and methodical in its approach to examining research 
trends in a particular field (Enns et al., 2016). Scoping studies are used to examine the extent, 
range and nature of research activity and help in understanding what is already known in the 
existing literature (Takahashi et al., 2014; Levac et al., 2010). The purpose is the ‘mapping’ of 
existing scholarly evidence to describe and interpret important issues that may inform the public 
and invite further research. Gibson and colleagues believe that “while systematic reviews are 
seen as desirable for very specific research questions, they can be restrictive when a broader 
focus is required” (Gibson et al., 2014). This view dictates a choice of a narrative review, 
allowing for the “examination of a range of topics that are related to the phenomenon under 
consideration” (Collins, 2004) and components of larger studies that are relevant to the author’s 
focus (Gibson et al., 2014).  
 
3.4 . Search Strategy 
A computer-assisted search of the databases PubMed, PsychInfo, Scopus and Google 
Scholar catalogues was carried out without assigning limits on publication dates (this approach 
was suggested by Dr. Pamela Seeds). The databases were searched using several search terms 
and keywords related to depression and anxiety disorders, as well as the need for and attitudes to 
mental health care from the patient's point of view. 
Number of studies received through this search combined with all above terms:  N= 520632 
Several authors undertaking systematic search for qualitative research have pointed out the 
difficulty in accessing sought qualitative studies due to imperfections in the setup of the search 
engines and lack of sensitivity to detect qualitative articles.  
Searching by means of the ‘snowball method’ (the reference lists of all relevant studies were 
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screened for potential articles) resulted in adding a number of articles to those selected from 
databases. Some articles were found in more than one database. Overall, 1779 articles were 
retrieved and a thorough study selection was then performed. 
 
3.5 . Study Selection 
The study selection was performed in several stages:  
1. The first selection, resulting in selecting 229 studies from Medline, was based excusively 
on titles and abstracts. Step two: after adding articles found in Scopus, PsycNET and 
Google and through the “snowball method”, the search stopped at the final number of 
1779 potentially relevant qualitative and quantitative studies. 
2. Again, titles and abstracts were screened in a search of relevant articles and 426 
qualitative and quantitative papers were chosen as bearing potential relevance to this 
thesis. All these papers were read, sometimes more than once, and their thematic 
application and validity were informally assessed in prediction of further selection. 
Qualitative and mixed methods studies  n = 128 
Reviews (incl. minireviews, overviews, commentaries, summaries of literature, etc.)  
n = 32 
 
From these 32 potentially important reviews, 11 studies were chosen as matching the validity 
criteria for the analysis. Consequently, each of the 11 reviews was read and their content was 
searched for studies that were the focus of the review analysis. This process presented a major 
challenge because most of the review articles did not explain the selection process nor did they 
tabulate or list articles that were reviewed. From 11 papers, only Pampallona 2002, Pound 2005, 
Malpass 2009 and Britten 2010 included formal tables of the articles that were the subject of 
their reviews. All other authors presented a summary of references which also included articles 
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that were reviewed in no specific order and without further indication. No distinction between 
review publications and secondary literature was made and I searched each bibliography for 
articles that were on my list of 426 primarily selected studies.    
The next step took me closer to the final review as I narrowed the number to selected 
qualitative articles to be further synthesised. In this process, the following studies were selected 
to be excluded from the tabulated 426 articles: 
a) eleven systematic and narrative reviews; 
b) 83 articles that have already been reviewed by other authors; 
c) Grey literature, n=3, (search discontinued due to saturation)  
d) Published dissertations, n = 13 
e) Published Master Theses, n = 2   
 The number of remaining qualitative, quantitative and mixed-methods studies was 326. 
From this list, I further selected 41 qualitative papers for the final data extraction, synthesis 
and narrative analysis. This is my final selection of publications that used qualitative methods 
only, to obtain data desired for this review. Among the originally tabulated papers, a number of 
studies were found that had obtained data using qualitative methods, but that also 
used statistical calculations for their analysis. I am not disqualifying those writings a priori, 
however, the main focus of this thesis is being put on qualitatively collected and analysed 
findings. I have used the quantitative and mixed-methods papers in the number of 71 later, in the 
triangulation phase, summarising research with statistical evidence in support of the qualitative 
findings that build the core of this work. 
I have followed Pound et al. (2005) and the model they used in the synthesis of their (total of 
38) papers. I have adopted their model of organising the studies into groups but modified them to 
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expose the themes and subthemes that emerged from the extracted data, and applied the charting 
by date of publication for my summary of data. These models proved to be ‘an invaluable 
organisational aid’ during the entire review process. I have used them in the synthesis process to 
include comprehensively the findings from all 41 studies. Similarly to what Pound at al. (2005) 
describe, this involved reading and re-reading each of the selected papers and a thorough 
deductive reading of extracted primary data (participants’ accounts of their experiences), and 
analysing and interpreting the data thematically. This created what Noblit and Hare (1988) 
describe as a ‘line of argument’ synthesis. At this stage, a reconceptualisation and reformulation 
of the findings is suggested to be possible, which is an attempt to produce concepts that offer 
explanation for all the data, in a fresh way. At this point, the working title of my thesis was 
reformulated to better capture the content of studies chosen to be synthetised.    
 
Table 1. Process of exclusion in data extraction: 
 
Papers initially included in synthesis  46  
Papers excluded during synthesis  5  
Total papers finally synthesised  41  
 
Adapted from: Pound et al. 2005 
 
The two following studies were excluded: Janakiraman, Hamilton and Wan (2016) and 
Lafrance and Stoppard (2006) as, despite providing relevant information, they do not present 
verbatim transcripts of participants’ accounts, therefore no excerpts could be extracted for the 
purpose of primary synthesis. Both Egede’s (2002) and Hansen and Cabassa’s (2012) papers 
were removed due to its focus on patients with type 2 diabetes with accompanying depression, 
which was beyond the scope of this review. Finally, Stanton and Randal’s (2016) article was 
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found to contain insufficient information about patient’s perception of antidepressants and was 
excluded as well. 
Description of all scanned papers (n = 426) is presented in a table that includes the following 
information: year of publication, name of the author(s), title, country in which the study was 
conducted, study design/method, diagnosis and diagnostic intruments, focus of the study, 
results/conclusion, recommendation for future studies/actions (Appendix F). 
 
3.6. Data Extraction   
 
The process of organizing reviewed studies and consequently, data extraction, is often 
facilitated by the use of tables or charts that summarize key aspects of the studies (Cruzes et al. 
2015). Their format may depend on the number of papers, but their validity is measured by the 
ability to make repeated examination and comparison of the relevant data from each study 
possible (Pope, Mays & Popay, 2007, p. 43). Data extraction performed for the purpose of this 
review is grounded in Todres’, Wertz’ and Hartley’s methodology, but has been dictated by the 
aim of this thesis to present individual beliefs about pharmacological treatment in depressive 
illness and people’s lived experiences of depression. In this regard, the narratives created here 
differ from Hartely’s et al. because I am not assigning thematic categories a priori, but let them 
result from the drafted narratives. I conducted data extraction separately for each of the above 
listed 41 qualitative studies (Appendix C)  
Extracting the 'key concepts' from the qualitative studies on patients' experiences has 
been performed by Campbell et al. (2003), yet depicting them may often pose difficulty (Thomas 
and Harden, 2008). Sandelowski and Barroso (2002) discovered that “identifying the findings in 
qualitative research can be complicated by varied reporting styles or the misrepresentation of 
data as findings (as for example when data are used to 'let participants speak for themselves')”. 
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They further argue that the findings of qualitative (and all empirical) research are distinct from 
the data upon which they are based, because of the methods used to derive them and researchers' 
conclusions and implications (Sandelowski and Barroso, 2004). I have chosen to use a model of 
the qualitative narrative analysis originally described by Todres (2007, 2008) and used by Wertz 
et al., (2011) and Hartley et al., (2014). This method has been used for presenting the original 
data as the most appropriate writing technique in the process of giving accounts of people’s 
experiences. This serves multiple purposes: first, in order to achieve factographic authenticity 
and credibility; second, to present a certain clarity of the writing style. According to Hartley et 
al., the “composite first person narrative provides a reflective story about individual’s 
experiences by constructing a composite picture from participants’ self-reports” (Hartley et al., 
2014). While Todres and Wertz et al. used the narration technique to expose the main findings 
collected from direct study participants’ accounts, Hartley et al. take it to the next level by 
generating summaries of the “key messages” coming from the articles under review. By drafting 
them into narratives, the researchers create a first-person-accounts so the reader gets the 
impression that study participants directly share their lived experiences and feels invited to enter 
the lived world of depression. This method is inevitably grounded in the phenomenological 
perception of reality but serves the purpose of being absolutely true to patients’ and lay persons’ 
own reflections. It “does not aim to be a mere re-telling of the evidence, but a narrative that 
reflects a richer and more evocative understanding of the complex experiences” (Hartley et al., 
2014).   
 
3.7. Qualitative Synthesis  
Synthesis is the point in the review process at which the findings from the included studies 
are combined in order to draw conclusions based on the studies as a whole (Pope, Mays & Popay, 
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2007, p. 43). The synthesis of qualitative research and especially the synthesis of qualitative with 
quantitative evidence are said to be relatively recent endeavours (Pope, Mays & Popay, 2007, p. 
43). There is a growing recognition of the value of synthesising qualitative research in the 
evidence base in order to facilitate effective and appropriate health care (Thomas and Harden, 
2008). Within the qualitative research community there has long been a recognition that writing 
and presentation of qualitative research is about representing the data and that this representation 
is influenced by the theoretical and methodological stance of the researcher. Writing up 
qualitative data needs to be coherent, but also capture the richness of presented information. 
White et al. (2003) note that this is a real challenge because it is not easy to summarise qualitative 
findings neatly (by tables or numbers). Qualitative researchers, therefore, have to find ways to 
order ‘disorderly data’ (White et al., 2003, p. 289). For a synthesis involving any qualitative 
evidence, a further problem for some of the potential audiences may be lack of familiarity with 
qualitative research methods. It is therefore important that in presenting the findings the reader is 
made aware of the types of study included and the kinds of inference and interpretation that are 
possible (Pope, Mays & Popay, 2007, p.147) 
The following is a justification of my choice to present the findings that emerged from 
reviewed studies as a thematic analysis. The decision is based on theories introduced by Thomas 
and Harden (2008) and Sandelowski and Barroso (2002, 2004). I tried to apply a rigorous 
combination of individual truths and review techniques to achieve validation of qualitative data. 
Retrospective narratives, of which almost all were extracted as citations from the original studies 
and few created on the basis of secondary text narration, have been summarised in Appendix D 
and serve the purpose of primary thematic data analysis, presented below. These excerpts are 
believed to build a true-value foundation that is used to ensure trustworthiness and academic 
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rigor, with the aim of avoiding second-line interpretation bias. Ridge et al. (2015) propose 
thematic analysis as the process of identifying important or recurrent themes that become visible 
in the extracted data. All findings are then summarised under thematic headings. Information is 
tabulated allowing identification of prominent themes and offering structured ways of dealing 
with the data in each theme. More recently the method has been refined, such that a new 
approach – thematic synthesis – has emerged: Thomas and Harden (2008) claim that seeking to 
synthesise qualitative research means stepping into more complex and contested research area 
and seeking unique and various ways to support RCTs with data emergining from individual 
accounts included in a review. They claim that precise methods are much less developed in this 
area, with fewer completed reviews available to serve as examples, and, the “whole enterprise of 
synthesising qualitative research” is still debated (Thomas and Harden, 2008). Qualitative 
research is believed not to be as easy to be generalised as are quantitative findings, due to being 
specific to a particular context, time and chosen group of often purposefully, rather than 
randomly, selected participants (Thomas and Harden, 2008). Thus, in acknowledgment of the 
validity of qualitative research, all the various methods that aim to bring their findings together 
for a broader audience, need to be recognised as heterogenous and unique, an d should not be 
disregarded a priori as not being able to offer universal application. At the same time, they 
preserve and respect their original context from which they emerge (Thomas and Harden, 2008). 
Explanations or theories extracted from individualized concepts may be presented as 'line of 
argument' bringing the results together but expanding the content of the primary data: “this 
notion of 'going beyond' the primary studies is a critical component of synthesis, and is what 
distinguishes it from the types of summaries of findings that typify traditional literature reviews” 
(Thomas and Harden, 2008). The interpretation will then depend on the range of concepts 
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depicted in the selected studies, their context, and mainly reflect the researcher’s point of view. 
However, deciding what to abstract from the published report of a 'qualitative' study is said to be 
much more difficult. Thomas and Harden (2008) conclude that this stage of a qualitative 
synthesis can be both, challenging and controversial, since it is dependent on the judgement and 
insights of the reviewers. The equivalent stage in meta-ethnography is the development of 'third 
order interpretations' which go beyond the content of original studies (Britten et al., 2002, 
Campbell et al., 2003). Using Thomas and Harden’s (2008) technique, I also included series of 
questions, derived directly from the selected studies that were associated with the main topic of 
the conducted review and applied narrative accounts as the findings of the primary studies: these 
were new propositions generated in the light of the synthesis. The application of this 
methodological strategy also shows that it is possible to synthesise data without conceptual 
innovation (Thomas and Harden, 2008). In studies where the primary analysis is concerned 
directly with the review question, it is not necessary to go beyond the contents of the original 
data in order to produce a satisfactory synthesis (Marston and King, 2006).  
 
3.7.1. What is Thematic Synthesis/Analysis? 
Pope, Mays and Popay (2007, pp. 96-97) define the ‘thematic analysis’ as one of the most 
commonly used methods for the synthesis of review findings (p.  96). It is said to be a great tool 
in organizing and summarizing the findings from a large, diverse body of research. Pope, Mays 
and Popay (2007) conclude that while thematic analysis is “primarily qualitative in origin”, 
tabulation of themes, similar to ‘content analysis’ is common. In the following thematic analysis 
of qualitative findings, I followed the suggestion that the data extraction be performed “without 
a complete set of a priori themes” (Pope, Mays and Popay (2007). The themes I introduce, were 
identified by reading and re-reading the included studies, coded by annotating the original papers, 
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and then extracted and summarized as recommended by the methodologists (Pope, Mays and 
Popay (2007). Thematic analysis is basically associated with qualitative or text-based data; 
however, it is potentially possible to include quantitative data. This could be achieved by 
‘qualitizing‘ data, for example, in the way that Dixon-Woods et al. (2006) extracted themes and 
findings from quantitative evidence; it is possible, having identified themes, to count the 
frequency with which they occur. The list of themes that emerged after reading and re-readung 
the papers, were refined by identifying key themes as recommended by Pope, Mays and Popay 
(2007, p.96).  
 
3.7.2. Framework Stages 
The Framework Method is gaining importance and broad application in contemporary 
health research as a well-suited approach to the management and analysis of qualitative data 
(Gale et al., 2013). It is a set of codes organised into categories and designed to help structure the 
review process. It creates a new structure for the data (rather than the full original accounts given 
by participants) that is helpful to summarize/reduce the data in a way that can support answering 
the research questions (Gale et al., 2013). The framework describes the stages as clearly 
designed steps in developing projects that the researcher/writer takes to gather data, which lead 
to conclusions. 
 
Framework Stage 1. Familiarization / Identifying Research Question(s) 
Questions that emerged in the initial phase of the review were developed through the process of 
reading the articles. They were ‘a priori issues’ that I was interested in exploring. They formed 
the basis of the themes formulated later. They fully related to the aims of the study, but were 
35 
 
subject to modification during the reading and further review process as recommended by 
Arksey and O’Malley, 2005: 
• What are the patients’ considerations and decisions in acceptance, maintenance and 
discontinuation of antidepressant therapy? (van Geffen, 2008). 
• What are the patients’ beliefs and lived experiences regarding clinical effectiveness of 
drugs in the treatment of depression and in the relief of depressive symptoms? 
• What are the patients’ beliefs about clinical evidence on the safety of antidepressants for 
the treatment of patients with major depressive disorder? 
• What are the reasons for refusal of pharmacological treatment? 
• What are the reasons for non-adherence with the medications after initial decision to start 
the treatment? 
 
Framework Stage 2. Identifying Relevant Studies 
At this stage, I decided upon criteria for eligibility, databases to search, and formulated a 
search strategy and proposed key terms (Appendix A). Arksey & O’Malley (2005) recommend 
that a saturation point should be set, beyond which no further references would be checked. I was 
interested in recent findings and unpublished papers; however, termination of this process 





















Qualitative studies selected for data extraction 




Epidemiological and quantitative studies 
selected for trangulation  
n=71 
 
Adapted from: Prins et al. (2008). Health beliefs and perceived need for mental health care 
of anxiety and depression- The patients' perspective explored Clinical Psychology Review, 





Potentially relevant studies identified 
through Medline, Scopus and 
PsychNET and screened on title and 
abstract   (n=1779) 
Potentially relevant studies identified 
through Scopus and screened on title and 
abstract (n=185) 
Potentially relevant studies identified 
through Medline and additional search 
and screened on full text (n=229) 
Exclusion criteria for studies excluded 
after screening on full text: 
• Similar studies (reviews) n = 11 
• Studies reviewed by others n = 
83 
• Dissertations n = 13 
• Master theses n = 2 
• Commentaries and mini reviews  
• Focus too broad 
• Insufficient data 
Potentially relevant studies screened on 




Sources that were searched were electronic databases accessed through UW Library (Public 
Health and Kinesiology Research Guide).  
Searching electronic databases 
After numerous primary searches that were applied as intensive training practice, the 
following electronic databases were recommended by the librarian Jackie Stapleton to be 
searched: MEDLINE through PubMed, Scopus, PsychNet, Web of Science and Google Scholar. 
The primary search strategy (MEDLINE through PubMed) was developed collaboratively with 
the help of two University of Waterloo librarians. We have decided that broader terms should be 
excluded from the search due to a large number of not topic-related articles that were identified 
by search engines. The search was limited to articles in English. I received detailed instructions 
to employ various search strategies appropriate for each relevant database that was searched. 
With both librarians’ help, I formulated search strategies that were subject to revision and 
modification before the final review process. Upon completion, the searches from each database 
were carefully documented and references were imported into database-specific folders in 
RefWorks, where duplicates were eliminated. The librarians played a key role in determining 
and testing appropriate keywords, MESH terms and filters to maximize sensitivity and specificity 
within the search. The exercise process was fundamental in modifying and applying search terms 
to comply with the various bibliographic databases.  
Reference lists  
It is recommended (Arksey & O’Malley, 2005) that reference lists and bibliographies 
included in Internet articles and academic reviews also be checked. There is a possibility of 
inclusion of the most recent papers not yet accessible through the electronic searches but found 
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in journals. Therefore, an additional search of relevant bibliographies and references was 
performed in addition to the electronic search. However, the overall sum of potentially relevant 
studies was rapidly growing and reached a high number of 1779. The realization that the number 
of studies is overwhelmingly large forced me to set a saturation point and the decision was made 
to discontinue reference list checks at some point.  
 
Framework Stage 3. Study selection 
Eligibility/inclusion criteria 
The exclusion/inclusion criteria introduced in the Review Protocol were subject to 
change.  All types of qualitative as well as epidemiological, quantitative, and mixed method 
studies (n=426) were included and synthetized in a chart (Appendix F). Studies were also 
included that introduced data collected from lay persons sharing their beliefs and opinions on 
drug treatment in depression. Eligible studies included those that mention all kinds of patients 
diagnosed with unipolar depression or comorbid unipolar depression who were prescribed or 
recommended medication, including: 
 (1) individuals suffering from depressive symptoms and at risk for major depression who refuse 
treatment with antidepressants;  
(2) outpatients with identified depressive disorder who are involved in pharmacological therapy;  
(3) individuals suffering from depressive symptoms and at risk for major or persistent depression 
who underwent pharmacological treatment, but decided to discontinue the medication;  
(4) persons that were pharmacologically treated for depressive illness and where the therapy has 
ended due to observed and recorded recovery;  
(5) outpatients with depression present in both single diagnosis and comorbid with other mental 
disorders or physical diseases.   
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All types of studies (qualitative, quantitative and mixed methods) have been reviewed with no 
restrictions on publication dates. 
Specific interventions included in the review: 
Studies of depression that introduced medications with at least one active single treatment 
(pharmacotherapy) were eligible for inclusion. The included studies address a variety of drugs 
known as the first and second generations of antidepressant drug development. Treatments can 
be applied during acute/episodic/ as well as maintenance/recurrent and chronic phases/ of the 
illness. A priori knowledge of possible side/adverse effects of these medications has been 
applied. The following inclusion criteria were used to guide the search and were also used during 
the review process: 
▸Qualitative, quantitative and mixed method studies including: published scholarly articles, 
reviews, case studies, narratives and vignettes, book reviews, opinion articles, commentaries or 
editorial reviews. Due to an overwhelmingly large body of articles, it was recommended by the 
librarian to exclude examples from the grey literature for the purposes of this scoping review. 
Excluded: Books, textbooks, magazines and the grey literature. 
Rationale: My focus was on published scholarly papers. 
Limitations: Some narrative or biographic material presenting opinions relevant to my study will 
be lost. 
▸ Published in the English language 
Rationale: Due to time constraints, translation of documents published in languages other than 
English was not considered. 
Limitations: Some potentially valuable multi-cultural and ethnic contributions might be lost. 
▸ Research that targets the general adult population (except those listed under exclusion criteria) 
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Rationale: Research on children’s and adolescents’ depression is beyond the scope of this study 
because a major difference between adult and pediatric depression is the response to 
pharmacotherapy (Bridge et al., 2007; Hazell et al., 1995; Kratochvil et al., 2006). 
Limitations: The review does not introduce the whole spectrum of human experience of 
depression. 
▸ Research findings that target individuals with depressive symptoms and those diagnosed with 
unipolar depression or comorbid depression: Major Depressive Disorder (MDD), Dysthymia or 
mild depression, recurrent depression (without mania), severe melancholic depression, ‘atypical’ 
depression, treatment-resistant depression. 
Rationale: It is very rare for depression to exist without another disorder (especially comorbid 
anxiety, either before onset or at the same time/after) (Seeds, 2015).   
▸ No geographical or ethnic limitations. 
Rationale: Various ethnic views, beliefs and lived experiences recorded globally are universal to 
representatives of these nations, thus apply to some degree to multi-cultural and multi-ethnic 
societies and minorities in Canada, USA, Australia, UK and any other countries. 
Limitations: This review is not specifically addressing Canadian or North-American issues.  
Explicit exclusion criteria have been identified as: 
Writings: 
▸Books and textbooks, self-help books, magazines, Web-sites, public forums  
Population: 
▸Patients remaining in supervised care who are unable to make independent decisions about 
their treatment; 
▸Children and adolescents 
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Framework Stage 4: Extracting the data and determination of quality 
 
I included an detailed report on how many papers were selected at each stage of data 
collection and extraction. A typical way of assessing quality of reviewed studies is the 
application of ‘hierarchy of evidence’ (Pope, Mays, and Popay, 2007; Dixon-Woods et al., 
2006). This approach, commonly used in epidemiological and quantitative research, assigns a 
higher scientific value to randomized controlled trials than to other designs, i.e. case-control 
studies (Dixon-Woods et al., 2006). In case of qualitative papers, where no hierarchy of study 
designs exists, the appraisal can be conduced by using a structured quality checklist, but several 
challenges will still appear, as stated by Dixon-Woods et al. (2006). In the light of missing 
definite rules regarding how, or whether at all, should the appraisal of qualitative papers be 
performed in an interpretive review, I decided to follow Dixon-Woods’ et al. (2006) model of 
assesment. Neither the quality nor validity of papers chosen for the review have been assessed, 
however, I reviewed the papers by seeking positive answers to questions presented below. The 
scheme illustrates Dixon-Wood’s et al. (2006) assessment criteria that should be met during the 
selection phase and also proposed by the National Health Service (NHS) National Electronic 
Library for Health for the evaluation of qualitative research. 
Appraisal prompts for informing judgements about quality of papers 
• Are the aims and objectives of the research clearly stated? 
• Is the research design clearly specified and appropriate for the aims and objectives of the 
research? 
• Do the researchers provide a clear account of the process by which their findings we 
reproduced? 
• Do the researchers display enough data to support their interpretations and conclusions? 
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• Is the method of analysis appropriate and adequately explicated? 
Adapted from: Dixon-Woods et al., 2006  
Data extraction 
Pope, Mays and Popay (2007) state that in the synthesis of qualitative studies, the data 
extraction depends on the method chosen by the reviewer(s). It is recommended to find a good 
way to capture the findings of interest. It can be interpretation offered by the authors, typically in 
the form of analytical concepts, methaphors or themes (interpretive synthesis), but in a realist 
synthesis, the focus will be less on specific concepts and more on overarching theories or 
explanations which can be synthetized. They claim that the way data are extracted and stored, 
would vary among reviewers. Whichever method is chosen, it is worth creating a standard record 
of the data extracted as this can enable sharing of the material within teams of reviewers, and in 
the long term provides a transparent record of how this part of the review was undertaken (Pope, 
Mays and Popay, 2007). They also state that in practice, “it would be rather impossible to decide 
whether a study is within the scope of the review question or of sufficient quality without a good 
knowledge of the content and this is difficult to do consistently across a number of studies 
without extracting information from the text reporting each study in a consistent way” (p.41). 
Therefore, data extraction is suggested to be the part of the previous two elements of a review. I 
applied their theory through the tabulation of all 426 articles that were carefully checked with the 
aim of selecting the most convincing findings.  
 
Title and abstract screening 
Data for the review were extracted by one person (myself).  
I have decided to work through a multiple-stage study selection process. 
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In the first stage, I reviewed the titles to determine eligibility of the study based on the defined 
inclusion and exclusion criteria. For example, titles that indicated a target population with an 
existing medical condition other than depression or where application of other treatment options 
in addition to medication was detected, were not considered. At this primary stage of the review, 
any uncertainty with a title did not eliminate the citation for consideration in the second stage. 
The second stage of the selection process included a further review of the titles and abstracts 
with the use of the above eligibility criteria. In studies where titles did not clearly indicate a 
target population or illness than depression, I read through the abstracts, and searched for 
information about participants, medical condition, and type of the study, if not formulated in the 
title. I accepted conditions such as unipolar depression accompanied by anxiety, but eliminated 
studies that analysed other major mental diseasses such as e.g. schizophrenia, as this was beyond 
the scope of this study.    
In the third stage, I used RefWorks, a bibliographic management program, to organize references 
and eliminate duplicates.  
The fourth stage brought a major change to my initial method of searching for relevant papers. 
My original intention to collect and sort key pieces of information from the abstracts of the 
selected articles changed when I realized that numerous abstracts did not provide information 
sought for the synthesis. I found a large number of abstracts that did not provide sufficient data 
about research methods, or target population and also, a clear description of the mental condition 
subject to analysis was missing. I was instructed that, if additional data extraction categories 
were needed, or if missing data emerge, consultation with the librarian will guide my decisions 
and will be reported with the findings. This, indeed, occurred and brought me to a final reading 
of over 500 articles that were initially found and seemed suitable for the review. 
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In the fifth stage, the full texts of all articles that met the inclusion criteria during the title, 
abstract and content screening process (n=426) have been retrieved and saved as PDF files in a 
separate folder. The idea of sorting out and storing the papers proved to be very helpful in the 
process of continuous extraction of further data.  
In the sixth stage, the charted data were entered onto a ‘data charting form’, using Excel. 
For the extraction process, as recommended by Arksey and O’Malley, I extracted general 
information about each study, such as: year of publication, author’s name, country of study or 
publication, study design/research method applied in the study, diagnosis, intervention/focus of 
the study, results/conclusions and implications for further research/actions. I did not assess the 
quality of evidence at this stage (as recommended by Arksey and O’Malley). The table of 426 
selected studies is a presentation of extracted data with attention to relevant details. Extracting 
the data in this systematic manner was a very helpful process that assisted me in further detection 
of studies already analysed by other researchers (they have been exposed by color in the table) as 
well as in consecutive reviewing of information during the write-up process. Another relevant 
strategy was sorting the papers in chronological order by year. The purpose for doing so was to 
visualize and expose the historical dimension and intensity of research on this topic and the 
gradually increasing number of studies parallel with development of insightful ideas and 
implications for further research and actions.     
 
Framework Stage 5: Collating, summarizing and reporting the results 
Outcomes assessed in the review 
The following collected/extracted data/information are introduced: 




• Depressive symptoms/ Depression type/diagnosis 
• Intervention (medication used/recommended) or alternative focus of the study 
• Important results and conclusions 
• Implications for further research/actions 
The qualitative studies have been logically grouped and divided into thematic clusters by using 
qualitative analysis. The review will then present the findings in form of a narrative synthesis 
regardless of the outcome, thus studies presenting recovery from depression as well as relapses 
and attrition (as defined by the authors) will be subject to discussion. 
The table below illustrates how my final interpretation of findings fits within the third order 
constructs (Noblit & Hare, 1988 and Britten et al., 2002). Patients’ accounts, either recorded 
verbatim, or transcribed by the autors, create the core content of each study. The first order 
constructs create the contextual base, and all other comments, interpretations and conclusions, 
are built upon them. The 11 previous reviews introduced here, as well as all authors’ comments 
and summaries from the articles reviewed in this study constitute the second order construct. By 
undertaking synthesis and analysis of the second order constructs, I present third order constructs 
that will be received as my own views and interpretation of the summary of findings based on 
original patients’ accounts. 
 
3.8 . Triangulation 
Using triangulation as a methodological ‘metaphor’ can help the researcher facilitate 
the integration of qualitative and quantitative findings with the aim to expose results from both 
research areas in the process of data validation (Östlund et al., 2011). Denzin (1978) and Patton 
(1999) identify four types of triangulation of a qualitative data: a) Methods triangulation (using 
different data collection methods); b) Theory/perspective triangulation (using multiple 
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theoretical perspectives to examine and interpret the data); c) Triangulation of 
sources (examining the consistency of different data sources from within the same method); 
and d) Analyst triangulation (using a group of analysts and implementing their various 
perspectives). The first and second from the above approaches were used in this review and 
served the purpose of: presenting qualitative and quantitative data together, adding new aspects 
of the same phenomenon, providing insights, produce an understanding and ensure that “an 
account is rich, robust, comprehensive and well-developed” (Denzin, 1978; Patton, 1999). 
Mixed methods analysis can be viewed as an approach which draws upon the strengths and 
perspectives of each method, recognising the existence and importance of both, may this be 
randomized controlled trials and larger cohort studies as well as the undisputable value of 
individual experience. The latter, recorded for the purpose of exploration of phenomena of 
interest, serves as literary proof of real human interactions that took place in the physical, natural 
world. Mixed methods approaches are believed to support a better understanding of the links 
between empirical findings emerging from multiple sources (Östlund et al., 2011). The technique 
of triangulation is used for the purpose of this review in the process of examining the consistency 
of qualitative, quantitative and mixed-methods data on non-adherence to antidepressants. Results 
from qualitative interviews and narrative textual synthesis are validated with presentation of 
narrative synthesis of quantitative data on depression, which emphasizes the importance of 







CHAPTER 4. SUMMARY OF FINDINGS 
4.1. Narrative Summary of Previous Reviews 
 I retrieved 11 existing reviews which demonstrate a focus similar to this thesis. The 
papers are introduced in Table 2, page 60. The presentation of data extracted from these reviews 
takes a form of a chart and includes details such as: authors in alphabetical order, title, journal 
and publication date, type of the review, the way data was collected, focus of the study and 
finally, implications for further research or clinical practice. Non-adherence is said to be a major 
problem in depression treatment as about one in three patients on average do not follow 
physicians’ recommenations and discontinue medication intake. However, Pampallona et al. 
(2002) claimed that adherence to medication did not grasp much of the research attention in 
comparison with the vast amount of studies on antidepressants. This definitely has changed 
since. A growing number of scholars have attempted to discover why patients taking 
antidepressant drugs continue or discontinue their treatment. The model of taking antidepressant 
drugs is found to be similar to other treatments of chronic conditions; yet mood modifying drugs 
are said to produce not only concerns in relation to the adverse side effects, but also pertain to 
the perception that society has about them and involves the aspect of stigma. Trying to 
understand the patient's perspective and all other factors present in decision making about 
adherence or non-adherence to mood modifying drugs, may help professionals avoid excessively 
long treatment or early dropouts (Mahtani-Chugani & Sanz, 2011). The intake of medication is 
found to involve a dual aspect: consideration of benefits and risk. By making decisions, patients 
balance their views and own experiences. Adherence can be improved, and several measures of 
adherence are discussed by Pampallona et al. (2002): pill counts, blood drug levels, behavioral 
indicators, psychological symptoms, subjective evaluations or adherence to pre-defined schedule 
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of appointments. Pampallona’s et al. 2002 review does not provide data on whether an increase 
in adherence relates to an increase in response rate. Similarily, no clear indications of specific 
interventions or combinations of different types of treatment that may be applied to improve 
adherence, could be found.  
I found the primary research model reported by Pound et al. (2005) to be most examplary 
within this thematic context. Their study focused on the synthesis of qualitative papers of lay 
experiences of medicine taking. Pound et al. claim that research shows the tendency to expose 
experiences of people not adhering to their drug treatment with a smaller number of papers 
concerned with those who fully reject pharmacological treatment or accept it uncritically. Pound 
et al. found issues such as fear of dependence, addiction, and tolerance, the potential harm from 
taking medicines on a long-term basis and the possibility of medicines masking other symptoms 
to be relevant in treatment adherence. Additionally, in some cases, medicines are believed to 
have a significant impact on patients’ identity, presenting problems of disclosure and stigma.  
Pound’s synthesis stresses the “widespread caution about taking medicines” and 
discusses the general practices of testing medicines in everyday use. By presenting the results of 
their review, Pound et al. (2005) claim that, generally, people tend to be approving of their 
medicines either passively or actively, or to fully reject them. Some are persuaded into taking 
medications by others. Active accepters might be found modifying their regimens by taking pills 
symptomatically or, strategically, also by minimizing doses to avoid adverse side effects, or to 
make the regimen more acceptable according to their preferences. It seems interesting that 
patients tend not to disclose those changes to their physicians. Pound’s conclusion evolves 
around treatment non-adherence. The authors claim that “the main reason why people do not 
take their medicines as prescribed is not because of failings in patients, doctors or systems, but 
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because of concerns about the medicines themselves”. Pound et al. (2005) point out the fact that 
patients’ resistance to medicine taking will continue and stress the importance of marketing safe 
drugs, as well as identifying and evaluating alternative treatments preferences.   
Mitchell (2007) examines “the evidence for and against intentionality in psychotropic 
adherence behaviour”. In his narrative review, he takes into consideration studies on depression, 
schizophrenia and bipolar disorder and draws a common conclusion for concordance in all three 
mental diseases. He concludes that adherence behaviour with psychotropic medication is a form 
of self-medication. Results from the studies that Mitchell reviewed indicate that patients’ 
attitudes towards psychopharmacological treatment depend upon the individual, illness and the 
medical specialist however, a patient’s choice and final desision are usually the strongest 
indicators. The model of self-medication in affective disorders is said to usually be referring to 
the intake of drugs and alcohol; and in this paper, we learn about a second possible form of self-
medication practiced by patients who supplement their prescription drugs with over-the counter 
medications. A third way of self-medicating, introduced by Mitchell, is the control that 
individuals exercise over conventionally prescribed medicines. People tend to not inform their 
doctors about their decisions to reduce or stop the medication and most individuals finish their 
therapy as soon as they feel better, or due to adverse effects or perceived stigma. Mitchell 
concludes that most of the studies he reviewed indicate the tendency to fully refuse 
pharmacological treatment in affective disorders, or to reduce the intake to the absolute 
minimum. Patients have been found to enjoy their personal control over the direction of 
treatment.      
 In 2007, Mitchell published another review in collaboration with Selmes. In their study, 
adherence and compliance are used as synonyms (as opposed to Pound et al., 2005) and define 
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them as an extent to which individuals change their health behavior to follow medical advice. 
‘Concordance’ on the other hand, is introduced as the degree to which health behaviour agrees 
with clinical advice. Furthermore, the terms of a) ‘therapeutic alliance’ and b) ‘therapeutic 
disagreement’ are being described as a) “an agreement between patients and health professionals 
to work together”, and b) “a divergence in the views of patients and doctors on the subject of 
treatment”.  Mitchell and Selmes (2007) further claim that synthetising data on adherence 
behaviour could present a challenge because of the wide range of assessment methods. Their 
conclusions are as follows: 
▪ Premature medication discontinuation is costly; 
▪ Undisclosed non-adherence appears to be particularly hazardous; 
▪ The outcome for patients who vary medication doses without consulting the physician is 
poorer. 
Predictors of non-adherence may be divided into: patient, clinician, and illness factors, and a 
distinction should be made between intentional non-adherence (missing or altering doses to suit 
one’s needs) and unintentional non-adherence (forgetting to take medication). 
- Predictors of intentional non-adherence: less severe disease symptoms, feeling well, self-
efficacy (the desire to manage medication independently), disagreement or low trust in 
clinicians, receiving insufficient information,  
▪ specific adverse effects causing non-adherence: weight gain (more distressing than any other 
side-effect), sexual dysfunction (associated with global lower ratings on quality of life 
(QoL), illness beliefs and knowledge of medication, doctor-patient relationship. 
This review summarizes the following research findings:  
▪ about 10 % of patients prescribed antidepressants fail to pick up their first prescription; 
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▪ 1/3 of depressed patients collect only the initial (typically 4 week) prescription; 
▪ of those who start antidepressants (ADs), non-adherence rates increase with time; 
▪ in those on long-term maintenance treatment, discontinuation rates for antidepressants are 
above 70%; 
▪ of all those who discontinue ADs, 60% have not informed their doctor by 3 months and ¼ by 
6 months (covert non-adherence); 
▪ unintentional non-adherence was associated with greater cognitive impairment; 
▪ providing more information is a way of improving adherence;  
▪  many patients change regular medication dose in a flexible as-required manner, apparently 
without harmful effect 
The authors suggest “simple strategies to improve concordance”: 
▪ Basic communication: establish trust and a therapeutic relationship between the 
physician and patient, identify the patient’s concerns, take into account the patient’s 
preferences, explain the benefits and hazards of existing treatment options. 
▪ Strategy-specific interventions: adjust medication timing and dosage in maximising 
efficacy and minimising adverse effects, offer support, encouragement and follow-ups. 
▪ Reminders: consider adherence aids (such as medication boxes and alarms, reminders 
via mail, email or telephone, home visits, family support, and counselling). 
▪ Evaluating adherence: ask about problems with medication, missed or changed doses, 
thoughts of discontinuation, and further suggest direct methods of adherence evaluation: 
pill counting, measuring serum or urine drug levels, colaboration with general 




Fig. 3. Why don’t patients take their medicine 
 
From: Mitchel and Selmes, 2007 
 
Patients’ perspectives and health beliefs have been further explored by Prins, M. A., Verhaak, P. 
F., Bensing, J. M., & Meer, K. V. (2008). The perceived need for mental health care in anxiety 
and depression as well as general views on recovery from both conditions had been summarised 
as follows:  
▪  The majority of lay people are rather optimistic about recovery from depression; 




▪ Similarly, perception of biological mechanisms of depression is more present in women than 
in men; 
▪ Non-melancholic depressed patients are more likely to rate non-biological causes of their 
depression than melancholic patients;  
▪ Younger, rather than older, patients believed in the biological model of depression 
▪ Older patients endorsed cognitive attributional styles as etiologically relevant; 
▪ Most people in both, depressed and non-depressed groups, provided multi-dimensional 
explanations for depression; 
▪ Depressed patients demonstrated more negative beliefs about the duration of illness than non-
depressed; 
▪ Primary care patients believe that they will see treatment benefits within one month; 
▪ Depressed patients showed concerns about their antidepressant treatment; 
▪ Beliefs in danger of addiction in treatment with antidepressants were frequent; 
▪ Men believe more in addictiveness of antidepressants than women do; 
Studies selected by Prins et al. (2008) were found to only indirectly indicate people’s awareness 
of depressive illness and effective treatment. Some more specific beliefs about the causes of 
depression as identified by the authors are: 
- non-biological, psychological or environmental causes; 
- physical and biological reasons; 
- reactions to external problems; 
- stressful life events; 
- interpersonal difficulties; 
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African Americans were found to be less willing to use antidepressants than Caucasians. Many 
depressed primary health care patients hold ambivalent beliefs about medicines; perceived need 
versus perceived harmfulness are the important factors in treatment adherence.   
Lay people recommended consultation with a professional in the case of depression; their 
treatment recommendations were dominated by psychotherapy (53.7%). In lack of inefficiency, 
psychotropic drugs (36.8%) and relaxation (18.3%) were suggested. 
 The following barriers to treatment were identified in the review: high cost, lack of time, 
emotional reservations, belief that one can work it out by him/herself, lack of information and 
knowledge about helpful resources. People in the general population also prefer to manage 
depressive symptoms by themselves. Another relevant issue identified by this study is an existing 
gap between patients’ beliefs about different treatment options for depression and their perceived 
needs, and the current guidelines regulating actions of physicians. For example, the Dutch 
guidelines for depression and anxiety have been cited here as attributing a more prominent role 
to antidepressants than patients would prefer. Also, a stepped care framework is recommended in 
this review. The stepped care model, used successfully in UK, seems to fit better to patients’ 
needs as it provides more alternatives to antidepressant medication.  
 
 Zivin and Kales’ (2008) study focuses on adherence to depression treatment in older 
adults. Studies included in this systematic review reported on patients with a range of disease 
severity, from depressive symptoms to mild depression and MDD, which are said to also 
influence adherence. Factors affecting patient adherence to depression treatment in older adults 
were divided into three groups and identified as follows: 
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Modifiable: attitudes, perceptions, preferences, spiritual beliefs, beliefs about aetiology as well as 
effectiveness of depression treatment, patient/provider communication, social norms, family 
caregiver opinions, and finally also stigma. 
Modifiable with difficulty/potentially modifiable: co-morbid anxiety, substance use, cognitive 
ability, polypharmacy and medical co-morbidity, cost of treatment, and social support. 
Non-modifiable: gender and race 
The authors stress the importance of more rigorous studies in the area of depression treatment 
adherence. There is a pressing need to further understand the characteristics of older depressed 
patients that lead to optimal benefits of recommended drug therapies. Zivin and Kales find 
similarly urgent need to understand the barriers to adherence in older patients. Also, while 
physicians may have objections in regards to prescribing antidepressants in the older population, 
due to concerns about polypharmacy, actions should be taken to make sure that patients actually 
take the drugs as prescribed. The reviewers believe that strategies to improve adherence need to 
be multidimensional.  
 Malpass A, Shaw A, Sharp D, et al (2009) present a philsophically inclined analysis of 16 
selected papers on patients’ experiences of antidepressants. Giving their meta-ethnography a title 
“Medication career” or “Moral career”?, they suggest a priori controversy. Indeed, their research 
synthesis tries to conceptualise the conflict between psychological, ‘moral’, and perhaps more 
human views of antidepressant therapy and the medicalized perception of ill emotions. The 
authors focus on how patients approach the meaning of drug therapy, in which “new self-
concepts emerge”, and the rationale of ‘decision-making process’, in which the treatment 
decisions are made and justified.  
2 groups of selected papers were created: 
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- Studies in the first group primarily showed how patients are involved in a decision-making 
process in which they are evaluating (a) their experience of antidepressant medication (b) 
models of illness causation and (c) the consultation/ relationship with the physician and how far 
it meets information needs;  
- Papers in the second group focussed on self-concept and how it is affected by antidepressants.   
The authors discuss two different sides of managing antidepressants however, they conclude, the 
problem requires further exploration through empirical studies. Trying to understand and explain 
the processes of transformations in self-concept is a difficult task and more qualitative data is 
needed. 
 Britten, N., Riley, R., & Morgan, M. (2010) analyze patients’ resistance to treatment with 
antidepressants. Their synthesis of qualitative studies on psychotropic medicine-taking presents 
the results of 12 papers on patients’ perspectives with the aim to suggest implications for clinical 
practice in mental health. The emerging concept was that of ‘resistance’, which is referring to the 
pattern of treatment, i.e. attempts to minimise the intake of medicine.  
The model of medicine-taking identified patients’ behavioral patterns and grouped them into 
four categories: 
▪ passive accepters take the medicine without resistance (often because patients trust the 
prescriber and are willing to do what the prescriber asks them to do); 
▪ active accepters take medicine as prescribed, but only after a period of lay evaluation; 
▪ active modifiers conduct lay evaluation, which leads them to take their medicines in their 




▪ rejecters reject the medication completely and may refuse to accept the prescription or fill the 
first prescription 
This is not a permanent behavior and patients’ approaches to medicine use may change over 
time. The authors’ focus was therefore on identifying the varying influences on patients’ 
decisions about their use of psychotropic medicines. 
How can health specialists help patients achieve concordance? 
▪ Create comfortable and develop trust  
▪ Avoid judgemental feedback to what patients’ opinions of their medicines 
▪ Develop curiosity about patients’ reasons for altering their medicines 
▪ Acknowledge patients lived experience 
▪ Detect patients’ preferences and priorities 
▪ Offer a professional opinion supported by facts  
▪ Discuss non-pharmacological treatments where appropriate 
▪ Be respectful in the process of involving patients only to the degree that they want to be 
involved.  
 
Alderson’s et al. (2012) study focus was the comorbidity of chronic physical diseases and 
depression. A range of clinically relevant beliefs was identified from 65 studies including the 
difficulty in labeling depression, complex psycho-social causalilty in place of the biomedical 
model, the roles of different treatments and negative views about the consequences of 
depression. Participants feared the outcome of others knowing about their condition. Depression 
was seen as poorly understood by the public, and misrepresented in the media, so that sufferers 
were to blame or responsible for their suffering. Individuals were ashamed of being seen as 
unable to cope. Perceived stigma in itself had consequences, such as their professional judgment 
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would no longer be trusted, leading to employment problems and reduced social involvement. In 
addition, other important themes less related to ideas about illness were found to be present in 
patients’ accounts: the existence of a self-sustaining ‘depression spiral’, depression as an 
existential state, the ambiguous status of suicidal thinking, and the role of stigma and blame in 
depression. In this thesis, I implemented Alderson’s et al. (2012) methodological approach and 
their model of mixed research methods involving a thematic analysis of qualitative and 
quantitative studies. 
In 2014, Gibson, Cartwright & Read published their patient-centered review of studies on 
prescription drugs use in depression. Analysed data show that depressive patients often have 
reservations about taking antidepressants and health care specialists are advised to take these 
concerns seriously. Gibson, Cartwright & Read suggest that physicians demonstrate the power to 
influence their patients’ decisions, particularly by suggesting a line of treatment in the initial 
prescribing period during which patients feel particularly vulnerable. To solve this problem, 
physicians should be more sensitive and initiate discussion of both the pros and cons of taking 
medication and, if necessary, delay a decision until patients are ready to start treatment. As 
antidepressants seem not to be the first choice of treatment for many patients, physicians should 
also explore a range of intervention options with their patients. This review also suggests that 
patients tend to develop concerns and doubts about antidepressants after leaving their physician’s 
office with a prescription. Patients who choose not to fill their prescription are often left without 
information about other sources of help; those who start treatment, may continue to take an 
antidepressant even when they are unhappy with this choice or experience side effects. This 
suggests the importance of a follow-up soon after the initial consultation as well as regular 
follow-ups to check for side effects and other concerns. 
59 
 
In terms of the sought-after model of self-care, the above reviews partially focus on independent 
decision making, however an advice on how to promote such behavior, is not presented. Of great 
relevance is Pound’s et al. (2005) exposure of Dowell and Hudson’s (1997) argument that 
medicine taking translates directly into admitting that one suffers from an illness.  
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Type Data acquisition 
 
Focus of the study 
 
Clinical or research implications  
Alderson, S. L., Foy, R., 
Glidewell, L., Mclintock, K., & 
House, A. (2012). How patients 
understand depression associated 
with chronic physical disease – a 
systematic review. BMC Fam 






Biosis, Web of Science, 





searched from database 
inception to December 
31st 2010 
Clinically relevant beliefs identified 
from 65 studies including the 
difficulty in labeling depression, 
complex causal factors instead of 
the biological model, the roles of 
different treatments and negative 
views about the consequences of 
depression. 
Approaches to detection of 
depression in physical illness that 
are sensitive to the range of beliefs 
held by patients.  
Further research is needed to 
understand fully how people 
comprehend depression associated 
with a physical illness and how this 
influences help-seeking and 
engagement with health care 
services. 
 
Britten, N., Riley, R., & 
Morgan, M. (2010). Resisting 
psychotropic medicines: A 
synthesis of qualitative studies of 
medicine-taking. Advances in 









Cinahl Plus, PsycInfo, 
Embase, Assia and Web 
of Science, 2002 to 
2008; Search was 
completed before the 
paper by Malpass et al 
(Malpass 2008) was 
published 
 
Lay perspectives on prescribed 
psychotropic medicines. Updates 
on a model of medicine-taking 





Gibson, K., Cartwright, C., & 
Read, J. (2014). Patient-
Centered Perspectives on 
Antidepressant Use. International 




PsychInfo (using “client 
attitudes” and 
“antidepressants”); Web 
of Science (using 
“patient attitudes” and 
“antidepressant 
medication” Google 
Scholar and manual 
search 
Patient centered perspective on 
antidepressant use, which examines 
research on patients’ attitudes to 
antidepressants and their treatment 
preferences; experiences of being 
prescribed antidepressants and 
taking antidepressants, as well as 




Studies investigating positive 
experiences of antidepressants in 
order to better understand the 
complex mixture of views and 
experiences of antidepressants that 
may result in patients remaining on 
antidepressants in spite of their 
misgivings. 
Mahtani-Chugani, V., & Sanz, 
E. J. (2011). Users Perception of 
Risk and Benefits of Mood 
Modifying Drugs. Current 








Users’ views about the 
consumption of mood modifying 
drugs; personal beliefs, fears and 
motivations for taking or not taking 
antidepressants  
How health care providers should 
provide support to patients who 
need treatment with antidepressants 
Malpass A, Shaw A, Sharp D, 
et al (2009). “Medication career” 
or “Moral career”? The two sides 
of managing antidepressants: a 
meta-ethnography of patients’ 
experiences of antidepressants. 






Systematic search of 
Medline, Embase, 
Cinahl, Web of Science 
(WoS) and PsycInfo. 
1990–June 2007, Hand 
search  
Patients involved in a decision-
making process in treatment with 
antidepressants  
Transformations in self-concept 
result in more involvement in 
decision-making 
  
Research needed on how more 
involvement helps to foster new 
types of self-concept 
Mitchell, A. J. (2007). 
Adherence behaviour with 
psychotropic medication is a 
form of self-medication. Medical 
Hypotheses, 68(1), 12-21. 
Narrative 
review 
Not provided The evidence for and against 
intentionality in psychotropic 
adherence behavior; 
 
Compliance and related predictors 
in depression, schizophrenia and 
bipolar disorder 
 
Further studies required to clarify if 
these predictors of missed 
medication hold true for partial 
non-adherence in depression 
62 
 
Mitchell, A. J., & Selmes, T. 
(2007). Why don’t patients take 
their medicine? Reasons and 
solutions in psychiatry. 




 Not provided   • Nonadherence, whether 
intentional or not; 
• Patients’ reasons for failure to 
concord with medical advice 
• Predictors of, and solutions to 
the problem of nonadherence 
▪ Advanced strategies  
▪ Simple strategies to improve 
concordance: 
▪ The emerging concept of partial 
adherence  
Pampallona et al. (2002). 
Patient adherence in the 
treatment of depression. British 





between Jan. 1973 and 
Dec. 1999; multiple 
systematic searches of 
Medline, Current 
Contents, PsychInfo, and 
the Cochrane 
Collaborative Register of 
Trials 
 
Non-adherence with antidepressant 
treatment is very common. 
Increasing adherence to 
pharmacological treatment may 
affect response rate. 
 
Factors associated with adherence 
and of adherence-enhancing 
interventions. 
A new drug will not likely 
dramatically reduce the high 
number of patients who do not 
adhere to treatment. Carefully 
designed clinical trials needed to 
clarify the effect of single and 
combined interventions on 
adherence, as well as to further 
investigate the factors affecting 
adherence. 
 
Pound, P., Britten, N., Morgan, 
M., Yardley, L., Pope, C., 
Daker-White, G., & Campbell, 
R. (2005). Resisting medicines: 
A synthesis of qualitative studies 
of medicine taking. Social 
Science & Medicine, 61(1). 
Systematic 
review 
Qualitative studies Jan. 
1, 1992 to Dec. 31, 
2001 in English: 
Medline, Embase, 
Cinahl, Web of Science, 
PsychInfo, Zetoc; 
handsearches; 
individual suggestions      
6 studies of psychotropic medicine 
and mental illness were chosen:  
1. Kalijee and Beardsley (1992) 
2. North et al. (1995) 
3. Barter and Cormack (1996) 
4. Rogers et al. (1998) 
5. Angermeyer et al. (2001) 
6. Usher (2001) 
▪ Importance of monitoring 
drugs’ effectiveness and 
acceptability to individual 
patients; 
▪ Determining patients’ treatment 
preferences and evaluate the 
safety and effectiveness of 
those preferred treatments 
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Prins, M. A., Verhaak, P. F., 
Bensing, J. M., & Meer, K. V. 
(2008). Health beliefs and 
perceived need for mental health 
care of anxiety and depression—
The patients’ perspective 
explored. Clinical Psychology 
Review, 28(6), 1038-1058. 
Systematic 
review 
Articles published in 
peer-reviewed journals; 
from Jan. 1995 to 
December 2006, in 
English, on adults, in: 
PubMed, PsychInfo, 




▪ Perceived causes of depression 
and specific needs for 
treatment; 
▪ Beliefs about the causes of 
depression: 
▪ Barriers to treatment 
 
Stepped care framework 
  
Zivin, K., & Kales, H. C. 
(2008). Adherence to Depression 
Treatment in Older Adults. 




Medline search for 
articles published btw. 
1950 and Jan. 2007; 
hand search. 
Factors affecting patient level 
adherence to depression treatment 
in older adults 
 
Need for more rigorous studies in 





4.2. Table 3. Qualitative Studies Selected for Synthesis (n=41)   
 
# Study 
1 Amey, C. (2010). Suspected antidepressant-induced switch to mania in unipolar depression: A 
first-person narrative. Journal of affective disorders, 125(1), 111-115. 
 
2 Anderson, C., Kirkpatrick, S., Ridge, D., Kokanovic, R., & Tanner, C. (2015). Starting 
antidepressant use: a qualitative synthesis of UK and Australian data. BMJ open, 5(12), e008636. 
 
3 Anderson, C., & Roy, T. (2013). Patient experiences of taking antidepressants for depression: A 
secondary qualitative analysis. Research in Social and Administrative Pharmacy, 9(6), 884-902. 
 
4 Badger, F., & Nolan, P. (2007). Attributing recovery from depression. Perceptions of people 
cared for in primary care. Journal of clinical nursing, 16(3a), 25-34. 
 
5 Bennett, H. A., Boon, H. S., Romans, S. E., & Grootendorst, P. (2007). Becoming the best 
mom that I can: women's experiences of managing depression during pregnancy–a qualitative 
study. BMC women's health, 7(1), 13. 
 
6 Bayliss, P., & Holttum, S. (2015). Experiences of antidepressant medication and cognitive–
behavioural therapy for depression: A grounded theory study. Psychology and Psychotherapy: 
Theory, Research and Practice, 88(3), 317-334. 
 
7 Boyle, E., & Chambers, M. (2000). Medication compliance in older individuals with depression: 
gaining the views of family carers. Journal of psychiatric and mental health nursing, 7(6), 515-
522. 
 
8 Brijnath, B., & Antoniades, J. (2016). “I'm running my depression:” Self-management of 
depression in neoliberal Australia. Social Science & Medicine, 152, 1-8. 
 
9 Buus, N. (2014). Adherence to anti-depressant medication: A medicine-taking career. Social 
Science & Medicine, 123, 105-113. 
 
10 Carpenter-Song, E., Chu, E., Drake, R. E., Ritsema, M., Smith, B., & Alverson, H. (2010). 
Ethno-cultural variations in the experience and meaning of mental illness and treatment: 
Implications for access and utilization. Transcultural Psychiatry, 47(2), 224-251. 
 
11 Castonguay, J., Filer, C. R., & Pitts, M. J. (2016). Seeking help for depression: Applying the 




12 Chur-Hansen, A., & Zion, D. (2006). Let’s fix the chemical imbalance first, and then we can 
work on the problems second’: an exploration of ethical implications of prescribing an SSRI for 
‘depression. Monash bioethics review, 25(1), 15-30. 
 
13 Cohen, D., & Hughes, S. (2011). How do people taking psychiatric drugs explain their “chemical 
imbalance?”. Ethical Human Psychology and Psychiatry, 13(3), 176-189. 
 
14 Dickinson, Rebecca, et al. (2010). "Long-term prescribing of antidepressants in the older 
population: a qualitative study." Br J Gen Pract. 60.573: e144-e155. 
 
15 Fosgerau, C. F., & Davidsen, A. S. (2014). Patients’ perspectives on antidepressant treatment in 
consultations with physicians. Qualitative health research, 24(5), 641-653. 
 
16 Frank, L., Matza, L. S., Hanlon, J., Mannix, S., Revicki, D. A., Feltner, D., & Morlock, R. J. 
(2007). The patient experience of depression and remission: focus group results. The Journal of 
nervous and mental disease, 195(8), 647-654. 
 
17 Fullagar, S. (2009). Negotiating the neurochemical self: anti-depressant consumption in women's 
recovery from depression. Health, 13(4), 389-406. 
 
18 Fullagar, S., & O’Brien, W. (2013). Problematizing the neurochemical subject of anti-depressant 
treatment: The limits of biomedical responses to women’s emotional distress. Health:, 17(1), 57-
74. 
 
19 Gammell, D. J., & Stoppard, J. M. (1999). Women's experiences of treatment of depression: 
Medicalization or empowerment? Canadian Psychology/Psychologie canadienne, 40(2), 112. 
 
20 Gibson, K., Cartwright, C., & Read, J. (2016). Conflict in Men’s Experiences with 
Antidepressants. American journal of men's health, 1557988316637645. 
 
21 Gibson, K., Cartwright, C., & Read, J. (2016). ‘In my life antidepressants have been…’: a 
qualitative analysis of users’ diverse experiences with antidepressants. BMC psychiatry, 16(1), 
135. 
 
22 Givens, J. L., Datto, C. J., Ruckdeschel, K., Knott, K., Zubritsky, C., Oslin, D. W., ... & 
Barg, F. K. (2006). Older patients' aversion to antidepressants. Journal of General Internal 
Medicine, 21(2), 146-151. 
 
23 Izquierdo, A., Sarkisian, C., Ryan, G., Wells, K. B., & Miranda, J. (2014). Older depressed 
Latinos’ experiences with primary care visits for personal, emotional and/or mental health 




24 Jaffray, M., Cardy, A. H., Reid, I. C., & Cameron, I. M. (2014). Why do patients discontinue 
antidepressant therapy early? A qualitative study. The European journal of general practice, 
20(3), 167-173. 
 
25 Kadir, N. B. Y. A., & Bifulco, A. (2010). Malaysian Moslem mothers’ experience of depression 
and service use. Culture, Medicine, and Psychiatry, 34(3), 443-467. 
 
26 Knudsen, P., Hansen, E. H., Traulsen, J. M., & Eskildsen, K. (2002). Changes in self-concept 
while using SSRI antidepressants. Qualitative Health Research, 12(7), 932-944. 
 
27 LaFrance, M. N. (2007). A bitter pill: A discursive analysis of women's medicalized accounts of 
depression. Journal of Health Psychology, 12(1), 127-140. 
 
28 Suzanne McKenzie-Mohr, Michelle N., Lafrance, ed. January 2014, Depression as oppression: 
Disrupting the biomedical discourse in women’s stories of sadness. Chapter in book: Women 
voicing resistance: Discursive and narrative explorations, Publisher: Routledge, pp.141-158. 
 
29 Lavender, H., Khondoker, A. H., & Jones, R. (2006). Understandings of depression: an 
interview study of Yoruba, Bangladeshi and White British people. Family practice, 23(6), 651-
658. 
 
30 Lawrence, V., Banerjee, S., Bhugra, D., Sangha, K., Turner, S., & Murray, J. (2006). Coping 
with depression in later life: a qualitative study of help-seeking in three ethnic groups. 
Psychological medicine, 36(10), 1375-1383. 
 
31 Malpass, A., Kessler, D., Sharp, D., & Shaw, A. (2011). ‘I didn't want her to panic’: unvoiced 
patient agendas in primary care consultations when consulting about antidepressants. Br J Gen 
Pract, 61(583), e63-e71. 
 
32 Murawiec S. (2008). Archives of Psychiatry and Psychotherapy, 3, 65–69. 
 
33 Patel, S., Wittkowski, A., Fox, J. R., & Wieck, A. (2013). An exploration of illness beliefs in 
mothers with postnatal depression. Midwifery, 29(6), 682-689. 
 
34 Ridge, D., Kokanovic, R., Broom, A., Kirkpatrick, S., Anderson, C., & Tanner, C. (2015). 
“My dirty little habit”: Patient constructions of antidepressant use and the ‘crisis’ of legitimacy. 
Social Science & Medicine, 146, 53-61. 
 
35 Simon, D., Loh, A., Wills, C. E., & Härter, M. (2007). Depressed patients’ perceptions of 
depression treatment decision‐making. Health Expectations, 10(1), 62-74. 
 
36 Smardon, R. (2008). I'd rather not take Prozac': stigma and commodification in antidepressant 




37 Stanners, M. N., Barton, C. A., Shakib, S., & Winefield, H. R. (2014). Depression diagnosis 
and treatment amongst multimorbid patients: a thematic analysis. BMC family practice, 15(1), 
124. 
 
38 van Geffen, E. C., Hermsen, J. H., Heerdink, E. R., Egberts, A. C., Verbeek-Heida, P. M., & 
van Hulten, R. (2011). The decision to continue or discontinue treatment: experiences and beliefs 
of users of selective serotonin-reuptake inhibitors in the initial months—a qualitative study. 
Research in Social and Administrative Pharmacy, 7(2), 134-150. 
 
39 van Grieken, R. A., Beune, E. J., Kirkenier, A. C., Koeter, M. W., van Zwieten, M. C., & 
Schene, A. H. (2014). Patients׳ perspectives on how treatment can impede their recovery from 
depression. Journal of affective disorders, 167, 153-159. 
 
40 Vargas, S. M., Cabassa, L. J., Nicasio, A., De La Cruz, A. A., Jackson, E., Rosario, M., ... & 
Lewis-Fernández, R. (2015). Toward a cultural adaptation of pharmacotherapy: Latino views of 
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4.3. Themes Emerging from Qualitative Studies Selected for Analysis 
 
Burnard et al., (2008) argue that strict formulas to determine the validity in qualitative 
analysis do not exist. However, to ensure that the process of analysis is systematic and rigorous, 
the whole body of collected data must be thoroughly examined. In this review, I used a strategy 
proposed by Noblit & Hare, (1988) and Britten et al., (2002), known as creation of the third 
order constructs (Table 2 below). It summarizes conclusions and theories drawn in the process of 
a) direct interpretation of patients’ narratives (first order constructs) and b) other researchers’ 
opinions and interpretations expressed as themes and concepts of patients' views of 
antidepressant use (second order constructs). 
 
Table 4. Definition of 1st, 2nd and 3rd order constructs  
 
First order constructs Patients' views, accounts and interpretations of their 
experiences of using antidepressants 
Second order constructs The authors' views and interpretations (expressed as themes 
and concepts) of patients' views of antidepressant use  
Third order constructs The views and interpretations of the synthesis team (expressed 
as themes and key concepts) 
 
Adapted from: Noblit & Hare, 1988 and Britten et al., 2002 
 
  
The basic concept of this review is to achieve a more in-depth focus on emergent issues 
around the use of antidepressants, such as non-acceptance and non-adherence to treatment, and 
to tackle problems that remained unsolved or were only partly addressed before (Heaton, 2004). 
This analysis, called an ‘amplified analysis’, said to be the most common form of qualitative 
secondary analysis used in health and social studies, is “by its nature closely related to the remit 
of the initial data collection and aims to extend the original work” (Heaton, 2004). Such analysis 
combines data emerging from secondary analysis with the primary research, and, by expanding 
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the volume of comparison, it highlights those aspects that were not attended to in the previous 
studies.   
Qualitative methodologists represent the opinion that “regardless of whether data are 
analysed by hand or using computer software, the process of thematic content analysis (…) 
involves identifying themes and categories that 'emerge from the data'” (Pope, Ziebland & Mays, 
1999). Discovering themes occurs through the process of verifying, confirming and qualifying 
findings “by searching through the data and repeating the process to identify further themes and 
categories” (Pope, Ziebland & Mays, 1999). I thoroughly read and re-read each transcript, 
making notes within the text and on the margins in the form of words, ideas and short phrases 
corresponding to what was said in the text. This process is described as open coding. The 
purpose of doing so is to present brief summaries and statements for each relevant element that is 
presented in the transcript. With the aim to achieve maximum clarity of my own findings, I 
adapted Anderson and Roy’s (2013) model of ‘Summary of key findings’. A fragment of my 
chart, presented below, demonstrates how certain themes emerged from the selected qualitative 
studies. Some themes identified by Anderson and Roy (2013) were found to match themes that 
emerged from the collected data. Each theme found multiple references in the studies that were 
analysed, and also, certain themes are visibly more prevalent than others. The full account of 
‘first order constructs’ is introduced in Appendix D.  
 





Table 5. Themes Emerging from Selected Qualitative Studies (Excerpts) 
 
Theme Positive views on antidepressants 
 
Experiences with health care 
 
 Concerns about medicines 
Treatment 
decision and 
initiation   
 
People went to see GP only after family and 
friends urged them to do so, others because 
their behaviour was obviously affecting 
others (Anderson at al., 2015) 
 
Husband urged patient to see her GP. Her 
behavior was hyperactive and out of 
character. Patient requested referral to a 
psychiatrist for assessment (Amey, 2010) 
 
The case underscores the important role the 
GP has in the early detection (Amey, 2010) 
 
Participants often felt depressed for a long 
time, only seeing a doctor and being 
prescribed an AD after reaching a crisis point 
(Anderson et al., 2015) 
 
overwhelming impact of depressive 
symptoms meant that not taking the treatment 
was not an option (Anderson et al., 2015) 
 
Patient started taking an SSRI which 
convinced him that there was a problem 
because he felt much better, and the change 
was fantastic (Anderson et al., 2015) 
 
Some women took AD medication during 
pregnancy, five commenced medication 
within two months of delivering, and one 
woman delayed commencing AD medication 
Trust and rapport established between 
them and their health practitioner 
(Anderson et al., 2015) 
 
“If she hadn’t been able to turn my 
thinking around in that first appointment 
in the way that she did, you know, I’m not 
convinced I would have been motivated to 
take the medication. And certainly, you 
know, knowing now that it does take sort 
of four to six weeks to really start to have 
an effect I might have—even if I had 
started taking it—I may well have given 
up after two weeks, you know. But her 
influence was powerful enough that it 
changed everything about the way I was 
looking at the illness and subsequently at 
myself…So she then spent the time 
explaining about depression and different 
causes and then the medications” 
(Anderson et al., 2015) 
 
During times of crisis, when they required 
immediate help, participants described 
being referred to under-resourced 
helplines and being given pamphlets and 
brochures, none of which were found to 
be helpful. 
Patient filed a complaint to the 
Parliamentary and Health Service 
The first mention of medication and 
antidepressants. And I don't think she'd even 
finished saying the word before I said ‘not a 
chance.’ I said ‘do you know who you're 
talking to here? I'm a detective. I think—this 
is—you can't do that.’ And there was no way. 
I'd entertain just the label of the drug. Just 
the term antidepressant to me was ah you just 
can't hack it, and I thought ‘well that's what I 
think so everybody else must think that.’ So I 
said ‘nup, not a chance’ (Anderson et al., 
2015) 
 
Carers wish for more easily accessible, 
detailed and user-friendly information (Boyle 
& Chambers, 2000) 
 
Three pregnant women elected not to use 
ADs at anytime during the pre- and 
postpartum periods (Bennett et al., 2007) 
 
Patient history and the speed of recovery, 
which was coincident with the 
discontinuation of AD treatment, is 
consistent with the hypothesis of mania as a 
side effect of AD treatment (Amey, 2010) 
 
people can feel unsure about what to expect 





until she had stopped breat feeding her baby. 
Three women elected not to use 
antidepressants at anytime during the pre- 
and postpartum periods (Bennett et al., 
2007) 
 
Receiving a diagnosis, being informed about 
depression, that it is a common illness and 
recovery is expected, were extremely 
important for recovery (Badger & Nolan, 
2007) 
 
Many patients acknowledged that they 
experienced poor memory and concentration 
and could remember very little verbal 
information, especially from the initial 
consultation (Badger & Nolan, 2007) 
 
Receiving a diagnosis was a turning point for 
many, especially if they had been unwell for 
some time, had been initially diagnosed with 
a physical illness, or not offered any 
diagnosis (Anderson et al., 2015) 
 
I Ieft them on my top shelf for ages and I just 
didn't want to take them because I was a bit 
confused as why I; he's prescribed me that 
after like a really short chat, just me saying I 
was down and maybe at the time they were 
handing them out left right and centre, I don't 
know (Anderson et al., 2015) 
 
First experience was pleasant and viewed 
antidepressants as essential (Anderson & 
Roy, 2013) 
 
Ombudsman about the management of her 
case by her GP (Amey, 2010) 
 
The extent to which patients accept their 
diagnosis and prescription of 
antidepressants at the early point of 
consultation with health professionals is 
critical in determining their ongoing 
adherence to medication in the future 
(Badger & Nolan, 2007) 
 
Concerns about the way consultations 
unfolded, particularly where patients felt 
like there was a lack of discussion and 
negotiation (Anderson et al., 2015) 
 
Practice nurses, community mental health 
nurses (CMHNs) and GPs were identified 
as information providers (Badger & 
Nolan, 2007) 
Community mental health nurses’ roles as 
good listeners and confidantes were 
complementary to GPs’ roles, most vital 
elements in patient’s recovery were the 
initial consultation with the GP and 
subsequently the practice-based visits 
(Badger & Nolan, 2007) 
Hearing ‘You have a common condition’ 
and ‘You will get better’ from 
practitioners was sometimes totally 
unexpected, but usually welcome 
information. People's shock at being told 
they were suffering from depression was 
generally more than compensated for by 
it can be difficult to make decisions and think 
things through when very ill with depression 
(Anderson et al., 2015) 
 
For some, attributing recovery to medication 
diminished their own roles and personal 
strengths emerged as important to beliefs 
about recovery (Badger & Nolan, 2007) 
 
ADs are regarded as more stigmatizing than 
depression (Badger & Nolan, 2007) 
 
Other people assume that I'm on it 
[antidepressants] because I'm lazy because I 
don't want to put in that effort to go see a 
psychologist and empty my emotional 
bucket all the time (Brijnath & Antoniades, 
2016) 
 
Frst prescribed an AD he said he felt it 
signified his depression as ‘official’, likening 
it to a defeat, as though he had ‘surrendered’ 
(Anderson et al., 2015) 
 
had felt it was taking the ‘lazy’ option when 
he was first prescribed an AD, and said it felt 
like avoiding responsibility for his own well-





taking ADs for the first time can be a 
particularly anxiety provoking time, and 
people may reject the medicines at this time, 
particularly if they feel unsupported 
(Anderson et al., 2015) 
 
people do want to know what to expect 
before they started taking an antidepressant 
(Anderson et al., 2015) 
 
They felt reassured when they were provided 
with information and told that they can try 
different types of antidepressants if side 
effects were intolerable (Anderson et al., 
2015) 
 
Readiness to take the medication linked to 
expectation regarding the medicine's 
therapeutic effects and to a strong belief in 
the authority of the prescribing therapists and 
healthcare professionals (Buus, 2014) 
 
Continued taking the medication in 
accordance with professional advice, mainly 
because they saw medicine as the primary 
means of recovery (Buus, 2014) 
 
Most of participants sceptical towards taking 
ADs and experienced some relatively mild 
adverse effects, but they justified continuing 
taking the medicine by referring to their 
necessity and to the risk of relapse. They 
feared stopping taking the medicine: “I don't 
know what it would be like if I didn't take 
them.” (Buus, 2014) 
the relief that they had a known and 
common illness and recovery was 
possible (Badger & Nolan, 2007)  
Understanding and unshockable health 
professionals who offered unhurried 
consultations had the potential to 
contribute towards recovery; for people 
were often extremely anxious about 
practitioners’ reactions to what they 
suspected was a mental illness (Badger & 
Nolan, 2007)  
Many feared that the stigma present 
among the public also existed among 
health professionals. One respondent's GP 
told him ‘I've been expecting you for some 
time’, making the consultation easier 
(Badger & Nolan, 2007)  
I felt completely excluded from the 
decision-making. Well, yeah, on her notes 
I think she wrote depressed, and I think 
she said to me, “I think you're suffering 
with depression and need 
antidepressants” And she put me on 
antidepressants straight away, and on 
sleeping tablets as well I think. She didn't 
even ask me! (Anderson & Roy, 2013) 
 
This GP insisted that I take her 
prescription. And I had said, ‘no,’ I had 
said ‘no’ about three times. In the end she 
said to me,‘ I don't know what's wrong 
with depressed people, why they always 
refuse to take my prescriptions. I think 
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Patients, who were initially very sceptical 
towards taking ADs, ended up accepting 
them as equivalent to taking vitamins (Buus, 
2014)  
 
Some went to the general practitioner (GP) 
only after family and friends urged them to 
do so, others because their behaviour was 
obviously affecting other people (Anderson 
et al., 2015) 
 
It can be difficult for people to recognise the 
signs and symptoms of depression 
(Anderson et al., 2015). 
 
Difficult for patients was feeling that they 
were being coerced into taking ADs, or that 
they do not have a choice in the matter 
(Anderson et al., 2015) 
Many people were relieved to be diagnosed 
with depression and be prescribed an AD 
(Badger & Nolan, 2007) 
Ten women took antidepressant medication 
during pregnancy, five commenced 
antidepressant medication within two months 
of delivering, and one woman delayed 
commencing antidepressant medication until 
she stopped breast feeding her baby (Bennett 
et al., 2007) 
 
Some people perceive ADs as being no 
different to other medicines (Anderson et 
al., 2015) 
 
depressed people like being depressed.’ I 
felt like she'd shamed me into taking her 
prescription (Anderson & Roy, 2013) 
 
being listened too and given sufficient 
time and information was universally 
recognised as positive and valuable, and 
key to the trust and rapport established 
between them and their health practitioner 
(Badger & Nolan, 2007) 
 
‘shared decision-making’ not experienced 
older people in particular described one-
way conversations which involved them 
simply acceding to their doctors wishes, 
saying they had always believed that the 
‘doctor knows best’ (Anderson et al., 
2015). 
People typically linked their experiences 
with ADs to their interactions with 
doctors in their consultations (Badger & 
Nolan, 2007) 
People need to feel supported by health 
professionals when they start taking 
antidepressants (Anderson et al. 2015) 
 
Participants reported that for health 
providers, prescriptions appeared to be an 
easier option (Anderson et al., 2015) 
 
Some felt they were not given sufficient 
time during their consultation information  
or support to take the medicines 
(Anderson et al., 2015) 
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Being offered a prescription for an AD 
brought significant relief, as it helped people 
to feel that their symptoms were recognised 
as a legitimate illness (Anderson et al., 
2015) 
 
Internet is routinely used by people to look 
up health information, including about 
different types of ADs and side effects 
(Anderson et al., 2015) 
 
Internet used to find out about others’ 
experiences with ADs (Anderson et al., 
2015) 
 
Internet forums used where witnessing 
others’ experiences helped people appreciate 




Some people recalled very positive initial 
experiences of concordant consultations 
involving shared decision making, 
including a good discussion about their 
views, fears and apprehensions and 
previous experiences of taking 
antidepressants (Anderson et al., 2015) 
 
Women sought care from providers who 
were experts in the field of reproductive 
mental health (Bennett et al., 2007) 
 
Some, particularly those with a pre-
existing depression, considered that only a 
psychiatrist experienced in the care of 
pregnant and postpartum women was 
acceptable (Bennett et al., 2007) 
 
Clinical inertia: doctors' unwillingness to 
initiate medicine even though that viewed 
essential by the patients themselves 
(Anderson & Roy, 2013) 
 
Apparent dismissive reactions and 
preoccupation with note taking or 





attitudes to and 
concerns about 
ADs  
Part of balancing the effects of antidepressant 
use included self-medication (Brijnath & 
Antoniades, 2016) 
 
In some instances, participants even went so 
far as to either buy medicines online or bring 
in medicines from overseas (Brijnath & 
Antoniades, 2016) 
 Once they label you, they never look at you 
the same. The psychiatric label “changes you 
forever.” (Carpenter-Song et al. 2010) 
  
I have “enferma de los nervios.” And there is 





The presence of, and support from, family 
and friends was often cited as central to 
recovery and identified by many as the major 
factor (Badger & Nolan, 2007) 
 
ADs did help improve mood: “Brain space 
springing up,” “even keel” and “reduces the 
pain” were common descriptions of the 
positive effects of ADs that had to be 
balanced against adverse effects (Brijnath & 
Antoniades, 2016) 
 I got labeled mentally retarded and a psycho 
by my friends and stuff when I got out [of the 
hospital]. I lost like all of my friends. It was 
rough (Carpenter-Song et al. 2010) 
 
I would “never” tell my co-workers about 
receiving treatment: Because they would pick 
on me. When you tell people you have a 
mental problem, they pick on you and blame 
everything on you because they know you 
have something wrong with you (Carpenter-
Song et al. 2010) 
 
I was hoping to get some distance from my 
family. It’s the blame and change syndrome. 
They think it’s my fault that I’m mentally ill. 
Fourteen years ago I was diagnosed as 
mentally ill and my father and my mother and 
my brother talked about me like a ladybug on 
a window. They talked in circles and then got 
angry at me (Carpenter-Song et al. 2010) 
 
They don’t know what works and what don’t 
work. First, they put you on a medication and 
when you tell them you don’t need it anymore 
they just put you on another one. I get sick of 
taking pills, pills, pills. I don’t need all this 
medication. They keep telling me I need 
medication but I don’t. The medication is 
what makes me sick. I don’t feel right when I 




Those who did not experience any adverse 
reactions- highlighted the importance of 
medicines and ignored minor side effects (if 
encountered any) (Anderson & Roy, 2013) 
 Continuous adverse side effects or at some 






negative side-effects such as dry mouth, 
sexual dysfunction, lethargy, tiredness, 
feeling dizzy and jittery (Brijnath & 
Antoniades, 2016) 
 
ADs were not ‘silver bullets’ or ‘magic,’ 
often caused severe side-effects, and required 
experimentation until an appropriate drug 




AD might make one feel ‘fluffy’ or ‘out of 
control’ (Anderson et al., 2015). 
 
Dry mouth, dizziness, inability to concentrate 
to routine work, sleep disruption, loss of 
motivation, weight loss/gain, agitation, hair 
loss. as side effects (Anderson & Roy, 2013) 
 
Difficulties to perform routine works/job due 
to medicines use (Anderson & Roy, 2013) 
 
Sexual dysfunction (Anderson & Roy, 2013) 
 
inferiority complex/loss of self-confidence 
(Anderson & Roy, 2013) 
 
suspected AD-induced mania (Amey, 2010) 
 
Weight gain and tiredness (Buus, 2014) 
 
I think any depression you have you’re half 
way, you’ve got to do it yourself, you cannot 
rely on the medication, you’ve got to be 
willing to try, you don’t get a miracle cure 
out of a bottle, it can help you over the bad 
times but it’s not a cure, that’s up to you. I 
might be mad but that’s how I think (Badger 




Validating ADs by gathering information on 
prescribed medicine, internet routinely used 
by people to look up health information 
(Anderson et al., 2015) 
Internet forums consulted to witness others’ 
experiences (Anderson et al., 2015) 
Most respondents expressed a strong wish 
to be more informed about their 
prescribed medicines so that they could 
develop a trustworthy relationship with 
their doctors to continue their medicines 
(Anderson & Roy, 2013) 
 
Part of balancing the effects of AD use 
included self-medication. Self-medication 
involved adjusting drug dosages, combining 
ADs with alcohol and other drugs, and 
concurrently using AD and complementary 







Many preferring to trust their practitioners 
to make choice on behalf of them. 
Many patients reflected good relationships 
with their doctors and had great 
confidence in the doctor’s skills 
(Anderson & Roy, 2013) 
 
Being able to talk to the doctor enabled 
many respondents to reflect on their 
difficulties, and to clarify or reframe their 
experiences (Anderson & Roy, 2013) 
 
Other reflected adversarial or 
disconnected relationships with their 
psychiatrists/GPs/consultants (Anderson 
& Roy, 2013) 
 
Patients’ disappointment regarding 
chronic depression often leads many 
respondents to challenge the authority or 
the working style of the service providers 
(GPs, consultants, counselors) (Anderson 
& Roy, 2013) 
 
A lack of information about ADs was a 
major cause of dissatisfaction often 
shaping attitudes to ADs (Anderson & 
Roy, 2013) 
 
Dissatisfaction with the doctor-patient 
interaction in terms of lack of attention or 
acknowledgement on the part of the 
doctor (for example, dismissive reactions 
or preoccupation with note taking) and 
superficial responses (Anderson & Roy, 
2013) 
One participant, who came out of a family 
with severe mental illness, found taking ADs 
stigmatising and she continued to put 
pressure on her general practitioner to 
authorise phasing out of the medicine even 
though she feared a relapse of depression 
(Buus, 2014) 
 
The participants often blamed the medicine 
having adverse effects rather than 
considering other reasons for their distress, 
such as their depressive illness (Buus, 2014) 
 
frustrated patients desperately sought to 
change their situation, who did not believe 
that the medicine was important for solving 
their issues, in most cases they believed that 
adverse effects added significantly to their 
problems (Buus, 2014) 
 
Patient successfully insisted on a gradual 
reduction and stop of the medicine simply 
because he had taken it for exactly six 
months, which, allegedly, was the period 
needed to have a low risk of relapse. This 
happened despite him having frequently 
experienced severe and disabling symptoms 
of relapse into depression (Buus, 2014) 
It is good that you can get medicine when 
you have pain and medicine when you are 
depressed. But I don't think it is a solution to 
just add more and more medicine because 
you go crazy because you're doped all the 
time. I think I’m taking something like 29 





doctors did not spend enough time with 
them, did not communicate well with 
them, did not listen well to them, did not 
inform the up-to date information about 
medicine and did not behave well 
(Anderson & Roy, 2013) 
 
Persistent tention between the patient and 
provider has a fatalistic dimension too 
(e.g. taking overdose) (Anderson & Roy, 
2013)  
 
Disconnected relationship with health care 
professionals further precipitated if 
patients were less informed about their 
health conditions and prescribed 
medicines (Anderson & Roy, 2013) 
 
A persistent tention was observed 
between “what was promised” and “what 
was actually delievered” in practice 
(Anderson & Roy, 2013)  
 
Most reported receiving little or no 
information from their providers about 
depression and their medicines (e.g. side 
effect, length of treatment, outcomes).  
They also felt the information they 
received from mental health professionals 
was inadequate (Anderson & Roy, 2013) 
 
Many welcomed information provided by 
the facilities and physicians. Few 
respondents reported having received 
Some adverse effects were experienced as 
intolerable if they threatened a particular 
person's identity (Buus, 2014) 
 
Some patients found weight gain or sexual 
disturbances stigmatising and intolerable 
(while others did not care much about it) 
(Buus, 2014) 
 
Experiences of such identity-threatening 
adverse effects added significantly to the 
patients’ eagerness to get off the medicine 
(Buus, 2014) 
 
Most patients were impatient to get back to 
their old life (Buus, 2014) 
 
For other patients, it was very hard following 
a regular treatment regime for an illness they 
were desperately eager to get rid of (Buus, 
2014) 
 
A lack of information on their medicines 
appeared to be a key issue of dissatisfaction 
for many respondents (Anderson & Roy, 
2013) 
 
Subjects often seeking out information from 
sources, such as books, broadcast media, the 
library, friends, and the Internet (Anderson 
et al., 2015) 
 
Deliberate adjustments were observed (either 
omissions or taking extra doses) (Anderson 




written information e.g. information 
leaflets (Anderson & Roy, 2013) 
 
Around 40% of patients who start treatment 
with ADs fill only a single prescription at the 
pharmacy, apparently not accepting treatment 
and, as with other new medicines stop taking 
them after 2 weeks (Anderson et al., 2015)  
 
Once people have got their ADs from the 
pharmacy they often struggle with actually 
taking the first dose (Anderson et al., 2015)  
 
Participant had previously been treated with 
ADs, but this time she experienced severe 
adverse effects of the medicine, which 
included a substantial weight gain and 
tiredness. But she was scared of 
discontinuing taking the medicine despite the 








Many women shared previous lack of 
awareness about the possibility of 
experiencing depression during pregnancy 
(Benett et al., 2007) 
 
Supportive safety offered by family, friends 
and health practitioners was identified by 
many participants and the importance 
attached to such support means that 
practitioners should aim to clarify patients’ 
‘supportive others’, and offer additional 
resources where appropriate (Badger & 
Nolan, 2007) 
People need to feel supported by health 
professionals when they start taking ADs 
(Anderson et al., 2015) 
 
People need additional support when they 
make decisions about starting ADs 
(Anderson et al., 2015) 
 
If people trusted and respected their 
doctor and felt guided and informed, they 
also reported initiation of treatment as less 
problematic (Badger & Nolan, 2007)  
 
 
ADs appear to occupy a central place in 
many people’s lives. Many people described 
how their medicines had helped them and 
how this served as a reinforcement to 
continue taking them in order to maintain a 
“normal life” (Anderson & Roy, 2013)  
 
Case of suspected antidepressant-induced 
mania strengthens the need for further 
investigation of this phenomenon in unipolar 
depression (Amey, 2010) 
 
case study cautionary against the use of 





Practitioners involved in prescribing and 
medication management for depression 
must aim to explore patients’ beliefs about 
appropriate treatments and recovery 
(Badger & Nolan, 2007)  
Addressing these can potentially promote 
treatment concordance and enhance 
recovery from depression by establishing 
and sustaining therapeutic relationships 
(Badger & Nolan, 2007) 
Need for prompt specialist treatment for 
patients with sub-threshold hypomanic 
symptoms (Amey, 2010) 
Due to difficulties encountered at 
initiation of antidepressant therapy, 
healthcare professionals should consider 
to optimally structure their consultations 
to provide the best information 
(Anderson et al. 2015) 
Conflicting information found online can 
be frightening and health professionals 
could help by directing people to credible 




4.4. Beliefs, Views, and Behaviors that Bring Patients to Start, Continue 
and/or Discontinue Treatment with Antidepressants 
 
The next step taken in the analytical process of searching for more in-depth information was 
the identification of sub-themes and additional concepts or clues in order to provide an even 
more detailed description of beliefs, rationale, and behavioral patterns that bring patients to 
refuse or discontinue the intake of antidepressants after the initial start of treatment. The 
following events and situations were found to be the breaking points in patients’ treatment 
decisions: 
1. Acceptance of antidepressant treatment option 
• Perceived health threat at start of treatment / Crisis 
• Treatment decision making and initiation of treatment 
• Reasons for accepting diagnosis and medication 
• Attitude towards own illness and treatment 
• Health literacy / knowledge of depression and available treatment options 
2. Execution of treatment 
• Benefits of antidepressant use 
• Negative consequences of antidepressant use 
• Self-efficacy in adherence and non-adherence to treatment 
• Communication and support of health care professionals during treatment 
• Social pressure and support to start and continue vs. luck of support and pressure to 
discontinue the drug use 
Table 6, adapted from van Geffen’s study, indicates how those issues are externalized and which 
studies touch upon them.   
82 
 
Table 6. Descriptions of beliefs, rationale, and behavioral patterns that bring patients to start, continue and/or 
discontinue treatment with antidepressants 
Topic list 
Initiation of treatment 





Type of symptoms (sadness, 
worry, anxiety, somatic 
complains) 
Duration of symptoms 
Perceived seriousness of the 
illness 
Labeling of symptoms 
Social impact of illness 
Family history 





Previous experience with 
antidepressants 
Role of GP in treatment decision 
Role of patient in treatment 
decision 
Influence of family and friends  
Lack of information about 
medication 
Extreme bothersome mental and 
physical symptoms 
Family support and 
encouragement 
Anderson & Roy 2013; Anderson et al 2015; Badger & 
Nolan 2007 (b); Bennett et al. 2007; Boyle & Chambers 
2000; Brijnath & Antoniades 2016; Buus 2014; 
Carpenter-Song 2010; Castonguay, Filer & Pitts 2016; 
Chur-Hansen & Zion 2006; Cohen & Hughes 2011; 
Dickinson et al. 2010; Fosgerau & Davidsen 2014; Frank 
et al. 2007; Fullagar 2009; Fullagar & O’Brien 2013; 
Gammel & Stoppard 1999; Gibson, Cartwright & Read 
2016 (a); Gibson, Cartwright & Read 2016 (b); Givens et 
al. 2006; Hansen & Cabassa 2012; Malpass et al. 2011; 
Murawiec 2008; Patel et al. 2013; Simon et al. 2007; 
Anderson et al. 2015; Bennett et al. 2007; Boyle & 
Chambers 2000; Buus 2014; Carpenter-Song 2010; 
Carpenter-Song 2010; Castonguay, Filer & Pitts 2016; 
Chur-Hansen & Zion 2006; Cohen & Hughes 2011; 
Frank et al. 2007; Gibson, Cartwright & Read 2016 (b); 
Fullagar & O’Brien 2013; Gammel & Stoppard 1999; 
Gibson, Cartwright & Read 2016 (a); Hansen & 
Cabassa 2012; Jaffray et al. 2014; Kadir & Bifulco 
2010; Murawiec 2008; Patel et al. 2013; Stanners et al. 
2014; Vilhelmson et al. 2013; 
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Stanners et al. 2014; Stanton & Randal 2016;van 
Grieken et al. 2014;Vilhelmson et al. 2013; 
Reasons for starting 
treatment 
Fatigue and loss of energy 
Medical diagnosis of illness 
Insomnia 
Lasting sadness 
Feelings of emotional emptiness 





Awareness of family history of 
depressive illness  
Knowledge of consequences of 
untreated symptoms 
Encouragement from others 
Loss of control 
Aid to surviving a crisis 
Old age 
;  Bennett et al. 2007; Bayliss & Holttum 2015; Buus 
2014;    Castonguay, Filer & Pitts 2016; Chur-Hansen & 
Zion 2006; Cohen & Hughes 2011; Fosgerau & 
Davidsen 2014; Frank et al. 2007; Fullagar 2009; 
Fullagar & O’Brien 2013; Gammel & Stoppard 1999; 
Gibson, Cartwright & Read 2016 (a); Gibson, Cartwright 
& Read 2016 (b); Givens et al. 2006; Hansen & Cabassa 
2012; Izquierdo et al. 2012; Jaffray et al. 2014; Kadir & 
Bifulco 2010; Lafrance 2007; Lavender, Khondoker & 
Jones 2006; Lawrence et al. 2006; Malpass et al. 2011; 
Murawiec 2008; Patel et al. 2013; Ridge et al. 2015; 
Simon et al. 2007; Smardon 2007; Stanners et al. 2014; 
Stanton & Randal 2016; van Geffen et al. 2011; Vargas 




Attitude toward illness 
and treatment 
Emotional vs physical problem 
Fear of side effects 
Fear of addiction 
Aversion toward medication 
(chemical, unnatural) 
Influence on self-esteem 
Religious beliefs and practices 
Social influences 
Anderson et al. 2015; Bennett et al. 2007; Boyle & 
Chambers 2000; Brijnath & Antoniades 2016; Buus 
2014; Carpenter-Song 2010; Castonguay, Filer & Pitts 
2016; Chur-Hansen & Zion 2006; Cohen & Hughes 
2011; Dickinson et al. 2010; Fosgerau & Davidsen 2014; 
Frank et al. 2007; Fullagar 2009; 
Fullagar & O’Brien 2013; Gammel & Stoppard 1999; 




Stereotypes and stigma 
Relief from symptoms  
Recovery 
Knowledge of depression and its 
treatment 
Ambivalence, disappointment   
Cartwright & Read 2016 (b); Givens et al. 2006; Hansen 
& Cabassa 2012; Izquierdo et al. 2014; Jaffray et al. 
2014; Kadir & Bifulco 2010; Knudsen et al. 2002 (a); 
Lafrance 2007; Lavender, Khondoker & Jones 2006; 
Lawrence et al. 2006; Malpass et a l. 2011; Murawiec 
2008; Patel et al. 2013; Ridge et al. 2015;  
Simon et al. 2007; Smardon 2007; Stanners et al. 2014; 
van Geffen et al. 2011; van Grieken et al. 2014; Vargas 
et al. 2015; Vilhelmson et al. 2013; 
 
Knowledge of depression 
and its treatment 
Own and others’ experience 
Delay in effect 
Risk and time course of side 
effects 
Duration of use according to 
guidelines 
Serotonin imbalance theory  




Amey 2010; Bennett et al. 2007; Boyle & Chambers 
2000; Carpenter-Song 2010; Chur-Hansen & Zion 2006; 
Cohen & Hughes 2011; Dickinson et al. 2010; 
Dickinson et al. 2010; 
Fullagar & O’Brien 2013; Gammel & Stoppard 1999; 
Gibson, Cartwright & Read 2016 (a); Gibson, Cartwright 
& Read 2016 (b); Patel et al. 2013; Simon et al. 2007; 
Smardon 2007; 
Stanton & Randal 2016; van Geffen et al. 2011; van 
Grieken et al. 2014;  
Execution of treatment 
Benefits of antidepressant 
use 
Effectiveness, improvement of 
symptoms 
Improved quality of life  
Social functioning 
Improved cognition 
Relief of symptoms 
Recovery 
Badger & Nolan 2007 (b); Bennett et al. 2007; Buus 
2014; Castonguay, Filer & Pitts 2016; Chur-Hansen & 
Zion 2006; Cohen & Hughes 2011; Dickinson et al. 
2010; Fosgerau & Davidsen 2014; Frank et al. 2007; 
Jaffray et al. 2014; Malpass et al. 2011; Murawiec 2008;  




Negative consequences of 
antidepressant use 
Experienced side effects 
Bothersomeness of side effects 
Ineffectiveness of treatment 
Stigmatization 
Feeling of ‘drug loop’ 
Amey 2010; Bayliss & Holttum 2015; Buus 2014; Chur-
Hansen & Zion 2006; Cohen & Hughes 2011; Fullagar 
2009; Fullagar & O’Brien 2013; Gammel & Stoppard 
1999; Gibson, Cartwright & Read 2016 (a); Gibson, 
Cartwright & Read 2016 (b); Givens et al. 2006; 
Lafrance 2014; Vargas et al. 2015; 
Self-efficacy Confidence in one’s ability to 
take action 
Adherence to treatment  
Able to communicate with GP 
Alternative treatment strategies 
Social involvement 
Taking control 
Non-adherence to treatment 
Bennett et al. 2007; Bayliss & Holttum 2015; Brijnath & 
Antoniades 2016; Buus 2014; Chur-Hansen & Zion 
2006; Cohen & Hughes 2011; Dickinson et al. 2010; 
Frank et al. 2007; Fullagar 2009; Fullagar & O’Brien 
2013; Gammel & Stoppard 1999; Gibson, Cartwright & 
Read 2016 (a); Gibson, Cartwright & Read 2016 (b); 
Lafrance 2007; Ridge et al. 2015; Vargas et al. 2015;  
Communication and 




Underlying cause not addressed 
Feeling ignored 
 
Anderson & Roy 2013; Anderson et al. 2015; Boyle & 
Chambers 2000; Buus 2014; Chur-Hansen & Zion 2006;  
Cohen & Hughes 2011; Fosgerau & Davidsen 2014; 
Gammel & Stoppard 1999; Izquierdo et al. 2014; 
Malpass et al. 2011; Stanton & Randal 2016;  
Social pressure and 
support to start and 
continue vs. luck of 
support and pressure to 
discontinue the drug use  
Partner, family and friends 
GP 
Boyle & Chambers 2000; Castonguay, Filer & Pitts 
2016; Chur-Hansen & Zion 2006; Fullagar 2009; 
Fullagar & O’Brien 2013; Gammel & Stoppard 1999; 
Gibson, Cartwright & Read 2016 (b); Lafrance 2014; 









  Feeling better 
Dilemmas about dependency,  
Side effects      
Frustration  
Lack of efficacy 
Adverse effects 
Balancing the risk 
Difficult process of withdrawing 
Self-regulation of drug treatment 
  Doubts about chemical imbalance, 
  Beliefs that medication causes a 
chemical imbalance 
Fear and uncertainty 
Amey 2010; Anderson & Roy 2013; Bayliss & Holttum 
2015; Boyle & Chambers 2000; Brijnath & Antoniades 
2016; Buus 2014; Fosgerau & Davidsen; Fullagar 2009; 
Fullagar & O’Brien 2013; Gammel & Stoppard 1999; 
Gibson, Cartwright & Read 2016 (a); Gibson, Cartwright 
& Read 2016 (b); Givens et al. 2006; Hansen & Cabassa 
2012; Jaffray et al. 2014; Kadir & Bifulco 2010; 
Lafrance 2014;  Lavender, Khondoker & Jones 2006; 
Lawrence et al. 2006; Malpass et al. 2011; Patel et al. 
2013; Smardon 2007; Stanton & Randal 2016; van 
Geffen et al. 2011;  




Improved sleep  
Optimism and hope 
Prior experiences 
Barriers to discontinuation 
Considerations to 
discontinue treatment 
Attitudes to taking ADs  
Conflicts about taking ADs 
Mixed experiences of ADs  
Adverse effects   
Social barriers 
Misconceptions and prejudice 
Prior experiences 
Amey 2010; Bennett et al. 2007; Bayliss & Holttum 
2015; Brijnath & Antoniades 2016; Buus 2014; 
Fosgerau & Davidsen 2014; Fullagar 2009; Fullagar 
& O’Brien 2013; Gibson, Cartwright & Read 2016 
(a); Gibson, Cartwright & Read 2016 (b); Givens et 
al. 2006; Malpass et al. 2011; Patel et al. 2013;  
 
Smardon 2007;  
Anderson et al. 2015; Buus 2014; Castonguay, Filer 
& Pitts 2016; Cohen & Hughes 2011; Dickinson et 
al. 2010; Fosgerau & Davidsen 2014; Frank et al. 
2007; Izquierdo et al. 2014; Murawiec 2008; Patel 
et al. 2013; Stanton & Randal 2016; van Geffen et 




4.5. Triangulation of Synthetized Qualitative Data 
 
Various approaches to data collection can be employed to confirm or disconfirm previous 
research results. “The underlying assumption is that the validity of research results is enhanced if 
the different methodological approaches produce convergent findings about the same empirical 
domain” (Erzerberger & Prein, 1997). Health research supports the analysis of mixed-methods 
studies with the belief that all types of scholarly investigation, qualitative as much as 
quantitative, “share a common goal of improving human condition” (Everest, 2014). 
Triangulation of data refers specifically to the application and combination of several research 
methods in the study of the same phenomenon. 
This study is conducted in such a way that the analysis of findings emerging from selected 
qualitative studies has been strenghtened by content analysis of quantitative data on the same 
topic: non-acceptance of and non-adherence to antidepressant treatment. The application of 
various sources of data and the use of multiple perspectives and theories serve the purpose of 
demonstrating the consistency of information. The end result is believed to be the assertion of the 
true value of all collected data, which indicates their credibility and trustworthiness.  
In promoting increasing adherence to therapeutic recommendations in depression, it is 
crucial to identify factors that are known to contribute to discontinuation of treatment (Bennett et 
al., 2010).  Summarizing, my findings fall into two major parts:  
(i) the ways people evaluate their needs of being treated with antidepressants;  
(ii) the difficulties patients encounter in adhering with drug therapy in depression. 
 
The following 71 epidemiological and quantitative studies have been used in the process of 
cross-examination of data. 
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Table 7. Epidemiological and quantitative studies selected for triangulation 
# Study 
1 Aikens, Nease & Klinkman (2008) 
Explaining patients’ beliefs about the necessity and harmfulness of antidepressants 
2 Aikens & Klinkman (2012) 
Changes in patients’ beliefs about their antidepressant during the acute phase of depression 
treatment 
3 Ambresin et al. (2015) 
What factors influence long-term antidepressant use in primary care? Findings from the 
Australian diamond cohort study 
4 Bazargan et al. (2005) 
Treatment of Self-Reported Depression Among Hispanics and African Americans 
5 Bennett et al. (2010) 
Pregnancy-Related Discontinuation of Antidepressants and Depression Care Visits Among 
Medicaid Recipients 
6 Bitner et al. (2003) 
Subjective Effects of Antidepressants. A Pilot Study of the Varieties of Antidepressant-
Induced Experiences in Meditators 
7 Brown et al. (2005) 
Beliefs About Antidepressant Medications in Primary Care Patients Relationship to Self-
Reported Adherence 
8 Burra et al. (2007) 
Predictors of Self-Reported Antidepressant Adherence 
9 Cabassa et al. (2007) 
“It’s like Being in a Labyrinth:” Hispanic Immigrants’ Perceptions of Depression and 
Attitudes Toward Treatment 
10 Chakraborty et al. (2009) 
Attitudes and beliefs of patients of first episode depression towards antidepressants and their 
adherence to treatment 
11 Cooper et al. (2007) 
Why people do not take their psychotropic drugs as prescribed: results of the 2000 National 
Psychiatric Morbidity Survey 
12 De las Cuevas et al. (2014) 
Risk factors for non-adherence to antidepressant treatment in patients with mood disorders 
13 Demyttenaere et al. (2015) 
What is important in being cured from depression? Does discordance between physicians and 
patients matter? 
14 Demyttenaere et al. (2015) 
What is important in being cured from depression? Discordance between physicians and 
patients 
15 Dijkstra and Jaspers (2008) 
Psychiatric and Psychological Factors in Patient Decision Making Concerning 
Antidepressant Use 
16 Dobscha et al. (2007) 
Depression Treatment Preferences of VA Primary Care Patients 
17 Dunlop et al. (2012) 
Depression beliefs, treatment preference, and outcomes 
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18 Ekselius, Bengtsson & von Knorring (2000) 
Non-compliance with pharmacotherapy of depression is associated with a sensation seeking 
personality 
19 Fawzi et al. (2012) 
Beliefs about medications predict adherence to antidepressants in older adults 
20 Frankenberger et al. (2004) 
Effects of Information on College Students’ Perceptions of Antidepressant Medication 
21 Gabriel & Violato (2010) 
Knowledge of and attitudes towards depression and adherence to treatment 
22 Gardner et al. (2007) 
A Comparison of Factors Used by Physicians and Patients in the Selection of Antidepressant 
Agents 
23 Gaudiano et al. (2013) 
Patients’ treatment expectancies in clinical trials of antidepressants versus psychotherapy for 
depression 
24 Goodman (2009) 
Women’s Attitudes, Preferences, and Perceived Barriers to Treatment for Perinatal 
Depression 
25 Hamilton et al. (1984) 
Gender Differences in Antidepressant and Activating Drug Effects on Self-Perceptions 
26 Hansson et al. (2012) 
What made me feel better? Patients’ own explanations for the improvement of their 
depression. 
27 Hanson and Scogin (2008) 
Older Adults’ Acceptance of Psychological, Pharmacological, and Combination Treatments 
for Geriatric Depression 
28 Houle et al. (2013) 
Treatment preferences in patients with first episode depression 
29 Hudson et al. (2015) 
Reduction of Patient-Reported Antidepressant Side Effects, by Type of Collaborative Care. 
30 Kasteenpohja et al. (2015) 
Treatment received and treatment adequacy of depressive disorders among young adults in 
Finland 
31 Keers et al. (2010) 
Stressful life events cognitive symptoms of depression and response to antidepressants in 
GENDEP 
32 Kessing et al. (2005) 
Depressive and bipolar disorders: patients’ attitudes and beliefs towards depression and 
antidepressants 
33 Kikuchi et al. (2011) 
Subjective recognition of adverse events with antidepressant in people with depression: A 
prospective study 
34 Kwan et al. (2010) 
Treatment preference, engagement, and clinical improvement in pharmacotherapy versus 
psychotherapy for depression 
35 Kwon et al. (2003) 
Antidepressant Use Concordance Between Self-Report and Claims Records 
36 Lewis-Fernández et al. (2013) 




37 Leykin et al. (2007) 
The relation of patients’ treatment preferences to outcome in a Randomized Clinical Trial 
38 Madsen et al. (2009) 
Working with Reactant Patients: Are We Prescribing Nonadherence? 
39 Lynch et al. (2011) 
Are patient beliefs important in determining adherence to treatment and outcome for 
depression? Development of the beliefs about depression questionnaire. 
40 Maidment et al. (2002) 
‘Just keep taking the tablets’: adherence to antidepressant treatment in older people in 
primary care 
41 Mergl et al. (2010) 
Are Treatment Preferences Relevant in Response to Serotonergic Antidepressants and 
Cognitive Behavioral Therapy in Depressed Primary Care Patients? Results from a 
Randomized Controlled Trial Including a Patients’ Choice Arm 
42 Misri et al. (2013) 
Factors impacting decisions to decline or adhere to antidepressant medication in perinatal 
women with mood and anxiety disorders 
43 Molenaar et al.  (2007) 
Does Adding Psychotherapy to Pharmacotherapy Improve Social Functioning in the 
Treatment of Outpatient Depression? 
44 Moradveisi et al. (2014) 
The influence of patients’ preference/attitude towards psychotherapy and antidepressant 
medication on the treatment of major depressive disorder 
45 Mundt et al. (2001) 
Effectiveness of Antidepressant Pharmacotherapy: The Impact of Medication Compliance 
and Patient Education 
46 Patten (2008) 
Confounding by severity and indication in observational studies of antidepressant 
effectiveness 
47 Parker and Crawford (2007) 
Judged effectiveness of differing antidepressant strategies by those with clinical depression 
48 Partridge, Lucke and Hall (2012) 
Public attitudes towards the acceptability of using drugs to treat depression and ADHD 
49 Pedrelli et al. (2008) 
Dysfunctional attitudes and perceived stress predict depressive symptoms severity following 
antidepressant treatment in patients with chronic depression 
50 Pilkington et al. (2013) 
The Australian public’s beliefs about the causes of depression 
51 Read et al. (2015) 
Beliefs of people taking antidepressants about the causes of their own depression 
52 Samples et al. (2015) 
Antidepressant Self-Discontinuation: Results from the Collaborative Psychiatric 
Epidemiology Surveys 
53 Serrano et al. (2014) 
Therapeutic adherence in primary care depressed patients: a longitudinal study 
54 Sher et al. (2005) 
Effects of Caregivers’ Perceived Stigma and Causal Beliefs on Patients’ Adherence to 
Antidepressant Treatment 
55 Shigemura et al. (2008) 
Patient satisfaction with antidepressants. An internet based study 
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56 Shigemura et al. (2010) 
Predictors of antidepressant adherence: Results of a Japanese Internet-based survey 
57 Sigurdsson et al. (2008) 
Public views on antidepressant treatment: Lessons from a national survey 
58 Sinokki et al. (2009) 
The association of social support at work and in private life with mental health and 
antidepressant use: The Health 2000 Study 
59 Sirey et al. (2001) 
Perceived Stigma and Patient-Rated Severity of Illness as Predictors of Antidepressant Drug 
Adherence 
60 Soudry et al. (2008) 
Factors associated with antidepressant use in depressed and non-depressed community-
dwelling elderly: the three-city study 
61 Sun et al. (2011) 
Mediating Roles of Adherence Attitude and Patient Education on Antidepressant Use in 
Patients with Depression 
62 Sundell et al. (2011) 
Antidepressant utilization patterns and mortality in Swedish men and women aged 20–34 
years 
63 Tatano Beck and Indman (2005) 
The Many Faces of Postpartum Depression 
64 Vanelli and Coca-Perraillon (2008) 
Role of Patient Experience in Antidepressant Adherence: A Retrospective Data Analysis  
65 Vega et al. 2010 
Addressing stigma of depression in Latino primary care patients 
66 Weich et al. (2007) 
Attitudes to depression and its treatment in primary care 
67 Wilhelm et al. (2005) 
Great expectations: Factors influencing patient expectations and doctor recommendations at 
a Mood Disorder Unit 
68 Wouters et al. (2014) 
Primary-care patients’ trade-off preferences with regard to antidepressants 
69 Wouters et al. (2014) 
Antidepressants in primary care: patients’ experiences, perceptions, self-efficacy beliefs, and 
nonadherence 
70 Yau1et al. (2014) 
Noncontinuous use of antidepressant in adults with major depressive disorders – a 
retrospective cohort study 
71 Yen et al. (2009) 
Predictive Value of Self-Stigma, Insight, and Perceived Adverse Effects of Medication for the 




CHAPTER 5.  KNOWLEDGE SYNTHESIS  
“Assessing medication depends upon appropriate knowledge and understanding”  
        (Dowell & Hudson, 1997) 
  
 The aim to detect the most significant and prevalent reasons for undertreatment in 
depressive illness should not be underestimated. The process of reviewing selected papers was a 
memorable and educational experience per se. By identifying the key points in interpretation of 
patients’ attitudes and views of pharmacological treatment, the researcher enters an area of real-
life experiences and gets exposure to human pain and suffering. The analysis feels like a 
disclosure of private, discrete and almost intimate information, touching upon people’s identities 
and also upon their deepest feelings and fears. The findings summed up, creating a research 
space where individuals shared their accounts of emotional highs and lows, complained about 
being misunderstood or marginalized, shared their religious and cultural beliefs, 
disappointments, anxieties and also their hopes. Almost all participants of the analysed studies 
were found to hold preconceptions about antidepressant treatments based on their own beliefs 
and on general views. Hence, the coexistence of several conflicting issues around the use of 
medicines in depression deserves further attention and explanation. People’s views may be based 
on their past experiences of the use of mood stimulizing drugs, but they can also result directly 
from depression paradigm, social judgments and stigma. Innovative steps must be taken with the 
attempt to explain not only “how treatment beliefs may influence treatment but also how and 
why treatment experiences in turn shape subsequent beliefs” (Aikens & Klinkman, 2012). Here, 
an effort was made to expose the most serious motives in patients’ decision making in regards to 
antidepressant therapy by extracting specific themes from the more extensive content presented 
earlier (Chapter 4.3.), and resulted in the following synthesis of findings:   
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5.1. Perceived Reasons for Non-acceptance of Antidepressants 
You want to put the baby first, but, at the same time, you're just balancing out what is the 
risk to the baby of having a mom who is on Prozac versus what is the risk to 
           the baby of having a mom who really can't cope and is falling apart (Bennett et al., 2007). 
 
Beliefs about the role and relevance of antidepressant treatment may affect whether or not 
patients wish to have depressive symptoms detected. Fear of social judgment and stigmatization 
plays a role in admitting to ill health. Misconceptions of depressive disorders, misinterpretation 
of symptoms and mismatches in patients’ and medical specialists’ beliefs and concepts about 
causes of depression negatively determined acceptance of treatment and subsequent adherence. 
Many patients raised concern about actual needfulness of their medicines. Resistance to viewing 
depression as an illness, the associated doubts about the need for antidepressants; and also, 
concerns about addiction and dependency, proved to play a significant role in the refusal of 
antidepressant treatment. A large number of people demonstrated strong resistance to being 
prescribed antidepressants, ascribing their attitude to the stigma attached to mood-regulating 
drugs. Patients were mostly concerned about side effects they might experience before they 
experience any therapeutic effects. Attitudes towards starting antidepressants use were shaped by 
stereotypes and stigmas related to perceived drug dependency and potentially extreme side 
effects. Views about cause of depressive symptoms were complex, and tended to evolve over 
time and through the experience of different medications. A large number of patients believed 
that underlying causes of illness cannot be not addressed by medication. The uncertainty was 
found particularly unsettling and had impact on patients’ ongoing views on and refusal of 
antidepressants as a potentially effective treatment option. People worried about the possibility 
of experiencing adverse effects and implications for their senses of self.  
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5.2. People’s Identities Feel Affected and Questioned 
 The reason I want to wean myself away from the medicine is simply 
because I will not conceive of myself as ill … I think that is very important 
   to my conception of myself that I don’t think  
   I’m some kind of therapeutic case (Knudsen et al., 2002 a)  
 
Religious and cultural beliefs may serve as protective measures against medical diagnosis; 
perceived need for autonomy may interpret drug treatment as ‘attack’ on the ‘self’. Knowledge 
and perception of depression, and viewing themselves as being given a label of mentally ill, may 
influence patients’ acceptance or refusal of medical diagnosis and treatment recommendations, 
thus patients may not engage in symptoms detection or chose denial as a form of self-protection. 
Taking antidepressants meant signifying either to themselves or others that they were a ‘failure’, 
someone who was ‘mentally ill’. In addition, there was not always awareness present that 
treatments for their ailments existed that might help. Some participants felt that medication was 
limiting their lifestyle and that antidepressants were not helping to address one’s real lifestyle’.  
 
5.3. Stigma, Blame & Responsibility 
There is a stigma definitely attached to them... of course there is you're 
doing something wrong if you're on antidepressants… 
I felt quite bad about taking them. It felt like kind of surrendering a bit… 
almost like having a criminal record…(Ridge et al., 2015). 
 
Often patients heard other people saying they are crazy because they were taking ‘depression 
pills’. They experienced this as hurtful, and felt marginalised and excluded (Egede, 2002).  
Quite often, close family members, in a fear of being blamed themselves for a relative’s 
emotional indisposition, developed feelings of shame and embarrassment, and demonstrated 
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negative attitudes toward antidepressant treatment. Being in denial of a next of kin’s depression 
and rejecting medical treatment is a frequently observed attitude, especially where concerns 
based on cultural or religious beliefs play a role (Vargas et al., 2015).  
 
5.4. Seeking and Accepting Help 
Antidepressants, they aren't a quick fix to make you better, but they help 
you to cope better with what you're going through (Anderson & Roy, 2015). 
 
Individuals often described trying to ‘manage’ on their own, long before seeking help. Also, 
difficulties caused by impaired cognitive ability to engage in decision making justified the 
reasons for denial of depressive conditions. However, the individuals who sought help from 
health services in order to gain and maintain control over their depression, accepted offered 
treatment options as suggested by their physicians. Others felt they benefited in time, if not 
immediately.  
 
5.5. Receiving/Obtaining Information about Medications 
…there is one person saying it’s a good idea to take them and somebody 
saying no, you should not take them; I was in the middle and I couldn’t 
make my mind up, I was really confused, I think, I’m worse at the minute; 
I just can’t make my own mind up’ (Malpass et al., 2011). 
 
In the absence of information from their doctors, patients wanted to find out more information 
before taking their first tablet. Primary information sources were media, culture, anecdotes, and 
past experiences with nonpsychotropic medications (Aiken, Nease & Klinkman, 2008). 
Depressive patients often wished to know how the antidepressants work by seeking information 
from the health care system or public sources such as libraries, media and Internet. There were 
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patients who spent days and weeks before or after filling the first prescription, educating 
themselves and wondering whether or not to take the antidepressant. Some had second thoughts 
after reading articles or public forums online. Printed information was found important; sources 
of non-verbal information included leaflets generally obtained from doctors. People also felt that 
the information they had received from the health care professional was true when confirmed by 
another source. In these instances, people more happily accepted the treatment option as 
suggested by their doctors, which fitted with their view of what treatment was needed. Carers 
wished for ‘detailed knowledge about the diagnosis and progress of the dependent individual's 
condition and, as far as possible, the prognosis: what to expect.’ 
 
5.6 . Initial Use of Antidepressants 
I did know a bit about antidepressants and I definitely didn't want 
any of that. The doctor suggested it to me three times, and all three times I 
pushed it off. Eventually, when the situation got quite desperate, I gave in 
(van Geffen et al., 2011). 
 
Interestingly, once people have actually made the decision to seek help, what happened at the 
initial consultation with their physician was critical for patients in their decisions to subsequently 
take their antidepressant or not. Anxieties were expressed about starting use, and about how long 
the antidepressant might begin to take effect, how much it might help, and about what to expect 
in the initial weeks. People who had not been prescribed an antidepressant straight away 
appreciated the time given to reflect about it. Some waited before deciding that medication was 
appropriate. First experiences with medicines were often not pleasant. The majority of patients 
preferred to be ‘in control’ of their own emotions and saw antidepressants only as a temporary 
rather than a permanent solution. Medication was often seen as an initial aid to surviving a crisis. 
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Once participants had survived a crisis, they often began to re-evaluate their treatment. For 
others, just the fact that they were taking the antidepressant and were doing something about 
their depression, helped. Some believed that antidepressants are not the only solution to improve 
one’s health and that alternative medicines are a better choice, or antidepressants combined with 
other therapy. Several respondents wanted to get rid of their depression and medicine was 
viewed as a necessity to overcome the depression. A number of patients started the prescribed 
drug treatment soon after diagnosis. Participants who received information about the ‘chemical 
imbalance’ in neurotransmitters found the ‘news’ helpful, as this enabled them to interpret their 
depression as a physical rather than a mental illness, and accepting antidepressants became 
easier. Medicines were then considered as an important aid through which one could gain a sense 
of having a “normal life.”  
 
5.7. Views of Antidepressants 
I started taking (an SSRI) which convinced me that there was a problem 
because I felt so much better, the change was fantastic (Badger & Nolan, 2007). 
 
People’s experiences with antidepressants use were found to have a major impact on treatment 
continuation and treatment outcomes. Participants differed in how they experienced and 
evaluated the effects of medication. Outside of crises, participants often felt more ambivalent 
about medication. Skepticism about antidepressants was strongest among younger patients who 
have never taken antidepressants, viewed their symptoms as mild and transient, and felt unclear 
about the factors affecting their depression (Aikens, Nease & Klinkman, 2008). Beliefs in 
efficiacy of mood stabilizing drugs also varied between cultures. For example, Chakraborty’s et 
al. (2009) study conducted in an Indian population found that most patients have erroneous 
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beliefs regarding antidepressants per se which in turn influence the drug compliance, particularly 
in male patients.  
 
5.8. Side effects 
[They were] greatly disappointing. I wish I had never tried them, because before I 
tried them at least there was hope that something could have helped. Each one has had a 
worse effect than the previous…. I can’t remember them all. It started with memory loss 
then progressed to me becoming borderline catatonic staring at the wall for hours unable 
to stand up. Within a few weeks and genuinely terrified. It was a relief to go back to the 
misery of depression after these experiences (Gibson, Cartwright & Read, 2016 b). 
 
Unexpected side effects were discovered that were severe, long-term or psychological in nature 
(such as feeling ‘flat’ or ‘dulled’). Perceiving a medication as ineffective or having unwanted 
‘side effects’ lead the patients and their prescriber to seek a different medication, maintaining the 
drug loop. In some cases, respondents believed their physicians withheld information about side 
effects of the medication.  
Table 8. Reported adverse effects associated with antidepressant use 
 
From: Burra et al., 2007 
99 
 
5.9. Personal Control and Perceived Effectiveness of Treatment 
Self discipline, I'd be disappointed to think it was just the medication. I would like 
to think that I don't need to go back on them (medication) again (Badger & Nolan, 2007). 
 
In multiple cases, medicines were said to have given the patients control over their health. 
Carpenter-Song et al., (2010) talks about efficacy of treatment. One of the patients from her 
study positively reflected on taking antidepressants: But I would never regret taking them 
because taking them has totally changed my life … Taking them … I don't feel that so much now 
… But when I first took them, I felt like I had been given my life back. I feel like I can now be a 
normal person (Carpenter-Song et al., 2010). Also, Anderson & Roy’s (2015) included patients’ 
positive feedback on antidepressants: People call them happy pills […]. But you don't walk 
around stoned or sort of “Oh isn't life wonderful.” You just feel normal, that's what they make 
you do, they just make you feel normal. You don't feel euphoric, you don't feel manic, you don't 
feel spaced out, drunk, stoned, whatever you want to call it. You just sort of feel yeah, this is the 
way life is supposed to be, everything just feels alright, balanced (31-year-old male). I had to try 
a lot of different antidepressants until they found one that worked and suited me (Anderson & 
Roy, 2015). 
However, medication was not always perceived as appropriate. In other situations, the act 
of taking medicines took away control over health as well as it was believed to have destroyed 
motivation and interest of life. Tensions/ambivalence around medicines was observed. A large 
number of people admitted they would prefer to manage their ill symptoms without 
antidepressants, wanting to come off them as soon as possible if continuing the therapy. One 
woman strongly felt that the root cause of her depression was living with an alcoholic partner 
and consequently, she perceived medication as irrelevant (Badger & Nolan, 2007). Participants 
100 
 
were more likely to experience a drug loop when they felt passive, which was often linked to a 
strong medical emphasis and lack of collaboration in consultations. Elements of the drug loop 
appeared to include medication effects, a limited ‘Prozac’ lifestyle, feelings of passivity, 
experiences of not being listened to, unaddressed underlying causes, perceived personal fragility, 
and dilemmas about dependency. At the same time, positive effects were noticed: respondents 
felt better as a result of their medicines.  
 
5.10. Communication and Relationship Issues with Health Care Specialists 
I felt neglected by my doctor that day and I was convinced that he had given up 
on me and my depression, because he did not care to listen: because he just wrote the 
prescriptions and then he was finished with me. He didn't say that I should return; he 
didn't say that I should come for some counselling; he didn't say, “I'd like to keep track of 
you”. “You can come and get a renewed prescription and we'll talk”.  
He didn't say that he had any such an offer, and, out I go (Buus, 2014). 
 
People’s views on effectiveness or harmfulnesss of antidepressant treatment was extremely often 
based on the quality of their relationships with healthcare providers. Having a good relationship 
with a doctor was an important indicator of whether people would discuss their need for 
information about adverse effects. Being able to talk to their doctor enabled them to reflect on 
their difficulties, and to better understand or reframe their experiences. In Chakraborty’s 
quantitative study, 92% agreed that doctor reserved sufficient time to listen to patient’s problem, 
explained the causes of depression sufficiently, and felt confident that antidepressants are 
suitable treatment of their depression etc. (Chakraborty et al., 2009). For some patients, the first 
experience was pleasant and antidepressants were viewed as essential in fighting illness. 
Unfortunately, many patients had unsatisfactory interactions with health care professionals and 
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patient-doctor interactions often implied treatment setbacks. Examples included thinking that the 
doctor did not communicate well or, did not listen to them, did not spend enough time with them. 
Doctors also tend to not provide sufficient up to date information. A common experience was 
feeling ill-informed about medication and about alternatives such as psychological therapies. 
Superficial or shallow responses from doctors to patients were commonly described and 
experienced as negative and disempowering.  
A large number of patients experienced limited autonomy in their encounters with health 
professionals. Often the reasons for their antidepressant prescriptions, or the side effects were not 
explained at all. Doctors who prescribe medication should engage in open dialogues about 
treatment options as patients weigh up their experiences of the effects of antidepressants, their 
beliefs in illness causation, and their relationships with health care professionals, to make a series 
of decisions about their treatment. Some people believed they were completely excluded from 
the decision-making. Several participants described prescribers not listening to their concerns, 
and this could also be a factor influencing them to seek alternative therapies.  
 
5.11. Timeline and Prediction of Recovery  
I don't really know. The doctors will keep an eye on things and if the time was 
appropriate then they would take me off it but… having kept me on it I assume they are 
happy for me to go on taking it so I take it but … with all this medication I would come 
off it if I could. If I can't come off it then I accept it (Dickinson et al., 2010). 
 
Patient beliefs about the course of their indisposition are said to affect detection of symptoms. 
Those who expect quick resolution may not think it to be appropriate to seek treatment. Those 
not believing in biological mechanism of depression, will be avoiding medical diagnosis and 
initiation of therapy. Others were surprised and even frightened by some of the things doctors 
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said about what antidepressant taking would mean for them in the future, for example, that the 
treatment would take a long time.  
 
5.12. Continuation of Treatment 
But I would never regret taking them because taking them has totally changed my 
life … Taking them … I don't feel that so much now … But when I first took them, 
I felt like I had been given my life back.  
I feel like I can now be a normal person (Anderson & Roy, 2015). 
 
A Canadian quantitative study by Burra et al., (2007) reported high levels of adherence. A rapid 
return to ‘normal’ functioning, supportive relationships with professionals, and information 
about medication effects all tended to lead people to continue taking their prescribed 
antidepressants. People who stopped medication and experienced a recurrence of depression 
often came to feel more dependent on medication, and feared stopping it again in the future. 
Frequent consultations with physicians, involving shared decision making, including a good 
discussion about their views, fears and goals and previous experiences of taking antidepressants, 
were found to be helpful. There was a frequent perception that taking medicines is an act of 
balancing benefit versus risks. 
 
5.13. Discontinuation of Treatment 
I had reached the point where I took very little of it. It was just once in a 
while. Really, there was no control. I just took it when I thought, “Well, it's been a 
while, so I'd better take a pill or two”. In the end, it was horrendous. And I just 
didn't feel that I needed it. And then I just stopped completely.  




The number of patients who discontinued the use of antidepressants due to adverse reactions was 
high. Forgetting or a change in the routine were the most frequently identified reasons for 
nonadherence. Staying on medication longer term resulted in some participants feeling caught in 
a ‘drug loop’. Feeling dependent on medication and viewing it as an artificial control of mind, 
created dilemmas. Frequent reasons leading individuals to stop the medication or to experiment 
with the dosage included a lack of regular follow-up routine from their doctors. Since 
consultations with practitioners were not always therapeutic and multiple patients’ questions 
about alternatives to prescribed medication were dismissed, people explained the intake of 
antidepressants as non-therapeutic and made the decision to withdraw from treatment after the 
initial start and short-term use. A number of people tend to stop using healthcare services and 
withdraw from treatment, trying to self-manage their depression through self-medication and 
alternative practices, but also with the use of controlled substances such as alcohol and drugs. 
 
5.14. Self-Reported Reasons for Nonadherence with Antidepressants 
Presented by Burra et al., 2007 model of ‘unintentional non-adherence’ (a term used by 
Gadkari & McHorney, 2012), describes a “passively inconsistent medication-taking behavior”, 
e.g. forgetfulness or carelessness, marking the most frequently identified grounds for not taking 
antidepressants as prescribed. For example, the most frequent reasons were simply forgetting, 
experiencing a change in daily routine, or running out of pills. Gadkari & McHorney (2012) 
studied the prevalence and predictors of unintentional non-adherence and explored the 
interrelationship between intentional and unintentional non-adherence in relation to patients’ 
medication beliefs. Yet if the non-adherence to antidepressant treatment is, indeed, caused by 
such simple factors, it should not be very problematic to improve it. The reasons for 
undertreatment of depression must be therefore much more serious than those indicated above. 
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Burra’s et al. (2007) quantitative data support the qualitative findings summarized in this 
review. However, it is important to remember that they are all based on self-reports; therefore, in 
consideration of possible bias, they should be seen as a possible variation of truth: “Reported 
levels of adherence, experience of side effects, and rating of depression severity may all have 
been subject to recall bias” (Burra et al., 2007). Beck stated that an astonishing contrast between 
the depressed person’s image of him-herself and the objective facts has been observed (Beck, 
2009). Thus, recall bias may be present in patients’ accounts as the result of cognitive 
disturbance. These factors should be substantiated in the analysis of the results and be accounted 
for in the interpretation (Althubaiti, 2016). 
 
Table 9. Self-reported reasons for non-adherence  
 




CHAPTER 6. DISCUSSION 
 Treatment beliefs changed as patients gained experience with medication. 
Moreover, these changes were in the proadherence direction.  
        (Aikens & Klinkman, 2012) 
 
Burra et al. (2007) propose a summary of factors which are believed to affect patients’ 
adherence to antidepressants. In support of their concepts (Table X), they also provide additional 
academic sources. These themes correspond with the concepts identified earlier in Chapter 5.  
Adherence to treatment resulting from satisfaction or refusal to use antidepressants is associated 
with patients’ ethical, cultural and religious choices, drug-tolerability, ease of administration and 
a preference for relatively inexpensive (covered by insurance) treatment in mental illness (Gussin 
and Raskin, 2000). Preferences can be discussed only in cases where individuals will receive the 
chance to try different treatments. Research findings suggest that people have predominantly 
negative views of antidepressants and most of patients as well as non-depressed persons prefer 
psychotherapy to medication, when given the choice (Gibson, Cartwright and Read, 2014). 
Negative views about the consequences of receiving diagnosis of depressive illness often lead to 
hopelessness and prolonged denial, or cause defensive attitudes. Pessimistic approach toward 
treatment with antidpressants may lead to refusal of medications or to discontinuation of initiated 
therapy. Consequences of untreated or undertreated depression can be serious, and lead to poor 
quality of life and in extreme cases, to suicidal ideation.  
Treatment adherence results from personal beliefs and treatment satisfaction in cases when the 
treatment is initiated. Patients who experience symptom relief and improvement of their quality 
of life, are believed to take the medication correctly for the prescribed time and their 
collaboration in treatment predicts the desired therapeutic outcome (Simon et al., 2001). 
106 
 
Table 10. Summary of factors that affect adherence to antidepressants 
Factor Supported by: 
The experience of adverse effects associated 
with the medication 
Hotopf et al., 1997; Williams et al. 2000; 
MacGillivray 2003; Sleath 2003; Ayalon 
2005; 
Medication efficacy   Geddes et al., 2000; Furukawa 2002; 
Physician-patient communication  Lin et al., 1995; Demyttenaere, 1997; Bull et 
al., 2002; Nierenberg, 1999; Bultman & 
Svarstad, 2000; Keller et al., 2002; 
Demyttenaere, 2004; Kessing et al., 2005; 
Cognitive behavioral constructs (eg. Patients’ 
general attitudes toward medication, specific 
attitudes toward mood disorders, perceieved 
stigma associated with mental illness) 
Lingam & Scott, 2002; Ayalon, 2005; 
Demyttenaere, 1997; Demyttenaere et al., 
2004; Kessing, 2005; Sirey et al., 2001; 
Becker & Maiman, 1975; Fawcett, 1995; 
Hoencamp et al., 2002; Brown et al., 2005; 
Sher et al., 2005;  
Fear of addiction or dependence and the 
desire to solve health problems without the 
use of medication 
Lin et al., 1995; Demyttenaere et al., 2004; 
Hoencamp et al., 2002; Delgado, 2000; 
Demyttenaere et al., 2001; 
Clinical features of depressive disorders, such 
as lack of insight, poor concentration, low 
motivation, excessive guilt, periods of 
remission 
Adams & Scott, 2000; Keller et al., 2002; 
Kessing et al., 2005; Sirey et al., 2001; 
Fawcett, 1995; Wrigth, 1993; 
Depression severity Adams & Scott, 2000; Cohen et al., 2004; 
Sirey et al., 2001; Brown et al., 2005; 
Comorbid anxiety or substance abuse 
disorders 
Fawcett, 1995; 
Sociodemographic characteristics such as age 
and gender 
Cohen et al., 2004; Ayalon et al., 2005; Lin et 
al., 1995; Bull et al., 2002; Sirey et al., 2001; 
Demyttenaere et al., 2001; 
 
By: Burra et al., 2007 
 
Key issues, such as quality of the relationship with health care professionals, or patient’s 
feelings of control over treatment and own well-being, influence the interpretation and use of 
medications (Benson and Britten, 2002; Ridge et al., 2015). Here, patients are increasingly 
considered to be active agents in medication management (Ridge et al., 2015). People who had 
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sought doctors’ help for depression were less likely to believe in the helpfulness of alternative 
treatment and they more likely believed in medical interventions and quick solution. The general 
belief patterns emerged in those who had sought help, were more likely to choose 
antidepressants as helpful, and assigned less value to external support. Those with current 
depressive symptoms were less likely to rate telephone counselling, family and friends as 
helpful. Patients with a history of depression who refused pharmacological intervention preferred 
counselling as the most effective strategy. At the same time, genuine compassion and full 
collaboration of health care professionals, family members and friends were found to be crucial 
in depression management. Also, patient-doctor relationship based on trust was believed to 
provide a positive environment where wise and careful treatment decisions were made. 
Generally speaking, having sought medical help reflected patients’ beliefs similar to those of 
health care providers and predicted improved adherence to drug treatment (Jorm et al., 2000).  
Dilemmas and uncertainty around medicines often arise and continue as treatment 
progresses. Long-term antidepressant use is said to be relatively common in primary care. Yet it 
occurs within the context of complex mental, physical and social problems. The most frequent 
long-term use of medications is associated with recurrent depression (Ambresin et al., 2015). The 
beliefs in treatment resistant depression and prognosis of prolonged symptomatic cycle lead 
patients to view medications as harmful and useless when facing the challenge of long term 
interventions. Perspectives of a long-life-treatment and necessity of tolerating bothersome side 
effects of antidepressants frequently lead to non-adherence. Patients reported feeling dependent 
on medication, but at the same time, they experienced fears that discontinuation would cause a 
relapse and another crisis. Therefore, constant treatment re-evaluation, adjustments, as well as 
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timely discontinuation of drug intake where cessation is recommended, should become a routine 
practice (Ambresin et al., 2015).  
The majority of studies presented descriptions of aspects that prevented individuals from 
taking their medications as prescribed. At the same time, a number of patients invested a great 
amount of trust into their drug therapies, hoping for a quick relief and prolonged control of 
depressive symptoms. Other hopes were for avoidance of relapse and hospitalisation, for disease 
progression to slow down or cease, for the prevention of a more serious and permanent illness, 
and mostly, for normality of everyday life. All studies reported people’s experiences of adverse 
effects of antidepressants. These reactions were unpleasant and caused individuals’ frustration, 
and also, because they were frequent, severe and unpredictable, they brought fear and distrust of 
the medicine. Some patients found drug treatment so overwhelming that they were no longer 
physically in control of their lives. The drug regimen had a long-term impact on social 
relationships, employment and studying, not just on daily routines.  
 The informants also claimed that aversion to psychotropic medications was much 
stronger in men than in women. Women were more concerned about the impact of the regimen 
on relationships while men were concerned about its impact on themselves. The intake of mood 
stimulating pills was also found to be problematic because it disrupted the individuals’ 
perception of ‘self’ and in their own beliefs, it marked them out as different (self-stigma). For 
these reasons, many patients decided not to pursue the treatment. Weighing and balancing the 
undesirable effects of pharmacological therapies against benefits occured almost in every single 
case. For some, the negative aspects of the medicine intake appeared to be so drastic that it was 
not negotiable to try them or continue with the treatment. Many patients felt that despite the 
possible benefits of treatment, side effects were too debilitating to make it worth the risk; others 
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believed that ‘alternative’ treatments were better for the quality of life they desired. In multiple 
interviews the informants described the medicine as more threatening to their well-being than the 
depressive disorder itself. Similarly, some individuals chose quality of life with untreated 
depression over using antidepressants. 
Patients tend to experiment with antidepressants by modifying their medication use 
without professional input. People are involved in a constant ‘lay evaluation’ process (Pound 
et al., 2005) which is characterised by uncertainty: Uncertainty is defined as an ongoing process 
of evaluation of antidepressant use, in which “risks and benefits, hopes and fears, positive and 
negative self-images are all balanced, and decisions reached” ( Verbeek-Heida & Mathot, 2006, 
p. 138). During this process, patients weigh up the evidence for starting, continuing and stopping 
antidepressants. This involves two key aspects – their medication experience and their 
consultation experience. Patients' experiential knowledge (based upon observations of their own 
and others' behaviour and experiences) is compared to information given by health practitioners. 
The latter was experienced as inadequate or even harmful by many patients (Bollini et al., 
2004, Garfield et al., 2004, Haslam et al., 2004 and Nolan and Badger, 2005). A study by Martin 
et al. (2005) found that some practitioners tend to ignore their patients’ symptoms, what may be 
resulting in late interventions (Martin et al., 2005). Multiple encounters with the health system 
were found unrewarding because health providers reinforced that the responsibility for help-
seeking and self-managing rested entirely on the patients.  
Health professionals should consult research findings to better understand and explore 
with patients their concerns before prescribing antidepressants. These insights are key to 
supporting patients, many of whom feel intimidated by the prospect of taking antidepressants, 
especially during the uncertain first few weeks of treatment (Aikens & Klinkman, 2012). 
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Aikens & Klinkman (2012) also suggest that prescribers should be advised to carefully elicit 
patient beliefs at the time of treatment initiation. Health care professionals might expect patients' 
beliefs about their antidepressant to evolve in a more pro-adherence direction as treatment 
proceeds. They should actively encourage this movement by pointing out when actual experience 
suggests either desired medication response or a lack of side effects. Prescriptions for those 
patients who express concerns about side effects should be tailored towards a less aggressive, 
“built for comfort” regimen that tends to minimize side effects even if this is at the expense of 
rapid relief. Another proactive strategy clinicians should adopt is to predict adverse effects and 
inform the patient about them. Perceiving a medication as ineffective or experiencing 
bothersome ‘side effects’ should lead the patient and the physician to seek a different medication 
to maintain the drug loop (Brown & Bussel, 2011). 
Clinicians could also encourage patients to observe and track their symptoms because this 
allows the clinician to evaluate the efficacy, which in turn may strengthen adherence. On the 
other hand, because perceived need increases regardless of actual symptomatic improvement, 
this approach must be balanced with active consideration of nonpharmacologic treatment 
strategies such as psychotherapy, physical exercise and supportive watchful waiting (Rottman et 
al., 2016). Moreover, because medication concerns can be expected to either strengthen or 
weaken based on treatment experience, suggesting brief counselling sessions in addition to drug 
therapy may help, and this actually is, what most patients wish for. Perhaps, depression treatment 
guidelines and policies should put less emphasis on attempting to modify people’s adherence 
behaviours and more on implementing efficient diagnostic tools.  
The perceived dependency on medication or difficulty communicating with doctors has 
been linked to patients’ own perceived values and personal goals, but also to the cognitive–
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behavioural presentations of that person's depression. In addition to featuring emotional 
instability, depression is associated with considerable cognitive dysfunction, although cognitive 
impairments may also be produced by chronic administration of some tricyclic antidepressants 
(Judd et al., 1987). Marazziti et al. (2010) claims that major depression affects the ability to 
think, focus, make decisions as well as formulate ideas and reasons. This becomes a concerning 
issue. Patients are expected to make wise decisions about their treatment, but, due to their mental 
confusion are unable to do so. When talking about depressive patients making firm treatment 
choices in the context of their cognitive impairment, we must not forget that their decisions may 
“deviate from a certain standard of rationality” (Patel, Kaufman and Arocha, 2001) and can be 
primarily heuristic and biased (also in: Chapman and Sonnenberg, eds. 2000; 2003).  
Depression is said to be a growing issue for the general population and a significant 
public health concern across all regions of the world, with the prediction to become a major 
contributor to the global disease burden by 2030 (WHO, 2001). While primary prevention in 
depressive disorder remains an elusive goal, provision of pharmacological treatment has been 
viewed as having the capacity to reduce its impact on population health. The newer 
antidepressants are said to be relatively safe and their administration is becoming very common 
(Hollon et al., 2002). Ironically, depression treatment quality and outcomes are thought to be 
relatively poor and result mainly from low compliance (Hidalgo et al., 2015).  
As the findings of this study confirmed, people’s beliefs, perceived personal values as well as the 
opinions of others, influence adherence to treatment in depressive disorder.  Patients’ accounts of 
their experiences with depressive illness, medical consultations, acceptance versus refusal of 
pharmacological treatment, and descriptions of adverse side effects of antidepressants, refer to 
the perceived rationality of thinking and to common behaviours in depression. In the times of the 
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overwhelming presence of media and social networks, public opinions are shaped and spread, 
influencing individual perceptions, views and beliefs. Since barriers to medication adherence are 
complex and diverse as described above, the solutions to improve compliance should also be 
multifactorial (Brown & Bussel, 2011); however, this problem is beyond the scope of this 
review.  
 Nevertheless, my final remarks in the adherence discussion will repeat what was indicated 
previously and are based upon the important aspect of prescribing antidepressants. In lieu of 
focussing on the patients and the issue of their nonadherence to antidepressants, the research 
might focus on ways to improve diagnostic procedure in depression. A simple reflection of one 
of the patients in Lavender, Khondoker and Jones’ (2006) study speaks volumes: My own advice 
to doctors..if it is a woman, they should try to invite the husband…and tell him that look, the wife 
got a depression […] and they should […] try to advise them that he is the right person to help 
the woman, because that woman is only with the doctos for a few minutes (Lavender, Khondoker 
and Jones’, 2006).      
 The aspect of rushed and seemingly premature administration of antidepressants was 
largely discussed earlier, nonetheless including the next of kin into a patient’s therapy in 
depression, and especially when medication treatment is being considered, should become a 
routine in health care practices. It is because that patient “is only with the doctos for a few 
minutes” (Lavender, Khondoker and Jones’, 2006) and there is a big chance that the person 
suffering from affective disorder is simply unable to give a full account ot their symptoms and 
behavioral patterns.      




     CHAPTER 7. CONCLUSION 
 “For population health management to work, 
 the population must feel empowered to manage its health”  
(Song & Lee, 2013) 
 
 Recent studies stress the need for continued research to assist patients and health care 
professionals in minimizing non-adherence to achieve maximum results in antidepressant 
treatment, in particular in chronic depression (Burra et al., 2007). There is a strong belief in the 
importance of contributions, which people with disabilities and illness make “to research and to 
their own care and the care of others” (Dupuis et al., 2012). Studies of anti-depressant 
medications also seem to possess a special value for research analysis because, as Karp (1993) 
stated, those pills “are linked with the meaning of emotional experience and they are designed to 
alter ‘abnormal’ moods and emotions”. Depression is a mental disorder that is pervasive in the 
world and affects us all. While efficacious therapies are said to be available, the resources remain 
unused. Cost-effective treatments are being offered to improve the health and lives of people 
suffering from this disorder. Ironically, all things a patient would need to do in order to recover 
from bothersome symptoms, are already made hard and unmanageable by depression alone: eat 
well, sleep well, be active, and develop realistic life approach; all greatly recommended as basic 
remedies. Typical symptoms of depression include anhedonia, insomnia, lethargy, negative 
thinking and cognitive impairment as well as feelings of emptiness and hopelessness in times 
when people should maintain optimism and hope. In addition, a large number of individuals 
suffering from depression resist taking their medicines. It is assumed that the most serious 
reasons for refusing or delaying treatment with antidepressants are of the social, 
cultural/religious, and/or financial nature (Lane, 2014). Changes in patients’ beliefs about their 
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antidepressant have been reported during both the acute phase of depression treatment and 
during continuous drug therapy (Aikens & Klinkman, 2012). The underlying mechanism of 
indeciseveness or wrong decision making may be rooted in memory and (sub)conscious 
awareness (Henke, Reber, and Duss, 2013). Research on undertreatment in depression provides 
data on undiagnosed and untreated individuals with self-awareness of depression (Cabassa et al., 
2007). Findings emerging from the studies reviewed here are based on self-reports and as such, 
they represent patients’ subjective views. Thus, individual motives leading to undertreatment in 
depressive illnss should continue to be explored; and hopefully, depression will be one day 
finally understood in terms of its paradoxes (Beck, 2009).  
By assigning value to patients’ opinions and beliefs, summarised by qualitative and 
quantitative research, this thesis aims to provide an in-depth understanding of people’s 
perspectives on mood-stimulizing medicines. Let us start with a basic question: What makes the 
diagnosis and treatment of depression so difficult in comparisson to other diseases? One 
respondent in Lafrance’s (2007) study voices the opinion: “[I]t is so personal. Nobody can 
understand how bad you’re feeling. And like you can go to a doctor, you got bad asthma, you 
can’t breathe? They can understand that. They can see it, they can feel bad for you and they can 
really try to help you without feeling sorry for you.  When you’re feeling depressed, people don’t 
understand, they figure you’ve just got the blues and you’re not dealing with it (Lafrance, 2007). 
A chronic disease management approach is becoming widespread practice for depressive 
disorder; qualitative studies of how patients behave when first seeking help in primary care and 
continuing treatment, is important. The ambiguity of understanding symptoms as either a disease 
or a normal emotional response to life events suggests significant differences between patients 
with recurrent depression and those with initial episodes. The findings presented here 
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demonstrate the individual nature of understandings of depression, and the variety of self-
management strategies used in primary care. In Brown’s et al. (2005) quantitative study, 
depressive patients generally confirmed the view that their current or future health depended on 
antidepressant medication. More than a half reported that mood-stimulizing drugs prevented 
them from getting worse. Bitner et al. (2003) found reductions in negative emotions of anger and 
sadness and the enhancement of positive emotions of happiness, joy, and love are consistent with 
therapeutic expectations, as are the improvements in calm and self-esteem. All positive changes 
were attributed to antidepressants by the respondents in this study (Bitner et al., 2003). One 
patient in Anderson’s et al., (2013) study confessed: I was relieved to be diagnosed with 
depression and be prescribed an antidepressant. Once that was done it was like such a relief 
because I knew what was wrong and I could see there was now a way of fixing it. I have to say 
my father had depression a few years ago so I knew that there was a ‘fix’ because he recovered, 
he got treatment and he got better, which helped me a lot (Anderson et al., 2013).  
Nevetheless, major concerns about antidepressants were also shared. Ambresin’ et al. 
(2015) study suggests that patients continue to experience symptoms and disability despite 
antidepressants and high primary care use. Many individuals admitted that they worried about 
the long-term effects of antidepressants, about becoming too dependent on tablets, or, that thay 
could not comprehend how psychotropic medications work. Commonly reported beliefs were 
concerns about the overuse of medication. Some patients endorsed the belief that medication was 
harmful; 20% of participants believed in addictive properties of medications (Brown et al. 2005). 
A 39-year-old male patient’s hesitation is explained as follows: I've been prescribed 
antidepressants in the past but I've always felt reluctant and apprehensive about taking it, 
largely because a) I feel that the effects are probably short-term, they're not going to actually 
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resolve the depression, b) because they do have side-effects and, and c) I didn't feel comfortable, 
myself, with taking some tablets (Anderson & Roy, 2015). Being ‘drug-free’ after a short-term or 
prolonged antidepressant treatment is perceived as a sign of being cured from depression 
(Brijnath & Antoniades, 2016). The most common way of coming off the medication is by 
experimenting by lowering doses: In time, adverse effects of the medicine became unacceptable 
to me and occasional slips, which seemed less scary than making a deliberate stop, became more 
frequent and eventually confirmed me in having no need for the medicine (Buus, 2014).  
My findings provide evidence that adherence to antidepressants is a complex health 
behavior that is mediated by multiple factors based on cultural, religious and ethical beliefs. The 
most serious reason for non-compliance are adverse side effects that people experience, similar 
to those presented in Chur-Hansen & Zion’s (2006) paper:  
Vanessa: I reacted badly: I was shaking, trembling, unable to sit still, being jittery, felling worse, 
felling ‘not normal’, dry mouth, felling sick, and being drowsy as side effects. 
Lily: I experienced adverse reactions to the SSRI, including apathy, emotional numbness and 
hallucinations (including seeing myself being hit by a car and falling on knifes). I simply 
believed that the SSRI actually induced a depressive state worse than the one for which it had 
been prescribed.  
Cheryl: I did not have any physical side effects, but I found that the medication resulted in me 
having ‘no emotions’. You just feel like a zombie at times. And I don’t know if it’s worth it. 
Julie: You name it: nausea, tremor, decreased appetite, headaches, thirst, feeling sick, agitation, 
anxiety, impulsivity and violence. I have become particularly worried about the increase in my 
impulsivity and violent behaviour, which is totally uncharacteristic for me, and which was 
becoming more frequent and pronounced over the last three weeks. I have never been violent to 
117 
 
anything ever in my life, I’ve always taken it out on me. And […] for the first time […] I just 
snapped, and I basically threw the cat five meters across the room. And that just scared me, I 
didn’t know what that was. And I was impulsive, there was no thought behind it (Chur-Hansen & 
Zion, 2006).  
Questioning physician’s abiliy to provide a correct diagnosis of depressive illness is 
voiced in multiple papers (Amey, 2010; Anderson & Roy, 2013; Anderson et al., 2015; Buus, 
2014; Bennett et al., 2007; Bayliss & Holttum, 2015; Carpenter-Song et al., 2010; Lavender, 
Khondoker & Jones, 20016). They don’t know what works and what don’t work. First, they put 
you on a medication and when you tell them you don’t need it anymore they just put you on 
another one. I get sick of taking pills, pills, pills. I don’t need all this medication. They keep 
telling me I need medication but I don’t. The medication is what makes me sick. I don’t feel right 
when I take it anyway (Carpenter-Song et al., 2010). 
Another similar view is presented in Bayliss & Holttum’s, (2015) study: [Doctors are] all about 
the medicines…we'd all like to think that we're visiting Frasier Crane but we're not, you don't get 
to lay on the couch, you don't get to discuss your problems…you get to go in for 10 minutes if 
you're lucky once every 3 months – ‘How are you feeling? Still taking medication? Sleeping 
alright? Well we'll leave you on that then’…and I've had that for 10 years so I guarantee 
you…that's what happens” (Bayliss & Holttum, 2015). 
The issue of being able to make a correct diagnosis after a brief conversation with the patient and 
relying on patient’s self-report has been stressed in multiple articles. Here an example of a 
participant’s reflection: “Even after deciding to start antidepressants, actually contemplating 
swallowing the tablet for the first time could feel like a momentous occasion: I Ieft them on my 
top shelf for ages and I just didn't want to take them because I was a bit confused as why I; he's 
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prescribed me that after like a really short chat, just me saying I was down and maybe at the 
time they were handing them out left right and centre, I don't know (Anderson & Roy, 2013).  
Hence, possible erroneous diagnoses in depression should be suggested, as they might lead to 
wrongfully recommended antidepressants, and consequently, to unsuccessful treatment with 
adverse effects and and ‘invited’ non-compliance (Gadkari & McHorney, 2012). Deciding how a 
false diagnosis may be made in depression is beyond the scope of this review, however, in my 
opinion, the issue predicts the nonadherence. It has been suggested that general practitioners 
need more training to perform diagnoses and treatment in depression more effectively. 
Although a precise assessment of levels of self-reported antidepressant adherence and reasons for 
nonadherence (Burra et al., 2007) presents a challenge, this review aims to provide knowledge 
support in the area of depression.  Pope, Mays and Popay (2007) propose “different objectives of 
reviews” by making a clear distinction between ‘knowledge’ versus ‘decision support’ (p.13). 
Here, patients’ beliefs and views that are emerging directly from their lived experiences of 
depression and antidepressant use are believed to create a solid fundament for continuous 
research. Hopefully the results presented here will broaden the general knowledge of how the 
drug treatment in depression is perceived by those directly affected by the disorder. This, in turn, 
may deepen the understanding of the multiple challenges in depression management. Public 
health should assist people in their lay evaluations of medicines by providing the necessary 
information, feedback and support and by raising general knowledge and awareness of dangers 
of untreated depressive illness. When prescribing antidepressant therapy, clinicians should be 
cognizant of this complexity and address not only issues related to medication efficacy and 
tolerability, but also social mediators and health beliefs (Burra et al., 2007). Gibson, Cartwright 
and Read (2014) formulated implications for further research indicating that more studies 
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investigating positive experiences of antidepressants are needed “in order to better understand 
the complex mixture of views and experiences of antidepressants that may result in patients 
remaining on antidepressants in spite of their misgivings”. Sensitivity and alertness in mental 
health care may increase patients’ acceptance of the fact that depression can be a concern of 
clinicians. This may lead to improved treatment adherence (Marcus et al., 2012). Also, it has 
been discovered that treatment beliefs frequently change from negative to more accepting as 
patients gain experience with antidepressants (Aikens & Klinkman, 2012). It is possible that the 
pro-medication views will receive a greater attention and exposure in future research to 
counterbalance the aversion to pharmacological treatment in depression. Aikens, Nease & 
Klinkman (2008) suggest that adherence to drug treatment in depressive disorder will improve 
when health care specialists take into consideration patients’ specific concerns (eg, adverse 
effects, addiction, personality change, financial cost, stigma) and then offer treatments that 
respect these sensitivities and choices. This could “translate to prescribing a conservative dosing 
and titration schedule that patients can self-pace and providing specific educational input where 
appropriate” (Aikens, Nease & Klinkman, 2008). This recommendation seems to confirm the 
special value of positive relationships between depressive patients and their doctors, or the lack 
thereof as the indication of non-adherence to recommended therapies. Also, it gives more control 
to the patient who feels empowered through continous support and gets a chance to develop the 
sense of responsibility and self-control. 
 
7.1 . Strengths and Weaknesses of this Review 
 This is the only existing review on the topic of patients’ beliefs on antidepressants that 
used mixed-methods data to extract meaningful theories on patients’ non-adherence to drug 
treatment. The usefulness of conducting parallel data analysis on quantitative and qualitative data 
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in healthcare research has been identified before (Östlund et al., 2011). Validating the findings 
emerging from qualitative studies with quantitative data in the process of triangulation, is 
believed to counterbalance the presumed weakness such as the selection of articles that may be 
questioned as biased. My exclusion tactic served the purpose of avoiding repetition in analysis of 
articles that had been previously reviewed. Another strength is an extensive summary of findings 
that has been presented in a tabulated form of 426 identified qualitative, epidemiological, and 
quantitative studies. This way, a rich data base has been created for academic references and 
their potential multiple use in future studies.  
 Another shortcoming might be the exclusion of grey literature, which seemed unavoidable 
and was also recommended by the librarian as a necessary search strategy. I think that examining 
Master’s and doctoral theses on this topic could be beneficial and these studies should be 
recommended for future inclusion.  
 
7.2 . What This Study Adds 
The relevance of this scoping review is believed to be found in creating an extensive data base 
that will serve as a large source of information about antidepressant use. Few themes that 
emerged from the findings about noncompliance were found to deserve special exposure. Some 
of them evolved around wrongful medical practices and patterns of unprofessional behavior in 
health care providers, perceived by their patients as being inappropriate, disappointing and 
discouraging: “Erroneous attitudes and beliefs were found regarding the effects of 
antidepressants. Many patients also had wrong ideas about how to comply with the treatment 
regimen” (Cabassa et al., 2007). In addition to patients’ personal beliefs grounded in their 
upbringing, culture or religion, the following aspects hindered positive treatment outcomes, and 
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they were all determined by external factors. This strongly suggests that their advancement, 
hence improvement of medication adherence, can be achieved: 
 
- Improper/quick diagnostic procedure in depression: first encounter with health care 
professional and the initial prescribing of antidepressants based on brief self-reports that 
might be inaccurate and misleading. It was found to determine future non-adherence. 
- Dismissive and careless behaviors during initial and/or continuous consultations with 
health-care professionals resulting in potentially wrongful prescription of inappropriate 
drugs predicts non-adherence to treatment. 
- Missing or inadequate information about mechanisms of action in administered 
medications, thus missing warnings about possible adverse effects. This may also predict 
refusal of medicines or non-adherence to recommended therapy. 
- Perceived lack of understanding and lack of interest in patients’ personal experiences, 
beliefs and treatment preferences, leads to patients’ withdrawal from therapy and health 
care services. 
- Perceived lack of deep knowledge about both depression and antidepressants that 
clinicians recommend, leads to patients developing doubts about their professional 
competency and efficacy of treatment, thus predicts non-adherence. All practitioners 
should ensure they have up-to-date knowledge of antidepressant medication. 
These are external reasons found by patients to be major determinants in medication and 
treatment adherence in depression. Their relevance in depression management cannot be ignored. 
When the quality of health care services improves, patients will feel empowered and supported. 
Attempts to improve adherence to treatment should therefore start with extensive work on 
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changing attitudes in health care providers, by raising their medical knowledge but also 
psychological awareness and understanding of depressive patients’ vulnerability and 
dependence.  When facing symptoms of depressive disorders, patients’ confrontation with the 
reality can be painful: fellings of being alone, misunderstood and helpless in their mental and 
physical suffering, also fears of stigmatization, often create what they describe as darkness. The 
decision of seeking help is usually inspired by others: friends or next-of kin. This moment is 
crucial and determines future effectiveness of treatment, or lack of thereof. The importance of 
first encounters with empathetic physician as well as a correct, not rushed, diagnosis and 
consequently, carefully chosen treatment, determine successful and efficacious therapy with 
positive outcomes. Cabassa et al. (2007) believe that distrust of physicians and their skepticism 
toward the effectiveness of antidepressants acts as barriers for seeking professional care and 
adhering to treatment. Physicians and other mental health professionals (e.g., social workers, 
psychologists) need to explore and openly discuss negative attitudes early on in the treatment 
process in order to actively engage patients into treatment (Cabassa et al., 2007). 
            
7.3 . Implications for Further Studies: 
 Hopefully, future attempts of discovering the most effective ways of treating depression 
will bring us closer to achieving remission. Further studies should focus more explicitly on self-
management, and how the response of the primary care practitioner encourages or inhibits it. 
There is evidence to suggest that GPs could be more actively involved in considering treatment 
discontinuation and that a sub-group of long-term users may be candidates for cessation of 
antidepressant treatment: this is an important focus for future research, which could provide a 
starting point for more targeted encouragement of behavioral activation in depression within the 
self-help model as part of a comprehensive approach in primary care. It is possible that different 
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belief patterns exist in groups not specifically exposed in this study, for instance, the black and 
minority ethnic population or those with chronic physical diseases, so new, separate studies of 
beliefs and views on drug treatment in these populations may bring interesting results. Only a 
limited number of studies with focus on lived experiences of depressive illness in men was found 
during the search conducted for this review. Masculinity is typically preceived as equivalent to 
strength, power and toughness therefore men admitting to symptoms of ill emotions, moreover, 
being treated with antidepressants, fear to appear as extremely weak. In addition, a focus on 
comparing the efficacy and side effects of brand antidepressants with those of their generic 
equivalents could lead to interesting and useful findings. Also, more empirical studies on placebo 
effects of antidepressant treatment could deepen our understanding of the power of human 
thought and belief in effectiveness of therapeutic means. In addition, some other issues were 
found important and deserving of greater exposure: pregnancy-related discontinuation of 
antidepressants (discussed by Bennett et al., 2010), increased probability of an atypical or 
nonspecific clinical presentation of depression (Bazargan et al., 2005) and emphasis on screening 
and expansion of treatment in depression (Bazargan et al., 2005). Presenting screening as a 
normal and routine part of health care routine may help reduce feelings of shame and “give 
permission” to discuss depression more openly, raising patients’ awareness of efficacious 
treatment options. On the basis of this study, care for depression as well as some preventive 
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Search Strategy Formulated in PubMed and Adapted for Use in Other 
Databases 
 
Keywords: experience, remission, depressive disorders, cognition, antidepressants, adult 
patients 
 
Main Terms: patients, experience, antidepressant, depression 
 
Search terms: 
accounts[tiab] OR perspective[tiab] OR perspectives[tiab] OR view[tiab] OR views[tiab] OR 
opinion[tiab] OR opinions[tiab] OR reflection[tiab] OR reflections[tiab] OR thoughts[tiab] OR 
insights[tiab] OR attitudes[tiab] OR perception*[tiab] OR beliefs[tiab] OR believe[tiab] OR 
belief*[tiab] OR think[tiab] OR thoughts[tiab] OR feel[tiab] OR feeling*[tiab] OR story[tiab] 
OR stories[tiab] OR “attitude to health”[mesh] OR comments[tiab] OR viewpoints[tiab] OR  
“Interview, Psychological”[mesh] OR interview*[tiab] OR “attitude to health”[mesh] OR “truth 
disclosure”[mesh] OR narrative*[tiab] OR narration[mesh] OR understanding[tiab] OR 
perception*[tiab] OR preferences[tiab] OR information[tiab] OR expression[tiab] OR 
define[tiab] OR definition*[tiab] OR complain*[tiab] OR interpretation*[tiab] OR evidence[tiab] 
OR feel*[tiab] OR regard[tiab] OR think*[tiab] OR reflect*[tiab]  
patient[tiab] OR patients[tiab] OR patients’[tiab] OR layperson*[tiab] OR adult*[tiab] OR 
women*[tiab] OR individual*[tiab] OR people*[tiab] OR patients[mesh:NoExp] OR 
outpatients[mesh] OR inpatients[mesh] OR informant*[tiab] OR female[mesh] OR male[tiab] 
OR men[tiab] OR user*[tiab] OR “treatment recipient*”[tiab] 
experienc*[tiab] OR experiences[tiab] OR life[tiab] OR lives[tiab] OR live[tiab] OR 
observation*[tiab] OR awareness[tiab] OR knowledge[tiab] OR record*[tiab] OR 
encounter*[tiab] OR “personal narratives as topic”[mesh] OR “patient medication 
knowledge”[mesh] OR “health education”[mesh] OR “health literacy”[mesh] OR 
knowledge[tiab] OR practices[tiab] OR “Health Knowledge, Attitudes, Practice”[mesh] OR 
“quality of life*”[mesh] OR “Patient satisfaction”[mesh] OR “men’s health”[tiab] OR “women’s 
health”[tiab] OR “patient preference”[mesh] OR “patient education as topic*”[mesh] OR 
coping[tiab] OR choice*[tiab] OR need*[tiab] OR tolerance[tiab] OR barrier*[tiab] OR 
obstacle*[tiab] OR denial[tiab] OR behavior[tiab] OR approach[tiab] OR difficulty[tiab] OR 
difficulties[tiab] 
antidepressant[tiab] OR antidepressants[tiab] OR pharmacotherapy[tiab] OR drug[tiab] OR 
drugs[tiab] OR pill[tiab] OR pills[tiab] OR medication[tiab] OR medications[tiab] OR “mood 
stabilizer*”[tiab] OR prescription*[tiab] OR “Antidepressive Agents”[tiab] OR “Drug 
Therapy”[subheading] OR “pharmacological treatment*”[tiab] OR “medication 
adherence*”[mesh] OR drug[tiab] OR drugs[tiab] OR “Mood stabilizer*”[tiab] OR 
Antidepressive Agents[mesh] OR “medication adherence”[tiab] OR therapy(ies)[tiab] OR 
therapy[subheading] OR adherent[tiab] OR non-adherent[tiab] OR compliance[tiab] OR non-
compliance[tiab] OR refusal[tiab] OR pharmacotherapy[tiab] OR response[tiab] OR 
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effective[tiab] OR ineffective[tiab] OR “side effect*”[tiab] OR “adverse effect*”[tiab] OR 
efficacy[tiab] OR “antidepressive agent*”[tiab] OR withdrawal[tiab] OR continue[tiab] OR 
discontinue[tiab] OR treatment regimen[mesh] OR take[tiab] OR intake[tiab] OR “drug 
effects”[subheading] OR “patient compliance”[mesh] OR “drug effects”[subheading] OR 
“treatment refusal”[mesh] 
depression[tiab] OR depressive[tiab] OR depressed[tiab] OR dysthymia[tiab] OR “psychological 
distress”[tiab] OR “emotional distress”[tiab] OR “affective disorders”[tiab] OR “Depressive 
Disorder”[mesh] OR “depressive illness”[tiab] OR “Mood Disorders”[mesh] OR 
melancholia[tiab] OR unipolar[tiab] OR mood[tiab] OR dysthymia[tiab] OR Major Depressive 
Disorder[tiab] OR MDD[tiab] OR episode*[tiab] OR symptom*[tiab] OR psychological[tiab] 
OR distress[tiab] OR struggle[tiab] OR “mental health”[tiab] OR suicide[tiab] OR “depressive 
syndrome*”[tiab] OR “affective disorder*”[tiab] OR “emotional condition”[tiab] OR “mental 
condition”[tiab]  
 
Results of database searches 
 
Medline – N=1779 
 
Initial attempts to search for qualitative studies were unsuccessful in sofar that unrealistic 
numbers of studies were pulled, among which the majority were not qualitative. Here are 
presented all the search words for ‘qualitative research’ that were approved by the librarian but 
were not included in the final search: 
qualitative[tiab] OR (interview[tiab] OR interview'[tiab] OR interview's[tiab] OR 
interviewability[tiab] OR interviewable[tiab] OR interviewable'[tiab] OR 
interviewadministered[tiab] OR interviewbased[tiab] OR interviewd[tiab] OR 
interviewdata[tiab] OR interviewe[tiab] OR interviewed[tiab] OR interviewed'[tiab] OR 
interviewedfor[tiab] OR interviewedited[tiab] OR intervieweds[tiab] OR interviewee[tiab] OR 
interviewee's[tiab] OR interviewee'speeches[tiab] OR interviewees[tiab] OR interviewees'[tiab] 
OR interviewer[tiab] OR interviewer'[tiab] OR interviewer's[tiab] OR interviewer3[tiab] OR 
intervieweradministered[tiab] OR interviewerd[tiab] OR interviewers[tiab] OR 
interviewers'[tiab] OR interviewes[tiab] OR interviewguide[tiab] OR interviewin[tiab] OR 
interviewing[tiab] OR interviewing'[tiab] OR interviewing's[tiab] OR interviewingfor[tiab] OR 
interviews[tiab] OR interviews'[tiab] OR interviews1[tiab] OR interviews3d[tiab] OR 
interviewsfrom[tiab] OR interviewshowed[tiab] OR interviewsurvey[tiab] OR interviewtext[tiab] 
OR interviewwas[tiab] OR interviewwd[tiab]) OR stories[tiab] OR narrative[tiab] OR 
(discussion[tiab] OR discussion'[tiab] OR discussion's[tiab] OR discussional[tiab] OR 
discussionconversations[tiab] OR discussiondetailing[tiab] OR discussionfigure[tiab] OR 
discussionfindings[tiab] OR discussionhostility[tiab] OR discussionin[tiab] OR 
discussioninteraction[tiab] OR discussionit[tiab] OR discussionnegative[tiab] OR 
discussionnotwithstanding[tiab] OR discussionof[tiab] OR discussionrelation[tiab] OR 
discussions[tiab] OR discussions'[tiab] OR discussionself[tiab] OR discussionskewed[tiab] OR 
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discussionthe[tiab] OR discussionthis[tiab] OR discussionwe[tiab]) OR "grounded theory"[tiab] 
OR "focus group*"[tiab] OR "semi-structured"[tiab] OR "open-ended"[tiab] OR 
phenomenology[tiab] OR diary[tiab] OR diaries[tiab] OR (questionnaire[tiab] OR 
questionnaire'[tiab] OR questionnaire'07[tiab] OR questionnaire's[tiab] OR questionnaire1[tiab] 
OR questionnaire11[tiab] OR questionnaire12[tiab] OR questionnaire2[tiab] OR 
questionnaire25[tiab] OR questionnaire30[tiab] OR questionnaireand[tiab] OR 
questionnairebased[tiab] OR questionnairebefore[tiab] OR questionnaireconsisted[tiab] OR 
questionnairecopyright[tiab] OR questionnaired[tiab] OR questionnairedeveloped[tiab] OR 
questionnaireforpediatric[tiab] OR questionnairehas[tiab] OR questionnairel02[tiab] OR 
questionnairenurse[tiab] OR questionnaireonline[tiab] OR questionnairepf[tiab] OR 
questionnairephq[tiab] OR questionnairers[tiab] OR questionnaires[tiab] OR 
questionnaires'[tiab] OR questionnaires''[tiab] OR questionnairescan[tiab] OR 
questionnairess[tiab] OR questionnairev[tiab] OR questionnairewere[tiab] OR 
questionnairex[tiab] OR questionnairey[tiab]) OR (observation[tiab] OR observation'[tiab] OR 
observation''[tiab] OR observation's[tiab] OR observation1[tiab] OR observationa[tiab] OR 
observationable[tiab] OR observational[tiab] OR observational'[tiab] OR observationalfield[tiab] 
OR observationallv[tiab] OR observationally[tiab] OR observationalprospectivecontrolled[tiab] 
OR observationals[tiab] OR observationary[tiab] OR observationd[tiab] OR observationes[tiab] 
OR observationf[tiab] OR observationn[tiab] OR observationnal[tiab] OR observationnel[tiab] 
OR observationnelle[tiab] OR observationnelles[tiab] OR observationof[tiab] OR 
observationprocedure[tiab] OR observations[tiab] OR observations'[tiab] OR 
observationsdemonstration[tiab] OR observationson[tiab] OR observationsreported[tiab] OR 
observationss[tiab] OR observationum[tiab] OR observationwere[tiab] OR observationzs[tiab]) 
OR "qualitative analysis"[All Fields] OR "qualitative research"[mesh] AND ("humans"[MeSH 





APPENDIX B  
 
Description of Selected Studies n = 426 
 
Most studies were from the USA (138), followed by the UK (77) and Canada (30), Australia 
(26), Netherlands (21), Denmark (12), Germany (11), New Zealand (10), Spain (10), Sweden (8), 
Belgium, Italy, Japan and Finland (5 each), Switzerland, Turkey, Korea and Saudi Arabia (3 
each), France, Ireland, India, Uganda, Taiwan, Greece, Hong Kong, Brazil, Malaysia and Iran (2 
each). Other countries that were represented are: Austria, Poland, Pakistan, Hungary, China, 
Iceland, Kuwait, Czech Republic, Sri Lanka, Portugal, Egypt, Israel, and South Africa (1 each). 
The number of participants differed greatly but was not specifically assessed on account of 
different qualitative research methods. 
Summary by year of publication: 
1961 (2); 1965 (1); 1985 (1); 1992 (2); 193 (1); 1994 (2); 1995 (5); 1996 (4); 1997 (4); 1998 (2); 
1999 (2); 2000 (9); 2001 (8); 2002 (15); 2003 (22); 2004 (16); 2005 (25); 2006 (32); 2007 (47); 
2008 (26); 2009 (22); 2010 (23); 2011 (21); 2012 (27); 2013 (29); 2014 (34); 2015 (30); 2016 
(14) 
Qualitative and mixed methods studies  n = 128 
Karp 1992; Karp 1993; Karp 1994; Garcia-Campayo et al. 1995; Lewis 1995; North et al. 1995; 
Rosholm et al. 1995; Ahnlund & Frodi 1996; Barter & Cormack 1996; Cooper-Patrick et al. 
1997; Ferreres 1997; Hagerty, Williams & Liken 1997; Lewis & Nicolson 1998; Gammel & 
Stoppard 1999; Boyle & Chambers 2000; Kadam et al. 2001; Andersson, Lindberg, & Troein 
2002; Castle, Morgan, & Jablensky 2002; Egede 2002; Hensley & Nurnberg 2002; Knudsen et 
al. 2002; Knudsen, Hansen & Traulsen 2002; Garfield, Smith & Francis 2003; Gask et al. 2003; 
Givens et al. 2003; Knudsen et al. 2003; Manning & Marr 2003; Bhugra & Hsiao-Rei Hicks 
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2004; Boath, Bradley & Henshaw 2004; Bollini et al. 2004; Dinos et al. 2004; Grime & Pollock 
2004; Halter 2004; Haslam et al. 2004; Anderson et al. 2005; Ashton 2005; Badger & Nolan 
2005; Maxwell 2005; Rieder-Heller, Matchinger & Angermeyer 2005; Burroughs et al. 2006; 
Chur-Hansen & Zion 2006; Givens et al. 2006; Hanley & Long 2006; Karasz & Watkins 2006; 
Lafrance & Stoppard 2006; Lavender, Khondoker & Jones 2006; Lawrence et al. 2006; 
Lawrence et al. 2006; Ros 2006; Verbeek-Heida & Mathot 2006; Zimmerman et al. 2006; 
Badger & Nolan 2007; Badger & Nolan 2007; Bennet et al. 2007; Buultjens & Liamputtong 
2007; Cornford, Hill & Reilly 2007; Frank et al. 2007; Holt 2007; Interian et al. 2007; Johnston 
et al. 2007; Lafrance 2007; Leydon, Rodgers & Kendrick 2007; Morawiec 2007; Slingsby et al. 
2007; Smardon 2007; Tentler et al. 2007; Unützer 2007; Cabassa et al. 2008; Lakey 2008; 
Turner et al. 2008; Wittkampf et al. 2008; Fullagar 2009; Liebert & Gavey 2009; Malpass 2009; 
McPherson & Armstrong 2009; Pohjanoksa et al. 2009; Price, Cole & Goodwin 2009; Amey 
2010; Carpenter et al. 2010; Ezeobele et al. 2010; Kadir & Bifulco 2010; Ragan & Kane 2010; 
Cohen & Hughes 2010; Malpass et al. 2011; Schofield et al. 2011; Sennfeld et al. 2011; van 
Geffen et al. 2011; Buus, Johannessen & Stage 2012; Hansen & Cabassa 2012; Knudsen et al. 
2012; Singh et al. 2012; Vega et al. 2012; Acosta, Rodriguez & Cabrera 2013; Aggarval et al. 
2013; Anderson & Roy 2013; DeJean et al. 2013; Fullagar & O’Brien 2013; Ngo et al. 2013; 
Patel et al. 2013; Treuer et al. 2013; Vilhelmson, Svensson & Meeuwisse 2013; Buus 2014; 
Fogtman-Fosgerau & Davidsen 2014; Hartley et al. 2014; Isquierdo et al. 2014; Jaffray et al. 
2014; Lafrance 2014; Lam & Sun 2014; Powell, Overton & Simpson 2014; Ramirez & Badger 
2014; Stanners et al. 2014; van Grieken et al. 2014; Ward, Mengesha & Issa 2014; Anderson et 
al. 2015; Arco 2015; Bayliss & Holttum 2015; Brown-Bowers et al. 2015; Chambers et al 2015; 
Ridge et al. 2015; Sari & Gencöz 2015; Vargas et al. 2015; Whiters et al. 2015; Brinijah & 
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Antoniades 2016; Castonguay, Filer & Pitts 2016; Gibson, Cartwright & Read 2016; Gibson, 
Cartwright & Read 2016; Janakiraman, Hamilton & Wan 2016; Stanton & Randal 2016. 
Reviews (incl. minireviews, overviews, commentaries, summaries of literature, etc.)  
n = 32 
Williams et al. 2000; Katona & Livingston 2002; Pampallona et al. 2002; Campbell, Clauw & 
Keefe 2003; Geddes et al. 2003; Masand 2003; Scheibe et al. 2003; Rabheru 2004; van Schaik et 
al. 2004; Pound et al. 2005; Martin-Lopez et al. 2006; Mitchell 2006; Moncrieff & Cohen 2006; 
Gilchrist & Gunn 2007; Hansen & Kessing 2007; Kates & Mach 2007; Lader 2007; Warren & 
McCarthy 2007; Mitchell 2007; Mitchell & Selmes 2007; Unützer 2007; Harmer 2008; Hwang 
et al. 2008; Levin et al. 2008; Prins et al.  2008; Zivin & Kales 2008; Cipriani et al. 2009; 
Demyttenaere 2009; Ööpik & Maaroos 2009; Britten, Riley & Morgan 2010; Glue et al. 2010; 
Abdullah & Brown 2011; Mahtani-Chugani & Sanz 2011; Al-Jumah & Qureshi 2012; Alderson 
et al. 2012; Baumeister 2012; Himmerich & Wranik 2012; Jenkins & Goldner 2012; Littrell 
2012; Agyapong 2013; Balan, Moyers & Lewis-Fernandez 2013; DeJean et al. 2013; Moncrieff, 
Cohen & Porter 2013;  Gibson, Cartwright & Read 2014; Katona, Bindman & Katona 2014; 







Summary of Content of Selected Qualitative Papers 
 
1 Amey (2010).  
This study describes a history of a patient suffering from mental illness and intensively 
treated with antidepressants (tricyclics, dosulepin, a 16-year history of sertraline and dosulepin 
for insomnia).  The coincidence of later speedy recovery with the discontinuation of the drug 
therapy, seems consistent with the patient’s (and author’s in one person), hypothesis of mania 
occurring as a side effect of antidepressant treatment. Patient, a medical writer, familiar with 
professional terminology, appears quite knowledgeable about mental illness and 
psychopharmacology. She describes in detail her symptoms and suffering, claiming that 
treatment with antidpressants triggered intense symptoms of mania that required hospitalization.  
2 Anderson and Roy (2013) 
While some people argue that there is no difference between taking antidepressants and 
medicines for other health conditions, such as insulin for diabetes, others reflect on the way 
antidepressants are considered to represent a different class, compared to other medicines: cited 
is experienced horror with psychiatric drugs, with many individuals turning against them; and a 
widespread judgement that they do not have the same lifesaving power as insulin or other drugs. 
A large number of patients refuse to take antidepressants. They think they can recover from 
depression on their own. Others report not having any ideological or philosophical position about 
medication.  Individuals’ views and accounts of their lived experiences offer a wide spectrum of 
perceived ‘truths’: One patient admitted to being aware of available drug treatment in depression 
but she was not willing to accept them because of a stigma and her own fear of getting addicted 
to drugs. Another woman resisted taking antidepressants because she saw it as a sign of 
weakness that proved something must be wrong with her and feared social rejection.  
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Lay beliefs are that male patients are particularly inclined to see using antidepressants in 
this way. Some think that stigma around taking antidepressants is unjustified.  People fear that 
antidepressants might mask personal problems but not actually resolve it, and the rationale is that 
people should manage their issues without medicines, rather than ‘papering over the cracks’. In 
the past, it was rather difficult for people to find information about prescribed medicines, but 
currently, the internet is being routinely used by people who look up symptoms and side effects 
of medications, as well as familiarize themselves with public forums where others share their 
illness and treatment experiences. A lay belief is that patients used to be more accepting of 
diagnoses and medical recommendations before. But there are also patients who, after trials of 
different medicines, find to be fortunate as to their knowledge, the medications they had been 
given have no major adverse effects as compared to others.   
Many individuals who have felt depressed for a long time and have tried to ‘manage’ the 
symptoms on their own, may see the doctor only after reaching a crisis point, and be prescribed 
antidepressants. Others go to see the general practitioner because their family and friends urge 
them to do so, as their behaviour obviously affects other people. A woman did not go to see her 
GP until her husband threatened to leave her. Another patient’s wife made him go to the doctor 
after he broke down at work. It is said to be difficult to recognise own signs and symptoms of 
depression, and certainly many are not aware of existing effective treatments.  
The physician’s role cannot be stressed enough: according to one female patient, if the doctor 
hadn’t been able to turn her thinking around depression and its effective treatment during the 
first appointment the way that she did, patient believes she would lack motivation to take the 
medication. And certainly, knowing now that it does take four to six weeks to see an effect, the 
patient might, even if she had started taking it, have given up after two weeks. But the doctor’s 
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influence was powerful enough to drastically change the patient’s perception. The physician took 
time to explain depression, its different causes and then, the medications. 
Patients might be resistant to accepting antidepressants due to the strong stigma attached 
to them. One male patient reflected on his experience admitting that he did not let the physician 
even finish, and his response was simply, ‘not a chance.’ Just the term ‘antidepressant’ to him 
was not acceptable and he was convinced that other people in his position would have similar 
approach. But there are also other patients who, believing that the ‘doctor knows best’, had taken 
antidepressants most of their adult life on the advice of their physicians. There are individuals for 
whom the overwhelming impact of their depressive symptoms translates into continuous 
treatment. These people admit that refusing the intake of medication is not even an option.  
Some patients in this study felt completely excluded from the treatment decision-making. 
One man’s account of the doctor writing on her notes the word ‘depressed’ says that this gesture 
made a negative impact on how the patient viewed himself and the diagnosis. The doctor 
diagnosed the man in a brief message, ‘I think you're suffering with depression and need 
antidepressants’ which was experienced as a non-personal and formal feedback. In another case, 
the GP put the patient on antidepressants and on sleeping tablets without hesitation and without 
any explanation. Patients often feel that their doctors have no time to listen. Another GP was 
particularly insistent that patient take her prescription. After the patient repeatedly refused it, the 
doctor’s response was, ‘I don't know what's wrong with depressed people, why they always 
refuse to take my prescriptions. I think depressed people like being depressed.’ Patient felt like 
the physician shamed her into taking the prescription.  
Another patient was surprised, even frightened, by some of the things his doctors said 
about what antidepressant taking would mean for him in the future, for example, that it would 
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take a long time to get better, or that he would be dependent on them for life. But at the same 
time, there are patients who are relieved to be diagnosed with depression and be prescribed 
antidepressants. Once that is done, they become more optimistic because their suffering finally 
gets acknowledged and there is hope for a possible cure. Some people demonstrated a raised 
awareness because of their depression treatment experience with their relatives. One participant’s 
father recovered in the past with the help of antidepressants, which significantly helped this 
patient to become very accepting of drug treatment for his own depressive symptoms. Another 
optimistic story of a woman who described the first doctor she ever saw as ‘absolutely fantastic’, 
ads to the serie of positive views. The physician is said to have noticed the depression signs and 
have asked proper questions. The woman felt being correctly diagnosed and prescribed effective 
treatment. When the treatment didn’t work very well, they adjusted it and got her back on track 
within a couple of months. Another patient was first prescribed an antidepressant, thus he felt it 
signified his depression as ‘official’. He said that seeing it written in his notes felt, ‘almost like 
having a criminal record’. It had affected the way he viewed himself and he felt designated to a 
marginalized category; in his opinion, he now became someone who was ‘mentally ill’ and it 
affected his identity. This patient’s preference was to manage his symptoms without 
antidepressants so his wish was, to come off them as soon as possible. It was important to him 
for there to be ‘an end in sight’.  
A number of individuals prefer to be ‘in control’ of their own emotions and they see 
antidepressants as a temporary ‘crutch’ to lean on rather than a permanent solution. To some 
people, receiving their first prescription for an antidepressant feels like avoiding responsibility 
for their own emotions and actions; they experience it as taking the ‘lazy’ option to create an 
emotional well-being. Such patients see taking antidepressant as a sign of a personal failure. 
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One participant wasn’t prescribed an antidepressant right away and he appreciated the time 
granted him to consider pros and cons: he didn't really want to go on medication but he was 
aware that he was at the point where he needed treatment. He was grateful for not being 
immediately given a prescription. The medical stuff offered several options: they described 
available medications and their efficacy. They also suggested monitoring the patient’s situation 
before starting the drug treatment which the man thought was a very responsible approach. He 
eventually did go onto antidepressants, because no improvement of his condition was noticed.  
People admit that even deciding to start the antidepressant treatment, and actually contemplating 
swallowing the tablet for the first time could become emotional and feel like a ‘momentous 
occasion’: one  patient described having left the medications ‘on his top shelf for ages’ and do 
not wanting to take them due to his confusion as why this would be his fate; the doctor 
prescribed him that after like a really short chat, with the patient saying his mood was down, and 
it crossed his mind that maybe at that time, doctors were handing the ‘happy pills” out left and 
right.  
In the absence of instruction expected to come from their medical providers, patients are 
interested in finding out more information before taking the first tablet. One individual reported 
of being told to go home and take the prescribed Prozac pills, but as a person with a scientific 
mind, he looked up Prozac online, and he decided not to take any, because of his concern about 
many side effects. He just threw the pills away. A woman got her prescription dispensed but it 
took time to read through the information leaflet before deciding whether or not to take the first 
dose. She worried that the antidepressant might make she feel ‘fluffy’ or ‘out of control’. She 
spent a full week wondering whether to take the antidepressant and she had second thoughts after 
reading an article online. She saw the GP for a second chat before deciding whether to take it.   
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People’s antidepressant treatment behaviors can be dictated by fears: there is a striking 
report of a patient who thought that if he can be seen to be compliant to treatment it would make 
him less likely to be sectioned; or a story of a woman who read the drug information and got 
scared, nevertheless she decided to take a tablet after—not right away, but after a few weeks. 
“She took a tablet and it made her so sick, she retched the whole night in the toilet, just retching, 
and it made her feel like she almost died”. Generally speaking, most people are uncertain about 
how long it would take for the antidepressant to take effect, the extent to which it might help, and 
what to expect in the first few weeks. They are concerned whether the pills could make them feel 
worse rather than better, and how long they would need to take an antidepressant for. Many 
patiens who initially accept the therapy, do not experience a quick relief from their bothersome 
symptoms. They may even feel a lot worse, at least at first, so they take the medicine for ‘a little 
bit’ and then stop it in the absence of immediate improvement. 
Another patient felt that he benefitted in time, if not immediately; one of the most striking 
things that he noticed the first time he took antidepressants was, all of a sudden he realised how 
much colour there is in the world. But when he was depressed, his perception of colour had 
diminished. The next female participant felt as spaced out, controlled, drunk, completely 
flattened and numb, although not depressed any more: the first week of taking medication she 
felt she'd been “hit over the head with a sledgehammer”. She found it really hard to have her 
bearings and cope. It was just the most bizarre feeling but she hung in there and after about ten 
days, it got better.  
For the next informant, just the fact that she was taking the antidepressant and was doing 
something about her depression, helped. She reflected on her experience: “straight away when 
you start taking it you feel great because somebody understands, somebody had listened to 
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what's wrong with you because you're in this bubble (and the only way you can describe it is a 
bubble), the whole world is going on around you and nobody seems to understand, at least you 
assume that you have no support…and all of a sudden, it just takes a lot of weight lifted off your 
shoulders that you're starting medication and that you're on the road to get better…”  
3 Anderson et al. (2015) 
A patient had been prescribed antidepressants in the past but he always felt reluctant and 
apprehensive about taking it, largely because a) he felt that the effects are probably short-term, 
they're not going to actually resolve the problems, b) because they do have side-effects and, and 
c) he didn't feel comfortable, himself, with taking tablets.  
Being prescribed an antidepressant was vital for another patient, and she gladly accepted the 
treatment option as suggested by her doctor and when she took the first tablets, they made her 
feel that the decision was justified. Another optimistic story was told by a male study participant 
who was prescribed Effexor (venlafaxine). He soon experienced side-effects: swelling in the face 
and headache, which he knew this medication can cause. He therefore contacted his physician 
who told him to stop the treatment. Similar bothersome adverse effects appeared on the Lustral 
(sertraline) and Cipramil (citalopram) in the same individual. Patient finally settled on Seroxat 
(paroxetine). It was his doctor, the GP, not the specialist, who recommended trying Seroxat. As 
patient accepted the treatment, he was recommended to try it in a liquid form first. After the trial, 
the treatment was continued with paroxetine tablets and the man has continued with about 30mg 
without ceasation. 
Treatment with Paroxetine was found quite unpleasant by another male patient. The man 
admitted that ‘it was pretty nasty, actually’. In addition, he said, it had absolutely no effect on the 
depression. Patient took it dutifully every morning out of the little foil packets for 5 or 6 months. 
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He admitted that a lot of the professional interventions were unable to help him, and 
antidepressants did not at all, either. He commented that in his opinion, “antidepressants should 
not be called that at all because they don't really do very much against depression”. They work 
more as anti-anxiety pills or sedatives. The next case was described by a female patient who was 
issued a prescription for antidepressants automatically, and she was also put on sleeping tablets 
without being asked. In the medical notes, the doctor wrote, patient was depressed and she said 
to her, ‘I think you're suffering with depression and need antidepressants.’ The patient found the 
physician’s behavior unacceptable. 
Prozac (fluoexetine) was fully accepted by another patient, and no bothersome side-effects of 
treatment were noticed. The open question remains, whether patients are feeling well anyway or 
is it the medication that is helping. But for that woman, the antidepressant therapy seemed to be 
working so she remained on the medication. One of the things that another patient thought was 
very important to him in this process was the fact that the doctor told him, ‘I'm going to get you 
out of this depression but don't expect a miracle. Don't expect to be okay tomorrow. It's a long 
process but I'll sort you out.’ Those were his words. That to the patient was very important.  
People admit that being treated with antidepressants is not like, ‘you might kind of crave 
a cigarette’, but experiencing side effects is unpleasant. And it seems unnatural that ‘you just 
have to do take a tablet to feel normal’. Some would call them ‘happy pills’. “But you don't walk 
around stoned or sort of ‘Oh isn't life wonderful.’ You just feel normal, that is what they make 
you do, they just make you feel normal. You don't feel euphoric, you don't feel manic, you don't 
feel spaced out, drunk, stoned, and whatever you want to call it. You just sort of feel yeah, this is 
the way life is supposed to be, everything just feels alright, balanced’.  ‘Antidepressants, they 
aren't a quick fix to make you better, but they help you to cope better with what you're going 
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through’ (patients’ accounts). Another female informant will never regret taking the medication 
because the treatment has totally changed her life. She no longer feels the intensity of it, but 
when she first took the pills, she felt like she had been given her life back. She feels like she can 
now be a normal person.  
An older man (73) felt that it was going to be a question of time that medicine got him right. This 
patient had continued on a small dose of Sertraline which he shall take for the rest of his life. For 
another male patient the antidepressant wasn't working. Luckilly, there was no pressure to 
deliver at work which, he found, was a tremendous blessing. The medication kind of worked - he 
found, it made him more functional. But how he described it, he was ‘a functional zombie’. He 
was able to function, to work, he could read, he did have his motivations, his mental capacities 
came back but he was still depressed. And some days, he said, he would be really 
overwhelmingly depressed.  
Lay beliefs are that doctors know, patients do not want to be on antidepressants for the 
rest of their lives. So they try, they experiment, take guesses and choose between medicines, 
increasing and decreasing the doses. It happened to one female patient, when she discontinued 
her treatment, everything just went backwards, so she went back and continued with citalopram 
(cipramil). She reported, she was on 40mgs, has been up and down on them, and she was on the 
medication but realised that it takes a while to discover the right dosage, and there is the right 
level dosage for every person, she said. So it's gone up and it's gone down. They've tried going 
down and it did not work, patient was not ready for it, so the dose was increased again. 
One female informant showed anger and frustration. She complained about the psychiatrist’s 
attitude and the manner he prescribed her the antidepressant. That was what made her come back 
to confront him. She questioned why the patients are not being informed about possible dangers 
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of medication treatment. She claimed that the intake of citalopram over a longer period of years 
can cause a brain damage. It is unclear how she obtained such information. 
A mature, 69-year-old male patient explained: the only way you can avoid pain is by just getting 
away from the incident that's causing the pain; and the only other way is just to cut down your 
awareness of it, which is what medication is mostly for, she thought; it's really to cut down your 
feeling of pain. “But the thing is the pain is nature's way of showing you what's wrong, and 
without it you're in the dark”. And the thing is we've been given the ability to know what's wrong 
with us ourselves. But if we keep taking pills, if we keep taking things that are going to stop us 
being aware, if we keep getting drunk, if we use anything as a drug to reduce our awareness, then 
our ability to be healthy is cut down. So the first necessity to be healed is to raise your 
awareness.  
Another possible reason for non-adherence is simple forgetfulness. Patients report having 
stopped their antidepressant therapy, without telling their physicians, just because they kept 
forgetting to take the pills. The next informant had been prescribed the tablets which felt like 
sedatives to her but she soon found out that they were also given to people with psychosis as well 
as other mental disorders, and patient just threw them away. One patient did take an overdose on 
one occasion, when things were quite desperate. It was a high dose of antidepressants and 
paracetamol. Patient later admitted to a pretty horrendous experience. A male participant was not 
certain whether these were side effect of the prescriptive medication what he suffered from. He 
thought it might have been a combination of both medication and depression because he had it 
before, he experienced it a little bit before he started taking the drugs and then it kind of got a 
little bit worse. Initially, with things like Tryptizol (amitriptyline, a trycyclic antidepressant), and 
later with other antidepressants, there was constipation, dizziness, double vision and as he 
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reported, all kind of other unpleasant side effects. But sertraline was prescribed later at a low 
dose and it was not a really significant experience.   
A female patient was unable to conclude if the medication would do her any good or not, 
but she added up one day that she would, over the years, had taken almost 20 different sorts of 
pills. And experienced a dry mouth and many side effects that were unpleasant.   
A patient treated with Effexor (venlafaxine) said that he was no longer himself. He reflected with 
a deep sadness: ‘[I]t took me away from me’. He was no longer able to do some of the things 
which he enjoyed doing before. He liked writing music and he was unable to do that. He could 
no longer see the patterns in written music. He no longer had the ideas of things that he could 
perform before he started treatment. Although it improved the patient’s mood, and he no longer 
felt depressed, it took the motivation away from him and it kind of took the fun out of his life as 
well.  
The next female informant complained that her brain functions went down while she was 
treated with antidepressant medication. Before, she used to enjoy her very good writing skills 
that disappeared completely. As also her confidence was gone, and as she said, she ‘couldn't 
string two sentences together which was quite frightening for her job’. A male patient was taking 
quite a lot of antidepressant drugs and was off work for about 6 months. When he went back to 
work he had no recollection of what had happened while he was away. And he knew the job well 
enough to go on doing it, but his memory remained impaired. Described was also a case of a 
patient who reported feeling drunk while on psychotropic medication. She described the 
antidepressants as ‘kind of old’. Most of the time, she was unable to function but she continued 
the therapy. She suffered from the adverse effects for six months. She described her experience 
as ‘something ridiculous’.  
218 
 
Male patients’ experiences with their sex life being negatively affected by antidepressants 
have been summarised by two other study participants. Their suspition was that physicians who 
issue prescriptions are not fully aware of all the side effects involved in the drugs. Besides the 
‘easy things like a dry mouth, and dizziness’ there other, more serious adversities. Lack of 
information can led to frustration and anger toward the physician. One of these patients suffered 
from impotence, which can put a great strain on the relationship and family life. Taking ‘Seroxat 
(paroxetine), the first thing a male patient noticed, and as he admitted, was a bit embarrassing, he 
couldn't ejaculate. In his words, “it's extraordinary, absolutely extraordinary, so you have no 
erection problems as such and you can have sex you know, but you just don't come. And it's kind 
of a weird … there's a question, you feel like a sort of porn star, you can go for hours you know”.  
The next female patient who eventually stopped the therapy with antidepressants, 
reported having experienced her body shaking while on the medication. She would wake up in 
the middle of the night with a bolt of fright, and shaking. She also realized that the medicine 
made her pupils dilate. So you look like you were on drugs, she said. 
One informant described some withdrawal symptoms that he experienced. He said, ‘those they're 
the strangest things ever’. When you make a gross movement, a gross muscle movement, you get 
this incredible buzz in your head. It’s different from a tingling and quite bizarre.  
Many informants stressed the importance of human sensitivity and acknowledgement of 
patient’s symptoms that is desired in medical care relations. A doctor who never criticises, who 
never makes judgements is described as trustworthy and reliable. Some people actually believe 
that when there is a new drug coming from America, suddenly all the psychiatrists want to treat 
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all with the same drug. A woman reported being prescribed a medication and soon, when talking 
to other patients in the hospital, she found out that everybody was taking the same drug. 
Another patient said, she came to the point where she was able to protest: ‘hang on this is my 
body here and this is me,’ she decided to speak up for herself, and she started to question the 
psychiatrist as well as her treatment. She suddenly realized the psychiatrist was becoming more 
respectful toward her. Her belief was that you have to fight for a proper treatment and attitude, 
even in medical settings. It is not a thing that is automatically given.  
One male informant saw the same psychiatrist after 10 years. During the first visit he was 
prescribed lithium. After 10 years, the doctor said, ‘Oh, I remember you, you had an overdose of 
lithium!’ And the patient responded, ‘You told me it was stress.’ And the physician’s response 
was that he could have made a mistake. So all the patient’s “faith in psychiatrists went zooming 
out the window with one man”. People’s perception of treatment is, ‘You're ill, here take this 
pill.’ And like medicalisation, that's not even a word, but medicalising and the fact that they did 
put you onto it so quickly, could make people kind of go, ‘Oh no, that's just really bad’, admitted 
study participants.   
Another patient always went to the clinic with a strange feeling that it was like a cattle-farm: you 
go in, you say what you feel, he gives you a prescription, and out the door you go, which isn't at 
all good, he complained. A new physician prescribed citalopram immediately, so within a week, 
the patient was on 40mg of Citalopram, and he found this being a high dose. 
A bitterly pessimistic reflection comes from a mouth of a women who had remained in 
the drug therapy for years. She described it as “some anti-depressants”. They just gave her a 
repeat prescription with the plan to leave her on them for as long as only possible. She has been 
on them for 4 years now. No-one asked her if she is thinking about coming off them. No-one has 
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said anything. Patient says: ‘they just shove you on them, as long as you're not trying to kill 
yourself, or coming in and crying to them, then they don't care’. And the patient knows the 
doctors are very busy. 
It was a tremendous, stressful period in another patient’s life. And when the 20-year-old 
female went to the clinic, a ‘lady doctor psychiatrist’ saw her in the day room and said something 
about ‘Is your illness imagined, or is it real?’ And she said this in front of several visitors and in 
a loud voice, so the patient felt ‘just about four inches off the ground’. 
Another study participant shared her story and found it actually interesting. She continued Efexor 
(venlafaxine). It was the slow release capsule, and she was taking 75 mg a day. She was once 
feeling really bad, so she was told to increase the dose. The patient followed the doctor’s advice 
but then, she went back to the psychiatrist and his response was, ‘What! If you were surviving on 
75mg, go back to it.’ Patient’s conclusion: ‘psychiatrists know about drugs, GPs don't know as 
much obviously … You could end up on so much … but it is serious stuff’.  
The next informant’s experience was very negative. She was bringing her memory loss to 
the doctors’ attention at the hospital, and after giving them an example, she heard that this was 
just normal and not an adverse effect of the medicine. As a consequence, the patient got 
disappointed and fully discouraged, and also doubtful about the effectiveness of treatment. She 
went into a suicidal mood feeling that she cannot be helped. She checked her life insurance 
policies believing that her husband and her son would be better off without her. Because what 
was the point in living like she was living, she hated it. She hated herself and she ended up 
taking an overdose. This is a drastic example, unfortunately, one of too many, where the medical 
personel instead of showing understanding and offering support, left a depressed patient in a 
pessimistic mood that worsened her already poor mental state.  
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Depressed patients cannot be blamed for not believing everything their doctors say. Some 
decide to go and check the recommendations, because they either experienced themselves or 
heard from others that what the physician said, was ‘most of the time just wrong’. Rationale: 
‘they can't be expected to know everything, especially GPs’. Patients generally want to know 
what options they have. They also want to learn about what methods others use to deal with their 
depression. They admit, a deeper knowledge of the illness and effective therapies would 
definitely be helpful. Most people go against taking medication, but if drug treatment is found 
necessary, ‘if that's the silver bullet’, people demonstrate willingness to recognise the needs and 
benefits. Individuals tend to question the antidepressant medicines and how much patients are 
being over sedated. Checking the websites has become trendy, looking at information that's 
available, reading about depression and really become informed customers because this is found 
to be an area where people aren't always telling you the right thing, and especially GPs are 
believed not always have that knowledge to hand.  
Most patient admitted to conducting their research prior to taking medicine and starting 
treatment.  
4 Badger and Nolan (2007) 
There is a common belief, in depression you cannot rely on the medication, you don't get 
a miracle cure out of a bottle, it can help you over the bad times but it's not a cure. To be cured is 
up to you; you've got to be willing to try, half way, you've got to do it yourself. Self discipline 
has been stressed; patients would be disappointed to think it was just the medication. They like to 
think that they do not need to go back on the drugs again after they tried some other remedies 
and used different self-help strategies. 
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Stories of patients who started taking an SSRI vary. Some are account of positive experiences, 
and other are discpouraging. One patient reported that after he started the antidperssants, the 
change was fantastic, which convinced him that there was a problem because he felt so much 
better. 
In another case, the tablets were helping to a certain extent but they weren't by any means 
clearing things up. They were no good, patient didn't take them after the first course, he didn't 
collect the repeat prescription. Patient didn't think he really knew what the medication is 
supposed to do to you. Is it supposed to calm you down 24 hours a day or is it for an hour or two. 
Not knowing what it was makes it twice as bad. However, hearing ‘You have a common 
condition’ and ‘You will get better’ from the general practitioner was totally unexpected, but a 
very welcome information for the patient.  
A GP told the patient: ‘I've been expecting you for some time’, making the consultation 
easier. It's the complete package, the doctor, voluntary work. The doctors have left the patient to 
make decisions, and he believed this was the thing that has done it for him, they haven't come up 
with a quick fix, like ‘here's a list’ but instead, they said ‘You're different to the next patient; let's 
put a package together for you’. Patient felt he had been involved in it; he haven't been on the 
outside. 
Patient is crediting her recovery to her family, her GP and finally the medication.  
She took them for three or four weeks before feeling normal. It was gradual. But what was 
interesting, the woman believed that some of the healing process is also psychological because 
you know you are actually taking something which is designed to help and psychologically she 




5 Bennett et al. (2007) 
People say, it is almost a relief to find out that you are not the only one, and there are 
actually reasons behind it. It was one of those things that you kind of sense, but you don't really 
admit it to anyone, even to yourself. Patients believe, family physicians and psychiatrists can be 
very open, especially when a patient comes with some informed knowledge. Reports exist that 
some doctors appear to be quite supportive, introducing facts based on research and may even 
bring relevant studies to patients’ attention. Unfortunately, other general practitioners seem not 
really equipped to deal with the questions of antidepressants use.  
The physician’s encouraging attitude was found very comforting by one of the informants, and 
prepared the patient to say how far she was willing to go with the treatment, not only with 
medications, but with the whole therapy planned in advance. This patient was convinced, the 
doctor’s approach set her in motion to say, she is willing to take control over her moods and try 
to change to course of her disorder. One patient reported having taken a depression test. The 
score was checked each time. It was very high in the beginning, and then slowly went down, 
when the woman started taking the antidepressant medication.  
Women’s experiences of depression during pregnancy are extremely important. You 
want to put the baby first, but, at the same time, you're just balancing out what is the risk to the 
baby of having a mom who is on Prozac versus what is the risk to the baby of having a mom who 
cannot cope with life situations and is falling apart. Often, a woman would admit, ‘I can only do 
the best I can as a mom’. Other women try to decrease the risk to the fetus by taking as low an 
antidepressant dose as possible to treat bothersome symptoms. Thanks to the counseling or to her 
medication, or perhaps the combination of both, the next study participant felt that she had 
arrived at a better place. Life still had moments of being ‘up and down’ but, there were ‘far less 
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bad days than there are good days’. Another patient reported to be in a much better place now 
than she was before even becoming pregnant. As the previous informant, she was still 
experiencing her ups and downs, but her ability to deal with some of the triggers had greatly 
improved. She had received counseling but remained medication-free during her obstetric and 
postpartum periods. She showed understanding of the slow pace in which the treatment was 
progressing. She still did get depressed sometimes. She still did get angry, exasperated. She still 
hasn't regained her full patience. It will take work, and that's what she believed and understood, it 
is a work in progress.  
There's so much more to juggle, says another study participant. When you come home, 
you become a wife, you become a mother, and something, one time or another has got to give, 
you can't always be catching the ball. You need to take a break to recharge. Patient thought it 
was important, unfortunately, sometimes we just forget to recharge. The woman learned about 
herself. It was almost a gift in that, she doesn't know how to describe this; she learned about 
herself, she has learned to take time for herself. Another informant never thought that she would 
have worries. She didn't know that she should look out for these types of things. One of the 
reasons patient wanted to do this study was because she really thought it is important for women 
that are pregnant, either the first time, the second time, to share their experiences. That if they 
really think that they can't handle life any more, they really need to talk to somebody. It's 
important. 
6 Bayliss and Holttum (2015) 
A male patient believed that Mirtazapine probably did save his life. But another patient 
thought you can get stuck in a loop where they just prescribe you. A female patient reported to 
have been on antidepressants for 26 years (Iris). Initially, they were tricyclic antidepressants, 
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then the doctors tried MAOIs, which didn't work, and more recently the SSRIs…and then she 
was on lithium as well, and she also had ECT. Although another individual had survived her 
depression, as she confessed, she kept questioning herself, ‘what's the point in surviving if you 
can't feel?’ She realized that her medication was ineffective: She was going through a really bad 
period while stil on medication.  
Medication was significantly limiting another patient’s lifestyle. On Prozac he was 
functioning nicely, he admitted, but he was living the lifestyle of somebody in their late 70s, 
early 80s, rather than their mid-50s. He was not working. It wasn't helping him to address his 
lifestyle. 
A quite pessimistic reflection come also from another informant: this patient believed he had 
every single pill on the market and every combination of pills. In addition, the drug therapy did 
not improve his condition, but he was hesitatant to admit this to his doctor. His prediction was 
that they woud say ‘okay, fine, we'll change the pills, we haven't tried this combination yet, you 
will have two of those, three of those and five of thos  
Lay beliefs are that doctors are all about the medicines. For somebody who is suffering 
from depressive symptoms, a listening ear could mean a world, but instead, ‘you get to go in for 
10 minutes if you're lucky once every 3 months – ‘How are you feeling? Still taking medication? 
Sleeping alright? Well we'll leave you on that then’. This patient had that for 10 years. 
Regretfully, he says, ‘you don't get to lay on the couch, you don't get to discuss your 
problems…’ 
Many patients feel that they would prefer discussing the underlying causes of depression 
with their physicians and they would like to open up and sort that out to gain some clarity of 
thought and experience feelings of relief in place of pills they are prescribed. Feeling dependent 
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on medication creates dilemmas for patients. They don’t want to rely on drugs because they 
perceive it as an artificial control. One patient reported to have felt very dependent on his 
amytriptiline tablets and that made him want to stop taking the medicine. At the same time, it 
might be really difficult coming off an antidepressant. It is said to be really uncomfortable and 
like one patient admitted, ‘sort of feeling like you're losing your mind and getting really 
depressed, so you have to put a bit of faith in the tablets’.  
7 Boyle and Chambers (2000)  
Carers' knowledge and understanding of antidepressant medication helps maintain care of people 
that suffer from depressive illness. Here, the care givers shared their experiences of managing 
drug treatment together with patients who remained in their care:  
• Being cautious and checking the names of the medication in case other people share 
 information about side effects; 
• Receiving information about the tablets from health care personel; 
• Receiving explaination from the physician and proper documentation included (leaflets); 
• Consulting other professionals to check the appropriateness of the medication; 
• Not being informed at all; 
• Understanding patient’s fears of taking antidepressants due to their adverse effects; 
Care givers’ attempts to ensure antidepressants treatment compliance and experienced obstacles: 
• Patient believes the medication is not helping; 
• Patient’s confusion about proper medicine and doses; 
• Patient’s belief that tablets make her feel worse; 
• Making sure the pills are taken; 
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Older persons’ perceptions of depression suggest that in the past depression was not seen as an 
illness; ‘you had to get up and get on with it. If you can't make yourself better they (medicines) 
are not going to help’. 
8 Brijnath and Antoniades (2016) 
Patients have been trying to balance the pros and cons of consuming antidepressants 
whereas for health providers, prescriptions appear to be an easier option. One informant was told 
by his psychiatrist: ‘You obviously function’ and also, ‘You know I see people that can barely sit 
down.’ He said the same thing as the GP and his recomendation was to look if the antidepressant 
works, and if the patient can tolerate its side effects. After five weeks of therapy and during 
follow-up, the psychiatrist said that he definitely recommended prescription over counselling. 
Taking pills was also found ‘easier’ by those adhering to treatment. You only have to consult 
two practitioners (the GP for a script and a pharmacist to fill the script), and could purchase 
medicines at reduced cost using benefits, and avoid the effort of finding a good mental health 
professional, care costs and the emotional work of psychotherapy. 
For this patient, antidepressants did help improve mood: he felt like brain space springing 
up, even keel and it reduced the pain however, positive effects of antidepressants need to be 
balanced against possible adverse side-effects such as dry mouth, sexual dysfunction, lethargy, 
tiredness, and feeling dizzy and jittery. Lay beliefs are that medicines, specifically 
antidepressants are not ‘silver bullets’ or ‘magic’. They often caused severe side-effects, and 
experimentation might be unavoidable until an appropriate drug and dosage is found.  
Some individuals would drink just to sleep. A man confessed, he wouldn't drink for the 
fun of it. It's just one of his depressive symptoms: if he doesn't drink, he will just lie awake and 
he will be awake for 72 hours. A female is questioning whether or not drinking wine would be 
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considered self-medicating. And she admits doing that a lot, knowing it is bad; but sometimes 
she goes home at night and all she wants to do is have a drink of wine because it helps her relax. 
And when the patient felt down, she added on five Lexapro® 10 mg tablets. Another informant 
run out of the Effexor® and instead of taking two she just took it down to one. She reduced her 
dosages with the intent of discontinuing medication.   
Among people who were medicated, being ‘drug-free’ is understood as a sign of being 
cured from depression. A case of a patient who was trying to manage the antidepressant 
treatment by himself is not an exception: It was July when patient started reducing his dosage. 
September–October he stopped it completely. November–December depression hit him really 
hard. He couldn't concentrate on anything, felt really bad, couldn’t even explain, it was so bad. 
And then when he went back to the doctor in January he was made aware that this happened 
because he stopped the medication. The physician wanted him to get back on the tablets. And 
after he started the antidepressant treatment anew, he started feeling much better. He reported not 
to have that much of head pain, nor did he feel ‘so yucky’ any more. But still, he said, it was 
kind of ‘dying inside’.  
One person argued that the consumption of pills, especially those that neuro-chemically alter the 
‘self’, are less about pathologising deviance and more about modulating unruly or uncontrollable 
aspects of the self.  
Many participants in this study perceived taking antidepressants as problematic and they 
called it ‘the easy way out’. Somebody concluded that people usually assume that one is on 
antidepressants because he/she is lazy and doesn’t want to make that effort to go see a 
psychologist and empty her emotional bucket all the time. Alternative medicine is recommended 
to substitute medicines. There is a belief that with herbal remedies, it's not just a simple matter of 
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consumption. Along with that you've to control or monitor a change of diet, the physical 
exercise, yoga and breathing and meditation. This is generally presumed to secure more control 
over the ‘self’ and person’s depressive symptoms. It could also be considered more of a money 
issue, to adhere to a long therapy; go to the doctor first and get referred to a psychologist and 
then possibly stay with the psychologist for another six times. So that strikes the patient, it is not 
really convenient. One person said, he could just go to some of his friends and family every 
weekend and talk.  
A female patient thought it would be up to her, she should be working on her depression. 
She felt she needed to do further studies in childcare, yoga, exercising, walking, shopping, going 
out with friends and visiting a holistic doctor to obtain numerous pills (when she can afford it). 
Such transformative labour does help her and she noticed an improvement in mood. But such 
labour required constant effort and was often prompted by a sense of obligation and exchange, 
for example, the need to honour commitments (“not let down the team”), maintain relationships 
(“If my dad would tell me, ‘Do you want to go for a dirt bikeride?’ I say, ‘Yeah we'll go’”) and 
use services that were paid for (“We paid for these kick boxing classes, you have to go”).  
Another woman confessed it was all her fault. She at times got ‘a little bit slack’ with her 
medication. She was a little bit overwhelmed when she came back to the house at the start of the 
year getting kids ready for school, schoolbooks, covering them, uniforms, just getting into that 
routine again. Patient was trying to get her depression and life under control with medication 
therapy. However, she refused to add eating healthy and exercising regularly to her drug 
treatment. She felt that adding additional responsibilities or activities would cause too much 
pressure and a break down. Another individual always kept a little hope alive, reminding himself 
230 
 
that if he follows everything properly, he will get out of this condition sooner or later. But 
unfortunately, he never made an effort to actually keep his own commitment. 
9 Buus (2014) 
Participant was depressed for the first time and he believed that it was caused by 
prolonged emotional stress. He had been discharged to psychotherapeutic follow-up at an 
outpatient clinic, but he did not think highly of the healthcare professionals or their 
psychotherapy. He thought that they did not provide him with anything useful beyond 
prescribing medicine, which he continued taking, and in time he choose to cancel his 
appointments with the therapists. Despite disliking the medical specialist, he would visit the 
psychiatric emergency room every time when he felt acutely depressed or desperately impatient 
about the time it took for him to recover. Participant’s visits to the emergency room: mostly, he 
would just talk to them and go home. Actually, it did help him a little, he admitted. He thought it 
was because he spoke with professionals who told him that it was not unusual that he was still so 
incredibly sad. You are told that it's normal even though you are discharged and take medicine. 
Things weren't happening fast enough, and it was when he couldn't understand that. The last time 
he went there seeking help, he got medication. He told the doctor they might as well admit him 
again, but the doctor refused and offered him another option: Lithium. 
The patient had no prior personal experience of treatment for depression, and he felt that 
his need for a healthcare authority is to normalise his experiences of depressive symptoms by 
interpreting them in a less distressing way. But after starting to take Lithium to augment his 
antidepressant treatment, he gradually felt less impatient and distressed. He continued taking the 
medication in accordance with professional advice, mainly because he saw medicine as the 
primary means of recovery. He was sceptical towards taking antidepressants and experienced 
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some relatively mild adverse effects, but he believed that taking the medicine was necessary to 
avoid the risk of relapse. He feared stopping taking the medicine: he didn't know what it would 
be like if he didn't take them.  
Another individual was initially very sceptical towards taking antidepressants, but ended 
up accepting them as equivalent to taking vitamins. In his family, he had relatives with severe 
mental illness. He found taking antidepressants stigmatising, so he was begging his general 
practitioner to authorise discontinuation of the medicine even though he feared a relapse and 
return of depressive symptoms. The next informant had previously been treated with 
antidepressants, but this time he experienced severe adverse effects of the medicine, which 
included a substantial weight gain and tiredness. But he was scared of stopping the medicine 
despite the adverse effects.  
Another male participant realised he was a little afraid of what would happen if he didn't take the 
antidepressant. He did not ever again want to feel the way he felt when he was admitted. His fear 
was, it might happen again if he stops taking the medicine. He didn’t say that he'd like to take it 
for the rest of his life. He is sure that things will be good again, but right now the thought of 
having that feeling again was scary. 
The next case is described, where in time, adverse effects of the medicine became 
unacceptable to the female patient. At the same time, occasional slips in the treatment routine 
became more frequent and seemed less scary than making a deliberate stop, and eventually 
confirmed her in having no need for the medicine. She had reached the point where she took very 
little of it. It was just once in a while. Really, there was no control. She just took it when she 
thought, “Well, it's been a while, so I'd better take a pill or two”. In the end, it was horrendous. 
And she just didn't feel that she needed it. And then she just stopped completely. She threw them 
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out and hasn't taken any since. She just felt better. She didn't feel, that the medicine changed 
anything for her, and her general practitioner and her psychiatrist kept on saying that it made her 
tired. So she thought, “Well, if that is what makes me tired, I have to … I don't feel up to this. I 
have to get off that rubbish”. 
Another woman’s account: No, she hasn't asked her doctor if there might be an 
alternative to the medication. She tried some other ones and she didn't take more than 3-4-5 
tablets before she gave up. It felt like fire burning out into her arms and she couldn't take it. She 
hasn't had that with Noritren [Nortriptylin]. She has dry mouth and they give her the shakes. She 
would like to get rid of one of the medicine, but what if she gets worse? She saw someone during 
the admission, reducing their medicine and they ended up feeling awful. 
A male patient was convinced that one of his two antidepressants was stressing him and gave 
him the restless evenings and nights. He eventually asked his general practitioner to reduce the 
prescribed dosage, but the doctor refused and told him that there was nothing to do but to 
continue. As a reaction to the GP's disheartening response the patient decided to solve the 
problems by halving the dosage on his own. Participant had continued taking Mirtazapin but had 
been allowed to halve it. He found out that when he went to bed something was stressing him. 
He would wake up and he couldn’t settle again. So, he was sure this medication was not working 
for him. The man admitted that after reducing the antidepressant to half dosage he was stressing 
about it until he found rest. 
The next person was unable to confirm that he was having rewarding or trusting 
relationships with the therapists. He was only receiving prescriptions, and patient felt that the 
therapists were not ready or competent to meet his need for change. The prescribing therapists 
predominantly suggested maintaining the existing strategy by continuing, increasing or 
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supplementing the medical treatment. Such responses were extremely frustrating, as the patient 
desperately sought to change his situation, and did not believe that the medicine was important 
for solving all the issues, in most cases he felt that adverse effects added significantly to his 
problems. Patient found it difficult – and sometimes impossible – to challenge the therapist's 
authority during the consultations: When he sat in front of a doctor or someone with great 
knowledge, then he tended to believe all that was being said.  
Another participant successfully insisted on a gradual reduction and ultimate ceseation of 
his antidepressant simply because he had taken it for exactly six months, which, allegedly, was 
the period needed to have a low risk of relapse. This happened despite him having frequently 
experienced severe and disabling symptoms of relapse into depression. Another informant was 
shocked over having been admitted to hospital for depression and he continued struggling to 
reconstruct what had happened the day he broke down. He felt neglected by his doctor that day 
and he was convinced that the doctor had given up on him and his depression, because he did not 
care to listen: because he just wrote the prescriptions and then he was finished with the patient. 
He didn't say that the patient should return; he didn't say that the patient should come for some 
counselling; he didn't say, ‘I'd like to keep track of you’. ‘You can come and get a renewed 
prescription and we'll talk’. Participant decided to adhere to the hospital's original 
recommendation to take the antidepressants for six months, but because he felt abandoned by his 
general practitioner, he decided to get help to phase out safely from a kind employee at the local 
pharmacy.  
This patient was treated by a consultant in an outreach team for several years, but he was 
increasingly unsatisfied with the treatment, because it made him feel very tired. By chance, due 
to overcrowding at the usual hospital, he was admitted to another hospital in a different town, 
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and he was pleased to get a second view on his illness and his medication. At the new hospital, 
the medication was altered because he asked for it. At the old place, which was the usual hospital 
he experienced what he believed was a dangerous lack of responsiveness: It could have been 
good if the medical personell at the usual hospital had been better at listening to the patient’s 
complaints regarding the medicine. He believed that the last admission could have been avoided 
if he'd stopped taking that Seroquel (Quetiapine) and started taking something else. Because the 
tiredness, he had, added to weaken the whole system. At first, he was pleased to have his 
medicine reorganised and he started using psychiatrists at the new hospital as his primary 
therapists. But then, he had started self-managing his medicine, moving to the frustrated search, 
because he felt bad and – paradoxically – by reducing the medicine, he could prove to hiself that 
things were good.  
Patient then believed that his own reduction of medication added to his distress. He was 
readmitted to the new hospital where the psychiatrists wanted to augment the antidepressant 
treatment with Lithium, because they believed that he suffered from a bipolar disorder. And then 
Lithium made him feel tired and after discharge he decided to stop taking all the medicine 
augmenting his antidepressant treatment without consulting any professionals. He checked it on 
the the Internet, and learned that Lithium was fundamentally harmful to the body and had too 
many adverse effects and that he might as well test if he could do without it: He made this 
decision without talking to the doctor…It was probably because the doctor would be against it. 
Patient thinks he had an appointment in about a month from then. He thought that if he stopped 
them he could see if it reduced his tiredness, and if there are no problems, then there is no reason 
to take them. His perspective on taking medicine changed and his self-regulation increased 
gradually and was kept hidden from healthcare professionals and his wife because he was 
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convinced she would not approve his decisions. He also planned on informing his doctor, but 
then decided to cancel the appointments. He intended to eventually inform his therapists of his 
self-regulation but then realised that he would rather avoid all the comments. 
Another individual self-regulated his medicine intake from the beginning. At first, he 
only regulated one of his medications. And whenever he felt bad and consulted a therapist, who 
was never the same because of institutional reorganisations, the only response was to prescribe 
more medicine. He felt more and more certain that this response added to the problem rather than 
to its solution. It is good that you can get medicine when you have pain and medicine when you 
are depressed. But he didn’t think it was a solution to just add more and more medicine because 
you go crazy because you're doped all the time. He believed taking something like 29 pills a day. 
A woman finally decided to reorganise her medication and she used her sister as a trusted 
person, who was the only one knowing about this complete and abrupt withdrawal. Her sister 
helped her by text-messaging frequently. And the decision just emerged: she had to say either or, 
and she felt so bad. Had it not been for her sister who texted her all the time, she would not have 
been here, she confessed. She didn’t think that she was going mad. She had to revise her life and 
find out ‘what is was that she wanted. It was so hard. She didn't sleep for four days after stopping 
taking Seroquel [Quetiapine]. She could not find rest. She had them, but she was stubborn and 
said no, it shouldn't be like that. Another person experienced adverse effects of the medicine, but 
in most situations, she was able to manage and tolerate them in her everyday life. Dry mouth, for 






10 Carpenter-Song et al. (2010) 
A patient wanted to talk to the psychiatrist to see if he could by prescribed a new 
medication to make him less nervous. Medications don’t do nothin’, said this young Latino man. 
They are effective in treating nerves.  
Another individual shared his belief that he would be sent back to the hospital for any reason, but 
his preference was to keep taking his meds and stay out of the hospital. He was under the 
impression that the specialists wanted to lower his medication dose, but that was exactly what 
happened last time and he did not want to go back to the inpatient clinic.  
A young woman reported that her visits usually lasted about fifteen minutes and the doctor’s 
main concern was, whether she was taking her medication. This person got extremely frustrated. 
She admitted that even her recent interaction with her vocational specialist was not helpful as his 
focus and only concern too was her taking the medication: ‘Take your medication and you will 
find work’, which she found absurd. 
People complain about prescriptions being expensive. Another patient’s frustration was 
growing because she had already paid $40 for her prescriptions, which then got changed. She 
puts her hands to her forehead: she’s so sick of this mess. She doesn’t understand why they 
changed her medication. She didn’t sleep for a few nights and they just changed her medication 
just like that.  
Patient got a feeling of being ‘experimented’ on, with all these changes to medications. But this 
all costs money, switiching medication isn’t cheap. Some patients believe the doctors don’t know 
what works and what don’t work. First, they put you on a medication and when you tell them 
you don’t need it anymore they just put you on another one. Patient gets sick of taking pills. He 
is convinced, he doesn’t need all this medication. He feels that the medication is what makes him 
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sick. He doesn’t feel right when he takes it anyway. A female informant felt that the 
antidepressant she had been prescribed was unnecessary: she tried to explain that she was only 
depressed for about four or five days and she didn’t need medicine for depression because the 
symptoms didn’t last. She thinks that everyone gets depressed and they don’t take medication for 
it. But doctors give you a pill for everything, she concluded. 
Many patients think, the psychiatrists just give you medications. Doctors’ idea is to get 
the patient stabilized on the meds first and then they hope he/she finds a job. Other depressed 
individuals may believe the doctors do not focus on patients’ needs. One man was convinced the 
doctor sees him anyway “so he can make the big bucks”. And, to support his diagnosis, he just 
gives him a little bit of medication ‘because he knows the patient is not crazy’ (says the patient 
about himself), so he takes it. Nothing changes for another patient, either– everything is the same 
and one just doesn’t have time for that game. She is trying to move on and do some positive 
things and they look like they are trying to keep people in the same old spot. The lay belief is, the 
doctors don’t really have any interest in helping people, they are trying to help themselves keep a 
job and that’s what that’s about. A patient asks: Why do I have to go talk to someone who 
doesn’t care about me or how I feel? I have spent seventeen years going to see doctors that didn’t 
really want to help. They get a paycheck and all they do is write prescriptions that don’t work.  
Patient believes in his frustration, medical specialists just ask questions and listen, they 
don’t provide any solutions. They are mainly concerned about you taking your medication. They 
ask if you’re sleeping all right and if you have any problems you want to talk about and that’s it. 
They don’t solve any of your problems for you even when you tell them what they are.  
Patient’s wish was, if someone would just talk to her and help her figure out what’s wrong in her 
life, she would be fine. Unfortunately, no one could tell the patient what was wrong with her. 
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All these pills and more pills, another patient was tired of taking all these medicines. He wished 
somebody would find out what is really wrong with him and stop just giving him pills that ‘don’t 
do nothin’’. They don’t even try to find out what’s wrong with you, he said. They think it’s all in 
your head. This is his life, this is his head. Why does he have to do what everyone else wants 
him to do? He is not crazy and he will never live a normal life if everyone is telling him what to 
do. Patients may feel controlled by mental health providers. Once they label you, they never look 
at you the same way. The psychiatric label ‘changes you forever’, believe the Latino people. 
Patient has ‘enferma de los nervios.’ And there is stigma attached to it. Patient got labeled 
mentally retarded and a psycho by his friends and stuff when he got out of the hospital. He lost 
all his his friends. It was rough. The next study participant was definitely against telling her co-
workers about antidepressant treatment he was receiving. Her fear of being bullied and 
marginalized raised from her belief that ‘when you tell people you have a mental problem they 
pick on you and blame everything on you because they know you have something wrong with 
you’. Patient was hoping to get some distance from his family. He called it the blame and change 
syndrome. He was held responsible for being mentally ill. Fourteen years earlier, he was 
diagnosed as mentally ill and his father and his mother and his brother talked about him like a 
ladybug on a window. They talked in circles and then got angry at him. 
Another story of a female participant who told her doctor she was depressed reflects the 
general perception of unnecassary medical treatment in depression. This woman was prescribed 
Prozac and she rejected the drug with the belief that being “simply” depressed does not require 
medication. The fact that doctor never took time to find out why she was depressed, made her 
vey upset. All he said was, ‘Oh, you’re depressed; I’m gonna give you some medication for that.’ 
. . . He never asked the patient anything; he just wrote the prescription out and gave it to her. 
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Patient found, this was not helpful. Latino people were bitterly responding to the questions about 
antidepressants. Yeah, the doctor wants to get paid, but he doesn’t care because patients are poor 
and most of them are black and what does he care. It’s a paycheck for him; it keeps him 
employed. They don’t want to deal with the problem and try to help you solve it; they just want 
to give you medication and keep you coming back. If the problem doesn’t get discussed it will 
never get solved. Patient dislikes the doctor: he doesn’t answer his questions; and he doesn’t 
explain what’s wrong with him. Patient wants him to break things down so he can understand 
what’s going on with his body. He doesn’t tell the patient anything and he hates that. 
Patients can be difficult to deal with. There is a story of Bernice who wished for a 
provider that would listen to her because she felt that she would benefit from ‘someone to talk 
to.’ Yet this was difficult because of the high turnover of clinicians. They assigned Bernice to a 
male doctor . . . But, the patient refused the treatment simply because she had no intentions of 
talking to a man about anything. She justified her decision explaining, ‘when you get 
comfortable with someone they change that person to another team or they leave’. Patient didn’t 
feel like starting all over again and was sure she is not going to talk to a man about her feelings. 
She can’t be building trust with someone new and then they get changed and then it’s someone 
else new. She can’t be pouring out her heart to everyone and they don’t stay long enough to help 
her. She needs someone to get to know her, she wants them to know her, so they can help her 
help herself. 
11 Castonguay, Filer and Pitts (2016) 
Interviewee was surprised that even celebrities suffer from depression: she felt that their 
life-style, at least on a materialistic level, would helpe them escape from going down with such 
things as depression. But it is obviously clear that materialistic plays no role, you can have a very 
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big house and 3 or 4 cars, whatever, at the end of the day it all depends how you feel within 
yourself and within your mind, and nothing in terms of monetary wealth can ever make any 
changes to that. 
Interviewee’s mother has always experienced depression in a sort of similar way to her, she 
thinks. The patient remembers saying to herself, ‘Oh no, not again.’ … she thought she was over 
it and it’s back. Just the sheer onslaught of negative thoughts that you just can’t push out, this is 
how it feels. 
It’s almost as if you’re going in slow motion. If you’ve seen these films where you’re standing 
still and everyone’s going around you, it was almost like that. It is a combination of panic, 
increased heart rate, changes in sleep patterns, getting tired quickly, acting out, eating disorders, 
inability to work, paranoia, and being uncommunicative. This experience means the deep 
depression, patient feels physiologically different, he has this sort of pressure around his brain, it 
feels that someone’s got their hands inside there.  
And then comes the extreme: everything that you seemed to look at…you looked at it from a 
suicide aspect, when you went over a bridge and you thought, that might be an idea, or a knife in 
the kitchen, yes, that would be a good one. When she is really down it occurs to her when she 
sees a train coming to jump in front of it. And again, she gets these compulsions, and she has to 
physically take a step backwards so as not to do it. And these are strong urges. The suicidal 
ideation is…’I just, just want to be out of it’, she confessed. 
The participant told his friend about his suicidal thoughts, to which she replied, ‘you must 
go and talk to your GP, you must do something about this.’ The friend called the doctor for him 
and accompanied him to the waiting room. And the man’s friend said to him, ‘You’re 
depressed.’ So, only because supported by his friend, he went to see the doctor.’ 
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Another informant admitted that at some point, did not feel like himself and he felt 
something was off, and this spurred him to seek help. He felt that he wanted to jump out of a 
third-story window and he understood his action was not ‘the norm’. He thinks when you’re 
actually faced with, ‘Oh my God, I would have jumped if someone hadn’t come in.’ That just 
absolutely petrifies you because you know that you’re young, you shouldn’t be feeling like that, 
it’s not right, there’s got to be something wrong. No support from the family environment was 
offered. No one was picking up on how severe things had got for him.  
There are people who think there is nothing ever to be ashamed about with mental health. 
Patient’s recalled his conversation with the doctor. His concern was formulated around ‘the 
awful stigma on antidepressants’. In return, the physician asked: ‘Well if you are a diabetic and I 
said you are going to need insulin for the rest of your life, you wouldn’t argue, would you?’So 
she seemed to give the patient permission to say, ‘Yeah I’ve got an illness. You know, this is not 
my fault.’ 
The next female interviewee giving account of her experience only sought counseling, 
but received both psychotherapy and medication. There was a great deal of fear expressed in 
relation to antidepressants due to her preconceptions. She was worried before she took them that 
she would become divorced from reality, and develop feelings of indifference. 
Another patient knew very few people had used psychotherapy treatment. She was not familiar 
with the criteria for receiving it and who would be eligible. She only knew there were very long 
waiting lists. She knew of people who were waiting for 3 years, and 3 years is a big chunk out of 
somebody’s life. It’s just very sad. Interviewee was hesitatant at first, but all things considered, 
she would rather put on weight than be depressed so she took antidepressants and she felt like 
she had been given her life back. 
242 
 
A man reported that he suddenly was walking up the street with a smile on his face. Yes, 
the antidepressants did help this individual. The therapist listened and she responded to him in a 
caring, sympathetic manner, not as a distant professional. One participant admitted to having 
come to realize that ‘a miracle cure’ does not exist for depression. He shared his reflection about 
the medication that kept him stable; he was able to go to work, he was able to perform his job, 
able to enjoy quite a few things. But the medication did not remove his fears. He found his 
thinking processes had not improved, either. There is no miracle cure in depression, he 
concluded, adding that people have to do some work to achieve a fuller relief from depressive 
symptoms. Hope was also stressed as an important factor in recovery. 
If people go to the doctors they know what they’re asking them, and they know what 
they’re expecting the patients to say, and they know what it’s all about. Patient knows the signs, 
and he knows what to do, and you get better. ‘This is my disease, it’s part of me, and I want to 
control it’, he admitted.  
The next interviewee strongly urged other people who might be depressed and recommend that 
they seek help. Don’t suffer in silence. It may be difficult for you to reach out, and patient 
understands that because he didn’t for a long time. But he really urges you to reach out if you can 
muster anything, reach out because there is help out there. 
One man recognized the need to seek help after struggling to read a children’s book to his 
daughter, and he needed his wife’s assistance to bring him closer to the source: he believed 
realistically in the stage that he was, he was not capable of doing anything. He needed somebody 
around him to do the initiating. It really needed somebody else to make that contact for him and 
ultimately, it was his wife saying, ‘You must go to the doctor, I will make the appointment. I will 
drive you there. I will take you there. I will sit in the waiting room with you,’ but, ‘you need the 
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help.’ It really had to come from somebody around him because he was incapable of doing it 
himself. 
12 Chur-Hansen and Zion (2006) 
Several patients do not receive any counselling or information from the pharmacists who fill the 
prescriptions. 
And here follow accounts of people who were treated for depression: 
• Patient was prescribed Cipramil and then Avanza, at the age of 18, after consulting a 
general practitioner because she was waking up at night, couldn’t sleep very well, feeling awful 
and sad all the time, following an end of a relationship.  
• Patient was prescribed an SSRI at the age of 19, following a “breakdown” preceeded by 
an eating disorder and trip overseas to work as a volunteer. She began on Aropax, which caused 
hallucinations, and was then prescribed Efexor.  
• At 19 years of age, patient experienced anxiety for about three years, which was 
progressively worsening, and so she went to her general practitioner who prescribed Zoloft. Prior 
to taking the SSRI, for the previous four months, she had been managing her anxiety with the 
help of a psychologist and CBT. 
• Patient was 14 when she was first prescribed Zoloft by a general practitioner after talking 
to a school counsellor, who referred her to the doctor. At that time she felt that there was no 
cause for her depression. She was again prescribed an SSRI at 18 years of age after the deat of 
her both grandparents, whilst studying.  
• Patient began taking SSRI medication at the age of 17, after a school counsellor noticed 
that she was cutting herself, and referred her to a psychiatrist. Over the last three years she has 
been prescribed three different SSRI medications – Luvox, Prozac, and Zoloft. She is non-
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adherent to her medication and she self-monitors the dosage, often taking more than the 
prescribed amount. 
• Patient reacted badly: she was shaking, trembling, unable to sit still, being jittery, felling 
worse, felling ‘not normal’, dry mouth, felling sick, and being drowsy as side effects. 
• Patient experienced adverse reactions to the SSRI, including apathy, emotional numbness 
and hallucinations (including seeing herself being hit by a car and falling on knifes). She simply 
believed that the SSRI actually induced a depressive state worse than the one for which it had 
been prescribed.  
• Patient did not have any physical side effects, but she found that the medication resulted 
in her having ‘no emotions’. ‘You just feel like a zombie at times’. And she doubted it was worth 
the struggle. 
• Another person reported: ‘You name it: nausea, tremor, decreased appetite, headaches, 
thirst, feeling sick, agitation, anxiety, impulsivity and violence’. This female patient became 
particularly worried about the increase in her impulsivity and violent behaviour, which before, 
was totally uncharacteristic for her, and which was becoming more frequent and pronounced 
over the weeks of medication intake. She admitted never being violent to anything ever in her 
life. And for the first time she just got, she just snapped, and she basically threw the cat five 
meters across the room. And that just scared her, she didn’t know what that was. And she was 
impulsive, there was no thought behind it, she said. 
• Another account came from a patient whose general practitioner “freaked out” when the 
young woman reported feeling depressed. The doctor’s daughter had attempted suicide and the 
patient was told about it in some detail.  
• The next person felt that her psychiatrist who used psychoanalytic psychotherapy in 
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conjunction with the medication to treat her depression, was uncaring: she thought his actions, to 
give her, to continue to prescribe medication without being concerned, at all, over the effects of 
it, was ignorant and unfair, and when she looked back, it became hurtful. Just unprofessional and 
completely inhumane, she admitted. 
• A male informant felt that his general practitioner was ‘informative’ and helped him to 
think through the options, providing him with information, even videos to take home. This 
doctor also discussed possible side effects and contra-indications, and discussed withdrawal and 
the possibility that the SSRI may not be effective. 
• Patient did not recall his general practitioner providing information about the medication 
he was prescribed. However, he found, just going and talking to the doctor was quite beneficial. 
He appreciated honesty of somebody outside of the family. He did not consider talking to any of 
his friends about it, because he thought, they couldn’t relate to how depression feels. 
• Some other patient had seen many different general practitioners over the three years 
when she was taking SSRIs. She no longer remembered whether or not she was informed about 
how these worked. But she described a very common pharmacy practice: pharmacist: ‘do you 
know how these work?’ Patient: ‘yea…within reason’; Pharmacist: ‘have you taken this before?’ 
Patient: ‘yes, ‘yes,’, and this is it. 
• Patient had suicidal ideation, which she had never experienced before.  
• Patient had hallucinations about her own death, and eventually thought about ending her 
life. 
• Another patient has repeatedly attempted suicide. She was positive that she wasn’t 
suicidal before she started the medication. She wasn’t sure whether it was just the SSRI not 
treating the depression, or a possible increase in suicidal ideation occured. 
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• Patient’s general practitioner explained that she needs to, her body chemical are not 
balanced, and that she needed to fix that first, and then they could work on the problems second.  
• To another informant, the doctor ‘explained something about a chemical imbalance’, and 
stated this needed to be fixed before other problems could be addressed. 
• Another patient’s psychiatrist explained depression in psychoanalytic terms. He said: 
‘Keep talking and you’ll figure it out. Well, it’s inside of you, you just need to concentrate on 
talking a bit more’. 
• The next informant was given a neurobiological explanation.  
• Patient was not provided with information about depression, as far as she could recall.  
• Patient was provided with neurobiological explanations. 
• Patient felt that her reaction to the breakdown of her relationship was ‘not normal’, but 
she thought that talking to people, not medication, was what she needed. 
• Another patient wondered whether her mental health might have been affected by her 
eating disorder and the experience of observing powerty during her volunteer work. She was also 
curious as to whether her anti-malarian medication (Larium) might have had some influence. She 
believed that the SSRI actually caused her depression, and that she was probably suffering from 
anxiety prior to being treated.  
• Another patient felt that while medication might make it easier to manage his anxiety, a 
positive outlook, exercise, fish oil, meditation, relaxation, and making an effort to change were 
more important.  
• Depression is an illness, and it can be treated. However, patient sees a difference between 
247 
 
her first episode of depression, which had no “trigger”, and the second experience, resulting from 
the death of both her grandparents. She thinks that medication was needed in the first episode, 
but that counselling was more important in the second. 
• Patient was overwhelmed by what was happening when she consulted the general 
practitioner: she was quite overwhelmed by the whole thing, what the doctor was saying to her 
because she didn’t really think that was what was going on…and the doctor didn’t actually 
prescribe it first, she gave the patient a trial pack to take home and then get the prescription 
filled. So it was kind of bombarded on the patient. ‘This is what’s wrong with you, you have to 
do this to fix it’, and patient was so overwhelmed by everything that the doctor was saying she 
just walked out of there and just took it. 
• Patient felt helpless, to the point that although she was unhappy with her treatment, she 
was unable to seek help elsewhere. 
• Although patient was satisfied with his general practitioner’s information, he felt that he 
needed to know more, particularly about adjunct therapies, so that he could make an informed 
decision. 
• Patient was frustrated with her psychiatrist, and with the medication, and its side effects. 
She said to her doctor: ‘Look, I’ve had enough, it’s not working for me, I feel completely 
apathetic’.  
• Patient was so frustrated because the doctor still kept saying to her: ‘Oh, just give it 
another week, you know, these things take time, your body is just adjusting’.  
• It was frustrating because despite the treatment, patient’s mental health seemed to be 
deteriorating. 
• It has, it’s fainted patient’s view a lot, because he went in there wanting help, and he said 
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what was going on, and it was just more the doctor trying to treat the symptoms, that actually 
what was happening. 
• The experience has negatively influenced the patient’s opinion about doctors: It just 
scared him to think that, fourty minutes into speaking to this person, he was prescribed what was 
going to be 18 months of hell, on medication.  
• Within fourty minutes physician felt he could make a decision. 
• Patient got a feeling that his general practitioner needed to have more knowledge about 
the treatment of depression. 
• Patient felt that these experiences have given her strength and wisdom, and that she 
knows now that she is the best judge of her own health. She now interviews health care providers 
before agreeing to treatment, and she seeks other opinions if she is not happy with what is 
offered. To regain control, she ceased seeing the psychiatrist. 
• Patient strongly believed that hope was an important factor in keeping her alive: And 
there is all these little promises which you just, as much as she really resent the way that her 
psychiatrist, she feel that, he didn’t give her any care, the one thing he did give the patient was 
hope. And that’s not something that he of course, actively gave her, but just by going to see him 
and by having these drugs, it gave the patient hope that there at least, was something. 
• Another patient perservered with SSRI medication: It’s the hope, it’s the hope that maybe 
this one will be the one. And so, a bit of nausea, physical pain is nothing until, you know, until 
you experience emotional pain. And, if it’s going to even reduce it by 1%, she is happy. 
• Patient felt that not only had the medication not helped but it had made him worse: So 
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having all this hope that he was getting better and that this pill that he was taking was going to 
relieve his symptoms, yet physically spiralling down, still, so not even reaching a plateau, 
continuing to slide down.  
• Another patient was doubtful about the efficacy of his medication.  
• Another patient felt that the medication initially helped, but after a few weeks and 
increased dosage, she continued to feel depressed, or felt flat rather than depressed.  
• Another female patient had never experienced a positive effect from a SSRI. 
• Whilst unsure that the medication was helpful, patient did think it might have been 
helping little bit. But it is working a little bit. That is, when he get into a sort of negative 
emotions, he find he can come out of it a little bit easier. So, it perhaps doesn’t quite last as long. 
Patient felt relieved in having been prescribed the medication, even though it was not 
alleviating her depressive symptoms. 
• The stigma of mental illness, and of taking an anti-depressant is there. For example, the 
reactions of his peers when he had to explain that he could not drink alcohol – ‘Oh, why do you 
need to be on that?’ Patient’s many close family and friends would be unaware of her 
experiences, and she finds it terrible even that she finds difficulty speaking about it. 
• Another patient also felt the stigma. His anxiety and treatment is something he finds 
difficult to talk about, and that it’s like a lot of mental health things, there is no good reason to 
feel that stigma, and you’ve thought it through, but you still feel it. 
• Another patient discussed his treatment with his parents who were very supportive. His 
close friends were also helpful.  
• Another patient’s parents are unaware of her depression and her main support is another 
suicidal student with whom she discusses plans about how to end her life…          
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• Another patient believes she is very good at keeping the façade.. 
The stigma the depressed individuals feel, it is visible in the way other people look down upon 
them. And mental health...there must be ‘something wrong’ with the person. Friends are 
important, as a component of treatment. There is a great need to stress the importance of 
everybody’s supports: Patients confessed, if they haven’t experienced family and friend support, 
they wouldn’t have been able to find enough things to live for, they wouldn’t have continued 
living. This is a very powerful message. 
13 Cohen and Hughes (2011) 
Lay beliefs in chemical imbalance because . . . 
• Medication caused a change in the well being 
• Medication wouldn’t do anything if there wasn’t an imbalance 
• Medication made people feel different 
• They’ve seen the change in their lives 
• Medication obviously helps 
• Trust in the physician’s diagnosis 
• Individual told by experts who suggested he takes the drug 
• The doctor explained it well 
• The doctor showed the mechanism of depression using a plastic brain 
• Patient knowledgeabl about the field and chemical imbalances 
• Patient has done his/her research 
• Pateint’s study showed how it works 
• Patient’s understanding of depression is physiological 
• Patient knows from own experience 
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• Knowledge from others’ experience 
• Symptoms are physical as well as psychological  
• Physical symptoms must have physical cause 
• Medication helps maintain serotonin levels 
Doubts about chemical imbalance because . . . 
• No way of being tested  
• No test can tell 
Disbelief in the chemical imbalance because . . . 
• Patient knows there is no biological cause for his problem 
• Patient doesn’t believe in chemical imbalances 
• Patient’s problem is due to environmental stress 
• Patient’s therapists told him so 
Beliefs that medication causes a chemical imbalance because . . . 
• It triggers unwanted physical effects 
• Drugs affect everyone the same 
• My medication leaves body quickly so it doesn’t have long term effects 
• I don’t know if drugs act chemically or psychologically 
• No reason given 
• Short half-life means no long term effect 
How Medication Acts in My Body: Users’ Descriptions (In Alphabetical Order) 
1. Causes a chemical imbalance 
2. Changes the chemistry of my brain and makes it function better 
3. Cleans the spark plugs so they fire properly 
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4. Completes the chemical dysfunction 
5. Fills my brain 
6. Fills the holes that depressed people have in the brain 
7. Helps maintain serotonin levels in the brain 
8. Increases dopamine release and produces more dopamine 
9. Increases whatever it is in my body that makes me happy and calm 
10. Levels out my brain 
11. Makes serotonin go around better in the brain when it gets blocked 
12. Manipulates chemicals like exercise releases endorphins 
13. Stimulates the frontal lobes 
Subject of chemical imbalance in 22 synthetised interviews with psychotropic medication users 
The patients were approached with the following questions: 
Do you think that the medications correct or help a chemical imbalance that people have in their 
body or brain? Why do you think it is a biochemical imbalance? Why do you think you had or 
you may have a chemical imbalance? Do you think that the medications you are currently on, 
may correct a biochemical imbalance? Do you think that the drug is correcting some imbalance, 
then, changing something in your brain? What makes you think that? How do you think the 
medication impacts your body or your mind? Do you think that the drugs are acting upon your 
body and mind, in what ways, in positive ways, in negative ways? How do you think and 
antidepressant acts in your body, your mind? Do you think that antidepressants correct some type 
of biochemical or hormonal imbalance? In your personal opinion, how do you think that these 
act upon your body, your mind? You said Celexa centers you. Do you feel it corrects a chemical 
imbalance? Are you able to explain to another person how this drug works for you?  
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The answers varied: 
1. Woman, 59, taking sertraline and lorazepam for depression, believed that yes, for some reason 
the person has an imbalance. And the only thing you can do is to take the medications. She 
thought it is an imbalance—from the moment you take the better medication, if an imbalance 
didn’t exist you could take the pills and they wouldn’t do anything to you because you don’t 
have it. 
2. Woman, age unknown, taking sertraline for depression. She believes that there is chemical 
imbalance. Because Zoloft made her feel different. 
3. Woman, 27, doctoral student in clinical psychology, taking amphetamines, venlafaxine, 
lorazepam, and clonazepam for 7 years. She knew about chemical imbalances and she knew how 
she felt before and while taking antidepressants. She felt that her medication helped her to be 
who she really is. She thought it made her more complete, it helped the chemical dysfunction. 
4. Man, 44, taking fluoxetine for 9 years. He was positive the medication was correcting his 
biochemical imbalance. His doctor showed him. He had a plastic brain with different colors, he 
demonstrated how it works. He showed the patient where the serotonin was going and how 
Prozac makes it go around better when it gets blocked, this is research. The patient had also done 
his own research and is now convinced about the mechanisms of drugs. 
5. Woman, 62, taking paroxetine and alprazolam. Most definitely she believed in chemical 
imbalance. Her study showed her most probably what the reason for her anxiety and upset was 
and so by understanding and researching it allowed her to be more accepting of Paxil and Xanax. 
6. Woman, 68, taking sertraline and alprazolam. She thinks in a very positive way. She believes 
the medication must be restoring the chemical imbalance in her brain so that she no longer has 
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her anxiety and panicky feelings. She definitely accepts the model of chemical imbalance 
because her symptoms were physical as well as psychological attacks. 
7.  Woman, 53, taking escitalopram for anxiety and depression, just switched from paroxetine 
and 
alprazolam. She believes that there is a biochemical imbalance in the brain. And not only from 
her own experience; she claims other people have felt the same. 
8. Woman, 56, taking fluoxetine for 8 years. Her doctor told her that Prozac changes the 
chemistry of her brain and makes it function better, resolving the depression that way. 
9. Woman, 30, just switched from fluoxetine to escitalopram, and also taking lamotrigine, 
ziprasidone, and lorazepam for last 4 years, has simultaneous diagnoses of post-traumatic stress 
disorder, borderline personality disorder, major depressive disorder, and generalized anxiety 
disorder. Talking to her doctor, she was explained that there have been studies done and 
breakthroughs that show the brain; that people who are depressed have holes in the brain and use 
medication to fill the holes so they help. She feels the medication is helping her and it fills her 
brain. 
10. Man, 31, taking paroxetine for depression. Biochemical, as within his brain? Yes, he believes 
that. This is what they told him the antidepressant was going to do, something biochemical. 
Something to do with increasing serotonin, increasing whatever it is in the body that makes you 
happy, makes you calm. It just kind of leveled out his brain. He believes that this was the 
ultimate goal. 
11. Man, 54, taking citalopram for depression. The analogy that he heard best describes it, is like, 
if you have dirty spark plugs and you use a detergent gasoline, it cleans those spark plugs so 
you’re getting a good, so they’re firing properly. Instead of getting sluggish performance, you 
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are getting peak performance. Being asked whether he tried any other solutions to aid his 
depression besides drug use, this man replyed that he does not see any reason to do so. His full 
understanding of depression is that it is physiological. So, if this drug allows him to cure that 
physiological problem then, there is really no need to seek any other help. Because, the problem 
is solved. He believes it because he had been told that by people who suggested he takes it. 
12. Woman, 51, taking sertraline for social anxiety disorder. She admitted not being familiar 
with medical terminology but she did know that the medication helps maintain the serotonin 
levels in the brain and causes her to feel calm. 
13. Woman, 23, taking lamotrigine for anxiety. She is convinced, antidepressants stimulate the 
chemistry of the brain. She would have panic attacks in her sleep. However, that never happens 
now since she is on the right medicine, so she knows that it had something to do with her brain. 
14. Man, early 40s, taking quetiapine, lithium, venlafaxine, and lorazepam for 5 years for bipolar 
disorder. He has seen the change in his life in the last five or six years. There’s no doubt in his 
mind that there’s something wrong mentally. Today he can safely and honestly say, yes, there is 
a mental issue that goes on in his mind. What created it—what triggered it— he believes, it was 
the divorce. 
15. Woman, 35, taking antidepressants on and off for 14 years, now taking sertraline for one 
year, since her marital breakup. She believes in chemical imbalance because the medication she 
is on, helps. And she took this medication almost vigorously just because she trusts her doctor. 
At the same time, having this long term experience with drugs she thinks that she can finally 
handle her problem without antidepressants, but this was a traumatic event. She got out of an 
abusive relationship so she understands anyone that goes through a trauma is going to react with 
sadness, grief and depression, this is normal. She was able to function for over a year without the 
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need of medications.  Living a healthy lifestyle and exercising, which is something that she had 
done consistently before and she strongly believes, that was enough to create the chemicals in 
her brain that made her ‘normal’ or made her feel good. Her guess is, her brain chemicals are 
being manipulated with a drug instead of endorphins that you get through exercise. 
16. Woman, 26, taking lorazepam, estazolam, and butalbital, does not think it is chemical. She 
thinks it is more of environmental stress, or some things that one can fix. But she is not certain 
because, she had not been tested for that. Also, she knows two professionals with degrees that 
outrank hers, and they too, work with anxiety and depression symptoms without medication, so 
she tends to believe that they’re correct.  
17. Woman, 25, taking sertraline and venlafaxine for depression, diagnosed with post-traumatic 
stress disorder 7 years earlier, following a gang rape. Her aunt says she has lost a lot of weight 
since she has been taking the Effexor. As it makes her dizzy and she tends to lose her balance 
sometimes. So she assumes, the medications are not good for her health. And she does not think 
there is a biological cause for what she has. She rather believes it has something to do with the 
way she was brought up. She is doubtful that she can explain to anyone that her self-esteem is 
caused by a biochemical imbalance. She does not believe in biochemical imbalances. She 
concludes, it is a stupid reason that people use when they don’t know how to explain things. 
18. Man, 32, taking methylphenidate, atomoxetine, venlafaxine, and alprazolam for attention-
deficit/hyperactivity disorder and obsessive-compulsive disorder. He is not so sure, if it is an 
issue with the chemical imbalance. To his knowledge, Concerta stimulates the frontal lobe, 
makes him focus a little bit, and most of other drugs, he is not sure. He thinks the medicines get 
out of the system quickly, so you don’t necessarily have a long-term chemical difference. He is 
not really looking to change the chemistry and certainly not drastically. 
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19. Woman, 55, taking lithium and clonazepam for bipolar disorder. She thinks, it has something 
in common with the chemical imbalance. She has gained weight, up to 30 pounds, and she is 
dizzy, and she is feeling thirsty, so to her, the medication is definitely causing a chemical 
imbalance instead of correcting it. 
20. Man, 29, graduate student in chemistry, taking amphetamines for 3 years for ADHD. He 
said, this is how it’s explained, with the chemical imbalance. But how can you tell? He has not 
been tested for an imbalance and it is unknown how would it be detected, how would they know, 
if one has an imbalance or none. Amphetamines affect dopamine. That’s right, but because they 
are all speed drugs they affect everyone the same, they increase dopamine release, you produce 
more dopamine, so this corrects a chemical imbalance. But he rather thinks, it probably causes a 
chemical imbalance. 
21. Man, 37, taking sertraline for 1 year.  He is not sure if the brain is affected chemically or 
psychologically, and he does not know what it is, or how it works. 
22. Woman, 58, taking escitalopram, chlorazepate, and lorazepam for depression. She does not 
know how her medicines work. 
14 Dickinson et al. (2010) 
Three main themes were identified from the interviews: the benefits of antidepressants; 
ambiguities and dissonances in the understanding of depression and its treatment; and barriers to 
the discontinuation of antidepressants. 
At the time of commencement of antidepressant treatment patient had a quite indifferent attitude. 
If the doctor had said take some rat poison the patient would have probably taken it, he was that 
down so he didn't bother; and then gradually, it got better. It seemed as if some fairy had waved a 
wand and got him this drug which brought him round. He swears by it. His worst point was when 
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he woke up in the morning. He just didn't see any point in going on and it certainly helped very 
much indeed.  
If the cause is a social factor people can't get rid of that, but the medication might alleviate their 
symptoms a little bit. They admit, ‘if it makes them feel even a bit better it's worth it. Because at 
the end of the day most antidepressants are not that expensive’  
Another patient started to get fatigue spells where he was abnormally tired, not sleepy, 
physically exhausted. It was an effort to walk and his GP said those were symptoms of 
depression, although the patient claimed he didn't feel depressed. But as far as he knows, not 
being very knowledgeable on medical matters, one could be what you call clinically depressed 
without being mentally depressed. That's how he understands it, so although he didn't feel 
depressed he accepted the fact that it could as well be the depressive illness.  
The GPs also acknowledged a difficulty in providing a solid diagnosis of depression and 
understanding and treating its causes: We have to keep figures of who is depressed, but of course 
a number of people come in and it says “depressed”, but they are not actually clinically 
depressed. They experience deep sadness because someone has just died, and that's where the 
medical figures are high. The doctor thought, for all their patients who have coded as depression, 
maybe 10%, if that, actually had clinical depression. This ambiguity in understanding depression 
as an emotional or physical condition influences GPs' views of antidepressants: In emotional 
medicine you are much more predisposed to the individual patient. In cardiology where 
essentially every patient comes in and gets an aspirin and a beta blocker and an ACE inhibitor 
and they all recover, you can't do the same with the emotional illness.  
The problem with general practice is that the perception of psychiatric illness is such that 
it is still not necessarily viewed as a biological condition. GPs acknowledged the difficulties in 
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providing treatments other than pharmaceutical:  In the area where this study was conducted, 
there is a 10 to 11 month waiting list for CBT [cognitive behavioural therapy], by which time the 
crisis has gone. People come to see the physician in extreme situations really, they are usually in 
a very distressed, disturbed state. The majority of patients have lived through the Second World 
War and they have an antipathy to counselling. The belief is, antidepressants do have a place, 
partly because it's not a lot of other things that help mild to moderately depressed elderly, the 
CBT has got a very limited place. Counselling works, admits the GP, but it is always very 
difficult to get elderly patients to engage, so the doctors are often stuck with just prescribing, so 
it is a bit “best of a bad bunch”. A patient didn’t want to go through counselling and he didn't 
because of his faith and his family, he said, he doesn't need anyone else. The doctor didn't offer 
anything else, what else could he offer? The older man felt that the young physician was rather 
embarrassed not being able to help him.  
General perception is that nowadays, a medicalisation of life can be observed. But, while 
there are problems that we all have in our lives, some people may really need to have it turned 
into a medical problem to get validation of their suffering. But others abuse the circumstance; 
instead of admitting, they are struggling to cope with a bitter divorce, they come and say they 
suffer from depressive illness. The doctor who was interviewed in this study, didn’t think it is 
right to prescribe something that you don't necessarily need, and felt that writing prescriptions 
for social issues is, indeed, becoming trendy, but should we prescribe “lifestyle drugs”? 
Diagnosis presents a challenge when you can't measure the outcome. If someone has high blood 
pressure it can be measured that and it's a definite. Depression really becomes a part of your life 
and you just have to cope with it.  
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Patient never gets really well, where he could go longer without the meds. He has lived 
on them all his life. His prediction is, he will be on them for the rest of his life because he cannot 
be helped in any other way, so he believes he will be taking them for the rest of his life.  
He already was able to cope very well with his depressive symptoms, but he then was diagnosed 
with cancer, which was a big shock to him; they coped with that very well, got over that. And he 
thinks he came off the first antidepressant and then, his eldest son was diagnosed with cancer so 
he was put back on the medication again and the son died but that was expected, patient coped 
with that quite well, and after a while came off the antidepressants; and then his youngest son 
collapsed and died, so patient was put back on antidepressants again.  
Patient is normally tired and now his life gets difficult, his wife should have had her hip 
replacement but her blood pressure is far too high and she can't have it. So it can only get worse 
so for the last few years he had to take on more and more to help her like he had to do all the 
shopping; it doesn't bug him and physically nor emotionally they just accept it, it's just another 
thing that's come over that you have to cope with.  
Patients acknowledged that often this was also a challenge for their doctor: they have done very 
well with this recent reduction to antidepressant regimen, in fact they have done better with these 
people than they have ever done. It can be very debilitating. GPs also acknowledged the 
intractability of some patient's situations: Doctor thinks some patients have horrible lives, a lot of 
them … doctor thinks it's a combination of all things, their health, their social circumstances. 
Doctor thinks a lot of people are on antidepressants because of everything put together. And you 
can't change most of the factors that cause it.  
They feel that unless they are on a tablet for it then they are not having any treatment. There are 
a lot of those kinds of people. 
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The doctors didn't say anything about why patient was depressed.  They just seemed to think it 
was a general condition for her age.  
With the old age, every year you sort of get something which as you get older is expected. If 
your eyes go they go. You see that doesn't bother me, my legs bother me, yes because I can't use 
them properly. I was a great walker at one time and I can't do that now.  
 Doctors are more bothered about blood tests, liver tests, breathing operations. No, the depression 
has gone into the bottom drawer according to the state of patients’ health and what the doctors 
think about older patients. Patient believes if he brought it up in conversation they would talk 
about depression, but if there is no need to talk … why not leave it alone!  
Patient is summoned to the surgery once a year because of his age, where he has blood tests and 
urine tests, and a general talk about his health. But he doesn't think that either the antidepressant 
or the depression has been mentioned in those talks.  
It's well known that depression is often overlooked in the elderly and people who have got 
physical disabilities and whose life has been significantly impaired by their illness …  
The general belief is that there are some bigger battles out there, than persuading the patients to 
stop their antidepressant treatment. 
Elderly people are generally more self effacing, and they don't make demands on the doctors for 
treatment. They say “oh I know it's old age”, you know, they expect that they are going to feel 
low because they are old. They have lower expectations of what can be achieved, and they are 
wary of antidepressants, but doctors thinks antidepressants do work in elderly people.  
It's always difficult to assess because there are so many more layers with elderly people, they tell 
you what they think you want them to say … It takes a lot more detective work.  
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Patient is not coming off these because every time he comes off, something else happens; but 
these, these are more for a panic attack.  
Patient takes half of the tablet for so long and then she thinks “oh blow this I'll get rid of it” but 
then, she is afraid to. She still doesn't know whether she would sleep if she came off them … She 
doesn't want to try!  
When the GP was there she said “well, we could get you off them slowly”, and patient was in 
fear of her doing that because he supposed they're a crutch really. Would it make any different at 
your age? Why bother changing something now?  
Patient thinks at his age he would just think “well carry on as he is with them”. Patient thinks it's 
too late to change now. It's scary to stop a medication that's been going for a long time, because 
you kind of think, are you opening a can of worms here, because you don't know what the 
reasons were for them starting that medication. To explore all that will take time. 
They're frightened of coming off, because they don't want to feel like they did initially. And you 
can understand that.  
Doctor doesn't agree with this treatment, it's not the best thing to do, but at the end of the day it 
depends whether harm outweighs benefit and is it worth having that major fall out with the 
patient and if I'm really stuck and I really want them off it I would send them to psychiatry to get 
someone else to try and do it for me. I've never had to do that.  
There are some patients who need that little bit of a crutch, almost a placebo effect, the kind of 
people who sometimes feel they want to be on a low dose more permanently because they feel it 
keeps them on an even keel. The long-term patients generally are on probably sub-therapeutic 
doses really, how much actual effect it has on their mental health is probably minimal but it gives 
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them psychological support. If somebody did become more symptomatic then we would up the 
dose.  
Patient just takes them … He just takes them thinking well if they do me good …  
Oh, he thinks, you will continue with the medication, think now he got to this age anyway that 
you know I'll just go on.  
Patient doesn't really know. The doctors will keep an eye on things and if the time was 
appropriate then they would take him off it but having kept me on it he assumes they are happy 
for me to go on taking it so he takes it but with all this medication he would come off it if he 
could. If he can't come off it then he accepts it.  
As patient feels now like she'll be taking them for the rest of her life … after 4 years she can't see 
it improving, as she says it keeps it in check.  
Well, older patient says he won't be here long so he thinks he'll keep on it ‘til he goes.  
It would be a marvellous thing if you didn't have to take anything at all, but patient thinks that is 
asking a bit too much at my age. He thinks you have to have something to help you along.  
Patient was called in to see the doctor because she thinks at that time they were a little concerned 
about what the long-term effects of taking it would be. And they chatted and the doctor said to 
her “I think you're taking these as a sophisticated sleeping pill, and if that is the case, I've no 
objection to that”. And the patient said “Well, they do help me to sleep, that's the reason why I 
keep taking them”.  
Patient feels it's one that suits her and she'd be reluctant either to change or stop it. 
Patient says he's reasonably happy with taking the medication; well very happy with taking the 
drug; it seems to be working and unless he suddenly get an attack of depression, he doesn't think 
he would mention it to the GP.  
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15 Egede (2002) 
A female patient heard other people saying she’s crazy because she’s taking depression 
pills. She heard it. It was hurtful. She felt being marginalised and excluded. 
The next participant thought diabetes is a sickness and depression is a state of the mind. 
Depression is something you can get rid of, diabetes you can’t.  
Another informant was convinced, depression it is a lack of ideology. Having a positive ideology 
instead of a weak mind is what is helping people protect themselves from depression. Only those 
get it that have no knowledge or understanding of how to overcome obstacles in life. They take 
to heart everything what others say and it destroys their strength.  
Somebody else concluded, people just sit back and worry about things. Things they want and 
can’t get. That is what some people do. This patient doesn’t care. She got that nonchalant attitude 
now. A lot of people tell her that. She doesn’t know if that is good or bad, she just doesn’t care. 
This is how she protects herself from depression. Another woman believed, with her it was a 
different story; she came from a poor family, they had nothing, there were 8 or 9 living in 3 
rooms; so when she was a child she learned how to provide for herself and take care of herself. 
Her father made about $8 a week, mother made about $3 a week, so she grew up learning not to 
worry about things. She just keep on living, she just never let it bother her.  
A male informant suffering from diabetes and depression feels to himself that depression 
can mean self-pity, it is like feeling sorry for what you have and then again thinking about the 
things you were able to do before you got sick. When they first put him on the pills, he used to 
think he doesn’t feel like taking these drugs, it just seemed like it started getting on his nerves at 
one point because he had to take those medications every day, and it was just like taking a pain 
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killer. It was what started him to get depressed, but then he had to shake it off. Because, he 
remembered, he had to shake it off…he just shook it off.  
Another patient regrets the chronic use of antidepressants. She only took them because 
she had this fear of being ill…She doesn’t want to get sick. That’s all. She is trying to keep it 
down for now. Because she knows how it gets, she wpuld need to go to the hospital. That’s some 
place she doesn’t like to be. She doesn’t like to go in there. So, that is why she does what she 
does, whatever is necessary to stop her from having depression. Diabetes can destroy you and 
depression can destroy you, both of them can do it to you. 
There is a story of a young man who found himself extremely stressed. He was up for promotion, 
they put somebody else in his place, and he didn’t get the job. He got stressed out. And the 
doctor put him on stress pills, and then, he was all right. But he refused to take the antidepressant 
and she believed, he didn’t need the pills. And he took himself off of the medications, and every 
time he took himself off it he would have to get back on them. But it was all because he didn’t 
have a strong mind, reported his father.  
The next participant just hopes he never gets depressed. He has a family history of depression, 
his both siblings have ‘a little nerve condition’ and he knows through dealing with them and 
seeing them, how it works. And he just hopes he will never have to get to that point.  
Somebody who is strongly against antidepressants, made a reflection, that, if a woman feels like 
she needs to talk to somebody, she should not be saying, ‘I am depressed’. She might be 
depressed, but she is taking no medicine. Sometimes, she needs to go lean on somebody’s chest, 
so somebody can hear her, hear how she is feeling. And thst is all. This is the therapy. 




A man who was about to receive prescription, told his physician, if just based on what’s on a 
piece of paper you are going to tell me that I’m depressed, and you’re just going to sell me some 
medication, it is not going to work like that. You give me medication when you know for sure, if 
you have enough evidence, over a period of time, but then it needs to be on a trial basis. For me, 
I need to know you for 6 months. 
With depression, let’s call it a sickness, and as another female participant’s said, one just needs 
somebody to talk to. And you can get depression that makes you feel bad, make you feel really 
old, but you do not need the depression medicine.  
A man protested: They’re no medications that can help depression. Not to him, it is all within 
yourself, your mind. Somebody else stated, ‘you may smoke cigarettes because you are 
depressed, but it actually relieves the stress, calms your mind. The medication for depression 
does the same thing. Depression is just relaxation backwards’. So, what is the difference? Would 
he tell anyone that he is depressed? Well, maybe his friends or people like that. He would 
probably let them know what he is going through but he would not allow people who don’t care 
for him or might want to do him harm to know.  
A male was certain that most men will not discuss certain things in front of a woman (referring 
to emotional issues such as depression). 
A woman on antidepressant medications talked about the shame and pain she felt because people 
around her made fun of depression. She began to cry, saying, well, they talk about you, laughing, 
and thinking, you’re crazy. She felt that something went bad for her. She raised 5 children and 
she thinks she did well. She didn’t recognize depression until she went and talked to her doctor; 
her doctor told her she has a little probem.         
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Another participant was positive that if he would really be depressed he knew, he was not going 
to take one doctor’s opinion as valid, because he might not be that depressed like this one doctor 
said he was. If the doctor said he is going to give him some medicine for depression, this patient 
was convinced, he would refuse to take it.  
One person reserved the right to be sceptical. He meant that the doctor may tell an individual to 
take pills for depression, and all he might be doing is giving you aspirin to make you think in 
your mind that he is giving you something to help your depression. But he isn’t giving you 
nothing really, but a little confidence to build yourself up inside to get over the depression…so 
you can deal with it then.  
Patient tries to do positive things, and she controls things, that she can control. If the physician 
says she is depressed, that’s just his opinion, but she’s not going to let him get her on medication 
or anything because that’s more depressing. 
16 Fosgerau and Davidsen (2014) 
A general practitioner’s and a psychiatrist’s interactions and little discussions with their patients 
about treatment with antidepressants have been recorded and are presented below. Both doctors 
challenged their patients to discover their views on treatment in depression. 
The following were the physicians’ questions:  
- Did you at all talk about what one could do about it or what is sort of treatment? 
- What about medicine? Do you really feel uncomfortable taking medicine? 
- So you have like integrated or accepted it? 
- What do you think about the effect of the medication? now you have a little more experience 
with them 
- It feels like the treatment puts a safety net underneath you? 
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The following statement are patients’ views, shared by different individuals. Interestingly, put 
together, they all created a convincing story, as if told by one person:  
Well, they urged me to start medication as fast as possible, to use their expression. To me that 
request was both a little shocking and also kind of a relief. Because it is like a hope about 
something that could give me a little help. It took a ridiculous amount of time before I accepted it 
to begin with. But I think it is okay now because what I am getting now…I do not feel there are 
any side effects and I feel that it works so I am really not as angry about the medication any more 
as I have been..Yes, I have accepted them pretty well. I believe I have been lucky that I have not 
had any side effects. I think that it is that it in one way or the other, how I describe this that I go 
up and down and at least it cuts off the lowest part. So, the third time I got depressed and chose 
to stay in bed and started a vicious circle then. Now, I get out of bed every day, I get from my 
bed every day. The medication takes me up to a place from where I can push myself further 
ahead and then comes the snowball effect and that is what I would like to get started so that I 
never get to the opposite, lying three days in bed. It is just my friend who knows that I get 
depression tablets and my family. And no one else knows. It is not something that I am 
advertising.  
17 Frank et al. (2007) 
Study participants were asked about their remission symptoms in depression treated with 
medications. All individuals reported that irritability was the first symptom to improve. 
As of depressive condition, one patient retrospectively shared her experience. It all started with a 
sleeping problem where the woman would only be sleeping maybe 4 hours a night, and in that 4 
hours, she would wake up, and then it got to be where she didn't even want to get out of bed, she 
didn't want to put on makeup, she didn't want to do housework, she wanted to do absolutely 
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nothing. Low mood, low energy, lack of motivation, lack of focus/concentration, feelings of 
guilt, self-critical thoughts, feeling overwhelmed, lack of enjoyment, hypersomnia, restlessness, 
anger, and irritability. Those were very bothersome symptoms. 
Another patient became more defensive. It felt to him that people were picking at him; and he 
was having a hard time enjoying things he used to enjoy; also, his inner anger was taking over. 
Fear and fear of the future; anxiety and fear that made the next patient want to completely draw 
in; the severity of the experience attacking through multiple symptoms; wanted to die …was 
afraid to die; wanted to withdraw … You just want to live in a cave … esteem is gone, self-
conscious and self-aware, over-analyze everything …; Forgetful … and then he is agitated and 
he is mad at the world and he is frustrated. Then, all of a sudden, you're barking at your children 
and your wife. Functional impairment that is prominent among most bothersome symptoms; It 
got to the point to where … especially at work, his performance just kept going downhill. 
Depressed mood, fatigue, and feelings of worthlessness… 
A male informant: Irritability was probably the key thing; he was grumpy and cranky; 
hypersensitivity and reactivity to describe the symptom of ‘being overly sensitive to everything’, 
and easily set off; ‘anger’ along with irritability; irritability subsiding in social situations with 
close friends or family members: ‘Not being as cranky and angry with him over every little 
thing. He wasn't as easily set off. He used to snap at his mom, bite her head off.’  
A male patient: medication helped me have ‘better impulse control at home—his first reaction 
wasn't ‘I am going to smack you’; the medication helped him stop ‘yelling’.  
A father: the medication helped him stop ‘being short with his children.’ 
A female participant: Her internal experience of reduced irritability was strong: ‘She went from 




The second most common symptom to remit early in treatment was a lack of energy or 
motivation. Female participant: She had noticed medication-related improvement when she 
actually got out of bed.  
Another informant adherent to treatment related her interest level to functioning: She had more 
interest in her husband, more interest in taking care of her house, bathing and putting on makeup 
… Participant: Increased motivation leads to other improvements that follow: If you're 
motivated, then you allow yourself the ability to enjoy some things, but if you have no 
motivation, there is no way to enjoy it. 
Woman: Her family noticed she was able to maintain more organization in our house.  
The increased energy was linked to her experience of irritability: The first was she had more 
energy and she was less irritable. By ‘irritable’ she meant like in a home situation, she had better 
impulse control. What she noticed was energy, she was less irritable and less fidgety 
Several participants: a sad mood was the first symptom they noticed improving.   
Female participant: she was happy, her mood; she was happy for no reason, was just happy; she 
also felt very carefree and did not have the negative thought pattern, and then her energy started 
to come back. 
Male participant: Happiness, that was his first thing; all of a sudden, he realized that he was 
walking around work whistling. 
Others: ‘lifting of the cloud or feeling’ ‘lighter’. Anhedonia was relieved as mood improved. 
Participants: other people frequently noticed improvements in their mood.  
Mother: Her daughter told her she was less miserable than she used to be.  
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Several patients said their psychiatrists commented that they appeared ‘brighter.’ Patients: 
symptoms of anxiety were among the first to improve with antidepressant treatment. Words and 
phrases used by patients to describe this anxiety included “worry,” “fear,” and “nervousness.” 
Most of the patients appeared to perceive symptoms of anxiety and depression as being 
interrelated. 
Patients: the first characteristics to improve with treatment was an ‘ability to cope.’ 
Patient: The ability to cope was a feeling of being ‘not quite so overwhelmed—he felt like he 
had more control of things that he was doing.’  
Participant: The ‘ability to make decisions’ was the first characteristic to improve.  
Two participants: said they quickly noticed improvements in the negative thought patterns that 
tend to accompany depressive episodes, such as hopelessness. 
Patients also identified symptoms that were slower to improve: Sleep difficulties, problems 
concentrating, and feelings of social isolation were often cited as being more treatment-resistant. 
Several of the patients reported: significant improvement in mood, irritability, and energy level 
said that their ability to concentrate or focus had still not improved.  
Most subjects: indicated that sleep improvements took longer to establish. 
18 Fullagar (2009) 
Kaz (33 years, urban): he was having his medication dose increased again. Which is to the level 
that he is at now, which is fantastic. He is not changing it. He has actually come to the 
conclusion, after his doctor said this to him once: ‘If you’re a diabetic, would you stop taking 
your medication because you felt good?’ And the patient said ‘No.’ And she said, ‘Well, why 
would you, as a person who has a chemical imbalance in your brain, stop taking the medication, 
because you feel good?’ He went, ‘Because you’re not depressed any more.’ And she goes, 
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‘Yeah, but your chemical imbalance hasn’t gone though’ … if you’re on it because you’ve 
obviously got a shortage of serotonin or something, if you are on that, you could be on it for life 
as maintenance. Jasmin (37 years, urban): When she is not on medication and she is depressed, 
she feels like she is already in deficit because her mind is not working properly and her brain is 
not working properly, so at least on medication she feels like she is on a level playing field … so 
she is not at a disadvantage for working on life’s xperiences. 
Kaz (33 years, urban): Taking medication is a practice of ‘doing’ something to create the 
conditions for normality: You are not doing it to feel good, you are doing it to feel normal.  
Sandy (53 years, rural): was relieved that it was her brain not her ‘self’ that was the problem: For 
the first time in her life she actually thought, ‘There is something wrong with my body.’ And that 
was a weight lifted off her shoulders. They explained it to her … in her case the serotonin was 
going across and going back quickly; not enough. 
Roslyn (43 years, urban): Her depression arose in relation to this sense of failing to meet 
multiple gender expectations that culminated in a frightening panic attack: she felt a failure … 
she’d failed her kids … pursued her career at the expense of her family. And now she’d failed in 
her career and she’d failed them. As of her depression and anxiety, that was always something 
that happened to malingerers and people who weren’t strong.’ 
Jasmin (37 years, urban): that little pill is a reminder that there’s something not quite right, and 
that you’re a little bit dependent on something to keep you sane. So patient believes, there’s an 
aspect of your life then that you don’t have control over? 
Irene (59 years, urban): You become two persons, two people in the one body, but there’s always 
the fear in the back of your mind that you are not standing hard enough on the other person 
(depressed self), and that other person is going to reappear, just when you don’t want them to. 
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Elisabeth (34 years, urban): Patient was quite shocked when she wanted to go off medication and 
that’s when she had terrible mood swings and she just kept crying and screaming. Roslyn (43 
years, urban): her conflicting desires: because they made such a difference, the medication, she is 
just sort of a bit anxious about getting off them; it’s a bit of a safety net for her … She tried to 
get off them once and the side effects were just horrible; the doctor who first prescribed them for 
her painted a pretty rosy picture, which she thinks was misleading because she has suffered 
significant side effects trying to withdraw from them. She also thinks it is a psychological thing 
that one is dependent on these. Is she dependent on these drugs to be well, or not? It will be 
interesting to see. 
Cathy (32 years, urban): You have to draw upon risk rationalities: she used medication to surveil 
her emotions as a prevention strategy: She thought as soon as she senses that something could be 
amiss, or that she’s at risk, like if there is a death in the family, she’ll start taking medication, 
even if she is not too grieved by it because maybe she might develop something, she always sort 
of keeps watching. 
19 Fullagar, Simone and O'Brien (2013) 
Tayla (31 years) was initially prescribed anti-depressants after she had suicidal thoughts. She 
decided to stop taking anti-depressants after a conversation with another person who had a 
similar experience. Tayla reflected on her own experience, she does not want to be on 
medication for five or six years. She believes she can beat this with the help of husband, kids, 
and friends.   
Allie (69 years), who lived through the era when barbiturates were prescribed to treat depression, 
challenged this form of treatment by refusing to take medication because it sedated her too 
much:  She thought no, this is no good, there must be something, something else. But she didn’t 
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know what that something else could be and it wasn’t until many, quite a few years later that she 
learned how to deal with depression. And then it was a matter of dealing with it, to learn how to 
live with it, but it was many more years after that before she came through it. Depression is 
complex and also the overcoming it is complex, so you try lots of things until you find what 
works for you. Renata (38 years) changed her relation to ‘self’, because she noticed that she 
hasn’t done exercise, or something for herself, or a massage, or something like that; that’s when 
she starts to go off the rails. And so what she does is, just say knowing her own triggers and 
signs, is, she kicks in the self-care. So, she mentioned the massage therapy or she cuts her 
workload down. 
20 Gammel and Stoppard (1999) 
The following questions were asked in the interview process of collecting data for this study: 
How did you come to be diagnosed as depressed? What forms of treatment have you received? 
What do you think caused your depression?; and, Do you think you are over or will get over this 
condition? 
The patient was afraid that her physician was going to say that she didn’t need an anti-depressant 
drug … she thinks she would fight tooth and nail if anybody refused to prescribe it for me. (Ann) 
Taking medication…It made patient feel weak. Like to have to take a chemical … And then he 
got thinking about like the medication, he was just like, so what does this mean if he has to take 
this medication in order to be, in order to be normal? Like it just felt so weird … She hasn’t told 
her doctors but she has stopped taking her medication. (Susan) 
And she is not really, at this point she is still deciding; she thinks partly it is the fear of the drugs 
themselves. Like she is not really sure what, in terms of side effects and in terms of sort of like 
275 
 
and addiction. And just, she guesses the idea of needing, whatever drug to feel okay is a really, 
she doesn’t know, it’s kind of a nasty idea. (Tracy) 
Patient felt she couldn’t talk to her psychiatrist. You’re in five minutes and okay we’ll try you on 
this pill. We’ll try you on that pill and there was no counselling. And she’d come home and there 
was no counselling, there was nowhere to go.  The psychiatrist said ‘I’ll put you in touch with a 
clinical psychologist and he did’, and he put the patient in touch with a clinical psychologist and 
that was the best thing that ever happened. Patient thinks, counselling has helped probably the 
most. Taking time to look back and go over, you know, things that should have been dealt with. 
When patient started going through all the healing for her sexual abuse, the depression started 
lifting. (Debbie) 
Patient doesn’t consider herself to be depressed just because she hates that classification … she 
doesn’t think about herself as depressed. Right now, like she doesn’t consider herself to be 
depressed. She doesn’t think she’s depressed right now. But she knows she is. If that makes 
sense. (Susan) Patient still did her daily activities of daily living. You know, had supper ready, 
had dinner ready, had their lunches ready. Did the wash. But none of that had ceased (Sarah) 
But she just let go and went with the illness. She thought to hell with other people, she’s not 
going to. If she wants to lay on this couch, she’s going to lay on this couch. (Jane) 
Patient want to go to law school and that’s another seven years and she just thought, if she can’t 
handle second year Arts, how in the hell she is supposed to be able to deal with this? (Susan) 
Patient is hoping she won’t have any recurrence … she’ll never say that it’ll never happen again, 
but she’s hoping that with each time and with her experience, she’s hoping that she can minimize 
this feeling, and that it’s going to get better. (Sarah) Patient doesn’t think it’s something that can 
ever be permanently fixed. Patient thinks it’s something that you can deal with, she thinks it’s 
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something you can learn how to live with. But Ishe doesn’t think it’s something you can ever 
cure. (Kelly) 
There was always something wrong, a lot of physical you know, couldn’t sleep, always tired, 
didn’t want to eat and things like that. The big one was the insomnia. She just couldn’t sleep. 
(Kelly) 
She’s got a small group of friends who are all suffering from various mental illnesses and they 
all, joke about it, how we’re all, we use the term crazy but we don’t use it in a derogatory sense. 
But there’s still that, when someone tells you your brain chemistry’s all messed up you’re sort of 
like ooh. (Kelly) Patient is not ashamed of depression, it was something that was natural, it was a 
natural occurrence. People aren’t ashamed to walk around with diabetes or a heart attack; people 
get cancer, it’s not something you’re going to hide. It’s the same thing. (Debbie) 
It’s a chemical imbalance and, to me it just happened, it may have had something to do with my 
menopause (Gloria) you do need your medication or patient felt she needed her medication to 
alter that, the thought process (Sarah) 
Patient thinks counselling probably was the best thing. More so than the Paxil. But she thinks she 
probably could have healed without the Paxil too, but the Paxil’s like an aid … giving you your 
ability to calm down. It takes awhile for it to work though, she thinks it helped, initially. 
(Debbie) 
Well, just if she gets a medication that works for her. (Gloria) 
And she knows she does need medication; they’ve tried three, well four different drugs now and 
this is the one that seems to be working the best. (Sarah) 
you’re going to have to acknowledge that sometimes you know depression is going to invade in 
your life and you know, and at that time, times like that you have to ride it out you know. (Kelly) 
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If she had something that brought depression on or something to keep it here, but there’s nothing. 
Patient has a really good life with her family. And she has her car to drive and no problems. If 
she wants to go shopping and buy something she can go shopping and buy something so it’s it’s, 
there’s nothing, not a thing. (Gloria) 
The psychologist knows so much more because patient sees him more often. He knows all about 
male acquaintances, and he knows all about situation with a relative and he knows all about you, 
the anxiety and stuff so I’d I’d say she talks more with him than she does with the psychiatrist. 
(Susan) 
But it may have a bearing, the stress of that, work, on the genetic. But she was always one to 
strive like she’s always had many irons in the pot. And whether she just let herself get 
overwhelmed by too many things going on at the same time. (Sarah) 
She still has to limit herself and that’s the hardest thing she does find is trying to limit. And, you 
know, take the ‘me time’, take that bubble bath. (Jane) 
Like, patient went into hospital, her husband had to take over the budget. He’d never once 
looked at the budget. (Jane) 
So therefore family members did not see a whole lot of change in me except that she couldn’t 
work outside the home. You know, because she worked around the home. (Sarah) 
Several women felt more positive and made positive changes in their lives since their diagnosis 
and treatment. Patient has been off medication for a year or so, she has managed to straighten out 
a lot of, a lot of things in her life; she’s doing much better in school now and she is enjoying it a 
lot more and so for the most part she’s pretty, pretty happy she didn’t know like happiness, how 
cool it could be, how great it could be. (Kelly) 
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Another young women with a history of abuse and depression, admitted that her treatment had 
helped her become a stronger, more confident person. She feels totally healed and very positive 
about herself and, it’s just like, like on top of the world. Really she just feels like she has a total 
grip on, on life and, a lot stronger than she used to be. Having to go through that, you know, 
depression, just to just to get where she is now is worth it for sure.  
Susan is concerned that depression will negatively influence her life in the future. For instance, 
the implications of her diagnosis for her future relationships. 
21 Gibson, Cartwright and Read (2016 a) 
Taking antidepressants makes you feel like a failure, like giving in (Participant 1).  
Patient understands antidepressant use as a weakness: Maybe that’s also wrapped up in this idea 
about, you know, one should be able to cope with it without medication as well. It’s maybe it’s 
some sort of failing, maybe it’s some sort of sense of failure about having, you know, I’m not 
doing what I could do, I’m not achieving what I could achieve because I need medication, I 
should be able to manage these sorts of things. 
Generally men tend to think that they can overpower any situation with just pure physical-ness. 
We’ve always had people that used to talk about taking their happy pills and yeah one was never 
sure that they’d done enough themselves to try and fix things. 
It’s not a sign of weakness, it helps your own mental stability sort of get back on even keel again.  
You’ve got to help yourself . . . there’s only so much that people from the outside can do. It’s got 
to come from within. 
Patient has got pretty good at sitting back and analyzing what’s going on and looking back over a 
week he is able to chop and dice and go ‘ I’m going to stop those meds now, I’m going to 
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monitor myself for a couple of days and if I don’t improve after those two days I’ll go back on 
the meds knowing that it’s something else. ‘ 
I didn’t want to be bothered going to the GP. I told the GP after I had done it . . . I made up my 
mind I was going to do it, I didn’t want the doctor to say no, it’s bad. I don’t think he would 
have. But I thought I can control this myself.  
What I felt it was the loss of control over my own life. ‘my brain belongs to Mr. Pfizer’ 
The whole unpleasant thing, you know, your libido is absolutely stripped. I might as well live in 
a monastery because I’ve got no libido and when it does come then I have erectile problems and 
so it’s really, for something that’s supposed to stop depression, it causes me a lot of depression, 
you know. There’s a stigma attached to, and particularly for a man, to be suffering from 
depression. So I kept wanting to get off [antidepressants] and so from time to time I would wean 
myself off. But I found that I couldn’t function under high pressure without them. And so here 
they are, they give you functioning for day to day activities but possibly take away marriages for 
certain people. . . . It makes you feel good but you can then coast into a separation that perhaps 
might not have happened.  
Well I think getting rid of the depression probably is the most important thing of all because it 
affects everything whereas impotence only affects part of your life. . . . But then on the other 
hand as you say it’s like do you sacrifice your sexuality or do you sacrifice your life and that’s 
what it felt like.  
Well it meant that I could never have another relationship. I mean how many people do you meet 
who might be interested in you for taking things further through a relationship once they know 
that you can’t perform a sex act. It would have to be a very special person. You can’t advertise 
on the net “this and this and this wonderful—but no sex. 
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Having said that when you get to your 60s your sex life is not as active as it used to be anyhow. 
(Participant 7).  
I re-engaged. I became a loving and I think a better partner in the fact that it made me more 
facilitating, like I wasn’t sweating the small stuff. Now some people would say that’s 
disengagement again but for me it wasn’t. I actually re-engaged. (Participant 20) 
So, I actually find the performance is actually great as well, because that means I can go for it 
quite a long time (Participant 9). 
Pretty much all the classic things . . . highly emotionally unstable I guess in the sense of bursting 
into tears at a moment’s notice (Participant 14).  
Well I’m quite a rational, stable sort of person but that would get me at times, in areas that were 
completely beyond my control. So, I was worried that I might be in the middle of a business 
presentation and suddenly crack up for no reason. (Participant 19)  
When you crack you show the signs that you see in a woman, crying, not being able to cope, you 
know, just bursting into tears at the drop of a hat, and no one wants to go there. I guess that’s 
why we take the pills. (Participant 3)  
You can’t think about how you feel if you are too clouded by emotion. You can’t step back from 
it. And even though I hate to admit it that was a really beneficial part of it. (Participant 1) 
They’re terrible things because they take away, yeah they take away the lows, there’s no doubt 
about it, but they take away the highs and they put you in the ‘nothing zone.’ So you don’t feel 
things (Participant 3).  
And then I found I wasn’t interested in movies. Oh I can’t be bothered. Couldn’t be bothered 
going to Art Galleries. No pleasure in it. Um sense of taste, just sort of flat. . . . I would eat in a 
completely functional way. (Participant 11) 
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Yeah I guess in one way [less emotion] is good. And in another way it’s not going to be good if 
you want to, you know, become more empathetic, more compassionate, or learn how to be more 
relational with people. (Participant 1) 
I know in New Zealand especially, I mean you know you’ve got to sort of man up and be a man 
and do everything else and all the rest of it. But I think a lot of people nowadays are sort of 
realizing that people do have feelings, whether you’re male or female. But you can still have 
feelings without degrading yourself or belittling yourself. (Participant 5) 
So I was trusting someone because I had lost all confidence, so I didn’t know what to do. It’s an 
all new experience for me, and you know. (Participant 15). 
I can’t remember how many I cycled through with [my doctor] in that five months. There was 
always the question of we’ll give it a bit longer and see if it works. But I just got to the point 
where I said “Doc it’s not working. I’m not prepared to elongate the timeline because it makes 
no difference for me physiologically. It’s not going to help.” (Participant 10) 
So you’ve just got to roll with it but I’m old enough and experienced enough now to know how 
to trust my own gut. This is telling me it’s not the thing for me then you know . . .  
There are times when you go well I don’t need to take the pills because I feel good. But of course 
you feel good because you are taking the pills. I’m like well I don’t think I’m depressed, but 
that’s because I am depressed, so I’m not thinking properly in terms of knowing whether I am 
depressed or not. (Participant 8) You are left feeling insecure in your own ability to understand 




Certainly a lot of the symptoms of depression that I exhibit, you know, I wonder whether they’re 
actually symptoms of depression or it just so happens to be that that’s the way that I am, if you 
know what I mean. (Participant 8) 
No doubt there was an element of going along with it because I was in the relationship and I 
enjoyed that and she thought this would help and I thought well maybe it will. 
I’m sure there would have been [my partner’s] expectations of what she wanted or expected me 
to be like, that would have been some kind of force.  
My wife is very good obviously at now identifying where I am at and saying: ‘Hey come on, 
don’t you think you need to be taking your antidepressants again’ (Participant 14). 
I wasn’t aware of the depression myself but my wife tells me my mood was much further down 
than I thought (Participant 16).  
It’s because I can’t trust my judgement anymore and you’re my wife, you’re supposed to know 
that I’m not well (Participant 10). 
(Participant 16) My wife would “divorce” me if I stopped. 
My wife seemed to appreciate me more when I was taking antidepressants.   
And I understand partners’ encouragement to take antidepressants as sign that they were 
uncomfortable with the emotional vulnerability of someone who is depressed…It’s just it seems 
to be, my wife expects you to be a male and be the strong one, and she’s a pretty strong person 
herself, but she expects me to be, I can’t really show too much vulnerability, which is hard work. 
(Participant 7) 
For me it was a matter of my wife pointing out to me that I need to be responsible for my own 
behaviour and if you can’t control it you need to see somebody about it or do something about it, 
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like ‘You are a complete [a…e] and I am not prepared to tolerate it, now are you prepared to do 
something about it.’ (Participant 20) 
My wife was saying: ‘ you have to do something. You’re depressed, you’ve changed. You’re not 
the man I knew.’ And so I found that each time. I discontinued it three times before I found a 
way off it. 
22 Gibson, Cartwright and Read (2016 b) 
 Its] just like diabetes – a chemical shortage…I need serotonin uptake inhibitors – simple!  
I would hope that one day I could stop taking them but realize that for me it is the same as taking 
heart pill for someone else. 
My GP said that if I had diabetes I would need to take insulin forever, so not to worry that I 
appear to need to continue to take anti-depressants forever. 
I can still remember the desperation and pain and if it meant taking them forever I would not 
hesitate. It was a life-saver in a real sense of the word. That medication had prevented me from 
committing suicide. I truly feel that I would not be alive if I had not taken them. [Antidepressants 
are] the sole reason I can now function as normally as possible as a human being and a 
participating member of my family and community.  
Antidepressants have been very helpful, they have allowed me to be a better parent than I would 
have otherwise been, I believe. 
 Antidepressants are helpful in enabling me to manage the stresses of job loss and 
unemployment. I feel that I can cope better with job interviews on them. 
I have had such good therapy that I have been able to address the wider issues that had 
contributed to my mental state. …Without the medication though, I would never have had the 
ability to do this. 
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They were a waste of time and did not help me.  
I get more benefit from mild to moderate exercise, or energy drinks, or spending quality time 
with friends.  
They drug treatment was greatly disappointing. I wish I had never tried the pills, because before I 
tried them at least there was hope that something could have helped. 
Each one has had a worse effect than the previous…. I can’t remember them all. It started with 
memory loss then progressed to me becoming borderline catatonic staring at the wall for hours 
unable to stand up. Within a few weeks and genuinely terrified. It was a relief to go back to the 
misery of depression after these experiences. 
They don’t make the problems go away. They just make me numb enough to not give a shit.  
By taking the medication I felt alienated from others almost as though I was walking around like 
a zombie in a kind of bubble. 
In my life, antidepressants have been prescribed to me to cover up what was wrong, and to me 
were a fake fix. I believe that I stayed in a relationship that was unhealthy for me, because the 
antidepressants made me tolerate treatment that was unacceptable.  [It’s] like smoking. When 
you smoke you know it’s bad for you, but you also feel momentary relief and therefore can’t (or 
don’t want to stop) because you miss that feeling of being slightly more capable to handle 
situations. 
I felt bullied into keeping taking them and at times told I would not receive therapeutic treatment 
if I didn’t take them. There felt like no alternative and I felt very trapped into taking them. It is a 
necessary evil, with very unfortunate side effects in terms of weight gain and sexual dysfunction 
which lead to me stopping the treatment despite its benefits for my mood. 
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I know they do me good and I am better on them, but they do make me feel physically sick, and 
not like myself. I seem to be constantly trying life without them, but always go back to them in 
the end. 
Antidepressants have been a two-edged sword. I felt less affected by things that would normally 
distress me while on anti-depressants… [but] when I came off them, my head felt clear, I felt like 
I was waking up and that I was in touch with myself again. 
[Antidepressants were] helpful in making my depression less. However, the effects that they had 
on me as a person and how I treated others is the main reason I came off them. I am a considerate 
and selfless person and while on the antidepressants I was the complete opposite. 
The thing is that I have been on them so long that I have no idea what it would be like not to be 
on them. I would love to come off them but they have become such a ‘normal’ part of my life 
since I was approximately 15 years old that I am not sure I would cope without them. 
They helped me get back on my feet when I was facing a difficult time. However I was never 
told when to go off them and …have not heard from the doctor who prescribed them to me in 
years. 
The withdrawal effects if I forget to take my pill are severe shakes, suicidal thoughts, a feeling of 
too much caffeine in my brain, electric shocks, hallucinations, insane mood swings. [I’m] kinda 
stuck on them now coz I’m too scared to come off it. I have been on MANY different 
antidepressants. None of them were helpful at all to me until I tried Fluoxetine 4 years ago. My 
life now is greatly improved by taking this medication and a quality of life has returned. 
I have tried almost all antidepressants available under prescription (including combinations), and 
most worked to varying amounts to start with, then stopped helping, then the dose was increased, 
then stopped working/made me worse, then dose increased to the maximum, then stopped 
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working, then I was put on something else. I’ve wondered if I would have been better off never 
starting taking them at all. 
23 Givens et al. (2006) 
I didn't want to start get myself hooked on a medication that I would have to be taking the rest of 
my life. I think sometimes medication is wonderful but I think you can't escape from your 
problems that way so I watch when I take it. I don't want to get dependent on it. 
I stopped taking it on my own … I felt that I didn't want to stay on the medication. I didn't want 
to become addicted to an antidepressant. 
I have a stressful time going, dealing with death in the family, losing my mother, losing my 
father a year ago. In fact, a year this February I lost six other family members in one year. And it 
just looked like it was just too much to cope with. 
It's not—I don't know whether it's the depression or not but I think when it changed why I feel 
that the death of my husband has changed me. He was the first man that I loved and I—even feel 
yet that a part of me is missing, that something—just something I feel that a part of me is missing 
because he is not around. …If you can't see and you feel like you're going to lose your eyesight, 
you know, it kinda gets you down. Especially when you don't have nobody. I do think that there's 
a reason for my depression. I don't think it's just there like a cloud because nothing's wrong. I 
think there are things that are wrong and that's why I kind of don't like to take medication for it 
because the medication doesn't change the basics. He prescribed Zoloft for me. Well I never took 
it. I mean, my feeling at the time was that I wasn't interested in the pill. I didn't want to do this 
because I couldn't just bury my husband and then go on and go out and party. 
I have to face reality and I think you have to feel some pain in life. 
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I didn't want to stay on the medication … why should I be different than everybody else? I didn't 
want to take them … 'cause I had taken tranquilizers when I was young … A doctor 
recommended that … I don't think they knew about antidepressants then … I never thought it 
was nerves but I couldn't take 'em, I slept. 
I'm not interested in pills anymore. I get bad dreams. I mean, they gave me pills that left me 
waking up and not knowing where I was. I was still in a dream. 
24 Hanssen and Cabassa (2012) 
I was urged by my husband to talk to a female doctor in hopes this would help me feel 
comfortable discussing health concerns, which I struggled to do until that point. 
Like the doctor tells me “You have to accept your diabetes. You have to accept your high blood 
pressure. You have to accept….bad moods….like you accept your problems, you have to accept 
your illness”. And I now, that is what I am trying to do, accept. (Focus group) 
At times I take a half of the pill for depression…it’s what helps me, it’s what calms me…. I 
don’t take it every day, only when I get to the point of feeling a lot, a desire to cry, with 
anxiety… (Individual interview) 
Look, in reality with the doctor here, I cannot communicate well, because he does not speak any 
Spanish. The doctor is informing me through an interpreter and so the interpreter does not tell us 
everything, because one very clearly sees… she is listening and in the whole time tells us two, 
three words. So realistically, you understand, that it is not everything that the doctor is saying. 
(Individual interview) 
Well, I heard that it makes you sick, like that is the medicine for when one is loco [crazy] and all 
that…Well, also because of that I didn’t want to take them, because I was scared they would 
make me ill in the head… (Individual interview) Well, since they treat me every six months… 
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we hardly have talked, I only come and they look me over, and they say to me “where does it 
hurt, if it hurts”. They only prescribe me the medication and that is it. 
Interviewer: You have never thought of talking to your doctor? 
Respondent: No, because almost it never lends itself to do so, or moreover, since I know there 




25 Izquierdo et al. (2014) 
A 61-year old woman said: I’m not happy that my body just doesn’t want to behave itself and 
that I have to use medications to correct this. I used to hate that I had to depend on a medication 
to make me feel normal, but then I realized that I had an imbalance and I had to take care of it. A 
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54-year old woman: You cannot control depression. Even if you discuss it with someone like a 
doc, by the time they finish medicating you and counseling you they didn’t cure it. It doesn’t 
stop. If you know that why put yourself through it? 
Some believed depression was a condition that would take care of itself, or did not require 
medical treatment. “My depression will heal naturally,” said a 52-year old woman. A 54-year old 
woman described, “I just have to let the depression run its course.” Participants who believed 
they had to manage depression on their own described reticence or refusal to use therapeutic 
treatments. Though my doctor suggested counseling, it’s up to me myself to get better. I have to 
do it on my own. I don’t need any medication,” (a 71-year old woman). 
A 58-year old woman: “I was prescribed my medication to be taken twice a day but I only take it 
that way sometimes because I don’t want to get hooked on pills.”  
Participants also described antidepressant medications as unnatural or illicit substances; they 
referred to them as chemicals (“químicas”) and drugs (“drogas”). 
A 61-year old woman said, “My mother was a prescription addict, so I didn’t even want to take 
aspirin. But I came to realize there’s a difference between tranquilizers and the medications I 
take for depression.”  
A 54-year old woman Schizophrenia runs in the family and I don’t want to be in a looney-tooney 
bin. I can’t talk to nobody about it, no professionals, because they want to lock you up. 
“I’ve been taking antidepressants a long time. I don’t like to take them but they help,” said a 55-
year old woman.  
A 57-year old woman stated, ‘I’ve tried to quit my anti-depressant medication twice by myself 
but my symptoms came back and I needed to go back on it. I know that if I stop taking it I will 
get sick and depressed and will be crying all the time.’ In contrast, participants who previously 
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experienced treatment side effects reported reluctance to re-start antidepressant medications. A 
56-year old woman stated: 
I used to take antidepressants years ago, but they made me have headaches and made me 
nervous. I generally felt worse throughout the day so I stopped taking them. I have no interest in 
getting antidepressants again. 
26 Jaffray et al. 2014 
…now that I’ve been to the doctor and the doctor said yeah you have a problem and 
everything…I can sort of go right, there is a bit of problems here I can do something about that. 
(continuer) 
I’ve a good friend who is a CPN [Community Psychiatric Nurse], she was supporting me and she 
said ‘I really think you should be going you know and speak to the doctor … I decided that yes I 
would go. (continuer) 
I didn’t ask to go on them but I had that in my head you know if she offered me to go on these, 
on something then I would, so she did offer them. (continuer) 
I felt quite embarrassed about it because I didn’t realise they were antidepressants she just said it 
was something to pick me up…like why do I need antidepressants? None of my family have ever 
needed antidepressants. (discontinuer) 
I suspect my depression was more reactive. (discontinuer) 
I just thought, well it’s a waste of time because they are not listening to me, they are not 
understanding what I’m saying. (discontinuer) 




 Some of the employers,…one of them I spoke to was okay but the other one was probably 
thinking ‘get over it’. (continuer) 
I think it’s just sort of got me over the worst of it, I think, that’s how I was starting to think 
perhaps I can come off of them. (discontinuer) 
As long as I am feeling good, I know I shouldn’t question it but you start to wonder how will I 
feel if I come off them? (continuer) 
I just felt perhaps now is the time to wean me off a bit, I have come to terms with a lot 
(continuer) Although things were explained quite clearly at the beginning I think at this point 
[now I feel better] I would have benefitted from a bit more support or just knowing a bit more 
about what I am doing (continuer) 
My sister said I had put on weight, she said you probably should stop your antidepressants. I said 
no. 
They just said that your moods will change, and you will have an upset tummy and your side 
effects. I thought, no, I am not going through that. (discontinuer) 
I just felt that I shouldn’t really be, well, always depending on tablets. (continuer) 
Latency period (perceieved lack of efficacy of antidepressants) 
Yeah, I was really, really surprised, although I did have my doubts, but no, I will persevere, and 
I’m glad I did actually. (continuer) No, I just, I actually felt more depressed, I just wanted to 
sleep, I just wanted to go to my bed and it [antidepressant] was encouraging me to do that…there 
was a spell that it wasn’t working. (discontinuer)  
If there’s just a little niggle, you can talk about it, a little peace of mind, and then as I said they 
monitor you, they don’t give you automatic prescriptions. (continuer)  
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I’ve kind of been left to it, she said to make sure that I come back, I don’t know what would have 
happened if I had just stopped them, and not come back. (continuer) 
I will know myself, if it’s not working then to increase it again. (continuer) 
27 Kadir and Bifulco (2010) 
I think I’ve got this illness because I’ve many worrisome thoughts… I went to see my GP at first, 
then I was referred to mental hospital. I believe I will be normal again with modern treatment but 
I can’t affort to pay for this treatment… so I decided to see bomoh too. It will help me get rid of 
this illness. (Anisa) 
I never sought treatment, I was unaware of services offered. I though that mental hospitals offer 
treatment only for those people with serious mental illness who ‘run amok’. Depression is just a 
‘thought problem’ and can be cured with ‘willpower’. This is why I never sought help. I cannot 
talk to other people, either… (Salina) 
I did receive treatment for my depression and I was given an antidepressant medication and 
referred to a psychiatric unit at our community clinic. Then, I’ve decided to stop the medication 
due to the side effects: fatigue, being unable to sleep and nausea. I didn’t want to see the 
psychiatrist for continuous treatment because of was afraid to be labeled as mentally ill. (Norma) 
I sought psychiatric treatment and was on medication for about a year, but stopped taking it 
because of the side effects: fatigue and memory loss. My parents decided I should seek 
alternative medicine.  The bomoh advised me to stop the medication and not to think or worry 
too much. 
The bomoh told me that evil spirits are happy if I feel depressed and do something stupid like 
attempting suicide.  
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I think the bomoh can cure my illness. I talked to her a lot about my illness … what I’ve felt … 
my sorrow… my sadness… my loss of interest… I’ve no job. The bomoh encouraged me to 
share my entire problem with her. I share lots of things with her. She gave holy water so I drink 
it everyday. I feel more confident. She asked me to chant every time after I perform my prayer. I 
did it… I feel relief. (Miriam) 
I think my illness is normal. Not really severe compared to others. I can go to work. I can speak 
to people. I … sometimes feel unhappy and am not in a mood for doing things I like to do… but 
I still think I’m fine … I don’t go out and kill people as a few mad people do. Oh yeah … I was 
on medication … the GP gave me antidepressants … but I became worse day-by-day so I 
decided to stop. (Norma) 
I’ve seen a psychiatrist and a bomoh. I knew it was not right to see bomoh but I do believe 
bomoh will help me strengthen my faith. To make me feel close to God and to make me feel I’m 
not alone in this world. I wanted to be a good follower … a good believer … I will see the 
psychiatrist again when my illness becomes severe but I do believe the power of will inside me 
will help me against my illness … you see … sorrow and sadness are not good for us … I should 
not grieve about my fate … I know that. (Rokiah) 
28 Knudsen et al. (2002 a) 
Informants’ accounts: 
Because you see yourself in the situation which you know is completely crazy. You see yourself 
and you can’t do anything ... That is what I think is really hard. Because you are thinking so 




You just felt so lonely. And that you were just killing time. Yeah … the emptiness … The 
feeling you don’t have anything to live for. That is what typically triggers the thinking about 
suicide. Life is hard. And you just sit and wallow in it, you know? And then you can fall apart. 
You’re caught in that kind of thinking.   
 I’m not really sociable. My work requires me to be quite extroverted and social. And that really 
drains my energy. When I get home, I can’t really stand being together with anyone … And 
perhaps that is partly why we’re getting a divorce. I don’t really think I can live up to it. I’m the 
one who wants a divorce. I can’t live up to what you’re supposed to live up to when you’re 
married. I spend such an incredible amount of energy getting my workday to function … and 
that’s how things are these days. In the society we live in, you have to work to survive … that’s 
how it is. It’s hard for me. And then when the doctor mentiones the medicine, I just feel 
paralyzed. For me to take those pills. It was … but haevens I don’t feel that I have that kind of 
illness, you know? Well, it was really a shock. Really. I found it unpleasant in the extreme. 
It’s one thing to have a psychological illness, but if then you have to take medicine for it. Well, 
then, that’s twice as bad. To be down and have psychological problems. Lots of people can have 
them. So, okay, maybe we can accept that. You get over that by yourself. It’s just that you don’t 
quite mention that you didn’t in fact do that, but you had to take those pills. Double whammy. If 
you get those pills then people think “Well, so it was real”.   
And I have always taken the stand that I wouldn’t take medicine. Because I have always believed 
that I could manage without it. So then I go see this psychiatrist and get a very positive 
impression of him. And he tells me that there is an imbalance in my brain that makes me get 
these depressions … and so after some major deliberations I start taking Seroxat [an SSRI]. It’s 
embarrassing, simply ... Yes, why it is embarrassing. It just is. Because it’s not normal. You just 
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aren’t ordinary, a person who can function without having to take something chemical. With 
other diseases, that’s allowed. It’s allowed because it’s a physical problem, you know? But the 
other thing, that’s in your head. It’s because your head doesn’t work too good. But that’s the 
thing. When my doctor said that it was something chemical, then, then it was easier for me to 
handle it. 
SSRIs users’ accounts: 
I have much more energy for other people. Hmmm… I’m more open and … that means that I 
have started to believe more in myself. And be more. Not just say yes and well but really give 
something to people. Give something back to them. And not always be the … what should I say 
… the neutral person … I’ve blossomed. But when I’m taking the pills, then I have…Then I can 
function. I can. I can. I can go to work. Smile and be happy. And can enjoy things and I… can 
stay out of bed except when I have to sleep… hmmm, and I can be sociable. I can do things 
together with my friends… but that’s all they do. 
The reason I want to wean myself away from the medicine is simply because I will not conceive 
of myself as ill … I think that is very important to my conception of myself that I don’t think I’m 
some kind of therapeutic case. 
Cutting down wasn’t a problem I don’t think. So in that way you’re not dependent on them … 
not like with other types of medicine. You’re not that dependent on them. I’m not anyway. I 
think it’s more the anxiety that makes you dependent. It’s a psychological that dependence. 
You’re afraid everything will go wrong if you don’t take your medicine.   
I hope it’s not something I’ll have to take the rest of my life. I’m not counting on that. I would be 
sorry about that. But if that’s what it takes for me to have a good life. Then I would be willing to 
do it. But right now I still hope that at some point I can manage without it.  
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29 Lafrance (2007) 
It was a validation that I had never had before and I had a name. It was like, you know, it’s a bad 
attitude, it’s not. I’m not … you know maladjusted, I’m not ill socially or whatever. It’s just I’m 
depressed. And that’s cool. Like it was really neat to have a name for it. (Kate) 
I was reading this book [which listed the diagnostic criteria of depression] and it was describing 
what I was going through […] and all of a sudden I said Geeze that’s what’s wrong. I’m 
depressed. That’s what it is. Just to be able to put a name on it? Because there are times when I 
thought I was different from everybody. But what I found in that book, I found that when you 
have the symptoms I had, that the way I was feeling in my condition was normal. See? I wasn’t 
going crazy. 
Something in me made me go to the doctor and I went into her office and she sat down and she 
said: ‘What’s the matter?’ And I said: “How do you know if you’re depressed?’ And she said, 
‘OK, I have got ten questions to ask you’. And I was nine out of ten. […] So she said, you know, 
you’re depressed! There’s no way out of it’. So anyway, fine I said, what do I have to do? 
I was so relieved! I was so relieved I thought thank God! There’s something wrong with me! I’m 
not- there-it’s got a name! Like it’s not that I am just a terrible, awful person who is unattractive  
It was kind of a relief to have somebody say, ‘Yes, you have something seriously wrong, you 
know, tis is what it is’. There’s something really wrong with me that they have even a name for 
it. It’s a sense of relief that there is something there that people know about that you know you’re 
not the only person in the world that’s had it and you really do have something. You’re not just 
making this up, you know. And that’s kind of good because people do have a tendency to sort of 
look at you and say, well, you just want attention. Well no, attention’s nice, but no, that was not 
the plan here. If I wanted attention I could dance on the table, I don’t have to try and kill myself.         
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I would like to see more women be honest about it and lose their shame because it doesn’t mean 
– And this is something that I’ve learned. I’m not a weak person because I have this, I’m not a 
bad person because I have this, I could just as easily have, you know diabetes or blond hair or 
red hair or long legs, I should be so lucky. You know it’s just, it’s one of those things and there’s 
no blame associated with it. So it’s right down the line, my mother, my brother, myself, my nice, 
my son. It certainly is hereditary. You know it’s … it is an illness the same as diabetes or a bad 
heart or anything like that, high blood pressure, it’s in the family.      
Well I think I did suffer depression. Because, and again I say, if I was on Prozac way back then, 
like I say to my boys, I’d say, ‘I know I would have been a much better mother. Because I would 
have put you in your snowsuits, we could have gone for walks, we could have gone out and 
made snowmen. I could have made cookies with you.’ You see? I could have enjoyed them. But 
they were just work. Laundry and laundry and bedding and it was just, it was just work work 
work work work no enjoyment eh?  
If you suffer from migraine headaches or say if you were diabetic you could say to a person ‘Oh, 
I’ve got a terrible migraine again’ or ‘My diabetes is acting up’. But with depression just to say 
‘Oh, I’m depressed’, that doesn’t go with people. ‘Oh come on, come on you promised, you’re 
you’re well, ther’s nothing wrong with you, you promised, you can go, you can go’. See?   
Interviewer: What do you think is the difference between people being able to say ‘I’ve got a 
migraine or my diabetes or’ and well, they accept that. But just to say, ‘Well I’m depressed, ah, 
they feel well … good kick in the butt. ‘You can do it, get up and you you can go. There’s 
nothing to prevent you from doing it. You haven’t got the flu, you haven’t got the cold. Whjat’s 
preventing you? So they don’t understand.  It’s a hell of a thing to have. It’s a really bad thing. 
I’d far sooner deal with any of my physical ailments than I would depression. Depression is hard.  
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Interviewer: What makes it so much harder? 
Well I find it’s so personal. Nobody can understand how bad you’re feeling. And like you can go 
to a doctor, you got bad asthma, you can’t breathe? They can understand that. They can see it, 
they can feel bad for you and they can really try to help you without feeling sorry for you.  When 
you’re feeling depressed, people don’t understand they figure you’ve just got the blues and 
you’re not dealing with it.   
30 Lafrance (2014) 
Terrible. Wellbutrin makes it so you’re jumpy. I got palpitations from it, I could feel my heart 
going whoop, whoop, whoop, and it made me dizzy. I couldn’t sleep at night, so that’s why he 
gave me Ativan. Ativan? I don’t want to get addicted to this stuff. But I couldn’t relax, so I said, 
‘No, this is not the way to go, I just don’t want to do this anymore.’   
I was given Luvox and it made my heart flutter. And I would get very angry a lot and one day I 
forgot to eat. I did some really strange things like, just being angry and short tempered and my 
sleeping was way of whack. I was staying up all night, sleeping during the day. It was very 
difficult to do anything because I was tired all the time and then when it was time for me to go to 
sleep I couldn’t sleep. And it was just a bad experience and they said, ‘Oh well we’ll just put you 
on another kind’ and I was like ‘I don’t want to go through a whole, you know, test all these 
drugs’. I didn’t want to do that so I stopped thaking that eventually just cold.  
Whenever I read about depression, it was always like ‘Go see your doctor, they will give you 
Prozac. And I especially found that with my doctor because the second it came up she’s like 
‘Here is a prescription’. And that kind of makes me mad. When I read about it because and like a 
lot of pressures that women have to face, family and work and you know there’s a lot of different 
other things that affect it too that can make it worse.  
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When I went to the doctor and explained I was depressed, Prozac, right away. And I really had a 
problem with that because I knew there was a lot of stuff wrong and I wanted to get to the 
bottom of what was wrong and not just simply take the Prozac.  
31 Lavender, Khondoker and Jones (2006)  
And that evening a friend rang and I told her, and she said ‘have you had anything to eat?’ And I 
realized I hadn’t had a thing to eat for about three days, not a thing. She said ‘you must have 
something to eat, you must do’. 
If it is this country’s only way to go to the doctor, but in Nigeria the people will tend to think of 
so many ways of helping out, according to individuals’ beliefs.  
My own advice to doctors … if it is a woman, they should try to invite the husband … and tell 
him that look, the wife got a depression. So what’s going on? And they should, yiu know, try to 
advise them that he is the right person to help the woman out, because that woman is only with 
the doctor for a few minutes.  
I think they are good, but not for a long period of time … because after a long time of it, your 
body is immune to them. I’ve took them … I think it’s only me that can make myself get better.  
In this situation medicine will not benefit. This is mind matter, unrest of mind. So doctors’ 
medicine can not work.  
So I decided to take the antidepressant even though I don’t feel good in taking it. Actually, it 
doesn’t help me much. I think going to my church for counselling has helped me a lot.  
Taking medicine can change the mind … So medicine can make the brain normal and can make 
the heart normal …medicine can make him better. If she is ill, there should be effect on her 
body, maybe stomach ache, or headache or some other effect on her body. Because there is no 
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effect on her body, therefore with my little knowledge I think she is not ill. Perhaps she has a 
mental problem.  
32 Lawrence et al. (2006) 
I think the main helping with depression, any kind of depression, physical, mental, it is self-help. 
If you help yourself the way you want to do it, you will get over the depression 100%, I am that 
sure. But if you don’t want to do it, there’s nothing you can do. Treat yourself. (South Asian, not 
depressed) 
It’s a mental attitude, mental attitude. If you change the mental attitude and all that and you 
become cheerful and start activities it will go. (South Asian/depressed & not treated) 
It’s easier said than done, not to concentrate on one particular thing, especially bad things. Don’t 
concentrate on it a lot. Let it go away as quickly as you possibly can. (Black Caribbean/not 
depressed) 
You think a bit differently you know with the way you think about things, it’s different but I 
don’t keep it in my mind. I like to read, I’m really interested in reading, papers, books, so then I 
forget everything. I kind of do it myself.  
Getting out of the house helps me enormously. I have been paying someone to take me out 
usually once a week, at the weekend, but she’s moving to Norfolk and that’s been sort of my life-
saver because I thought I would go mad if I didn’t get out the house…Yes, it’s the one thing that 
is guaranteed to help.  
The first thing is communicating, that somebody is listening to what I am going through. You are 
pouring out your heart to that person and you feel a bit better that you have passed on your 
worries and problems to another person.  
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You’ve got to try aand keep cheerful when you are with people, it’s difficult, you want them to 
know but no I put on a brave face and make out I’ve got no troubles. If they ask me how I am, 
‘I’m all right, I’m fine, I don’t best to look on the bright side I find otherwise people get fed up, 
‘Oh, she’s a misery’.  
But of course, religion means that you are in talk with God and if God can’t help you what else 
will help you?  
You see the GPs are so tied up with so much work they don’t have time to talk to their patients 
and they find a lot of people don’t get the necessary benefit that they would get from the GP if 
the GP talked to them. Even give them less medication and have a talk because it makes them 
feel good within themselves is like a self-healing power you know. That builds them up.  
There’s so much to say and so little time. So you always feel like you haven’t got enough time 
with the doctor. Yes so then you think to yourself, ah well, the important thing, first, cure your 
pains and then think about the depression later on.  
I mean you hear of people taking these drugs for years and years and they got so dependent on 
them. 
I would feel that if someone was to say we are ging to make an appointment for you to see a 
psychiatrist, straight away I would think oh I am going off me rocker kind of thing. 
When you get a counsellor to talk to you, what the persn says to you is encouraging, strengthen 
your body, strengthen your mind and whatever is there, it come right out.  
Counsellors would be able to spend more time with them, to chat with them, to make them feel at 
home and things like that you know. Whereas a GP, tey would be considered to be an official, 
authority, while these counsellors are normal people who gve their time in counsel. I suppose 
that’s what it is, so that would help them, the counsellors would be more helpful.  
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33 Malpas et al. (2011) 
I was dreading going and saying I don’t feel better … that was getting me down … the pressure 
of having to tell someone ‘no I still feel terrible’; I want to say ‘this is really working’. I didn’t 
want her to panic and suddenly think ‘oh things have got so much worse’ …I felt I was in control 
of it, I didn’t want her to change my medication because of it’. (female patient) 
I tend not to like to tell doctors what to do…I want someone to tell me what to do…I have 
always sort of thought, ‘right, a doctor just tells me what I have and I just say thanks and go’. 
(female patient) 
I have this panic that there’s not going to be anything else to help me so I’m trying to kid myself, 
‘it’s alright, it’s quite contained, just tell her everything’s fine’, and I haven’t, I mean I’ve gone 
along and said ‘it’s been a difficult month’. (female patient) 
As a doctor she really asks, she doesn’t just ask ‘Is the medication okay?’ she really asks how I 
am and how I am coping with things. (female patient). [sighs] she wasn’t very…sympathetic, 
and I just burst into tears as soon as I says [sic!] that I was sent over by the, health visitor [sighs]. 
I suppose some people you click with, some people you don’t and she just seemed a bit distant 
… I know she’s following procedures … it’s just I expected someone to be oh, you know, and 
she was ‘right, let’s start with … sleeping tablets first and then see how’... maybe she was in a 
hurry … I probably felt guilty for taking up the time, I was just crying, so she couldn’t get the 
information out of me because I was in a bit of a state’. (female patient) 
I thought I’d come away with antidepressants and came away with sleeping tablets … perhaps 
she felt that I needed to have a decent sleep and see how I felt after that, so maybe she didn’t 
want to jump into things too quickly … In some ways that was good, but at the time I think I just 
wanted something to make me feel better’. (patient) 
303 
 
… he was just on your side because he’s sort of with you … He can empathise …I was quite 
determined tat I’ll go in and talk to him, tell him how I’m feeling …  I did explain I don’t want 
anything too heavy but I’d like something to lift my spirits a bit …I felt like I’d got the goods. I 
felt like mission accomplished. (patient) 
…there is one person saying it’s a good idea to take them and somebody saying no, you should 
not take them; I was in the middle and I couldn’t make my mind up, I was really confused, I 
think, I’m worse at the minute; I just can’t make my own mind up’. (patient)   
What can they say to me if I go back and say ‘I haven’t taken the tablets but I still feel 
down’…they’ll probably say ‘Take the tablets’ they might just think why am I back in the 
surgery…will I look a fool if I go back? I don’t know … the feeling I’ve got is that they happily 
give you tablets but they won’t recommend things like counselling. (patient) 
She kept sort of going through the various options and kept avoiding going up dosage and I kept 
thinking ‘Well I think I need to’, but then I always have something my mother’s instilled in me 
“Don’t tell a doctor what to do”. (patient) 
  But I don’t know…if there’s an issue on dosage or not? …So shall I just carry on with this 
[dosage]?  
GP: Well at the end of the day it’s up to you, but yes, I’d say carry on a bit longer and I think it 
will help answer your questions [about latency in the recovery process].   
 I want that guidance really which I don’t necessarily get … I want someone to say, ‘this is what 
you need, this will make you feel better.’ (patient) 
34 Murawiec (2008)    
Case study. Patient’s report. Treatment with citalopram and later fluoxetine for a year 
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Before starting the treatment I had experienced a continually increasing feeling of helplessness 
towards the course of life and a progressive loss, or at least a significant limitation of intellectual 
properties necessary for me to deal with my problems. I have noticed incread problems with 
concentration, memory, making association (deduction) and motivation for effort. I associated 
these symptoms with aging, although it seemed unusual, that at the age of 40 they were so 
intensive. These symptoms were accompanied by a decreasing self-esteem, poignant frustration 
and lack of success, and an increasing need of self-control unsuccessfully aiming to turn around 
this unfavourable situation. I realised that I needed medical help. 
 The medication started to be effective surprisingly quickly and in the right direction. In the first 
months of treatment its effect was even a little too strong. I could burst out laughing at my 
thoughts or speak to myself in the street. I started acting spontaneously, which was funny both 
for me and my surrounding: I would make frivolous remarks toward others, I paid complements 
to my female work colleagues; overstepping not so much the bounds of customs and morale, but 
my own psychologica boundaries. With a good effect, I have gone back to spending my free time 
enjoying myself, and all the time being able to return to my duties (controlling everything). 
Having control over life is the key aspect for mental wellness here: it relates to i.e. drinking 
alcohol. I have successfully started to spend more time enjoying myself being sober than being 
drunk. As the mood functions as a background for emotional experiences, which are made 
gloomy by the alcohol, I decided that in this respect it has a negative influence and it is worth 
avoiding it. 
At work I am able to impose discipline on myself, but at the same time I know when to stop an 
arduous activity, at least for a few minutes, to regenerate my strength.  
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Surprisingly, this self-centred attitude towards myself, allows me to develop altruism: this 
inclination, in turn, I define as a luxury of a person with a well-balanced self-esteem, who does 
not have to confirm his/her image perceived by other people, and in this way is able to step 
beyond his/her own needs. During the last 2 years, I have started many acquaintances, most of 
which go back to my school years, forgotten for the last 20 years and renewed with a great effort. 
Therefore I have a large circle of friends (my wife’s and mine) with whom I stay in touch. Some 
of them are my close friends, some I contact only occasionally. My present intensive social life 
reveals the loneliness I felt for the last few years and is a way of compensation for it. It is 
especially visible when one looks at my position in the professional circles. 
If I were to name other areas in which I have become active recently, it is necessary to mention 
many sublimations (there are artistic and literary projects which I had abandoned in my adult 
years, and to which I have returned now, as well as social and scientific projects). The high 
number of engagements may suggest that I have fallen in a state of exaltation. Using an album of 
photographs of Camposanto, a necropolis in Genoa, publishe before the war, and being inspired 
by the whiteness of the walls in my living room, I have painted of both sides of the entrance 
natural size figures of Adam and Eve. By painting these figures I have dealth with getting used to 
the anonymous space, time giving it, at the same, intimate and universal dimensions. The figures 
live in various circumstances: I am socially praised by friends visiting our house, but in the 
lonely evenings I contemplate with pleasure these figures, laughing at the irritating insufficiency 
of my skills. 
Considering that I am in the course of treatment and that I have wanted to get out of the magic 
circle of incapability, and do something useful (as opposed to professional activities undertaken 
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in recent years, which di not give me any satisfaction), I believe that this state reflects my needs 
and inclinations, and that it represents the emanation of my mental health.                
35 Patel et al. (2013) 
… that’s one more stress on top of every stress you’ve been put under and sort of, one of them 
must have been the straw that broke the camel’s back. But which one? There are just so many 
straws. I found it difficult to distinguish between what was just complete exhaustion and maybe 
what was the depression really and I still think that they are still linked. 
I think it’s harder to grasp because it’s all to do with feelings and emotions and it’s hard to sort 
of try and understand that it’s a chemical that’s causing that.  
I should just accept it and I just don’t know I am worried about what other people think about 
me… 
…but I was adamant that I was fine and that it was just a lack of sleep and this, that and the other 
and I would not let her refer me to anybody because I was fine, I was just blocking it out.  
 I just can’t bring myself to say it. Fear of ridicule I suppose … and I don’t want people to feel 
that I can’t look after my children because I can …and I love them  
People will think she needs to be on meds to be a normal mother 
…if you are not taking the drugs you can kind of pretend you haven’t got it but when you are 
taking drugs, you can’t hide behind anything, you have a mental illness that you are taking drugs 
for and therefore, you’ve got that stigma.   
 I’d rather not, but it’s the lesser of two evils I guess.  
I’m not the sort of person who easily gives into things. If I can possibly do it without the drugs, 
then I must be a stronger person.  
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I am quite happy to take it forever if it maks me feel like I can get up in the morning …but …I 
would like to think I could stop taking it and go back to my normal self but I don’t know whether 
I would want to for fear of going back to that crazed fool.  You can’t really put a timescale on it; 
you just need to keep working towards it.  
36 Ridge et al. (2015)  
My general experience of antidepressants has been very positive in terms of all the horrible 
things that people talk about that can happen with them. (Tony) 
…we have just a bit of a pill culture, take a pill for that, take a pill for a headache, that kind of 
thing, it's easy. (Michael) 
…part of me feels like a failure for not being able to manage my life without chemicals. 
(Samantha) 
It felt harder going back on antidepressants the second time because you sort of feel as if it 
should be sorted and you feel as if you're taking this antidepressant and it should be fine…(Paul) 
… the doctor didn't think there was something wrong with me… I felt like I was just being a 
drain on my doctor. I was given antidepressants at one point, I think it was Prozac, and I was on 
those for about eighteen months or so. But I was never given a particular explanation of what 
they were to do with, other than they might help - have a side-effect of weight loss. I don't think 
that's a particularly good thing...(Rosey) 
I Ieft them on my top shelf for ages and I just didn't want to take them because I was a bit 
confused as why I; he's prescribed me that after like a really short chat, just me saying I was 




Isn't that strange… I don't tell them [children] that I am taking antidepressants. I never have told 
them that I was diagnosed with depression. (Liza) 
For me medication was a means to an end…but I wasn't going around shouting from the roof-
tops…(Catherine). There is a stigma definitely attached to them... absolutely, I mean well of 
course there is you're doing something wrong if you're on antidepressants…(Steve) 
I felt quite bad about taking them. It felt like kind of surrendering a bit… almost like having a 
criminal record…(Tony) 
And I think I'm quite afraid of the thought of ever not having it, because I know how awful I feel 
if I stop taking it for a couple of days. I wish I didn't have to always go back and get those damn 
prescriptions. I wish I could just have the drugs - just hand them [over] - because each time I go 
back I think oh, maybe this time that doctor's going to fuss…(Charlotte)  
They gave a bit of hope I didn't have any negative feelings about the drugs, I was very happy to 
take them because they were a straw to clutch at I guess. (Spencer) 
I'm certainly not one of these people who thinks Oh God, some kind of poison in my body. It's 
like no, it makes me feel better… some people are diabetic, they take drugs, you know. And I 
know people say, “Oh, it's not the same”. But I'm afraid it bloody well is! (Matthew) 
...the more people talk about antidepressants as a positive thing, the better it is that people don't 
end up, you know, people don't end up not taking something they need because of the stigma. 
(Layla) 
I would like 100% take them [antidepressants] again… I'm not saying it's suitable for everyone 
but for me it is and so I'm not going to feel ashamed that I need them. Because like it's just an 
illness like anything else. (Lilly) 
It was like being on really strong drugs… made your pupils dilate. (Peter) 
309 
 
I found it quite scary… I wasn't really ready for taking drugs of that strength. (Gary) 
… it was amazing…within two hours I could feel different. (Christina) 
I think between 24 and 48 hours I felt so different that I rang the doctor and I said, look do I have 
to go up to a full dose, because this is amazing. (George) 
People call them like happy pills and stuff, you don't feel spaced out, drunk, stoned, whatever 
you want to call it. You just sort of feel yeah, this is the way life is supposed to be…(Matthew) 
Actually I just don't see any bad in them other than potentially the stigma… you don't have to 
share it with the world, you can do it yourself, it's a tiny little pill that you take and nobody ever 
needs to know about it. (Sean) 
I feared it was going to lead to drug addiction in a sense. (Gabriel) One of my friends was like 
“Oh well we've got to get you off them straight away,” and I sort of went “Well no because I've 
only just been on them and I need them for a bit,” …I think he was acting like I'd told him I'd got 
addicted or something…(Val) 
[I did not take them] …she [doctor] said “they're not addictive anyway” but I was still scared. 
(Sasha) 
I overdosed on everything I had, including Seroxat. I took all the rest of the tablets, [um] which, 
it turns out hasn't had any bad effect on me. (Nicola) 
I think I might well be on this medication for life… They seem to suit me very well…. and for 
the next four and a half years from now I am quite safe. I can still continue taking that. But in 
five years time, do I have to go back [to the doctor] and sort of plead my case again? (Liza) 
Zoloft, yeah, and I couldn't think and I took myself off it when [son] was about six months old 
and just went cold turkey. And I wouldn't recommend that. Never ever do that. [laughs] I had the 
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zapping - you get this zapping in your tongue… it was just awful. I had the shakes, I had dry 
mouth, it was just horrendous…(Catherine) 
was full of anxiety around [um] becoming addicted to them… however they did help and they 
helped me to find what I would call the equilibrium… so my experience of kind of 
antidepressants have gone from kind of the very first ones that I got that were fantastic I lost 
weight but I would never want to take them again because I think they're now banned 
[um]…they messed with my mind. (Catherine) 
Anyway, I can say, here we are, it is April, 29th 2010 and I am proudly still on one capsule of 
Lovan (fluoxetine). It gives me confidence, it is like a security blanket and I think it is 
fine...(Miho) 
37 Simon et al. (2007) 
For a long time I used every occasion as a reason and excuse for my problems and tried to live 
with it before I finally realized that I needed to look for some kind of treatment (male, age 33).  
I would have liked to know more about how to cope with a severe depression and how to 
continue with my life, but all my GP said was that I have to accept the fact that I am depressive. 
It took several weeks until I received more information in the hospital (female, age 48).  
When I was told that in-patient treatment would be necessary all that came to my mind was that I 
would be completely isolated from the world outside. I could not think of anything positive a 
psychiatric hospital could have to offer (female, age 56) 
I went to see my GP and said: I can’t go on anymore. I don’t know what to do. Please help me 
and do something (female, age 39).  
I was not in a mood to feel anything or to be satisfied. Now I would say that the decision was 
alright but at that time I did not really care about what had happened (male, age 51). 
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38 Smardon (2007) 
[A]nd I like, I have to tell you that I like taking something that’s not Prozac or Zoloft; it’s just 
this thing that nobody knows about. I didn’t attach it to anything in particular… it’s just 
enigmatic enough that I wouldn’t… you know like if somebody looked in my medicine cabinet 
they wouldn’t know. Not like anybody would look in my medicine cabinet. (Celexa consumer) 
author: What kind of antidepressant did they give you? 
Helena: a serotonin reuptake inhibitor. 
Helena: No, it was Celexa. Which is a European antidepressant and I had really good results. 
And I wasn’t too keen on taking... I’d rather not take Prozac. Just because of all the stuff attached 
to that.  
Helena: No, I wasn’t afraid of it, I just, you know if there were another one that could be 
effective that didn’t have this mystique about it. 
Helena: He takes antidepressants. 
Helena: It is very interesting how people … I was getting a prescription filled at the drug store 
and there were a lot of people there and there was this guy in front of me. And she said do you 
have any questions about taking Celexa and he said no. But I was like, hey he’s taking 
antidepressants, you know when you become aware of something it’s like … 
You might not have known what Celexa was before you started taking it? 
Helena: Right yeah right … and I like, I have to tell you that I like taking something that’s not 
Prozac or Zoloft; it’s just like this thing that nobody knows about. Helena: I didn’t attach it to 
anything in particular … it’s just enigmatic enough that I wouldn’t … you know like if 
somebody looked in my medicine cabinet they wouldn’t know. Not like anyone would look in 
my medicine cabinet. 
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Author: Did you discuss your decision about taking the antidepressants with anybody besides 
your doctor? 
Mary: Um well, I think I talked about it with Annie, with my boyfriend, I think I just told my 
mom. I don’t think she really understood. I was just like, ‘well, this is what they’re doing’. I just 
sort of announced it. I was thinking tomorrow I’m supposed to be starting my Klonopin, that’s 
when I started Klonopin which is an anti-anxiety … 
Mary: And it worked to help me fall asleep, temporarily … 
Well I guess I questioned it first of all. And second of all I was seconded by my therapist. She 
said she believed the patient had a low grade depression for a while. And actually  she had said 
that two years ago. Maybe a year prior to my going on the antidepressant. And I went to a 
psychiatrist and the psychiatrist said no you’re not depressed. So I knew that it wasn’t normal 
when I was questioning it and then through talking about it to her.And the resilience that I used 
to have wasn’t there. (Helena) 
I didn’t like the word depression. I thought it was terrible. In my hyperliterary state I thought it 
was an awful word, you know, I preferred melancholy you know. Because that had more of a 
literary history too it, so I thought OK. But I was very resistant to the idea that what I had was 
clinical depression. So to me what I had was hypersensitivity to the side of life that ... the dark 
side, the void, that life was just a painful experience. That’s what I had, I didn’t have depression. 
I didn’t really admit that I had depression for a few years. Even when I was in the hospital I 
wasn’t willing to admit that I was just one of many many people that suffered from this. 
(Thomas) 
39 Stanners et al. (2014) 
313 
 
I started to get depressed because I couldn’t do the things that I was always doing. You know, 
looking after my family, cooking, things like that because I was told I had to get off my feet, I 
wasn’t allowed to walk… So my life sort of just, you know, from being a normal mother, wife 
and that, running around and doing my thing, to doing nothing at all. (Female aged 59, 10 
chronic conditions) 
Every day’s so hard, you know, to cope, well that’s with—the [morphine] pump’s good, but all it 
does is take the edge off, you still have severe, you still have severe pain. (Male aged 49, 7 
chronic conditions) 
I guess initially it sort of shocked me, because I thought that I wasn’t sort of in that category… 
(Male aged 65, 10 chronic conditions).  
I’m very strong person, and I don’t allow myself, you know, to be how shall I say, overcome, 
you know, by emotions… Well, I was surprised. (Female aged 80, 8 chronic conditions) 
See, on TV now there’s adverts about depression with young people, and that type of thing? So I 
haven’t felt like that, just maybe down for a little while”. (Female aged 61, 5 chronic conditions) 
But because I know why I’m like that and I feel that it’s justified, I don’t think that I’m clinically 
depressed, do you know what I mean? Because I feel that my condition justifies my feelings”. 
(Female aged 75, 12 chronic conditions) 
I had no reasons for being in this [state] (Male aged 62, 5 chronic conditions) 
…here I go, I’m nutsville.’ And I didn’t agree with it. At first I fought the idea of being on 
antidepressants, but then realized I couldn’t cope the way I was going, and then went on 
antidepressants. . . . But at first I thought, oh no, here I go, I’m a nutcase, nobody’s going to take 
me seriously, and you know, it was embarrassing. (Female aged 48, 8 chronic conditions) 
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So there’s highs and lows, but I wouldn’t say, like, great depression. (Female aged 61, 5 chronic 
conditions). 
The psychotherapy was helpful, unfortunately it doesn’t last forever. . . You get it off your chest. 
But as I said it doesn’t last forever. (Male aged 65, 10 chronic conditions) 
I was pretty down on myself in all respects, and couldn’t understand how a tablet could take that 
away. (Male aged 62, 5 chronic conditions) 
40 Stanton and Randal (2016) 
And I suspect it was a thoroughly horrible situation for the psychiatrist as well. (DP 6) 
I didn’t want to appear too assertive and too knowledgeable and too threatening. (DP 3) 
The training keeps you away from a feeling state…allows you to stay even more in your head.  
You end up talking about brain biochemistry to your doctor which doesn’t fix the problem at all  
I wasn’t listening to the cry of my heart, I wasn’t listening to my pain, I wasn’t listening to the 
truth I knew about what had happened and who I was.  
The psychiatrist immediately made up his/her mind that it was clearly biological cause which I 
totally disagreed with and that was fine, let him/her talk and ramble on. 
I’m actually not going back now, that’s me, I’ll just get your okay to increase my prescription 
and say, I’m just going to go now and I’ll go to my GP.  
Doctors don’t want to know if their patients are angry with them. Doctors want to feel really 
good and helpful and wonderful.  
I said I want another option. I have no bipolar disorder…I was very clear about it.  
The psychiatrist just said ‘you’re depressed’ and started me on medication. It was just again that 
huge sense of relief that I just, I’m unwell and I’m doing something proper about it.  
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I went because I thought I was having a few problems. And [psychiatrist] told me I was 
depressed and that I needed antidepressants and I was devastated  
I just take it and I don’t give it much thought really. Except I know they keep me well and I don’t 
stop. I mean I realized very quickly that they worked.  I didn’t want to be a doctor. I didn’t want 
to be a diagnosis. I didn’t want to be on medication. I wanted and needed to be me…as I learned 
to live with myself, then I kind of…this illness thing evaporated.  
I’d never talked to anyone about it before in my life. I didn’t know you could, thinking back, I 
just didn’t know you could do that…  
Not bound by ‘I’ve got to fill in my risk assessment documents and I’ve got to give you a 
diagnosis’. It just felt like, actually ‘I’m here and I’m listening to you and I’m going to do 
whatever I need to.’ 
I’m a doctor and I care about doctors, yeah, part of it’s about treating your own kind, like helping 
people in your own family.  
Ranged from being extremely enjoyable, rewarding, interesting, worthwhile to being one of 
those things I had to do but wanted to get out of  
They’re either being good patients or being really difficult and foul and revolting.  
It’s brilliant, I really love the fact that I’ve been depressed….It stinks as an illness but it’s a great 
extra dimension as a psychiatrist.  
I feel really comfortable to talk about [taking time off work] because it’s part of my experience 
and I talk about how I push myself to work, even though I know probably that it would be better 





41 Van Geffen et al. (2011) 
I felt very depressed and down. I was unable to settle down and do something. I started getting 
upset easily, even with my children. I felt fatigued and tense all the time; I didn’t have the 
energy. (patient 3, discontinuer) 
For quite a while already I was suffering from anxiety and panic attacks. At some point it got out 
of control; I couldn’t suppress it any more. I was truly afraid of my fears and wasn’t looking 
forward to anything. Even opening the mailbox felt like it was too much to handle. (patient 13, 
continuer) 
What I would usually get done in a day now took me three days. That, in turn, made me feel 
guilty, and even more depressed. It felt as if I had failed; I just couldn’t do it. (patient 15, 
continuer) 
Until, at some point, you reach your limit, and then cross it. Just to avoid the constant thinking, 
the feeling of fear. That’s when I realised this is it, I have to stop this. (patient 13, continuer) 
I didn’t believe it would work, as with the other antidepressant I hadn’t noticed any improvement 
either. I reluctantly went along; now it has become very clear to me that it actually works. I was 
truly surprised by its effect. (patient 10, continuer) 
I started getting specific symptoms that I recognised from before. It didn’t seem like a good idea 
to let it get much worse, so I went back to our GP. Having used it before definitely helped; it 
makes it easier to explain certain side effects you might experience. You know it will all be just 
fine, if you give it some time. (patient 16, continuer) 
I had used paroxetine before, several years ago. That had made me feel so much better. This time 
I again felt weird and awful, so I went to our GP. He said that since I had experience with using 
this medication, and it went well before, I got it again this time. (patient 17, continuer) 
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I’m not the kind of person that takes a lot of medication, but if I have to, I will. Our GP is 
knowledgeable, and he recommends this to me, so I will take it. (patient 11, continuer) 
He told me “This is better for you,” so then I went ahead and started using it. Not really a 
conscious decision. You don’t really know why, or for how long; you don’t really know 
anything. (patient 3, discontinuer) 
I did know a bit about antidepressants and I definitely didn’t want any of that. The doctor 
suggested it to me three times, and all three times I pushed it off. Eventually, when the situation 
got quite desperate, I gave in. (patient 7, discontinuer) My GP explained that your brain produces 
certain chemicals that have to be in balance. That balance may be what I’m missing. If this pill 
makes me get my balance back then I would sell myself short if I don’t take it, according to him. 
(patient 8, discontinuer) 
The doctor had first prescribed a “Benzo,” but that made me feel quite groggy. There had to be a 
better alternative. That’s when I read about Prozac, and brought it up myself. I felt the doctor 
was taking me seriously. (patient 13, continuer) I don’t have a problem with it and don’t feel 
weird about this kind of medication. Obviously I’d rather be healthy without medication, but if 
you can’t live without then you have to take them. If the medication was bad then the GP 
wouldn’t have prescribed if to me. (patient 17, continuer) 
To me it’s quite simple: a person with heart problems takes heart medication, so if there’s a 
short-circuit in your brain which causes you to have too little serotonin, then you take fluoxetine. 
(patient 13, continuer) 
I actually wanted to fix it myself. If you can resolve it without medication then you’re part of the 
regular people, but now I no longer belong to that group. Taking medication means admitting 
failure. (patient 10, continuer) To me, cholesterol reducers are something different; that you can’t 
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really do anything about. In this you can’t really either, but still … it’s something that’s in your 
brain. That’s what makes it difficult for me to take medication. (patient 3, discontinuer) 
I’m afraid to get labeled unstable. You generally get told to just get off you’re a[…] and do 
something about it, then it will be just fine. (patient 12, continuer) 
You can get dependent on SSRIs. When you stop using it the depression can return even worse. I 
believe you should use an antidepressant only temporarily. (patient 7, discontinuer) 
I always want to maintain control over my own life, but the medication dominates. The problem 
doesn’t get treated. You become depressed for various reasons, and you have to do something 
about it. (patient 7, discontinuer) 
I was actually quite relieved when I got the medication. You are really sick and you’re not just 
pretending. Your behavior is no longer strange; it’s okay now. If you have a broken leg, then 
everyone accepts that you can’t move around. But if they can’t tell what your problem is, then 
you’re just weak, lazy, or egocentric, then you’re just not right. (patient 10, continuer) 
I kept insisting it wasn’t a depression I was feeling, and I still don’t like it. (patient 12, continuer) 
I was glad this guy on the radio explained it this way, that when you’re depressed your brain has 
too little of a certain chemical. I had heard that before and realise there are contradicting theories. 
But now it’s quite convenient for me to believe this particular one. (patient 10, continuer) For me 
it’s quite difficult to take medication for this. That’s because I don’t know what exactly I’m 
using it for. Perhaps if they had told me there’s a certain chemical that my body doesn’t produce 
by itself, then I’d be okay with it. (patient 3, discontinuer) The GP told me that the medication 
can take a little while to work, and what side effects might occur. He also said that I have to use 
it for at least six months, plus that I can’t quit all of a sudden, but rather reduce the dose over 
time. (patient 11, continuer) The doctor didn’t discuss any side effects. That’s what I had 
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indicated, because when they tell you, then you’ll probably get them. I don’t ask any questions, I 
don’t need to know everything. (patient 18, continuer) 
I don’t remember what the GP said. From the conversation I had with him I only remember how 
it made me feel at the time. (patient 12, continuer) 
I was told by the GP that in the beginning I might feel rushed. I’m glad I learned about that, 
because I did suffer from that in the beginning. So when that happened I knew it was part of the 
process and would soon pass. (patient 3, discontinuer) 
When I started with this medication, I didn’t receive any information whatsoever, not even about 
side effects. They did tell me in passing that it could take a while before I would notice the 
intended effect. The doctors should be much keener about this. It would be so easy to just give 
the main messages, and refer to the information leaflet for more information. When I asked my 
doctor whether this medication has any side effects, he just grabbed a big book and said “If you 
like I can read them for you.” (patient 6, discontinuer) 
The first time the GP said it’s not addictive. I had reduced the dose over time, but yet from the 
way I was walking it seemed like I was drunk. I had a headache all the time. I believe it actually 
is addictive. The doctors better stop telling that story. (patient 16, continuer) My GP had 
consulted the gynaecologist and said there appeared to be something wrong with my hormone 
balance. I trusted him. I didn’t know then that it was an antidepressant until later when I read the 
information leaflet. If a doctor can’t explain why you need it, then you won’t accept the 
medication as easily either. (patient 3, discontinuer) 
The first four weeks were really difficult. You don’t feel too great to start with, and on top of that 
these side effects. The stomach aches were the worst part. I couldn’t keep any food down, just 
tea I was able to manage. I was shaking a lot, felt nervous and restless. I had the feeling there 
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was so much I was supposed to be doing, but I didn’t have the energy to get to it. (patient 12, 
continuer) 
I was rather apathetic. Temporarily, perhaps that’s a good thing, but not over a long period of 
time. I no longer had the energy to take any initiative; it seemed as if I lived in a bell jar. (patient 
7, discontinuer) 
I’m a lot less tense now, and more relaxed. I can take setbacks a lot better, and don’t let things 
get to me as much. I enjoy moving around and started picking up basic things like making 
coffee. The household is back in operation. (patient 10, continuer) 
I no longer have panic attacks, and I’m not as scared. I’m noticing that the negative feelings are 
diminishing. I am more open now to positive aspects, which helps me focus on my inner self. 
(patient 16, continuer) 
My emotions in general are more subdued. Some things I don’t care about any more; I’ve 
become more egocentric. (patient 10, continuer) 
My head feels calmer now; it’s not churning thoughts as much any more. It doesn’t feel as 
heavy, though it’s not stable yet. I still have days of much doubt, of not being my true self. 
(patient 15, continuer) 
I received a medication that didn’t do anything; the situation got worse. I kept sliding down 
further and further. (patient 6, discontinuer) My disease is a so-called “self-finishing process.” I 
feel better now, but I don’t know if it’s thanks to the medication or just because of time passing. 
If you don’t take anything, you’ll also get better. I started biking again; that may have actually 
helped me more than the Efexor. (patient 6, discontinuer) 
My relationship with our GP is really good. He is always willing to listen to my side of the story. 
He understands my situation; I think that’s important. (patient 16, continuer) 
321 
 
My previous doctors never really counseled me. They just wrote out a prescription, opened a 
drawer, and before I knew it I was back outside. My current doctor is willing to admit he doesn’t 
know everything. He’s just trying to get things started again. He explains everything, and I feel 
comfortable discussing my doubts with him. (patient 6, discontinuer) 
[SSRI]: The first four weeks I felt really lousy: heart palpitations, perspiring often, ear drums 
closing, and headaches. It was as if I was having a heart attack. I called the doctor at least six 
times because I thought it wasn’t normal. The doctor kept telling me that these were common 
side effects, that I had just had to bite the bullet. I thought that was quite limited. (patient 7, 
discontinuer) 
I did tell my GP about the bruising, but he wasn’t too concerned. It’s not about craving for 
attention, or making up stories; it just worries me. (patient 10, continuer) 
I’ve discussed the medication with my GP, a psychologist, and a psychiatrist. They each have a 
different opinion, that’s annoying. I was always told to avoid alcohol when taking an 
antidepressant. Then the psychiatrist told me: sure, that’s what we’re saying, but in principle 
there’s no such correlation. (patient 7, discontinuer) 
Some people probably think it’s crazy that I’m taking this medication. Only my family knows, 
and my friend. I use it and it helps me, and I don’t care what anyone else says. (patient 17, 
continuer) 
My family knows I use medication, but what for they don’t know. I believe they think it’s just 
some relaxation pills, nothing more. I’d rather not tell anyone. I’m afraid to get labeled mentally 
unsound, and not being able to get rid of it. When I get back to work I want to have all of my 




When I talk about it with other people they’re often wondering if taking this kind of medication 
is a wise thing to do. You hear a lot of negative stories about these medicines. That’s a shame 
because I’m sure there are people who benefit from it. (patient 7, discontinuer) 
My wife thinks this medication is scary since it’s affecting your brain. That doesn’t bother me. 
The list of side effects on the information leaflet was quite shocking to her. So we talked about it, 
and then asked our GP if I could stop using it. I am doing okay now, but the deepest fears 
haven’t gone away yet. (patient 1, discontinuer) 
In my case the benefits outweigh the downsides, as far as I can tell. Obviously, I’m worried 
about the bruising and the muscle aches; what does that mean about what’s happening in your 
body? Perhaps if I knew more about that I would decide to quit. But I had thought long and hard 
on whether I should start with it, so you don’t quit just like that. After all, my quality of life did 
improve (patient 10, continuer) 
The weather was fine, and I was doing okay. I was tired of being dependent on medication any 
longer, so I just quit. I thought I could do without; others also can. (patient 3, discontinuer) 
I don’t believe I could do without my medication yet. I’m still feeling too unstable. Once I can 
quit I will do so, but I’m afraid I’ll slide back to my previous conditions. I update the GP on how 
I feel and leave the decision when to quit to him. After all, he’s the expert. (patient 11, continuer) 
I don’t want to take any pills if it’s not absolutely necessary. I had called the doctor to start 
reducing the dose. I thought, if I don’t speak up, a year from now I would still be taking these 
pills. But he thought it was too soon, so I’ll continue for a little while longer, which is fine. 
(patient 15, continuer). I felt much better and was not sure whether this was due to the fact that I 
started dancing and sporting again, or due to the medicine. That’s what I wanted to find out, and 
that’s why I stopped taking the medicine. (patient 6, discontinuer) 
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I’d like to try quitting one more time. If I still get the symptoms back even after this third time, 
then I’ll accept that I just have to take this pill. Then it would no longer bother me. (patient 8, 
discontinuer) To me, quitting was a very positive experience. I did suffer from side effects, but 
with every day I felt I was becoming more “me.” I felt a boost in energy and started picking up 
activities. I do worry about the depression returning, knowing that I quit too soon. However, I 
would never take an antidepressant again. The cure is worse than the disease! (patient 7, 
discontinuer) 
He just couldn’t go on any longer. So he started again; he has arranged it all himself. He just 
knows by now that it’s better for him to take this medicine. (patient 3, discontinuer) 
42 van Grieken et al. 2014 
I felt that I was more held back than that there was a connection to what I was experiencing. So 
the treatment method was leading more than I was. It was also really the method that didn׳t work 
for me. (ID26) 
Everybody was in the same process and at the same courses… I think it was primarily the people 
who were taking a lot of antipsychotic medication, and were sometimes suddenly screaming 
loudly or demanding a lot of attention, and were physically very slow at the time that we were 
doing an activity, interfering more than that they were able to participate. I sometimes found that 
horrible, I really had trouble with that. (ID28) 
The lack of a framework has a very negative impact: what are you working on, where are you 
headed, how long will it take? If I know what his or her perspective is, I can speak more easily. 
Then I know what׳s being measured, and in what direction someone wants to take me. It also has 
to be clear, I really missed that. You see, of course there is an end. At a certain moment you׳ll be 
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discharged. And that doesn׳t mean that you׳ll be 100% recovered and healthy, but it׳s nice to 
know that in advance.’ (ID23) 
There must be a plan, a beginning and an end, and you have to have goals. I found that lacking 
very much. … What you were working towards and what you wanted. (ID4) 
Because then if I went into therapy, very frequently I had to go through my whole childhood, 
family, and work, whereas that׳s not where the problem was. It lay primarily with the way I was 
thinking and incorrectly reacting to situations. You don׳t solve that directly by discussing your 
marriage, parents, or childhood, that in fact had nothing to do with it. (ID4) 
Then I was referred to a psychologist for [therapy] sessions. And I thought, I׳d also find 
medication perfectly fine. But I thought, they׳ll know… I would have preferred to think along 
and be involved in the decision-making. … So, we weren׳t making any progress, we were only 
talking about my past and meanwhile I was not recovering from my depression. … I experienced 
several times that in hindsight I thought: why are we doing it this way? (ID19) 
If, for example, every psychiatrist would tell a client: we׳re going to work together for four 
sessions, and after those four sessions, you can say whether you think it׳s working or not. I׳ve 
never experienced a psychiatrist who evaluates. (ID15) 
The only reason why I am on medication now, is because friends and family have given me 
incredible support with this. Otherwise I wouldn׳t have taken pills. Thirty minutes with my 
psychiatrist was not enough to convince me. He didn׳t take enough time for that. I had a very 
serious fear that was not being recognised. And it was also not taken seriously. And that has a 
very large influence on adherence. (ID11) 
I don׳t think that the confidence was really there to just talk about myself over there. It׳s just very 
important that there is a click in order to move forward together. (ID16) 
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Hope is incredibly important. That always has been a tremendously important basis for me. 
Therapists who have the balls to say that everything will be all right: that requires courage. 
Because there are also therapists who do not dare to say that, because they don׳t know whether 
that׳s true and they think it׳s not right to say it then. (ID20) 
‘I had a very good psychiatrist, but then I couldn׳t go to him anymore and I had to go to someone 
else. And then you feel you need to start all over again. (ID2) 
What doesn׳t work: someone who doesn׳t take you seriously. He wasn׳t warm, he didn׳t show 
any compassion…. Apparently I felt ‘you׳re not going to help me’. No, I didn׳t even start with 
him.’ (ID20) 
There has to be a good mix between a professional attitude and not too much distance, And also 
not someone who sits across from or next to me and will continuously say ‘oh yeah, that׳s 
horrible’… yes, who will only commiserate. So also there will have to be a balance actually. 
That I have someone who confronts me with things, but where I also feel, whenever there is a 
confrontation, that he understands me.’ (ID9) 
You also feel very dependent. I actually felt growing smaller and smaller during that 
conversation. I absolutely did not have a good feeling then. (ID16) 
‘I would rather have someone who knows better than I do. That׳s what you need. There are 
certain phases where you really need to be told what to do. If that doesn׳t happen then, that 
works badly.’ (ID23) 
‘A three month-waiting list! And one week afterwards I attempted suicide. Exactly because 
you׳re going there to ask for help because you can׳t deal with it anymore.’ (ID21) 
What can be worse for someone with a depression than to be abandoned? I attempted suicide, 
amongst others because I could not get a hold of my therapist… who was just not available. Then 
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I thought now I׳m done…. What I really find heart-warming, I now have an agreement with my 
psychiatrist: ‘I will never call you. And if I call you, all alarms are on red. Then I want you to 
directly intervene, to put me on medication, and to set me up with a specialist.’ That kind of 
agreements has a very high value for me. (ID20) At a certain point you׳re not sure who your 
primary contact person is. I also found that to be something very difficult. I never had the feeling 
that there was one person who I could always contact. (ID28) 
You end therapy and after a while, you relapse again. Aftercare, that was not available. I think 
that it׳s better if you follow-up on people, that you let them return every month or every two 
months, and that you just go through those check-lists, like how is this going, how is that going, 
how is the other thing going? Because that׳s my experience, you yourself do not ring an alarm 
bell. Because you׳re already so fed up and you׳re ashamed that you failed again, and then you 
think, tomorrow things will be better again. (ID4) 
To involve the significant other is important, not in the least for the significant other him/herself. 
Also that attention be paid to the possibilities of the partner to be supportive or to need support 
themselves. That should be part of treatment, as at least for me, one of the success factors has 
been my system. (ID20) 
43 Vargas et al. 2015  
Certain conclusions on the rationale and various misconceptions could be drawn upon accounts 
of participants’ of Vargas et al.’s study. Many individuals concluded, their depression can be 
treated by medication as such “helps to regularize the nerves (ayuda a regularizar los nervios).” 
Labeling occured because of their depression: Close associates, such as relatives, friends, or 
acquaintances, viewed participants’ depression as a sign of personal weakness or lack of drive to 
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feel better, as if, ‘one wanted to feel depressed… but general opinions are that ‘with just a little 
extra effort, one can get out of it.’ 
Other people viewed depression as something which ‘does not exist, something that you cause 
yourself,’ through excessive investment in your own dilemmas (“believing in your own crap”), 
dwelling on problems, attending too strongly to negative circumstances, or apathy about negative 
emotive states (“you let yourself fall and let it happen”). 
A female participant (María) explained that her family and friends believe, depressed people 
need to ‘put forth effort (poner de su parte), because depression is not an illness and the 
symptoms can be cured by oneself putting forth effort and going to church.’ 
Another woman (Silvia) described her depressive symptoms as chronic, but with her strong will 
(fuerza de voluntad) she had prevailed, however recently, she is no longer able to manage it 
herself. She used to have a quite healthy attitude and learned to disregard many issues by not 
paying attention until her mind started feeling changed. 
Diego described his father’s negative attitude toward antidepressants. The man was not accepting 
of his son’s drug therapy and claimed he can get better on his own, but it was much harder for 
his son to manage depressive symptoms without the medication. 
Gabriela described her preference for natural medicine, like tea, but explained how it did not 
address her mental health needs: she had always liked natural medicine, but finally came to 
realization that natural remedies are not strong enough to help her condition; indicating that her 
depression was too severe for alternate treatments. 
One participant expressed her frustration at not being well informed about the diagnosis: (“so 
far they haven’t told me what class of depression I have”). “My psychiatrist would give me tests 
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similar to this one and I never knew what came of those tests.” He eventually dropped out of that 
treatment. 
Many participants described delaying psychiatric treatment by trying first to “keep fighting with 
my problems and control myself.” 
Pamela explained why she avoided treatment in the past: “I thought … I am going to take 
medicine and my nerves are going to become unwell (voy a estar mala de los nervios), I will 
have to start seeing a psychiatrist—the psychiatrist is for crazy people.”  
Daniela stated that her family thought antidepressants could also precipitate the onset of 
madness. Seeing a psychiatrist could be construed as a pathway to madness.  
Miguel explained how seeing a psychiatrist could yield further stigmatization: “[People say 
about a depressed person] that he is crazy  … And if he sees a psychiatrist or something, they 
say, no, that one really becomes crazier every day. Because psychiatrists, they say …  make 
people crazy.” 
Ricardo explained this difficulty: “It took a lot from me to come [to the clinic] because of all the 
myths, the negative aspects … [attributed to] a person with depression … who sees a 
psychiatrist.” 
Most sought help only when completely unable to cope: “If I were to find a solution … I would 
not look for help. But … this is overtaking me [me está rebasando]. And each time it’s … more 
so.” 
Gabriela explained that she stopped going to a previous treatment because she at that point 
“thought I could … help myself without needing the medication.” 
Other concerns with bodily effects included fluctuations in weight, sleeping habits, sexual 
function, dizziness, and “the way medications can alter one’s brain.” 
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Elena described, “if … they need to remove my liver because I have hepatitis as a result of the 
medications, my depression will get worse, it will get stronger.” 
Margarita said she worried over feeling “abobada” (befuddled) as a result of taking the 
medication, and that “other people could do with me whatever they want , that I would not be 
aware of what was happening.” 
If I stop taking it … you can feel more down, more depressed, a greater sense of guilt or a desire 
to kill yourself … if I don’t feel that way now, and by ceasing medication treatment I’d feel that 
way, well then I say things are just going to get worse. 
Using medication for a long time would mean relying entirely on the pill to feel well. And in the 
public opinion, the pills should only be used for a limited time to help the person return to their 
normal state. A woman (Carolina) said, she heard that if you take antidepressanst every day, they 
are addictive. But she put trust in her doctor’s professional judgement: “ If the doctor says you 
must take it, you must take it. He will know when to stop it.” And Carmen explained, “If I go to 
the gym, I feel better as well, but right now I feel so impotent, so bad, that I can’t find the way to 
go exercise.” Elena explained that while others thought visiting a psychiatrist was “a thing crazy 
people do (cosa de loco),” she thought treatment was meant “to help everyone, crazy people and 
those who are not crazy.” 
44 Vilhelmson, Svensson and Meeuwisse 2013 
Woman (63) believed that her ‘so-called depression’ was a normal reaction to a distress that 
resulted from separation, homelessness, loss of two jobs within three years, and death in the 
family. 
Woman, (41) sought help because she felt exhausted. Other symptoms she was experiencing 
were insomnia and cognitive impairment so she had to stop working. The doctor diagnosed her 
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with depression, but she refused to accept the diagnosis. She did not feel depressed, just tired and 
sad about her terrible life situation. But the physician insisted that all her symptoms of chronic 
fatigue were signs of depression. Woman (34) experienced a very severe, lonely, and anxious, 
but not a violent childhood and as an adult she suffered from frequent and deep periods of apathy 
and depression. Her memory was also impaired. Woman (50) felt ill after surviving her second 
breast cancer and was offered psychiatric help. She believed it would be useful to talk to 
someone, but after twenty minutes during the first consultation, she was offered ‘happy pills’ and 
she got very disappointed. Woman (36) refused taking pills and shared her reservations with the 
physician. In place of Seroxat (Paroxetine) she was willing to take Valium (Diazepam) however, 
her doctor wanted her to continue the antidepressant and recommended understanding the 
treatment as a ‘vitamin boost’. Woman (38) had doubts about the root cause of her depression 
being a chemical imbalance in the brain. Woman (38) was aware of her low levels of serotonin 
and she was suggested taking Cipramil (Citalopram) for the rest of her life. Woman (38) believed 
that the reason behind so many prescriptions for antidepressant medications might be the drugs 
being the only help doctors can offer, thus patients’ rejection of this help causes doctors’ 
frustration. 
Woman (22): all she wanted was someone to talk to, some sort of conversational therapy. 
Woman (42): The first doctor she visited, barely looked at her when she described her 
symptoms. 
Woman (49) believes to be lucky of having an ongoing contact with psychiatrists with solid 
knowledge of the field who order laboratory tests to ensure that the right medicine is prescribed. 
Woman (26): After a couple of months of being on sick leave due to severe burnout, the doctor 
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decided to issue an ultimatum: either the patient started treatment with an antidepressant 
(Fluoxetine) or he would not continue signing her sick-leave. 
Woman (34) refused taking the antidepressant despite threats of ending her sick-leave. Doctor’s 
conclusion was that patient did not want to get better and was avoiding work. 
Man (56): While the patient continued antidepressant treatment, no follow-up consultation took 
place. Woman (41): after she decided to end her antidepressant treatment, her physician had been 





Qualitative Narratives with the Application of the Verbatim style 
 
1 Amey, 2010 
 Experience of psychotic mania suspected to have been induced by the tricyclic antidepressant, 
dosulepin. 
I describe, as a first-person narrative, my own experience of psychotic mania, which was 
suspected to have been induced by the tricyclic antidepressant, dosulepin. I have had a 16-year 
history of depression and was receiving sertraline 50 mg when I was prescribed, off licence, 
dosulepin 25 mg for insomnia. Within days, I developed mild hypomanic symptoms and returned 
to my GP, who discontinued dosulepin but continued treatment with sertraline. I was also 
referred for psychiatric assessment. Two months later, I was detained under Section II of the 
Mental Health Act 1983 and admitted to hospital with psychotic manic symptoms. 
I was admitted, at the age of 36 years, to a mental health centre in February 2009 with psychotic 
manic symptoms, including thought disorder, persistent psychomotor agitation, pressure of 
speech and visual, auditory, and olfactory hallucinations. At the time, I was receiving sertraline 
50 mg, which had been prescribed to me by my GP. I had no personal or family history of 
bipolar disorder, although my maternal grandmother had been diagnosed with postnatal 
affective disorder, and later, with schizophrenia. 
I had first been treated for depression with dosulepin 75 mg between March 1993 and April 
1997. Since then, I had been treated with antidepressants intermittently, namely fluoxetine 20 mg 
and sertraline 50–100 mg. I had been treated mainly by my GP, although I had been assessed by 
a psychiatrist in June 2004, who, in view of the chronic nature of my recurrent depressive 
disorder, deemed it appropriate for me to receive long-term maintenance antidepressant 
medication. 
On 19 November 2008, a locum GP prescribed me, off-label, dosulepin 25 mg 1–2 nocte, to help 
treat insomnia. The insomnia had been caused by work-related stress from a demanding job as a 
medical writer. I was already receiving sertraline 50 mg at the time. On 6 December 2008, I 
returned to my GP surgery with self-reported mild hypomanic symptoms. My insomnia had 
worsened and I had lost half a stone in weight through lack of appetite. In contrast, I had 
excelled at my work, exceeding my sales target by 200% and I had received an e-mail of 
commendation from the company's Vice President. However, my husband had urged me to see 
my GP. He had described my behaviour as ‘hyperactive’ and ’out of character’. I stopped taking 
dosulepin, but continued on sertraline 50 mg on my GP's direction. My hypomanic symptoms 
subsided during the first few days following discontinuation of dosulepin. I reported my side 
effect on the Yellow Card Scheme and also requested referral to a psychiatrist for assessment as 
I feared I may have bipolar disorder. I hoped, however, that the experience was merely a 
disturbing, yet temporary drug side effect and I resumed my life as normal. 
Prodromal phase 
In early February 2009, I was under considerable stress. My husband was away and I was 
looking after my three-year-old son alone. I was also due to visit a particularly demanding 
client. I took Friday, 6 February 2009 off work as a holiday as I was feeling tired and knew that 
I needed rest. By midday, I phoned a friend sobbing in an inexplicable panic. A few hours later, 
my friend came with me to see my GP. I could not access my usual GP but the doctor I did see 
prescribed me a short course of zopiclone 7.5 mg and suggested that I see my usual GP the 
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following week. My friend called round other friends, who then worked as a tag team so that 
someone was with me the entire weekend until my husband returned home. My symptoms 
meanwhile worsened rapidly. 
The next day I was thought disordered and delusional, believing myself to be a tortured genius. 
My delusion of grandiosity was that I had concealed my true intellect even from myself in an 
effort not to be considered a freak. Feeling alone, I tried to contact the cleverest people I knew 
but no one could understand what I was saying. I also regressed, reliving my difficult childhood, 
which had involved bullying and childhood abuse. 
Acute psychosis 
On Monday, 9 February 2009, my husband returned home and took me, in a terrified state, to 
see my usual GP for an emergency appointment. I told her that: “I'm not a risk to myself or 
others but I'm in so much pain I don't know whether I'm alive or dead”. 
I could not understand her reply. I had finally been overwhelmed by the psychosis. She 
prescribed diazepam 5 mg 1–2 nocte and trifluoperazine 1 mg 1–2 tds. I spent the night at home, 
awake and with vivid hallucinations. I thought I heard my husband kill my son. I heard my son 
crying and the imaginary sound of my husband hitting him but my body was paralysed. I 
believed my doctor must have told my husband that to save me he must re-enact what my father 
had done to me. 
The following morning, I thought I was dead and that everyone around me was trying to bring 
me back to life. My metaphor at the time for death was ‘to leave the room’ – I raved continually 
about wanting ‘to leave the room’. I thought that people were challenging my decision to die by 
showing me that I had reason to live. My mother-in-law arrived at my home and I thought her 
challenge to me was her age – I was younger than her and therefore too young to die. 
My husband again took me to see my GP who recommended that I be detained under Section II 
of the Mental Health Act 1983 due to acute psychotic presentation with thought disorder, 
anxiety, pacing, inability to settle, pressure of speech, flight of ideas and visual, auditory and 
olfactory hallucinations. I was taken from the GP surgery to the local Community Mental Health 
Team. As the healthcare professionals poured in the room to assess me, I tried to work out how 
each one of them was challenging me to live. One of the nurses was overweight and I thought his 
challenge to me was that I was too slim to die. To explain this, I lifted up my top to show that I 
was not in fact so very thin and could therefore die. The assessing psychiatrist quickly exclaimed 
“she's disinhibited” and noted on my acute care screening form that I had exposed myself and 
was exhibiting sexually inappropriate behaviour. 
I was administered rapid tranquilization in the form of lorazepam 2 mg and olanzapine 10 mg, 
before being taken by ambulance to a mental health centre in a nearby town under Section II of 
the Mental Health Act 1983. I was assessed on admission and prescribed olanzapine 10 mg 
nocte. Sertraline 50 mg was discontinued. I was also prescribed 1–2 mg lorazepam prn 
(maximum 4 mg) for agitation. Admission laboratory tests were performed, the results of which 
were all normal. 
Recovery 
My recovery was rapid and the next day I was able to communicate my distress. I wrote: 
“This is how I can explain it to you at present. It hurt so much to be alive that I thought that I 
might as well be dead. When that happened, the boundaries between life and death became 
blurred. When that happened I got so scared that the only way I could feel comforted was to take 
refuge in madness. When I did it didn't hurt so much. But it appears that I might be ready to 
wake up now. It is not that I don't like being in here. I do feel safe but also very bored. Partly this 
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is because the people round here seem to have two topics of conversation: 1: their meds; 2: 
moaning about nurses – usually because they want them to give them more meds! I am not sure 
why that would possibly want more meds because if I ever saw another pill again I would want 
to stamp on it! Anyway, that's not the only reason. I want to feel alive again so I want to go back 
to my normal life. By normal, I mean before the breakdown.The breakdown was horrific for me. 
If I die and go to hell now I won't mind because I can't see any way that anyone could make a 
worse hell for me than the one I made for myself. So if I ever die and find myself in such a place 
as hell, I will track the devil down and laugh: “Is this really the best you can do?” So I am not 
even scared of the devil now. I therefore feel ready to join my friends and family. I don't want to 
hurt them so I put my complete trust in you to decide what is best for me. But like a child who is 
going on holiday but the journey there seems to be very long, I shall say to you continuously: 
“Am I ready to leave here now?” 
A pivotal moment in my recovery came during a session in the hospital gym. While I was on the 
treadmill, my perception of time suddenly coincided with the time on the treadmill screen. Until 
that moment, time as I perceived it bore no resemblance to what it said on the clock and I could 
not tell the staff and the patients apart. Coming out of the psychosis, my initial feeling was of 
euphoria. I thought even the devil could not create a worse hell than the one that I had created 
for myself. 
I was transferred to a mental health hospital nearer to where I live as a bed there had become 
available. I pleaded with my psychiatrist to allow me to leave the hospital and go home. On 17 
February 2009, I returned home, for a week's leave, after which my section was rescinded. I 
received four doses of lorazepam 1 mg during my week's stay in hospital. I made several escape 
attempts during my stay when not under sedation with both olanzapine and lorazepam and was 
apparently difficult for the staff to manage. 
I switched from olanzapine 10 mg to aripiprazole 15 mg due to poor tolerability to olzanapine. 
The apriprazole dosage was later reduced to 10 mg then to 5 mg. Following discharge from 
hospital I also received citalopram 20 mg for depression. This was replaced by fluoxetine 20 mg 
due to my own preference and perceived lack of efficacy of citalopram. My consultant tapered 
me off the antidepressant, fluoxetine, and, two months later, I was able to discontinue the mood 
stabiliser as well. This was done in parallel with psychoeducation in the form of cognitive 
behavioural therapy-based group therapy. In addition, I am currently receiving psychotherapy 
and continue to receive monitoring by my consultant psychiatrist. 
Since my illness and subsequent hospital admission, I have not felt able to resume my career as a 
medical writer. I have, however, been working part-time as first as a shop assistant and then as 
an editorial assistant for a medical publisher. 
Conclusions 
My patient history, in particular, the speed of my recovery, which was coincident with the 
discontinuation of antidepressant treatment, is consistent with the hypothesis of mania as a side 
effect of antidepressant treatment. Only a diagnosis of suspected antidepressant-induced switch 
to mania could be made in my case, however. The first reason for doubt was that the dose of 
dosulepin that prompted my initial, hypomanic episode was low. Even in combination with 
sertraline 50 mg od, raised serotonin levels seem an unlikely explanation for the switch 
considering that I had received sertraline at 100 mg od before and had experienced no 
hypomanic or manic symptoms. The second confounding factor was the time delay between me 
discontinuing dosulepin and the onset of psychotic manic symptoms. 
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However, TCAs are known to be associated with a higher risk of switch to mania than non-TCA 
antidepressants. (Peet, 1994, Boerlin et al., 1998, Gijsman et al., 2004, Hausmann et al., 2007, 
Truman et al., 2007, Mundo et al., 2006, Salvi et al., 2008, Goodwin, 2009, Koszewska & 
Rybakowski, 2009 and Sorvaniemi, 2009). It has been hypothesized that the higher frequency of 
TCA-induced mood conversions may, in part, be accounted for by anticholinergic activity 
(Koszewska and Rybakowski, 2009). 
 
Since I had taken dosulepin before as monotherapy with no ill effects, the possibility of a drug–
drug interaction with sertraline cannot be ruled out. One case study of antidepressant-associated 
mania reported possible switch due to complex drug interactions during a shift from fluoxetine to 
mirtazapine (Liu et al., 2009). However, in contrast to my own case, the patient's pre-morbid 
characters and clinical presentations suggested an implicit bipolarity that pre-disposed her to a 
manic switch. These included ‘mixed’ features of depression, that is, irritable mood and 
psychomotor agitation. 
Patients with bipolar disorder often spend more time experiencing depression than mania, which 
means that bipolar disorder may be incorrectly diagnosed as unipolar depression (Nierenberg, 
2009). If depression in bipolar disorder is misdiagnosed as unipolar depression, the likelihood of 
treatment with antidepressants alone and the incumbent risk of treatment-associated switch to 
mania increases (Thase, 2006). In an European College of Neuropsychopharmacology (ECNP) 
consensus meeting in Nice, France, in March 2007, the risk that unipolar patients ultimately turn 
out as bipolar disorder in the longer run was estimated at >10% (Goodwin et al., 2008). 
However, in my case, due to the almost immediate onset of hypomanic symptoms associated with 
the prescription of dosulepin at the age of 36, antidepressant-induced mania seems more likely 
than a missed diagnosis of bipolar disorder. 
Risk factors for antidepressant-induced switch to mania in unipolar depression are poorly 
characterized. Predictors of subsequent bipolarity in people with depression may include: 
history of psychosis, family history of bipolar disorder, psychotic features and reverse 
neurovegetative features (Goldberg et al., 2001, Thase, 2006 and Wada et al., 2006). None of 
these applied in my case; however, as more investigation needs to be done to identify risk factors 
for antidepressant-induced switch to mania, it may be that I had some unidentified risk factor. 
One possible risk factor may have been having a history of childhood abuse (Janssen et al., 
2004). Increased exposure to antidepressant trials has been identified to increase the risk of 
manic switch (Goldberg and Truman, 2003). I had been exposed to different antidepressants for 
16 years and this too could have pre-disposed me to antidepressant-induced mania. 
My treatment with fluoxetine plus an antipsychotic, aripiprazole, and the decision to discontinue 
the antidepressant after successful treatment of my depressive episode is in accordance with 
current guidelines for the treatment of depression in bipolar disorder (National Institute for 
Health and Clinical Excellence, 2006 and Goodwin, 2009). The decision to discontinue the mood 
stabiliser in my case was more difficult given that one manic episode is a strong predictor for 
subsequent episodes in bipolar disorder. The rate of relapse of hypomania or mania in patients 
with antidepressant-induced switch to mania is unknown, which means there is little to guide the 
physician on long-term treatment for such patients. However, the idea that exposure to an 
antidepressant could cause permanent damage (the scar hypothesis) contradicts the increasing 
appreciation of the plasticity of the central nervous system and its ability to repair. It will be 
interesting to follow my patient journey now that I have discontinued medication. If I experience 
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no relapse of mania, this would be in keeping with the side-effect hypothesis of antidepressant-
induced switch to mania rather than the ignition or alternative hypotheses. 
I believe my case of suspected antidepressant-induced mania strengthens the need for further 
investigation of this phenomenon in unipolar depression. I hope that this article also offers some 
insight into the patient's experience of psychosis. Clinicians need to realise that patients with 
psychosis may try to communicate through seemingly random actions or through metaphors, 
such as my repeatedly expressed desire ‘to leave the room‘and these need to be dealt with 
sensitively. 
I believe my case study highlights the need for prompt specialist treatment for patients with sub-
threshold hypomanic symptoms. In a study of clinical outcome in almost 600 patients with 
recurrent major depressive disorder and no family history of bipolar disorder, 9.6% had a 
lifetime history of sub-threshold manic symptoms similar to those that I experienced while on the 
dosulepin/sertraline combination treatment (Smith et al., 2009). Sub-threshold manic symptoms 
in this study were associated with a more morbid long-term clinical course, including a higher 
likelihood of psychosis and hospital admission. My case study is also cautionary against the use 
of multiple antidepressants. Finally, my case underscores the important role of the GP in the 
early detection of antidepressant-induced mania. 
 
2 Anderson and Roy, 2013 
Attitudes to taking antidepressants 
I actually didn’t have an ideological or philosophical position about medication. For me 
medication was a means to an end. (Catherine, 39) 
Although people frequently argued that it was no different to taking medicines for other health 
conditions, such as using insulin for diabetes, others reflected on the way antidepressants are 
considered to be in a different class to other medicines: I don't put my hands up in horror with 
psychiatric drugs…there's a lot of people turning against them…they wouldn't have the same 
attitude towards insulin or other drugs that were lifesaving. (Jean, 71) 
I think taking medication is something I really struggled with because I didn't want to take it. I 
didn't want to—you know I thought I could just get better on my own. (Nicole, 27) 
I obviously knew that there was antidepressants available but they've kind of got a stigma and I 
was worried that I didn't want anything I could get addicted to. (Maggie, 44) 
I resisted taking antidepressants because I saw it as a sign of weakness that proved that 
something's wrong and a lot of people don't like to admit that something's wrong”. I feel that 
men are particularly inclined to see using antidepressants in this way. And I feel that the stigma 
around taking antidepressants is unjustified. 
I feared that antidepressants might mask my problems but not actually resolve it, and I believe 
that people should manage it themselves, free of medicines, rather than ‘papering over the 
cracks’. (Ellie, 30) 
Information 
In the past, it was difficult for people to find information about the medicine they were 
prescribed, but these days the internet is routinely used by people to look up health information. 
I routinely use the internet to find information, including about different types of antidepressants 
and side effects, as well as to find out about others’ experiences with them. Years ago I kind of 
just accepted what I was given and didn't really ask any questions but now I know to kind of do 
research on the internet and to you know, which websites are good to look at and which ones are 
not too good. (Esther, 31) 
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I use internet forums where witnessing others’ experiences help me appreciate my own 
experience better. Ah I've also seen a lot of other people on the internet as well that have been 
through far worse than me. They've trialled different medications and I've been fortunate that the 
medication I've been given hasn't had any, to my knowledge, any major effects. Because if 
something don't get ya something else will, something else will. (Joshua, 51) 
The initial consultation: seeing the doctor 
I had felt depressed for a long time, and saw the doctor and was prescribed an antidepressant 
after reaching a crisis point. I was trying to ‘manage’ on my own, long before seeking help.  
I went to the general practitioner only after my family and friends urged me to do so.  
My behaviour was obviously affecting other people.  
I went to see my GP when my husband was threatening to leave me (Charlotte, 51) 
My wife made me go to the doctor after I broke down at work. (Scott, 46)  
It was difficult for me to recognise the signs and symptoms of depression myself, and certainly I 
was not aware that treatments existed that might help me. (Spencer's, 52) 
The consultation 
If she hadn’t been able to turn my thinking around in that first appointment in the way that she 
did, you know, I’m not convinced I would have been motivated to take the medication. And 
certainly, you know, knowing now that it does take sort of four to six weeks to really start to have 
an effect I might have—even if I had started taking it—I may well have given up after two weeks, 
you know. But her, her influence was powerful enough that, you know, it changed everything 
about the way I was looking at the illness and subsequently at myself…So she then spent the time 
explaining about depression and different causes and, and then the medications and all of that. 
(Scott, 46) 
The first mention of medication and antidepressants. 
I was resistant to being prescribed antidepressants due to the strong stigma attached to them. 
And um I don't think she'd even finished saying the word before I said ‘not a chance.’ I said ‘do 
you know who you're talking to here? I'm a detective. I think—this is—you can't do that.’ And 
there was no way I, I'd entertain um just the label of the drug. Just the term antidepressant to me 
was ah you just can't hack it. Um and I thought ‘well that's what I think so everybody else must 
think that.’ So I said ‘nup, not a chance.’ (Sean, 39) 
I always believed that the ‘doctor knows best’. I had taken antidepressants most of my adult life 
on the advice of my doctors. For me, the overwhelming impact of my depressive symptoms meant 
that not taking the treatment was not an option. (Malcolm, 72) 
I felt completely excluded from the decision-making. Well, yeah, on her notes I think she wrote 
depressed, and I think she said to me, “I think you're suffering with depression and need 
antidepressants”…And she put me on antidepressants straight away, and on sleeping tablets as 
well I think. She didn't even ask me! (Belinda, 33) 
I wasn’t told the reason for my antidepressant prescription; I had never been given an 
explanation of what they would do, nor the side effects. (Rosey, 40) 
I'm just thinking, ‘My God, you know, they [doctors] don't believe me,’ but that's what I felt, they 
just don't have time to listen [about side-effects]. (Anne, 39) 
This GP was particularly um insistent that I take her prescription. And I had said, ‘no,’ I had 
said ‘no’ about three times. In the end she said to me, ‘um I don't know what's wrong with 
depressed people, why they always refuse to take um my prescriptions. I think depressed people 




I was surprised, even frightened, by some of the things doctors said about what antidepressant 
taking would mean for me in the future, for example, that it would take a long time to get better, 
or that I would be dependent on them for life. 
Being prescribed an antidepressant 
I was relieved to be diagnosed with depression and be prescribed an antidepressant. Once that 
was done it was like such a relief because I knew what was wrong and I could see there was now 
a way of fixing it. I have to say my father had depression a few years ago so I knew that there 
was a ‘fix’ because he recovered, he got treatment and he got better, which helped me a lot. 
(Spencer, 52) 
I think the first doctor I ever saw was absolutely fantastic. You know, he noticed the signs, he 
asked the questions. He diagnosed me, treated me, when the treatment didn’t work so well, you 
know, we adjusted it and got me back on track within a couple of months. (Nancy, 26) 
When I was first prescribed an antidepressant, I felt it signified my depression as ‘official’. 
Seeing it written in my notes felt, ‘almost like having a criminal record’. It had affected the way I 
felt about myself and I felt designated to a denigrated category; now I was someone who was 
‘mentally ill’. (Tony) 
I would prefer to ‘manage’ without antidepressants. 
I want to come off them as soon as possible. 
It was important to me for there to be ‘an end in sight’.  
I prefer to be ‘in control’ of my own emotions and I see antidepressants as a temporary ‘crutch’ 
to lean on rather than a permanent solution. 
When I was first prescribed an antidepressant, it felt like avoiding responsibility for my own I 
felt it was taking the ‘lazy’ option well-being. (Sam, 31) 
I saw taking antidepressant as signifying to myself and to others that I was a ‘failure’. 
I wasn’t prescribed an antidepressant right away and I really appreciated the time to think about 
it: I didn't really want to go on medication but I thought that I was at the point where I needed 
something to help me. They were very, very good in that they didn't just immediately give me a 
prescription. Actually, we went through the options of what kind of medication…what they do, 
what they're designed for. And they said that they would rather monitor my situation before 
letting me go onto them, which I think was very responsible of them. I did eventually, because I 
wasn't getting any better, did go onto antidepressants. (Patrick, 30) 
Taking an antidepressant for the first time 
Even after deciding to start antidepressants, actually contemplating swallowing the tablet for the 
first time could feel like a momentous occasion: I Ieft them on my top shelf for ages and I just 
didn't want to take them because I was a bit confused as why I; he's prescribed me that after like 
a really short chat, just me saying I was down and maybe at the time they were handing them out 
left right and centre, I don't know. (George, 34) 
In the absence of information from my doctor, I wanted to find out more information before 
taking the first tablet. He said go home and take these Prozac but as a person with a scientific 
mind as myself, I look up Prozac, I didn’t take any, because so many side effect, I was so 
worried. I just threw it away, threw them away… (Phuong, 59) 
 
I got my prescription dispensed but it took time to read through the information leaflet before 
deciding whether or not to take the first dose. I worried that the antidepressant might make me 
feel ‘fluffy’ or ‘out of control’. (Maggie, 44) 
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I spent a full week wondering whether to take the antidepressant and I had second thoughts after 
reading an article online. I saw the GP for a second chat before deciding whether to take it. 
(Hilary, 28)  
I thought if I can be seen to be compliant to treatment it would make me less likely to be 
sectioned. (Tony, 34) 
Obviously the medication does what the medication does but if, if she, I went home and I was, I 
read the thing and I was very scared too, and I took a tablet after—not straight away, a few 
weeks. I took a tablet, I took a tablet and it sort of made me so sick I retched the whole night in 
the toilet, just retching, and it made me feel like I almost died… (Phuong, 59) 
I was uncertain about how long it would take for the antidepressant to take effect, the extent to 
which it might help, and about what to expect in the first few weeks. I was also concerned that it 
could make me feel worse rather than better, and how long I would need to take an 
antidepressant for.  
I did feel a lot worse, at least at first, so I took the antidepressants for ‘a little bit’ and then 
stopped. 
And so I started taking the medicine, um and it was amazing. In, within two hours I could feel 
different. I felt, well, like there were side effects…there was my jaw would shake, and I would 
feel really sick, but within two hours I felt calm; that sort of anxiety wasn’t there so much. I felt 
calm and tired, too tired. I slept for, you know, like 12 hours straight and then I had to go work. 
It was very difficult to go to work. (Laura, 55 
I felt that I benefitted in time, if not immediately: one of the most striking things that struck me 
the first time I took antidepressants…is all of a sudden you realise how much colour is, there is 
in the world. But I think when I was depressed my, my perception of colour had diminished. 
(Craig, 33) 
I felt as spaced out, controlled, drunk, completely flattened and numb, although not depressed 
any more: the first week of it I felt I'd been hit over the head with a sledgehammer. I found it 
really hard to have my bearings and, and ah cope. It was just the most bizarre feeling but I hung 
in there and after about ten days it, that got better. (Edith, 55) 
For me, just the fact that I was taking the antidepressant and doing something about my 
depression helped: straight away when you start taking it you feel great because somebody 
understands, somebody has listened to what's wrong with you because you're in this bubble the 
only way I can describe it is a bubble, the whole world is going on around you and nobody seems 
to understand you assume that nobody…it just takes a lot of weight lifted off your shoulders that 
you're starting medication and that you're starting on the road to get better… (Ellie, 30) 
 
3 Anderson et al., 2015 
Treatment initiation and initial experiences 
I've been prescribed antidepressants in the past but I've always felt reluctant and apprehensive 
about taking it, largely because a) I feel that the effects are probably short-term, they're not 
going to actually resolve the depression, b) because they do have side-effects and, and c) I didn't 
feel comfortable, myself, with taking some tablets. (39-year-old male) 
Being prescribed an antidepressant was vital for me, and I gladly accepted the treatment option 
as suggested by my doctor. 
You know like what I was saying about when I first took antidepressants that made me feel that, 
sort of vindicated … (27-year-old female) 
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After about 2 months, having been signed off from work for 2 months, I found myself getting 
worse and worse and approached the subject with them about going onto medication which I 
sort of … I didn't really … before I thought, “I didn't really want to go on medication” but I 
thought that I was at the point where I needed something to help me. They were very, very good 
in that they didn't just immediately give me a prescription. Actually, we went through the options 
of what kind of medication, what sort of … what they do, what they're designed for. And they 
said that they would rather monitor my situation before letting me go onto them which I think 
was very responsible of them. I did eventually, because I wasn't getting any better, did go onto 
antidepressants. (30-year-old male) 
I had to try a lot of different antidepressants until they found one that worked and suited me. 
Effexor [venlafaxine] and I had that, about two tablets, this was last year some—about May of 
last year I think. And as soon as I had it I came up with side-effects, sort of swelling in the face, 
and headache and so on which I know it can cause, cos I'd already read in the leaflet that can … 
came with it. And that was no good at all, the Effexor, because I knew I couldn't go on with that. 
And I rang the doctor and he said, “Oh well you’ll have to stop it.” And so, that was it. And it 
was the same I think with the Lustral [sertraline], before that as well, and another one called 
Cipramil [citalopram] I was on. That was no good either. (35-year-old male) 
I finally settled on Seroxat [paroxetine]. So anyway so my doctor, the GP, not the specialist, 
said, “well try Seroxat. And so I said, “well alright” and I did, so I tried it in a liquid form first 
of all. And she said, “Well see if it suits you.” and I said, “well alright, I will do.” And 
fortunately it did. And then since then I've been on the tablets, probably about 30mg which I'm 
still on.” (35-year-old male) 
That was paroxetine. It was pretty nasty, actually [laughing]. It had, again it had absolutely no 
effect on the depression. I took it dutifully every morning out of the little foil packets for, I think, 
5 or 6 months … a lot of the professional interventions didn't help me, antidepressants didn't. I'm 
always in two minds about whether to say … give my opinion that I don't think antidepressants 
should be called that at all because they don't really do very much against depression. They're 
more anti-anxiety, or sedating or something, possibly … (35-year-old male) 
Well, yeah, on her notes I think she wrote depressed … and I think she said to me, “I think you're 
suffering with depression and need antidepressants.” And she put me on antidepressants straight 
away, and oh sleeping tablets as well I think … she didn't even ask me! (33-year-old female) 
It (Prozac) [fluoexetine] was good because for me it had no side-effects or anything that, that 
bothered me. And it's hard to tell, you know, am I feeling like this anyway or is it the, the 
medication that's helping me? But for me, it seems to be good and I'm taking it again at the 
moment because I had a bad patch recently and, and I feel good so I don't know if it's the drugs 
or if it's me or whatever it is … (33-year-old female) 
Continuation of treatment, expectations and uncertainty around medicine use was a big concern. 
One of the things that I thought was very important to me in this process was the fact that the 
doctor said to me, “I'm going to get you out of this depression but don't expect a miracle. Don't 
expect to be okay tomorrow. It's a long process but I'll sort you out.” Those were his words. That 
to me was very important. (45-year-old male) 
So it's not like, you might, I don't know, you might kind of crave a cigarette or whatever for itself. 
It's just that you just don't want to be experiencing this … like side effects. It's not like you feel … 
you just have to do it [take a tablet] to feel normal, you know. (27-year-old female) 
Now I felt in myself that it was going to be a question of time that [medicine] got me right, I 
wasn't having to deliver at work which was a tremendous blessing. (66-year-old male) 
341 
 
People call them like happy pills and stuff […]. But you don't walk around stoned or sort of “Oh 
isn't life wonderful.” You just feel normal, that's what they make you do, they just make you feel 
normal. You don't feel euphoric, you don't feel manic, you don't feel spaced out, drunk, stoned, 
whatever you want to call it. You just sort of feel yeah, this is the way life is supposed to be, 
everything just feels alright, balanced. (31-year-old male)  
Antidepressants, they aren't a quick fix to make you better, but they help you to cope better with 
what you're going through. (19-year-old female) 
But I would never regret taking them because taking them has totally changed my life … Taking 
them … I don't feel that so much now … But when I first took them, I felt like I had been given my 
life back. I feel like I can now be a normal person. (27-year-old female)  
And I now take one, one small dose of Sertraline which I shall take for the rest of my life. (73-
year-old male) 
It wasn't working. I still, it kind of worked in that it made me more functional. I was a functional 
zombie. I could function, I could work, I could read, I did have my motivations, my mental 
capacities back but I was still depressed. And some days would be, I would be really 
overwhelmingly depressed. (33-year-old male) 
Because he knows I don't want to be on them for the rest of my life. And we tried between us and 
they have gone down. And last year I was, I was at the point where I was off them, and then 
everything just went backwards, so … I take citalopram or some call it cipramil. I am on 40mgs, 
I have been up and down on them, and I was on … it takes, I mean people find this a general 
thing, because they, it takes a while to take the right dosage, the right level dosage for every 
person. So it's gone up and it's gone down. They've tried … we've tried going down and it's not 
worked, I'm not ready for it, so it's gone back up again in the last 2 months (43-year-old female) 
And it blew my mind out basically, and that what made me come back and start confronting the 
psychiatrist about medication and the ins and outs and why aren't we being told about the 
dangers and this that, and the other. Well an example is being on a certain drug over a period of 
so many years, and it's not a lot of years either, that can actually cause mental health damage, it 
can actually cause brain damage. This one is actually a very popular one. It's called citalopram. 
(45-year-old female) 
The only way you can avoid pain is by … well part of just getting away from the incident that's 
causing the pain but the … the only other way is just to cut down your awareness which is what, 
what medication is mostly for, it's really to cut down your … your feeling of pain. But the thing is 
the pain is nature's way of showing you what's wrong, and without it you're in the dark. And the 
thing is we've been given the ability to know what's wrong with us ourselves. But if we keep 
taking pills, if we keep taking things that are going to stop us being aware, if we keep getting 
drunk, if we use anything as a drug to reduce our awareness, then our ability to be healthy is cut 
down. So the first necessity to be healed is to raise your awareness (69-year-old male) 
I then kind of stopped taking them, without telling my GP, just 'cos I just kept forgetting to take 
them, and I thought I'll take them later, I’ll take them later, I'll take them later. (20-year-old 
female) 
He just prescribed me these tablets which were kind of sedatives but prescribed for people with 
psychosis as well as other things, and I just thought, what? And I threw them away. (27-year-old 
female) 
I did take an overdose on one occasion, when things were quite desperate. Some of these well … 




Adverse effects and non-adherence 
I'm not certain whether it's a side effect of the prescriptive medication. I think it's the 
combination of both medication and depression because I had it, I experienced it a little, little bit 
before I started taking the drugs, medication and then it kind of got a little bit worse. (21-year-
old male) 
I mean initially with things like Tryptizol (amitriptyline, a trycyclic antidepressant), and those 
sort of antidepressants, there was constipation, and oh, all manner of unpleasant things. 
Dizziness, double vision, and all those sort of things. But this [sertraline] is such a low dose as 
well that its insignificant really. But the other ones, when I first went on them, they were ghastly. 
(75-year-old male) 
I didn't know if they would do any good or not, but I added up one day that I would, over the 
years, I had taken almost 20 different sorts of pills of one description or another. And had all the 
dry mouth and all the side effects that were unpleasant. (58-year-old female) 
The problem that I did find … with Effexor [venlafaxine] is it took, it took me away from me, if 
you wish. I was no longer myself. I was no longer able to do some of the things which I liked 
doing. I liked writing music and I was, I was unable to do that. I couldn't, I could no longer see 
the patterns in… in written music. I could no longer; I no longer had the ideas of things that I 
could do. (33-year-old male) 
Although it improved my mood, I no longer felt depressed, it did, it took motivation away from 
me and it kind of took the fun out of my life as well. (49-year-old male) 
My brain, and I was always very good at writing letters and reports and all sorts of things, I 
suppose I was a bit of a wordsmith really, but that had gone completely. As also my confidence 
had gone, and I couldn't string two sentences together which is quite frightening, quite 
frightening for my job. (55-year-old female) 
So that period then I was taking quite a lot of antidepressants drugs as well and I was off work 
for about 6 weeks … 6 months, I mean 6 months. When I went back to work I had no recollection 
of what had happened while I was away. And I knew the job well enough to go on doing it, but I 
my memory was bad so … all gone! (64-year-old male) 
The antidepressants were kind of old. I felt drunk really on them [laugh]. Most of the time, I 
couldn't work with them. I … I was working, I was still working at the time and I went on with 
them actually. I suffered them for six months or something ridiculous. (33-year-old female). 
They then fired me [laugh] which was like “what?” you know hanging around all this time I've 
been really depressed and doing nothing, now that I'm feeling good again and I, I can start 
doing things, you know they told me that I'm no longer needed. Essentially they were having 
difficulties themselves and as I'd known for a long time and yeah, I'd be, I'd be one of the first to 
go. (25-year-old male) 
 
The other thing too, is I don't think that the physicians who treat you are totally aware of all the 
side effects involved in the drugs]. So many there—there are the easy things like a dry mouth, 
and dizziness, and things. What they don't tell you is, or didn't tell me, was one of the major side 
effects was impotence. Which can put a great strain on the relationship if you're married, or if 
you're living with someone (45-year-old male) 
“Seroxat [paroxetine] the first thing I noticed was, [laughs] this is a bit embarrassing, but I 
couldn't ejaculate … It's extraordinary, absolutely extraordinary, so you have no erection 
problems as such and you can have sex you know, but you just don't come [laughs]. And it's kind 
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of a weird … there's a question, you feel like a sort of porn star, you can go for hours you know 
[laughs]” (31-year-old male) 
You looked like you were on pills. Because it made your pupils dilate. And I was shaking. And I 
would wake up in the middle of the night with a bolt of fright, and shaking and stuff. And I 
stopped taking them. (27-year-old female) 
Yeah, I had a week of withdrawal. And when you experience those they're the strangest things 
ever. When you make a gross movement, a gross muscle movement, you get this incredible, uh … 
it's not a tingling, you get this incredible buzz in your head. Which is quite bizarre. (43-year-old 
female) 
Interactions with doctors 
Yes, that's right. Acknowledgement of … he never criticised, he never made judgements. And he 
was terribly sensitive, or he made me feel that he was. And I'm sure he was, and I had great 
confidence in his skill! (55-year-old female) 
I think in a sense of medication wise, from what I can see from my experiences and others, is … 
if there is a new drug coming from America, suddenly all the psychiatrists want everybody in 
that area on the same drug, because one minute you will be on one drug and the next minute 
you'll talk to other people in the hospital, and you'll find out that they're all on the same one. And 
that will happen in one week … and it's to find out the side effects of this one and you’re being 
used as a guinea-pig. That I, I … when I came to the point where I was able to sort of “hang on 
this is my body here and this is me,” speak up for myself and I started to question the psychiatrist 
what they were doing for me, or what they … and finding that suddenly I started getting respect 
from psychiatrists because I was starting to think for myself and questioning “is this right for 
me, is this not right for me” or “what do I think is right for me” and it was only though constant 
pressuring the psychiatrist and the NHS that I got psychotherapy. You have to fight for it, you 
have to fight for it. It's not a thing that is automatically given. (43-year-old female) 
And I saw this same psychiatrist. This was about another 10 years after the first visit to him 
when he had prescribed lithium. And when I walked in he said, “Oh, I remember you, you had an 
overdose of lithium!” And I said, “You told me it was stress.” And he said that he could have 
made a mistake. So all my faith in psychiatrists went zooming out the window with one man. (75-
year-old male) 
 ‘You're ill, here take this pill.’ [Um], and like medicalisation of, that's not even a word, but like 
[um], medicalising these low, these really low parts and it is kind of umming and erring, and the 
fact that they did put me onto it so quickly, [um], could make people kind of go, “Oh no, that's 
just really bad.” (20-year-old female) 
I always went in there feeling that I was just being … I was … it was like a cattle-farm: I go in, I 
say what I feel, he gives me a prescription, and out the door I go, which wasn't at all good …. 
(30-year-old male) 
 
This guy, the new guy prescribed citalopram immediately, so within, within, within a week I was 
on 40mg of Citalopram, so it's a high dose. (21-year-old female) 
So they'll hand me some anti-depressants, give me a repeat prescription, especially in London 
I'm probably … this is the impression I'm getting. Give me a repeat prescription and just leave 
me on them for as long as … I've been on them for 4 years now. No-one has told me, said to me 
“Are you thinking about coming off them?” No-one has said anything, they just shove you on 
them, as long as you're not trying to kill yourself, or coming in and crying to them, then they 
don't care. And I know they're very busy (27-year-old female) 
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It was a tremendous, stressful period. And when I was in there a lady doctor psychiatrist saw me 
in the day room and said something about “Is your illness imagined, or is it real?” And she said 
this in front of several visitors and in a loud voice, so I was just about four inches off the ground. 
(20-year-old female) 
I take Efexor [venlafaxine]. It is the slow release capsule, and I take 75 mg a day. So I’ve not 
changed the dose …. It is interesting actually, I was once feeling really bad, and they told me to 
up the dose, so I listened to them, and went back to the psychiatrist and he was like “What! If 
you were surviving on 75mg, go back to it.” Psychiatrists know about drugs, GPs don't know as 
much obviously … You could end up on so much … but it is serious stuff. (27-year-old female) 
I, I felt my psychiatrist was a very …. oh … like wet individual. Again, I … I think because I'd 
been quite a numerate, factual, organised person, to have someone to talking about feelings and 
what about this and what about that? And it was … nothing could ever be pin-pointed or …. I 
just found it annoying. And they, I found that they didn't deliver on things that they'd promised. 
(39-year-old female) 
I'm just thinking, ‘My God, you know, they don't believe me but that's what I felt … they just 
don't have time to listen to.’ (22-year-old male) 
I've tried to talk about my memory loss with the doctors at the hospital and they say, ‘Give me an 
example’ and I give them an example and they say, ‘Oh that's normal, that's just normal, that's 
not the medicine, that's normal’. I mean when they hear it, they don't want to hear, you know. 
(33-year-old female) 
I started thinking that I couldn't carry on like that. That my life wasn't worth living, what's the 
point if the … if these are the people that are supposed to be helping me, then I don't stand a 
chance. I checked out my life insurance policies … I just thought my husband and my son would 
be better off without me …. because what was the point in living like I was living, I hated it. I 
hated myself and I ended up … I took an overdose. (39-year-old female) 
My feeling now is that I will not believe anything that a doctor says, and I'll go and check it, 
because most of the time it's just wrong. Which they can't be expected to know everything, 
especially GPs. (27-year-old female) 
I wanna know what options I have. I wanna know the ways that other people deal with it. I want 
to know, I don't like taking medication, but if, if that's the silver bullet, I, I'm willing to recognise 
that. (18-year-old male) 
I do question really the medicine and how much these patients are being over sedated …. I do 
worry let's put it that way, I worry for the people I know that I think about now back in those 
days that I knew and I worry for them and I think, ‘Has the system given up on them?’ (33-year-
old female) 
 
So I'd say look at websites, look at information that's available, read up about it and really 
become an informed customer because it is an area where people aren't always telling you the 
right thing, especially GPs don't always have that knowledge to hand. (21-year-old female) 
But if ever I was going to take medicine or have any kind of treatment I'll do my research first—
if you've got access to the Internet or a library research. It is so important to do your own 
research because the professionals will only give you their side of the story. I was never told this 
may cause you long term memory problems, which it has done. I have massive blanks, short-term 
and long-term. (33-year-old female) 
 
4 Badger and Nolan, 2007 
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I think any depression you have you're half way, you've got to do it yourself, you cannot rely on 
the medication, you've got to be willing to try, you don't get a miracle cure out of a bottle, it can 
help you over the bad times but it's not a cure, that's up to you. I might be mad but that's how I 
think (Patient 44). 
Self discipline, I'd be disappointed to think it was just the medication. I would like to think that I 
don't need to go back on them (medication) again (Patient 20). 
I started taking (an SSRI) which convinced me that there was a problem because I felt so much 
better, the change was fantastic (Patient 26). 
The tablets were helping to a certain extent but they weren't by any means clearing things up 
(Patient 60). 
They were no good, I didn't take them after the first course, I didn't collect the repeat 
prescription (Patient 29). 
I don't think I really know what (the medication) is supposed to do to you. Is it supposed to calm 
you down 24 hours a day or is it for an hour or two? (Patient 44) 
Not knowing what it was making it twice as bad. Hearing ‘You have a common condition’ and 
‘You will get better’ from my practitioner was totally unexpected, but very welcome information.  
My GP told me: ‘I've been expecting you for some time’, making the consultation easier.  
It's the complete package, the doctor, voluntary work. The doctors have left me to make decisions 
with them and I think this is the thing that has done it for me, they haven't come up with a quick 
fix, you know, here's a list, they've said ‘You're different to the next patient let's put a package 
together for you’. I've felt I've been involved in it; I haven't been on the outside. I hope you won't 
recommend just one thing…… (Patient 27) 
I am crediting my recovery to ‘my family, my GP and finally the medication’ (Patient 43).  
I took them for three or four weeks before feeling normal. It was gradual, some of this is also 
psychological because you know you are actually taking something which is designed to help 
and psychologically I was probably thinking ‘Yeah, this is great’ (Patient 53). 
 
5 Bennett et al., 2007 
Hearing the diagnosis 
So, it's sort of almost a relief to find out that you are not the only one, and there are actually 
reasons behind it. (#20) 
It was one of those things that you kind of know, but you don't really admit it to anyone, even to 
yourself. (#19) 
Seeking information 
But, he [family physician] was very open, probably because I came with some informed sort of 
knowledge already, but he was very willing, he did research on it as well, and he brought a 
couple of studies to my attention. (#7) 
My family doctor wasn't really equipped to deal with the question of antidepressant use. 
I received information about depression and its management from the psychiatrist which was 
really helpful, and which I found sufficient. 
She told me everything, and she also told me I could call Motherisk and ask them. I didn't call 
them, because I thought about it, and her information was good. (#21) 
I started off with Motherisk and then medical journals online and abstracts. I've definitely read 
stuff like on Safe Parent Web Site, or Baby Centre Web Site. I tend to not trust them as much..... I 




Taking control and making a plan 
It was comforting, and prepared me to say okay, how far I am willing to go, not only medication, 
but therapy wise. I think that set me in motion to say I am taking control over my moods, my 
disorder. (#16) 
Re(Assessing) progress 
I was doing that test, the EPDS. She would check the score each time. It was very high in the 
beginning, and then slowly when I started taking the medication, it became low. (#21) 
(Re)Balancing the risks 
You want to put the baby first, but, at the same time, you're just balancing out what is the risk to 
the baby of having a mom who is on Prozac versus what is the risk to the baby of having a mom 
who is, really can't cope and is falling apart. I kind of got to the point where I was like, well, I 
can only do the best I can as a mom. (#7) 
I tried to decrease the risk to the fetus by taking as low an antidepressant dose as possible. I was 
kind of just teetering on, like I was trying to take the lowest dosage possible to treat my 
symptoms. (#18) 
Being in a better place 
Thanks to the counseling or to my medication, or perhaps the combination of both, I felt that had 
arrived at a better place. Life still had moments of being "up and down" but, there were "far less 
bad days than there are good days". 
I'm in a much better place now than I was before even becoming pregnant. I still have ups and 
downs, but my ability to deal with some of the things that are triggers for me, is much better. 
(#18) 
 
I had received counseling but remained medication-free during my obstetric and postpartum 
periods. For me I know it's slowly going. I do get depressed sometimes. I still do get angry, 
exasperated. I still haven't regained my full patience. It will take work, and that's what I believe 
– understand, it's a work in progress. It's like building a beautiful couture dress, it takes time. It's 
a work of art. It takes time. You are the art piece, and you are just slowly, you know, getting 
primped up. (#17) 
Knowing self 
There's so much more to juggle. When you come home, you be [come] a wife, you be [come] a 
mother, and ... something, one time or another has got to give, you can't always be catching the 
ball. You need to take a break to recharge. I think that's important, sometimes we just forget to 
recharge. (#3) 
I learned about myself. It was almost a gift in that, I don't know how to describe this..... I learned 
about myself... I've learned to take time for myself. (#19) 
I never thought that I would have worries. I didn't know that I should look out for, you know, 
these types of things. (#16) 
One of the reasons I wanted to do this study was because I really think it's important for women 
that are pregnant, either the first time, the second time, that if they really think that they can't 
handle it any more, they really need to talk to somebody. It's important. (#3) 
 
6 Bayliss and Holttum, 2015 
Experiences of antidepressants 
Mirtazapine probably did save my life. [Gerald] 
 I think you can get stuck in a loop where they just prescribe you. 
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The drug loop 
Initially it was tricyclic antidepressants, then they tried MAOIs, which didn't work, and now 
more recently the SSRIs…and then I'm on lithium as well…I also have ECT. (Iris, on 
antidepressants for 26 years) 
Medication effects 
There came a point where, alright, I've survived, but what's the point in surviving if you can't 
feel?  
I realized that my medication is ineffective: I was…going through a really bad period [although] 
I was still…on medication. [Frances] 
The Prozac lifestyle 
Medication was limiting my lifestyle in some way. [On Prozac] I was ticking along nicely, but I 
was living the lifestyle of somebody in their late 70s, early 80s, rather than their mid-50s. I was 
not working… It wasn't helping me to address my lifestyle. [David] 
I didn't feel better…but if I said that they'd say ‘okay, fine, we'll change the pills, we haven't tried 
this combination yet, have we, you'll have two of those, three of those and five of those’. I've had 
every single pill on the market and every combination of pills. [Brian] 
 
Nobody listening 
[Doctors are] all about the medicines…we'd all like to think that we're visiting Frasier Crane 
but we're not, you don't get to lay on the couch, you don't get to discuss your problems…you get 
to go in for 10 minutes if you're lucky once every 3 months – ‘How are you feeling? Still taking 
medication? Sleeping alright? Well we'll leave you on that then’…and I've had that for 10 years 
so I guarantee you…that's what happens’. [Charlie] 
Underlying cause not addressed 
And I told my GP: ‘I'm on this medication and there's obviously some underlying cause and I'd 
like to try and sort that out’. [Leonard] 
Dilemmas about dependency 
It's always been really difficult coming off one…really uncomfortable and really feeling like 
you're losing your mind and getting really depressed…and so you have to put a bit of faith in the 
tablets. [Jerry] 
Feeling dependent on medication creates dilemmas for me. I don't want to rely on drugs because 
I see it as an artificial control. [David] 
I felt very dependent on [my amytriptiline tablets] and I didn't want to be dependent on them, 
and so that made me want to…stop taking them. [Jerry] 
 
7 Boyle and Chambers, 2000 
Carers' knowledge and understanding of antidepressant medication 
- I brought the names of my mother's tablets in case I heard something bad about them.  
- A primary nurse kindly informed me about the tablets. 
- The doctor explained the situation and the documentation was in the tablets. 
- I always phoned the chemist and asked was it suitable for her to be taking them. 
- No one ever told me about the medication. 
- When I ask I am told they are the anti-depressant ones. 
- I could understand her not wanting to take it because it would frighten the life out of you. 




- She believes that they are doing her no good. 
- He says he will get mixed up so I have to give them to him. 
- She felt the side-effects made her worse. 
- I like to ensure he gets them. 
- If I didn't give them to him he wouldn't take them. 
Older persons’ perceptions of depression 
My mother had felt about antidepressants: ‘If you can't make yourself better they are not going 
to.’ 
In the past ‘it’ [depression] was not seen as an illness; ‘you had to get up and get on with it. 
 
8 Brijnath and Antoniades, 2016 
Managing through self-medication 
My psychiatrist told me: “You obviously function” and he's like, “You know I see people that 
can barely sit down.” He said the same thing [as the GP], he said, “Look if it [antidepressants] 
works, it works but you'll have side effects. You just have to balance it up and you know it's up to 
you” (Adam, 33yrs, Anglo-Australian). 
I am trying to balance the pros and cons of consuming antidepressants. 
For health providers, prescriptions appear to be an easier option. 
After five weeks of therapy, my psychiatrist said that he recommended prescription over 
counselling. (Adam) 
For me, antidepressants did help improve mood: I feel like brain space springing up, even keel 
and it reduces the pain.   
The positive effects of antidepressants had to be balanced against negative side-effects such as 
dry mouth, sexual dysfunction, lethargy, tiredness, feeling dizzy and jittery.  
Medicines, specifically antidepressants are not ‘silver bullets’ or ‘magic’.  
They often caused severe side-effects, and required experimentation until an appropriate drug 
and dosage was found.  
Taking antidepressants is ‘easier’. You only have to consult two practitioners (the GP for a 
script and a pharmacist to fill the script), and could purchase medicines at reduced cost on the 
government funded Pharmaceutical Benefits Scheme and avoid the effort of finding a mental 
health professional, care costs and the emotional work of therapy. 
Self-medication 
I would drink just to sleep. I wouldn't drink for the fun of it. It's just a case of if I don't drink, I 
will just lie awake and I will be awake for 72 hours. It was a no brainer (Michael, 27yrs, Anglo-
Australian). 
Wine, is that self-medicating? Because if it is then I do that a lot, a lot and I know it's bad but 
sometimes … I'll go home at night and all I want to do is have a drink of wine because I know 
it'll help me relax (Jennifer, 31yrs, Anglo-Australian). 
When I felt ‘down, I'd add on like five [Lexapro® 10 mg tablets]. (Julie) 
I run out of the Effexor® and instead of taking two I just took it down to one. I reduced my 
dosages with the intent of discontinuing medication. [Karen] 
 
Being ‘drug-free’ is a sign of being cured from depression. It was July or something like that, I 
started reducing my dosage. September–October I stopped it completely. November–December it 
hit me really hard. Just couldn't concentrate on anything, felt really bad, I just can't explain, it 
was so bad. And then when I went back to the doctor in Jan (sic) I was made aware that it's 
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because that I stopped the medication and they wanted to try getting me back on. And after me 
starting it, I started feeling much better … and I don't have that much of head pain, I don't feel so 
yucky. But still, it's kind of dying inside. (Amir, 35yrs, Indian-Australian) 
Rose (2003) argues that the consumption of pills, especially ones that alter the self neuro-
chemically, are less about pathologising deviance and more about modulating unruly or 
uncontrollable aspects of the self. But many participants in this study perceived just taking 
antidepressants as problematic because it was ‘the easy way out’. 
Other people assume that I'm on it [antidepressants] because I'm lazy because I don't want to 
put in that effort to go see a psychologist and empty my emotional bucket all the time (Natalie, 
31yrs, Anglo-Australian). 
With some of the herbal or the Ayurvedic remedies, it's not just a matter of swallowing that. 
Along with that you've to control or monitor a change of diet, the physical exercise, yoga and 
breathing and meditation (Sumant, m, 31yrs, Indian-Australian). 
Transformation and self-labour 
It is more of a money issue, say for like long therapy … go to the doctor first and get referred to 
a psychologist and then possibly stay with the psychologist for another six times. So that strikes 
me, it is not really convenient. You know, I could just go to some of my friends and family every 
weekend and talk. So yeah, cheaper therapy (Clifford, m, 29yrs, Indian-Australian). 
I think it's me, I should be working on [my] depression. I need to do further studies in childcare, 
yoga, exercising, walking, shopping, going out with friends and visiting a holistic doctor to 
obtain numerous CAM pills (when I can afford it). Such transformative labour does help me and 
I notice an improvement in mood. But such labour required constant effort and was often 
prompted by a sense of obligation and exchange, for example, the need to honour commitments 
(“not let down the team”), maintain relationships (“If my dad would tell me, ‘Do you want to go 
for a dirt bike ride?’ I say, ‘Yeah we'll go’”) and use services that were paid for (“We paid for 
these kick boxing classes, you have to go”). (Dia, 59 years, Indian-Australian) 
He [psychologist] left the practice and I dropped the ball from there (Nikhil, m, 25yrs, Indian-
Australian). 
My fault. Sometimes I get a little bit slack with my medication … I was a little bit overwhelmed 
when I came back to the house at the start of the year getting kids ready for school, schoolbooks, 
covering them, uniforms, just getting into that routine again (Karen, f, 45yrs, Anglo-Australian). 
I'm trying to get my depression and everything under control with medication therapy. I can't 
add eating healthily and exercising regularly to that right now. If I add that it's too much 
pressure and I break (Olivia, f, 19yrs, Anglo-Australian,). 
I always have that kind of little hope, which always says that if I follow everything properly, I'll 




9 Buus, 2014 
Participant 13: I was depressed for the first time and I believed that it was caused by prolonged 
emotional stress. I had been discharged to psychotherapeutic follow-up at an outpatient clinic, 
but I did not think highly of the healthcare professionals or their psychotherapy. I thought that 
they did not provide me with anything useful beyond prescribing medicine, which I continued 
taking, and in time I chose to cancel appointments with the therapists. Despite despising my 
professionals, I would visit the psychiatric emergency room when I felt acutely depressed or 
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desperately impatient about the time it took for me to recover. In the following data extract from 
the 4th interview, she reflects back on the visits to the emergency room: 
Participant 13 (4th interview): My visits to the emergency room: mostly, I would just talk to them 
and go home. Actually, it did help a little. I think it was because I spoke with professionals who 
told you that it was not unusual that you were still so incredibly sad. You are told that it's normal 
even though you are discharged and take medicine. Things weren't happening fast enough, and it 
was when I couldn't understand that, that I went out there. The last time I was out there, I got 
Lithium. I told the doctor they might as well admit me again, but he said no and presented this 
other option [Lithium]. 
Participant 13: I had no prior personal experience of treatment for depression, and I feel that my 
need for a healthcare authority is to normalise my experiences of depressive symptoms by 
interpreting them in a less distressing way. But after starting to take Lithium to augment my 
antidepressant treatment, I gradually felt less impatient and distressed. 
I continued taking the medication in accordance with professional advice, mainly because I saw 
medicine as the primary means of recovery.  
I was sceptical towards taking antidepressants and experienced some relatively mild adverse 
effects, but I believe that taking the medicine was necessary to avoid the risk of relapse.  
I fear stopping taking the medicine: I don't know what it would be like if I didn't take them.  
(Participant 5): I was initially very sceptical towards taking antidepressants, but I ended up 
accepting them as equivalent to taking vitamins.  
Participant (3): In my family…I mean… we had family members with severe mental illness. I find 
taking antidepressants stigmatising… so I was begging my general practitioner to authorise 
phasing out of the medicine even though I feared a relapse of depression. 
Participant 16: I had previously been treated with antidepressants, but this time I experienced 
severe adverse effects of the medicine, which included a substantial weight gain and tiredness. 
But I was scared of discontinuing taking the medicine despite the adverse effects. 
Participant 16 (2nd interview): I think I am a little afraid of what would happen if I didn't take it 
(…) I don't ever again want to feel the way I felt when I was admitted. I am afraid it would 
happen again if I stop taking the medicine. I am not saying that I'd like to take it for the rest of 
my life. I am sure that things will be good again, but right now it scares me if I was to have that 
feeling again. 
Respondent: In time, adverse effects of the medicine became unacceptable to me and occasional 
slips, which seemed less scary than making a deliberate stop, became more frequent and 
eventually confirmed me in having no need for the medicine.  
 
Participant 16 (4th interview): I had reached the point where I took very little of it. It was just 
once in a while. Really, there was no control. I just took it when I thought, “Well, it's been a 
while, so I'd better take a pill or two”. In the end, it was horrendous. And I just didn't feel that I 
needed it. And then I just stopped completely. I threw them out and haven't taken any since. 
Respondent 16: I just felt better. I didn't feel, that the medicine changed anything for me, and 
they [her general practitioner and her psychiatrist] kept on saying that it made me tired. So I 
thought, “Well, if that is what makes me tired, I have to … I don't feel up to this. I have to get off 
that rubbish”. 
Participant 2 (2nd interview): No, I haven't asked my doctor if there might be an alternative to 
the medication. I tried some other ones and I didn't take more than 3-4-5 tablets before I gave 
up. It felt like fire burning out into my arms and I couldn't take it. I haven't had that with 
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Noritren [Nortriptylin]. I have dry mouth and they give you the shakes and things like that. (…) 
I'd like to get rid of one of the medicine, but what if I get worse? I saw someone [during the 
admission] reducing their medicine and they ended up feeling awful. 
Respondent: I was convinced that one of my two antidepressants was stressing me and gave me 
the restless evenings and nights. I eventually asked my general practitioner to reduce the 
prescribed dosage, but he refused and told me that there was nothing to do but to continue. As a 
reaction to the GP's disheartening response I decided to solve the problems by halving the 
dosage on my own. 
Participant 2: I am still taking Mirtazapin but we've halved it, or rather, I've been allowed to 
halve it. I found out that when I go to bed something is stressing me. I wake up and I can't settle 
again. So, I am sure it's not good for me. 
Participant 2: After reducing to half dosage I stress about until I find rest. 
Interacting with healthcare professionals 
I cannot say that I was having rewarding or trusting relationships with the therapists. 
They [therapists] only prescribed my medicine, and I felt that the therapists were not ready (or 
competent) to meet my need for change. The prescribing therapists predominantly suggested 
maintaining the existing strategy by continuing, increasing or supplementing the medical 
treatment. Such responses were extremely frustrating, as I desperately sought to change their 
situation, and did not believe that the medicine was important for solving all the issues, in most 
cases I felt that adverse effects added significantly to my problems. 
I found it difficult – and sometimes impossible – to challenge the therapist's authority during the 
consultations: When I sit in front of a doctor or someone with great knowledge, well, then I 
believe all that's being said (Participant 8, 3rd interview).  
Participant 14: I successfully insisted on a gradual reduction and stop of the medicine simply 
because I had taken it for exactly six months, which, allegedly, was the period needed to have a 
low risk of relapse. This happened despite me having frequently experienced severe and 
disabling symptoms of relapse into depression.   
Participant 4: I was shocked over having been admitted to hospital for depression and I 
continued struggling to reconstruct what had happened the day I broke down.  
I felt neglected by my doctor that day and I was convinced that he had given up on me and my 
depression, because he did not care to listen: because he just wrote the prescriptions and then he 
was finished with me. He didn't say that I should return; he didn't say that I should come for 
some counselling; he didn't say, “I'd like to keep track of you”. “You can come and get a 
renewed prescription and we'll talk”. He didn't say that he had any such an offer, and [whistles] 
out I go. 
(Participant 4): I decided to adhere to the hospital's original recommendation to take the 
antidepressants for six months, but because I felt abandoned by my general practitioner, I 
decided to get help to phase out safely from a kind employee at the local pharmacy.  
Participant 12: I was treated by a consultant in an outreach team for several years, but I was 
increasingly unsatisfied with the treatment, because it made me feel very tired. By chance, due to 
overcrowding at the usual hospital, I was admitted to another hospital in a different town, and I 
was pleased to get a second view on my illness and my medication. At the new hospital, the 
medication was altered because I asked for it. At the old place [usual hospital] I experienced 
what I belive was a dangerous lack of responsiveness: It could have been good if they [at the 
usual hospital] had been better at listening to my complaints regarding the medicine. I believe 
that the last admission could have been avoided if I'd stopped taking that Seroquel [Quetiapine] 
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and started taking something else. Because the tiredness, I had, added to weaken the whole 
system. 
At first, I was pleased to have his medicine reorganised and I started using psychiatrists at the 
new hospital as my primary therapists. But then, I had started self-managing my medicine, 
moving to the frustrated search, because I felt bad and – paradoxically – by reducing the 
medicine, I could prove to myself that things were good.  
Self-regulation of drug treatment 
Honestly, I then believed that my own reduction added to my distress. I was readmitted to the 
new hospital where the psychiatrists wanted to augment the antidepressant treatment with 
Lithium, because they believed that I suffered from a bipolar disorder. And then Lithium made 
me feel tired and after discharge I decided to stop taking all the medicine augmenting my 
antidepressant treatment without consulting any professionals. I checked it on the the Internet, 
and learned that Lithium was fundamentally harmful to the body and had too many adverse 
effects and that I might as well test if I could do without it: I made this decision without talking to 
the doctor…It was probably because the doctor would be against it. I think I have an 
appointment in about a month from now. I thought that if I stopped them I could see if it reduced 
my tiredness, and if there are no problems, then there is no reason to take them. 
My perspective on taking medicine changed and my self-regulation increased gradually and was 
kept hidden from healthcare professionals and my wife because I was convinced she would not 
approve my decisions. I also planned on informing my doctor, but then decided to cancel the 
appointments. I intended to eventually inform my therapists of my self-regulation but then 
realised that I would rather avoid all the comments. 
Participant 6: I self-regulated my medicines from the beginning. At first, I only regulated one of 
my medicines. And whenever I felt bad and consulted a therapist, who was never the same 
because of institutional reorganisations, the only response was to prescribe more medicine. I felt 
more and more certain that this response added to the problem rather than to its solution. 
It is good that you can get medicine when you have pain and medicine when you are depressed. 
But I don't think it is a solution to just add more and more medicine because you go crazy 
because you're doped all the time. I think I am taking something like 29 pills a day. 
 
I finally decided to reorganise my medication and I used my sister as a trusted person, who was 
the only one knowing about this complete and abrupt withdrawal. My sister helped me by text-
messaging frequently. And the decision just emerged: I had to say either or (…) I felt so bad. 
Had it not been for my sister who texted me all the time, I would not have been here. I don't think 
so (…) I was going mad. I had to revise my life and find out “what is it you want”. It was so 
hard. I didn't sleep for four days after stopping taking Seroquel [Quetiapine]. I didn't. I could 
not find rest. I had them, but I was stubborn and said ”no, Hell no, it shouldn't be like that.” 
I experienced adverse effects of the medicine, but in most situations, I was able to manage and 
tolerate them in my everyday life. Dry mouth, for instance, was managed by chewing gum and by 
always having a water bottle within reach.  
 
10 Carpenter-Song et al., 2010 
Latinos and Euro-Americans taking medication 
Roberto: I gotta talk to the psychiatrist and see if he can give me a new medication to make me 
less nervous.. Medications don’t do nothin’. They are effective in treating “nerves”. 
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Mario: But you know they’d send me back for anything, and I’d just as soon keep taking my meds 
and stay out of there [the hospital.] I mean, they want to lower my meds, but that’s what 
happened last time and I don’t want to go back. They could have just raised my meds and kept 
me out of the hospital, but they just sent me back and I don’t want to go back.  
Tamara: My visit usually last about fifteen minutes and his main topic is, ‘Am I taking my 
medication?’ and how I feel since I began taking the new medication. 
Gladys: I am so frustrated!...even my recent interaction with my vocational specialist: He don’t 
try to help me. He won’t try to help me find a job, yes. He doesn’t want me to do his job. I beg 
him to help me. I beg him to help me, yes, and he didn’t. All he would say is, “Are you taking 
your medication?” I say, “Yes, yes I take my medication.” I tell him I need work, he would say, 
“Take your medication and you will find work.” I have to pay for a portion of my prescription. 
I’ve already paid $40 for my prescriptions and now they change them. [puts her hands to her 
forehead] I’m so sick of this mess . . I don’t understand why they changed my medication. I 
didn’t sleep for a few nights and they just changed my medication just like that.  
Gladys: I’ve got a feeling of being “experimented” on, with all these changes to medications. 
But this all costs money, switiching medication isn’t cheap! 
Jerome: They don’t know what works and what don’t work. First, they put you on a medication 
and when you tell them you don’t need it anymore they just put you on another one. I get sick of 
taking pills, pills, pills. I don’t need all this medication. They keep telling me I need medication 
but I don’t. The medication is what makes me sick. I don’t feel right when I take it anyway.  
Bernice: I felt that the antidepressant I had been prescribed was unnecessary: I told [my case 
manager] I was only depressed for about four or five days and I don’t need medicine for 
depression because it didn’t last. Everyone gets depressed and they don’t take medication for it. 
Just because I have a mental illness doesn’t mean I’m never going to get depressed. But doctors 
give you a pill for everything. 
 
Randy: They want me to get stabilized on the meds first and then get a job. They don’t think I’m 
ready [to get a job]. 
Roberto: The psychiatrist…? He just gives me medications. I just go there for my medications. I 
don’t go there for psychiatric care. 
Mario: Yeah, they’ve got a lot of services, that’s why I go. They give me medications, and they 
have counseling though I haven’t used that. And they have groups that you can go to. I haven’t 
used that either because I don’t think I need it, but I could go if I wanted. I’m not crazy. I just go 
to the club so I can get a check . . . I just started acting crazy, but I fooled them. My doctor 
knows that I “ain’t crazy”: The doctor sees me anyway so he can make the big bucks . . . He just 
gives me a little bit [of medication] ‘cause he knows I ain’t crazy, so I take it. 
Bernice: Nothin’ changes – everything is the same and I just don’t have time for that . . . I’m 
trying to move on and do some positive things and they look like they are trying to keep people in 
the same ol’ spot . . . They really don’t have an interest in helping people, they are trying to help 
themselves keep a job and that’s what that’s about. Do you really think they don’t care about the 
people who are at [the clubhouse]? I was there so I know that they don’t care. Remember I was 
one of those people.  
Jerome: Why do I have to go talk to someone who don’t care about me or how I feel? I have 
spent seventeen years going to see doctors that don’t really want to help. They get a paycheck 
and all they do is write prescriptions that don’t work. All they say […] is if you don’t take your 
medicine I’ll lose my benefits. It’s like they tryin’ to blackmail me.  
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Gladys: No one wants to help me find work.  
Tamara: They just ask questions and listen, they don’t provide any solutions. They are mainly 
concerned about you taking your medication. They ask if you’re sleeping all right and if you 
have any problems you want to talk about and that’s it. They don’t solve any of your problems 
for you even when you tell them what they are.  
Bernice: If someone would just talk to me and help me figure out what’s wrong I’d be fine. 
Tamara: No one could tell me what was wrong with me. 
Jerome: All these pills pills, I’m tired of taking all this medication. I wish somebody would find 
out what is really wrong with me and stop just giving me pills that don’t do nothin’. They don’t 
even try to find out what’s wrong with you. They think it’s all in your head.  
This is my life, this is my head. Why do I have to do what everyone else wants me to do? I’m not 
crazy and I’ll never live a normal life if everyone is telling me what to do. 
I honestly feel controlled by these mental health providers. 
Conceptions of Problems 
Fred: I have a pathology, ADT . . . it’s not being able to concentrate. It’s a personality disorder, 
get highs and lows and irritability and it’s an anxiety disorder, it leaves me sexually 
dysfunctional . . . I watched a video tape about it and knew I had it. Then a doctor showed me 
what I had. 
Horacio: Once they label you, they never look at you the same. The psychiatric label “changes 
you forever.”  
 
Alicia: I have “enferma de los nervios.” And there is stigma attached to it. 
Horacio: I got labeled mentally retarded and a psycho by my friends and stuff when I got out [of 
the hospital]. I lost like all of my friends. It was rough. 
Bernice: I would “never” tell my co-workers about receiving treatment: Because they would pick 
on me. When you tell people you have a mental problem, they pick on you and blame everything 
on you because they know you have something wrong with you. 
Social Contexts of Distress 
Fred: I was hoping to get some distance from my family. It’s the blame and change syndrome. 
They think it’s my fault that I’m mentally ill. Fourteen years ago I was diagnosed as mentally ill 
and my father and my mother and my brother talked about me like a ladybug on a window. They 
talked in circles and then got angry at me. 
Bernice: I told the doctor I was depressed and he put me on Prozac. He put me on more 
medication when I don’t need it . . . I’m not taking that medication because I was [simply] 
depressed and that was it . . . The doctor never took time to find out why I was depressed. All he 
said was, ‘Oh, you’re depressed; I’m gonna give you some medication for that.’ . . . He never 
asked me anything; he just wrote the prescription out and gave it to me. 
Yeah, [the doctor] wants to get paid, but he doesn’t care because we are poor and most of us are 
black and what does he care. It’s a paycheck for him; it keeps him employed. They don’t want to 
deal with the problem and try to help you solve it; they just want to give you medication and keep 
you coming back. If the problem doesn’t get discussed it will never get solved. I dislike him:he 
doesn’t answer my questions; and he doesn’t explain what’s wrong with me. I want him to break 
things down so I can understand what’s going on with my body. He doesn’t tell me anything and 
I hate that. 
I wished for a provider who would listen because I felt that I would benefit from “someone to 
talk to.” Yet this was difficult because of the high turnover of clinicians. Sometimes I talk to [my 
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case manager.] But now I find out that [she] won’t be my clinician anymore. They assigned me 
to a man . . . I have no intentions of talking to him about anything. I told you before: when you 
get comfortable with someone they change that person to another team or they leave. I don’t feel 
like starting all over again and I sure as hell ain’t talking to a man. I can’t be building trust with 
someone new and then they get changed and then it’s someone else new. I can’t be pouring out 
my heart to  everyone and they don’t stay long enough to help me. I need someone to get to know 
me, I want them to know me, Bernice, so they can help me help myself. 
 
11 Castonguay, Filer and Pitts, 2016 
Susceptibility 
Interviewee 33: I am surprised that even celebrities are experiencing depression: I felt that the 
kind of life-style, at least on a materialistic level, that that would have helped them to escape 
from going down with such things as depression. But it is obviously clear that, you know, 
materialistic, you can have a very big house and 3 or 4 cars, whatever, at the end of the day it all 
depends how you feel within yourself and within your mind, and nothing in terms of monetary 
wealth can ever make any changes to that. 
 
Family history of depression 
Interviewee 2: [M]y Mum has always experienced depression in a sort of similar way to me, I 
think. 
Interviewee 4: I remember saying to myself, ‘Oh no, not again.’ … I thought I was over it and 
it’s back. Just the sheer onslaught of negative thoughts that you just can’t push out. 
Severity 
Interviewee 11: it’s almost as if you’re going in slow motion. If you’ve seen these films where 
you’re standing still and everyone’s going around you, it was almost like that. 
It is a combination of panic, increased heart rate, changes in sleep patterns, getting tired 
quickly, acting out, eating disorders, inability to work, paranoia, and being uncommunicative.  
Interviewee 23: this experience means [t]he deep depression, I feel physiologically different, I 
have this sort of pressure around my brain, you know I feel that someone’s got their hands inside 
there. 
Interviewee 36: everything that you seemed to look at…you looked at it from a suicide aspect, 
when you went over a bridge and you thought, that might be an idea, or a knife in the kitchen, 
yes, that would be a good one. 
Interviewee 12: [W]hen I’m really down it occurs to me when I see a train coming to jump in 
front of it. And again, I get these compulsions, and I have to physically take a step backwards so 
as not to do it. And these are strong urges. 
Interviewee 34: The suicidal ideation is…I just, just want to be out of it. 
Interviewee 6: I told my friend about my suicidal thoughts, to which she replied, “you must go 
and talk to your GP [general practitioner], you must do something about this.” The friend called 
the doctor for me and accompanied me to the waiting room.  
Interviewee 32: My mate says to me, ‘You’re depressed.’ And I said, ‘I’m not.’ She said, ‘You 
are’ so, as I say, I went to the doctor.” 
Interviewee: I did not feel like myself and I felt something was off, and this spurred me to seek 
help.  
Interviewee 15: I felt that I wanted to jump out of a third-story window and this led me to seek 
help, as I understood my action was not “the norm”. I think when you’re actually faced with, 
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“Oh my God I would have jumped if someone hadn’t come in.” That just absolutely petrifies you 
because you know that you’re young, you shouldn’t be feeling like that, it’s not right, there’s got 
to be something wrong. No support from the family environment. No one was picking up on how 
severe things had got for me.  
Barriers 
Interviewee 8: There is nothing ever to be ashamed about with mental health. You know, there 
really isn’t.  
Interviewee 19: I recall my conversation with the doctor: I said, “But, oh but there is an awful 
stigma to bring on antidepressants and stuff.” And she said, “Well if you are a diabetic and I 
said you are going to need insulin for the rest of your life, you wouldn’t argue would you?” … 
So she gave me permission really to say, “Yeah I’ve got an illness. You know, this is not my 
fault.” 
 
Interviewee 15: I recall comments made during the first therapy session that addressed my initial 
fears: So she explained to me that you know they’re not going to patronize me, they’re not gonna 
make me feel bad, they’re not gonna force me to talk about anything …All of these fears and 
concerns and worries that I had, she brought down a level I suppose. 
Interviewee 2: I only sought counseling, but received both psychotherapy and medication. There 
was a great deal of fear expressed in relation to antidepressants. It was my preconceptions. I 
was worried before I took them that I would become divorced from reality…like you don’t care 
about anything. 
Interviewee: I mean I know very few people in all these years who have had psychotherapy. I 
don’t know what the criteria [are] for choosing who has it, who doesn’t. I know there are very 
long waiting lists. I know people wait for 3 years, and 3 years is a big chunk out of somebody’s 
life. It’s just very sad. 
Benefits 
Interviewee 2: I was hesitatant at first, but all things considered, I would rather put on weight 
than be depressed [so I took antidepressants and] I felt like I had been given my life back. 
Positive experiences:   
Interviewee 32: I could walk up the street with a smile on my face. Yeah, they [antidepressants] 
did help. 
Interviewee 8: The therapist listens and she responds to me as a human being, not as a 
professional. She gives me time…She cares. 
Interviewee 14: I had come to realize that ‘a miracle cure’ does not exist for depression.  
Interviewee: And the medication keeps you stable… you’re able to go to work, you’re able to do 
your job, able to enjoy quite a few things. But it doesn’t get rid of the fears and whatnot because 
that’s a sort of a different, different area, your thinking processes… They’re yours and that’s 
where it’s got to come from you, you’ve got to get there yourself, I don’t think there’s a miracle 
cure. 
You need to hope that it’s not the end of the line for you (Interviewee 3)   
You need hope to believe that there is a light at the end of the tunnel (Interviewee 19) 
Self-efficacy 
Interviewee 2: [I]f I go to the doctor’s I know what they’re asking me, and I know what they’re 
expecting me to say, and I know what it’s all about. 
Interviewee 4: I know the signs, and I know what to do, and you get better. 
Interviewee 5: This is my disease, it’s part of me, and I want to control it. 
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Interviewee 33: I would strongly urge other people who might be depressed and recommend that 
they seek help. Don’t suffer in silence. 
Interviewee 8: It may be difficult for you to reach out, and I understand that because I didn’t for 
a long time. But I would really urge you to reach out if you can muster anything, reach out 
because there is help out there. 
 
Interviewee 5: I recognized that I needed to seek help after struggling to read a children’s book 
to my daughter, and I needed My wife’s assistance to do so: I think realistically in the stage that 
I was, I was not capable of doing anything. I needed somebody around me to do the initiating… 
It really needed somebody else to make that contact for me and ultimately yeah, it was my wife 
saying, “You must go to the doctor, I will make the appointment. I will drive you there. I will 
take you there. I will sit in the waiting room with you,” but, “you need the help.” It really had to 
come from somebody around me because I was incapable of doing it myself. 
 
12 Chur-Hansen and Zion, 2006 
Vanessa: I was prescribed Cipramil and then Avanza, at the age of 18, after consulting a general 
practitioner because I was waking up at night, couldn’t sleep very well and feeling awful and sad 
all the time, following an end of a relationship.  
Lily: I was prescribed an SSRI at the age of 19, following a “breakdown” preceeded by an 
eating disorder and trip overseas to work as a volunteer. I began on Aropax, which caused 
hallucinations, and was then prescribed Efexor. 
Hamish: At 19 years of age, I experienced anxiety for about three years, which was progressively 
worsening, and so I went to my general practitioner who prescribed Zoloft. Prior to taking the 
SSRI, for the previous four months, I had been managing my anxiety with the help of a 
psychologist and CBT. 
Cheryl: I was 14 when I was first prescribed Zoloft by a general practitioner after talking to a 
school counsellor, who referred me to the doctor. At that time I felt that there was no cause for 
my depression. I was again prescribed an SSRI at 18 years of age after the deat of my both 
grandparents, whilst studying.  
Julie: I began taking SSRI medication at the age of 17, after a school counsellor noticed that I 
was cutting myself, and referred me to a psychiatrist. Over the last three years I have been 
prescribed three different SSRI medications – Luvox, Prozac, and Zoloft. I am non-adherent to 
my medication and I self-monitor the dosage, often taking more than the prescribed amount. 
Side effects 
Vanessa: I reacted badly: I was shaking, trembling, unable to sit still, being jittery, felling worse, 
felling ‘not normal’, dry mouth, felling sick, and being drowsy as side effects. 
Lily: I experienced adverse reactions to the SSRI, including apathy, emotional numbness and 
hallucinations (including seeing myself being hit by a car and falling on knifes). I simply 
believed that the SSRI actually induced a depressive state worse than the one for which it had 
been prescribed.  
Cheryl: I did not have any physical side effects, but I found that the medication resulted in me 
having ‘no emotions’. You just feel like a zombie at times. And I don’t know if it’s worth it. 
Julie: You name it: nausea, tremor, decreased appetite, headaches, thirst, feeling sick, agitation, 
anxiety, impulsivity and violence. I have become particularly worried about the increase in my 
impulsivity and violent behaviour, which is totally uncharacteristic for me, and which was 
becoming more frequent and pronounced over the last three weeks. I have never been violent to 
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anything ever in my life, I’ve always taken it out on me. And ummm, for the first time I just got, I 
just snapped, and I basically threw the cat five meters across the room. And that just scared me, 
I didn’t know what that was. And I was impulsive, there was no thought behind it. 
Role of the pharmacists 
Vanessa, Lily, Cheryl, Julie: No, we haven’t received any counselling or information from the 
pharmacist who filled the prescriptions. 
Doctor-patient communication 
Vanessa: my general practitioner “freaked out” when I said that I was feeling depressed. The 
doctor’s daughter had attempted suicide and I was told about it in some detail. 
Lily: I felt that my psychiatrist who used psychoanalytic psychotherapy in conjunction with the 
medication to treat my depression, was uncaring: I think his actions, to give me, to continue to 
prescribe medication without being concerned, at all, over the effects of it, was, ummm, ignorant 
and unfair, and ummm, whe I look back, it’s hurtful now. Ummm and ummm, just unprofessional 
and completely inhumane, really. 
Hamish: I felt that my general practitioner was ‘informative’ and helped me to think through the 
options, providing him with information, videos to take home. This doctor also discussed 
possible side effects and contra-indications, and discussed withdrawal and the possibility that 
the SSRI may not be effective. 
Cheryl: I do not remember whether my general practitioner had given me information about the 
medication I was prescribed. However, I found, just going and talking to him [was] quite 
beneficial. You know, somebody outside of the family, ‘cause I didn’t reslly talk to any of my 
friends about it, cause they couldn’t relate to how it felt, feels… 
Julie: I have seen many different general practitioners over the three years that I had taken 
SSRIs. I no longer remember what I had been told, but thought that when I had first been 
prescribed the medication I had probably been given information. They say: ‘do you know how 
these work? And I say, yea…within reason, and so they just sort of said, ‘have you taken this 
before?’ and I say, ‘yes,’, and they don’t ask or tell you anything else. 
Suicide 
Vanessa: I had suicidal ideation, which I had never experienced before.  
Lily: I had hallucinations about my own death, and eventually thought about ending my life. 
Julie has repeatedly attempted suicide. She stated: “I know, I wasn’t suicidal before I was put on 
them…I don’t know whether it’s just the SSRI not treating the depression, or whatever it’s an 
increase in suicide”. 
Medical explanation for depression and its treatment 
Vanessa: my general practitioner explained that I need to, my body chemicals are not balanced, 
and that I need to fix that first, and then we could work on the problems second…yea...she 
explained something about a chemical imbalance, and we have to fix that before we fix the 
problem. 
Lily: my psychiatrist explained depression in psychoanalytic terms. He said: ‘Keep talking and 
you’ll figure it out. Well, it’s inside of you, you just need to concentrate on talking a bit more’. 
Hamish: I was given a neurobiological explanation.  
Cheryl: I was not provided with info about depression, as far as I can recall.  
Julie: I was provided with neurobiological explanations. 
Patient’s explanation for depression and its treatment 
Vanessa: I felt that my reaction to the breakdown of my relationship was ‘not normal’, but I 
thought that talking to people, not medication, was what I needed. 
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Lily: I wondered whether my mental health might have been affected by my eating disorder and 
the experience of observing powerty during my volunteer work. I was also curious as to whether 
my anti-malarian medication (Larium) might have had some influence. I believed that the SSRI 
actually caused my depression, and that I was probably suffering from anxiety prior to being 
treated.  
Hamish: I felt that while medication might make it easier to manage my anxiety, a positive 
outlook, exercise, fish oil, meditation, relaxation, and making an effort to change were more 
important.  
Cheryl: depression is an illness, and it can be treated. However, I see a difference between my 
first episode of depression, which had no “trigger”, and the second experience, resulting from 
the death of both my grandparents. I think that medication was needed in the first episode, but 
that counselling was more important in the second. 
Feelings of loss of control and helplessness     
Vanessa: I was overwhelmed by what was happening when I consulted the general practitioner: I 
was quite overwhelmed by the whole thing, what she was saying to me ‘cause I didn’t really 
think that was what was going on…and she didn’t actually prescribe it first, she gave me a trial 
pack to take home and then get the prescription filled. So, it was kind of bombarded on me. “This 
is what’s wrong with you, you have to do this to fix it”, and I was so overwhelmed by everything 
that she was saying I just walked out of there and just took it. 
Lily: I felt helpless, to the point that although I was unhappy with my treatment, I was unable to 
seek help elsewhere. 
Hamish: although I was satisfied with my general practitioner’s information, I felt that I needed 
to know more, particularly about adjunct therapies, so that I could make an informed decision. 
Frustration 
Lily: I was frustrated with my psychiatrist, and with the medication, and its side effects. I said to 
my doctor: Look, I’ve had enough, it’s not working for me, I feel completely apathetic. I was so 
frustrated because he still kept saying to me: “Oh, just give it another week, you know, these 
things take time, your body is just adjusting.  
Julie: It was frustrating because despite the treatment, my mental health seemed to be 
deteriorating. 
Negative views about medical practitioners from the experience      
Vanessa: It has, it’s fainted my view a lot, ‘cause I went in there wanting help, and I said what 
was going on, and I guess, it was just more her trying to treat the symptoms that actually what 
was happening. 
Lily: I found that the experience has negatively influenced my opinion about doctors: It just 
scares me to think that, ummm, fourty minutes into speaking to this person, I was prescribed 
what was going to be 18 months of hell, on medication. Within fourty minutes he felt he could 
make a decision. 
 
Hamish: I’ve got a feeling that my general practitioner needed to have more knowledge about 
the treatment of depression. 
Gaining control 
Lily: I feel that my experiences have given me strength and wisdom, and that I know now that I 
am the best judge of my own health. I now interview health care providers before agreeing to 
treatment, and I seek other opinions if I am not happy with what is offered. To regain control, I 




Lily: I strongly believe that hope was an important factor in keeping me alive: And there is all 
these little promises which you just, as much as I really resent the way that my psychiatrist, I feel 
that, he didn’t give me any care, the one thing he did give me was hope. And that’s not something 
that he of course, I think, actively gave me, but just by going to see him and by having these 
drugs, it gave me hope that there at least, was something. 
Julie: I perservered with SSRI medication: It’s the hope, it’s the hope that maybe this one will be 
the one. And so, you know, a bit of nausea, if I could, you know, I mean, physical pain is nothing 
until, you know, until you experience emotional pain. And, if it’s going to even reduce it by 1%, 
I’m happy. 
Lack of SSRI efficacy 
Lily: I felt that not only had the medication not helped but it had made me worse: “So having all 
this hope that I was getting better and that this pill that I was taking was going to relieve my 
symptoms, yet physically, ummm, spiralling down, still, so not even reaching a plateau, 
continuing to slide down.. 
Hamish: I was doubtful about the efficacy of my medication. 
Cheryl: I felt that the medication initially helped, but after a few weeks and increased dosage, I 
continued to feel depressed, or felt flat rather than depressed.  
Julie: I had never experienced a positive effect from a SSRI. 
Efficacy of the SSRI 
Hamish: Whilst unsure that the medication was helpful, I did think it might have been helping a 
little bit. But yea, I mean, I think, it is working a little bit. That is, when I get into a sort of 
negative emotions or whatever, umm, I find I can come out of it a little bit easier. So, it perhaps 
doesn’t quite last as long. 
Cheryl: I felt relieved in having been prescribed the medication, even though it was not 
alleviating my depression. 
Stigma 
Vanessa: The stigma of mental illness, and of taking an anti-depressant is there. For example, 
the reactions of my peers when I had to explain that I could not drink alcohol – Oh, why do you 
need to be on that? 
Lily: many of my close family and friends would be unaware of my experiences, and I find it 
terrible even that I find difficulty speaking about it. 
Hamish: I feel the stigma. My anxiety and treatment is something I find difficult to talk about, 
and that it’s like a lot of mental health things, you know, there is no good reason to feel that 
stigma, and you’ve thought it through, but you still feel it. 
Cheryl: The stigma I feel, it gets to me how other people look down upon it, you know, mental 
health, you know, you must have something wrong with you. 
Julie: I am very good at keeping the façade.. 
Social support 
Vanessa: Friends are important, as a component of treatment.  
Lily: I need to stress the importance of my supports: If I didn’t have that family and friend 
support, if I wouldn’t have been able to find enough things to live for, I wouldn’t 
have…continued living.. 
Hamish: I discussed my treatment with my parents, and they were very supportive. My close 
friends were also helpful.  
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Julie: My parents are unaware of my depression and my main support is another suicidal student 
with whom I discuss plans about how to end my life…          
    
13 Cohen and Hughes, 2011 
I have a chemical imbalance because . . . 
• Medication did something to me 
• Medication wouldn’t do anything if I didn’t have an imbalance 
• Medication made me feel different 
• I’ve seen the change in my life 
• Medication obviously helps 
• My doctor told me 
• I’ve been told by experts who suggested I take the drug 
• My doctor explained it to me 
• My doctor showed me using a plastic brain 
• I know about the field and chemical imbalances 
• I’ve done my research 
• My study showed me 
• My understanding of depression is physiological 
• I know by experience 
• Others’ experience is like mine 
• My symptoms are physical as well as psychological  
• Physical symptoms must have physical cause 
• Medication helps maintain serotonin levels 
I don’t know if I have a chemical imbalance because . . . 
• I haven’t been tested for one 
• No test can tell 
I don’t have a chemical imbalance because . . . 
• I know of no biological cause for my problem 
• I don’t believe in chemical imbalances 
• My problem is due to environmental stress 
• My therapists told me so 
My medication causes a chemical imbalance because . . . 
• It triggers unwanted physical effects 
• Drugs affect everyone the same 
• My medication leaves body quickly so it doesn’t have long term effects 
• I don’t know if drugs act chemically or psychologically 
• No reason given 
• Short half-life means no long term effect 
 
How Medication Acts in My Body: Users’ Descriptions (In Alphabetical Order) 
1. Causes a chemical imbalance 
2. Changes the chemistry of my brain and makes it function better 
3. Cleans the spark plugs so they fire properly 
4. Completes the chemical dysfunction 
5. Fills my brain 
6. Fills the holes that depressed people have in the brain 
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7. Helps maintain serotonin levels in the brain 
8. Increases dopamine release and produces more dopamine 
9. Increases whatever it is in my body that makes me happy and calm 
10. Levels out my brain 
11. Makes serotonin go around better in the brain when it gets blocked 
12. Manipulates chemicals like exercise releases endorphins 
13. Stimulates the frontal lobes 
 
Bearing on the Subject of Chemical Imbalance in 22 Transcribed Interviews with Psychotropic 
Medication Users. Excerpts 
1. Woman, 59, taking sertraline and lorazepam for depression. 
Q: Do you think that the medications correct or help a chemical imbalance that people 
have in their body or brain? 
A: Definitely yes, for some reason the person has an imbalance. And the only thing you can do is 
to take the medications. 
Q: Why do you think it’s a biochemical imbalance? What makes you think so? 
A: I think it’s an imbalance—from the moment you take the better medication, if an imbalance 
didn’t exist you could take the pills and they wouldn’t do anything to you because you don’t have 
it. 
2. Woman, age unknown, taking sertraline for depression. 
Q: OK, umm, why do you think you had a, why do you think you may have had a chemical 
imbalance? 
A: Because Zoloft made me feel different. 
3. Woman, 27, doctoral student in clinical psychology, taking amphetamines, venlafaxine, 
lorazepam, and clonazepam for 7 years. 
Q: So do you think that the medications you’re currently on, may correct a biochemical 
imbalance, or— 
A: Absolutely, yeah. 
Q: And why do you think this? 
A: Umm, because, well, what I know about the field I guess, what I know about chemical 
imbalances and I know how I felt before and how I feel now [. . .] I feel that my medication helps 
me to be who I really am, umm, I think it makes me more complete, it completes the chemical 
dysfunction, it helps the chemical dysfunction. 
4. Man, 44, taking fluoxetine for 9 years. 
Q: Do you think that the drug is correcting some imbalance, then, changing something in your 
brain? 
A: Definitely. It’s correcting a biochemical imbalance. It’s— 
Q: What, what makes you think that? 
A: My doctor showed me. He had a plastic brain with different colors, he showed me. He showed 
me where the serotonin was going and how Prozac makes it go around better when it gets 
blocked, this is research. I’ve also done my own research and that’s how it works. 
5. Woman, 62, taking paroxetine and alprazolam. 
Q: How do you [think] the medication impacts your body or your mind? Do you think it has 
corrected a biochemical imbalance? 
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A: Most definitely, yes. I do. My study showed me most probably what the reason for my anxiety 
and upset was and so by understanding and researching it allowed me to be more accepting of 
Paxil and Xanax. 
6. Woman, 68, taking sertraline and alprazolam. 
Q: And so how do you think that the drugs are acting upon your body and mind, in what ways, in 
positive ways, in negative ways? 
A: I think in a very positive way. I think it must be restoring the chemical imbalance in my brain 
so that I don’t have any of these anxiety and panicky feelings. 
Q: That was actually my next question. Do you think these drugs are correcting a biochemical 
imbalance? 
A: I definitely think they are because my symptoms were physical as well as psychological 
attacks. 
7. Woman, 53, taking escitalopram for anxiety and depression, just switched from paroxetine and 
alprazolam. 
Q: Do you think that the drugs correct a biochemical imbalance? 
A: Yes, I do believe that. That there is a biochemical imbalance in the brain. And not only by 
experience—other people have felt the same. 
8. Woman, 56, taking fluoxetine for 8 years. 
Q: How do you think Prozac acts in your body, your mind? Do you think that Prozac corrects 
some type of biochemical or hormonal imbalance? 
A: Well, that’s what the doctor tells me, that Prozac changes the chemistry of my brain and 
makes it function better, resolving the depression that way. 
9. Woman, 30, just switched from fluoxetine to escitalopram, and also taking lamotrigine, 
ziprasidone, and lorazepam for last 4 years, has simultaneous diagnoses of post-traumatic stress 
disorder, borderline personality disorder, major depressive disorder, and generalized anxiety 
disorder. 
Q: What would you think, in your personal opinion, how do you think that these act upon your 
body, your mind? [. . .] 
A: Well, I know that, talking to my doctor, he explained that there have been studies done and 
breakthroughs that show the brain, people [who] are depressed have holes in the brain and use 
medication to fill the holes so they, they help. 
Q: So you are referring to biochemical imbalance. 
A: I don’t know what the term is, I’m just, I’m sure he put it in simple terms for me but that’s 
how he explained it, so I feel the medication’s helping me and it fills my brain. 
10. Man, 31, taking paroxetine for depression. 
Q: Do you think that the drugs corrected a biochemical imbalance? 
A: Biochemical, as in within my brain? 
Q: Yes. 
A: Yes, I believe that’s what they told me it was gonna do, it was gonna, something Biochemical, 
as in within my brain? 
Q: Yes. 
A: Yes, I believe that’s what they told me it was gonna do, it was gonna, something to do with 
increasing serotonin, increasing you know whatever it is in my body that makes you happy, 
makes you calm. It just kind of leveled out my brain. I think that was the, umm, overall goal. 
11. Man, 54, taking citalopram for depression. 
Q: How do you feel the drug acts upon your body and your mind? 
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A: Well, the analogy that I’ve heard best describes it, is like, if you have dirty spark plugs and 
you use a detergent gasoline, it cleans those spark plugs so you’re getting a good, so they’re 
firing properly. Instead of getting sluggish performance, you’re getting peak performance. [. . .] 
Q: Have you tried any other solutions to aid your depression besides drug use? 
A: I don’t see any reason to. I mean, again, my understanding of depression is that it is 
physiological. So, if this drug allows me to cure that physiological problem then, you know there 
is really no need to seek any other help. Because, the problem is solved. [. . .] 
Q: You said Celexa centers you. Do you feel it corrects a chemical imbalance? 
A: Yes. 
Q: Why do you believe that? 
A: I believe it because I’ve been told that by people who suggested I take it. 
12. Woman, 51, taking sertraline for social anxiety disorder. 
Q: Are you able to explain to another person how this drug works for you? 
A: In a way, I am not good at the medical term but I do know that the medication helps maintain 
the serotonin levels in the brain and cause me to feel calm. 
13. Woman, 23, taking lamotrigine for anxiety. 
Q: Do you think that, umm, do you think that the drug in a way is correcting a chemical 
imbalance? 
A: Yes. 
Q: Why do you think that? 
A: Umm, because I know it’s not in my head. 
Q: What do you mean by that? 
A: Because it would happen in my sleep. I would have panic attacks in my sleep. And that never 
happens now that I am on the right medicine, so I know that it had something to do with my 
brain. 
14. Man, early 40s, taking quetiapine, lithium, venlafaxine, and lorazepam for 5 years for bipolar 
disorder. 
Q: Do you, let me just [ask] for a second about, do you believe that you, because you tell me that 
you have been diagnosed with manic depressive, you tell me that you’ve experienced obsessive-
compulsive disorder symptoms, do you believe that you have a biochemical imbalance, or 
something? 
A: Yeah, I would have to say yes. I would have to say yes because I’ve seen the change in my life 
in the last five or six years. There’s no doubt in my mind that there’s something wrong mentally. 
[. . .] Uh, today I can, you know, safely and honestly say, yes, there is a mental issue that goes on 
in my mind. What created it—what triggered it—I would say would have been the divorce. 
15. Woman, 35, taking antidepressants on and off for 14 years, now taking sertraline for one 
year, since marital breakup. 
Q: Do you think it corrects any biochemical imbalance? 
A: Yeah, I would say so because obviously, it does help, uh— 
Q: Why would you say that? Do you have any facts? 
A: No, no, no, actually it’s just, I am, let’s put it this way, I took this medication almost 
vigorously just because I trust my doctor but, I don’t know, seeing that I have experience with 
drugs for enough time I don’t know, I think that I can handle my problem without it, but this was 
a traumatic event. I got out of an abusive relationship so I understand anyone that goes through 
a trauma is going to react with sadness, grief and depression, this is normal, but, I mean I was 




A: —living a healthy lifestyle and exercising which is something that I have done consistently 
before and that was enough to create the chemicals in my brain that made me normal or made 
me feel good. So I don’t know, I guess so, I guess the answer to your question is yes, it’s 
manipulating my chemicals [with] a drug instead of endorphins that you get through exercise. 
16. Woman, 26, taking lorazepam, estazolam, and butalbital. 
Q: Do you think that you have a chemical imbalance or that these, the medications, are 
correcting a chemical imbalance that is giving you [. . .] the anxiety, the depression, and [lack of] 
sleep? What is your view on that? 
A: Well, seeing is that I have two professionals with degrees that outrank mine, whatever, 
experience, umm, say that I can, umm, work with these anxiety, umm, symptoms and these 
depression symptoms without medication, I tend to believe that they’re correct.[. . .] I mean, I 
don’t think it’s chemical. I think it’s more, you know, environmental stress, or some things that I 
can fix. Umm, but I don’t know because I, I haven’t been tested for any thing like that so I have 
no idea. 
17. Woman, 25, taking sertraline and venlafaxine for depression, diagnosed with post-traumatic 
stress disorder 7 years earlier, following a gang rape. 
Q: How do you think the drugs act upon your body or mind? Do you think the drugs correct a 
biochemical imbalance? Why or why not? 
A: Well, my aunt says I have lost a lot of weight since I’ve been taking the Effexor. As I told you 
before it makes me dizzy and I tend to lose my balance sometimes. So I think this is not good for 
my health. Can you repeat the other part? I forgot what else you asked— 
Q: Do you think the drugs correct a biochemical imbalance? Why or why not? 
A: I don’t think there is a biological cause for what I have. . . I do think that it is the way I was 
brought up. How can I explain to anyone that my self-esteem is caused by a biochemical 
imbalance? I don’t believe in biochemical imbalances. That’s a stupid reason that people use 
when they don’t know how to explain things.. 
18. Man, 32, taking methylphenidate, atomoxetine, venlafaxine, and alprazolam for attention-
deficit/hyperactivity disorder and obsessive-compulsive disorder. 
Q: So, do you think that the drugs corrected [a] chemical imbalance? 
A: You know, I’m not so sure, if it’s an issue with the chemical imbalance. I think, I mean I know 
what some of these drugs do, I’m going to go with Concerta, which stimulates the frontal lobe, 
makes me focus a little bit, and most of them I’m not sure. I mean a lot of these drugs get out of 
the system quickly so you don’t necessarily have a long-term chemical difference. You know, I’m 
not really looking to change the chemistry and certainly not drastically. 
19. Woman, 55, taking lithium and clonazepam for bipolar disorder. 
Q: So is it causing a chemical imbalance or— 
A: Well, for sure. I’m gaining weight, up to 30 pounds, and I’m dizzy, and I’m feeling thirsty, so 
it’s definitely causing a chemical imbalance. 
Q: Causing or correcting an imbalance? 
A: Well it’s supposed to correct one. 
20. Man, 29, graduate student in chemistry, taking amphetamines for 3 years for ADHD. 
Q: My next question is, do you think that the drug helps to correct a biochemical imbalance, that 
you have a biochemical imbalance? 




A: That’s how it’s explained. But how can you tell? I haven’t been tested for an imbalance and 
how would they look for it, how would they know, if you have an imbalance or if you don’t? 
Q: Amphetamines affect dopamine. So, could— 
A: That’s right, but because they’re speed drugs they affect everyone the same, they increase 
dopamine release, you produce more dopamine – 
Q: So, this corrects a chemical imbalance. 
A: This corrects your problem! But it probably causes a chemical imbalance. 
21. Man, 37, taking sertraline for 1 year. 
Q: So, do you think it corrects a quote unquote biochemical imbalance? 
A: Yeah, I mean, yeah, it definitely does something, umm, I wouldn’t know if it’s chemically or 
psychologically, I don’t know what it is, or how it works . . . 
22. Woman, 58, taking escitalopram, chlorazepate, and lorazepam for depression. 
Q: I wanted to ask you about your psychological wellbeing. Do you think you have any chemical 
imbalance? 
A: Maybe to balance out my mind.  
Q: Do you think you had an imbalance? 
A: I cannot respond if I do not know if that is the case. 
 
14 Dickinson et al., 2010 
Three main themes were identified from the interviews: the benefits of antidepressants; 
ambiguities and dissonances in the understanding of depression and its treatment; and barriers to 
the discontinuation of antidepressants. 
The benefits of antidepressants 
At that time [commencement of treatment] I didn't really care! If he'd have said take some rat 
poison I would have probably taken it, you know, I was that down so I didn't bother; and then 
gradually … it got better. (Patient 33) 
It seemed as if some fairy had waved a wand and got me this [drug] which brought me round. I 
swear by it. (Patient 4) 
My worst point was when I woke in the morning. I just didn't see any point in going on and it 
certainly helped very much indeed. (Patient 18) 
If the cause is a social factor I can't get rid of that … but I might alleviate their symptoms a little 
bit. (GP 5) 
‘If it makes them feel even a bit better it's worth it. Because at the end of the day a lot of them 
don't cost a huge amount, they are quite cheap.’ (GP 8) 
Ambiguities and dissonances in the understanding of depression and its treatment 
After that I started to get tired spells where I was abnormally tired, not sleepy, physically tired 
… it's an effort to walk about and that was when [the GP] said that this was depression, 
although I'll say I didn't feel depressed. But as far as I know not being very knowledgeable on 
medical matters you could be what you call clinically depressed without being mentally 
depressed. That's how I understand it, so although I didn't feel depressed I accepted the fact that 
it could well be. (Patient 4) 
The GPs also acknowledged a difficulty in providing a solid diagnosis of depression and 
understanding and treating its causes: 
We have to keep figures of who is depressed, but of course loads of people come in and it 
says“depressed”, but they are not actually clinically depressed. They are depressed because 
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someone has just died … and that's where our figures have been mucked up … I think for all our 
patients who have coded as depression, maybe 10%, if that, actually have depression. (GP 6) 
 
This ambiguity in understanding depression as an emotional or physical condition influences 
GPs' views of antidepressants: 
In emotional medicine you are much more predisposed to the individual patient. In cardiology 
where essentially every patient comes into the sausage factory and gets an aspirin and a beta 
blocker and an ACE inhibitor and they all come out at the other end, you can't do that with the 
emotional illness. (GP 7) 
Statins, yes I have my concerns about statins. But I suppose the gain from that is more tangible 
and more … easy to sell. The problem with general practice is that the perception of psychiatric 
illness is one where it's still not seen necessarily as a biological condition. I happen to believe it 
is. (GP 10) 
GPs acknowledged the difficulties in providing treatments other than pharmaceuticals: 
We have … a 10 to 11 month waiting list here for CBT [cognitive behavioural therapy], by which 
time the crisis has gone. People come to us in extremis really, they are usually in a very, very 
distressed, disturbed state. (GP 5) 
The majority of [patients] have lived through the Second World War and they have an antipathy 
to counselling. (GP 1) 
I think [antidepressants] do have a place, partly because it's not a lot of other things that help 
mild to moderately depressed elderly, the CBT has got a very limited place. Counselling; its 
always very difficult to get them to engage, so we are often stuck with just prescribing, so it's a 
bit “best of a bad bunch” really. (GP 4) 
The GP said “Well, do you want to go for bereavement counselling?” Well I didn't and I don't 
because with my faith and my family, I don't need anyone else. He didn't offer anything else, 
poor lad, what else could he offer? You feel that they're embarrassed about it sometimes. He's 
only a youngish man … no, I haven't ever spoken to anybody about it really. (Patient 11) 
I've been offered one or two [alternatives] … and I said,“Well I'll see”and let them know. In the 
meantime I've been missing my little walks. I was offered walks from home but they had to close 
because no funds. I was offered people to come and have conversation with me … no funds; no 
volunteers and that's the problem whatever I've been offered. (Patient 21) 
Nowadays there is medicalisation of life, really. There are problems that we all have in our life. 
Some people need to have it turned into a medical problem to make it more valid or something. 
Rather than say I'm struggling to cope with my divorce or whatever, they come and say I'm 
depressed. (GP 2) 
I don't think it's right to prescribe something that they don't necessarily need, so we prescribe for 
social issues, but should we prescribe … lifestyle drugs? I don't think we should … But it's 
difficult when you can't measure an outcome. If someone has high blood pressure I can measure 
that and it's a definite. (GP 6) 
Barriers to discontinuation of antidepressants 
It's a part of my life really and I've just got to cope with it. (Patient 20) 
I never get really well … where I can do without these things. I've lived on them all my life. 
(Patient 19) 
I don't think now at my age … I think I'll be on them for the rest of my life because they can't do 




He coped with that very well and then was diagnosed with cancer … so that was a big shock to 
me … we coped with that very well, got over that. And I think I came off the first antidepressant, 
or whatever they call them … and then 2000 my eldest son was diagnosed with cancer so they 
put me back on them again … and he died in June 2001 but that was expected, I coped with that 
quite well, and after a while came off the antidepressants; and then 2003 my youngest son 
collapsed and died … so my GP put me back on them again (Patient 5) 
I'm normally tired and now you see my situation, my wife should have had her hip replacement 
but her blood pressure is far too high and she can't have it. So it can only get worse so for the 
last few years I've had to take on more and more to help her like I've had to do all the shopping 
and … it doesn't bug me and … physically nor emotionally I just do and … we just accept it, it's 
just another thing that's come over that we have to cope with … (Patient 21) 
Patients acknowledged that often this was also a challenge for their doctor: 
Oh I have done very well with this [recent reduction to antidepressant regimen], in fact I have 
done better with these people than I have ever done. With the other people, well I think they were 
just … I don't think they knew what to give me … I mean more than once I've been told “just get 
on with you” you know. I do get on with it but it can be very debilitating. (Patient 19) 
GPs also acknowledged the intractability of some patient's situations: 
I think they have horrible lives, a lot of them … I think it's a combination of all things, their 
health, their social circumstances … I think a lot of people are on antidepressants because of 
everything put together. And you can't … change most of the factors that cause it. (GP 8) 
They feel that unless they are on a tablet for it then they are not having any treatment. There are 
a lot of those kinds of people. (GP 2) 
Negative perceptions of ageing 
They didn't say anything about why I was depressed or anything … they just seemed to think it 
was a general condition for my age. (Patient 20) 
With old age every year you sort of get something which as you get older is expected. I mean if 
my eyes go they go. You see that doesn't bother me, my legs bother me, yes because I can't use 
them properly. I was a great walker at one time and I can't do that now. (Patient 19) 
 [Doctors] are more bothered about blood tests, liver tests, breathing operations. No, the 
depression has gone into the bottom drawer … I think according to the state of my health and 
what the doctors think about me … I suppose if I brought it up in conversation they would talk 
about depression, but if there is no need to talk … why not leave it alone! (Patient 4) 
I'm summoned to the surgery once a year because of my age, where I have blood tests and urine 
tests, and a general talk about my health. But I don't think that either the [antidepressant] or the 
depression has been mentioned in those talks. (Patient 17) 
I think it's well known that depression is often overlooked in the elderly and people who have got 
physical disabilities and whose life has been significantly impaired by their illness … (GP 2) 
 
There are some bigger battles I think out there, than persuading them to stop their 
[antidepressant treatment].(GP 8) 
Elderly people are generally more self effacing, and they don't make demands on us for 
treatment. They say “oh I know it's old age”, you know, they expect that they are going to feel 
low because they are old. They have lower expectations of what can be achieved, I think, and 
they are wary of antidepressants, but I think antidepressants do work in elderly people. (GP 9) 
It's always difficult to assess because there are so many more layers with elderly people, they tell 
you what they think you want them to say … I think it takes a lot more detective work. (GP 4) 
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I'm not coming off these because every time I come off, something else happens; but these, these 
are more for a panic attack. (Patient 5) 
I sort of take half of one for so long and then I think “oh blow this I'll get rid of it” and then of 
course I get the collywobbles then. (Patient 19) 
I still don't know whether I would sleep if I came off them … I don't want to try! (Patient 32) 
When [the GP] was there she said,“well, we could get you off them slowly”, and I was in fear of 
her doing that because I suppose they're a crutch really. (Patient 34) 
I'm not being funny but … would it make any different at my age? I mean why bother changing 
something now? (Patient 6) 
I think at my age I would just think “well carry on as I am with them”. I think it's too late to 
change now. (Patient 20) 
It's scary to stop a medication that's been going for a long time, because you kind of think am I 
opening a can of worms here, because I don't know what the reasons were for them starting that 
medication. To explore all that will take, you know, I can't do all that now, I will have to do that 
at another time. (GP 9) 
They're frightened of coming off, because they don't want to feel like they did initially. And you 
can understand that. (GP 8) 
I don't agree with this treatment, it's not the best thing to do, but at the end of the day it depends 
whether harm outweighs benefit and is it worth having that major fall out with the patient and if 
I'm really stuck and I really want them off it I would send them to psychiatry to get someone else 
to try and do it for me. I've never had to do that. (GP 5) 
There are some patients who need that little bit of a crutch, almost a placebo effect, the kind of 
people who sometimes feel they want to be on a low dose more permanently because they feel it 
keeps them on an even keel. (GP 2) 
The long-term patients generally are on probably sub-therapeutic doses really, how much actual 
effect it has on their mental health is probably minimal but it gives them psychological support. 
If somebody did become more symptomatic then we would up the dose. (GP 2) 
But I just do. I take them … I just take them thinking well if they do me good … (Patient 23) 
Patient (P): Oh, I think, I you will continue with the medication think now I've got to this age 
anyway that you know I'll just go on. (Patient 26) 
 
I don't really know. The doctors will keep an eye on things and if the time was appropriate then 
they would take me off it but… having kept me on it I assume they are happy for me to go on 
taking it so I take it but … with all this medication I would come off it if I could. If I can't come 
off it then I accept it. (Patient 21) 
As I feel now I feel like I'll be taking them for the rest of my life … after 4 years I can't see it 
improving, as I say it keeps it in check. (Patient 1) 
Well, I won't be here long so I think I'll keep on it ‘til I go. (Patient 27) 
It would be a marvellous thing if you didn't have to take anything at all, but I think that is asking 
a bit too much at my age. I think you have to have something to help you along. (Patient 29) 
Patient: I was called in to see the doctor because I think at that time they were a little concerned 
about what the long-term effects of taking it would be. And we chatted and the doctor said to me 
“I think you're taking these as a sophisticated sleeping pill, and if that is the case, I've no 
objection to that”. And I said “Well, they do help me to sleep, that's the reason why I keep taking 
them”. 
Patient: I feel it's one that suits me and I'd be reluctant either to change or stop it. 
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Patient: As I say I'm reasonably happy with taking the … well very happy with taking the drug; it 
seems to be working and unless I suddenly get an attack of depression, I don't think I would 
mention it to the GP. (Patient 17) 
 
15 Egede 2002 
I don’t know what other people are thinking but I have heard other people saying she’s crazy 
because she’s taking depression pills. I heard it. So, that is what comes to mind; so, I just let 
them know that I ain’t crazy…because I don’t want nobody saying: “Yea, she is crazy, she is 
taking those depression pills”. And I feel badly because they say that. They don’t have to laugh 
like that. (A woman). 
I think diabetes is a sickness and depression is a state of the mind. Depression is something you 
can get rid of, diabetes you can’t, okay. (a participant) 
I think it is a lack of ideology, a positive ideology instead of a weak mind. They don’t have 
knowledge or understanding of how to overcome it. They take what people say in the street and it 
destroys their strength. (a participant) 
People just sit back and worry about things, you know. Things they want and can’t get, or 
whatever, you know. That is what some people do. And see, I just don’t care. I got that 
nonchalant attitude now. And you know, a lot of people tell me that. I don’t know if that is good 
or bad, I just don’t care. (a woman) 
I guess with me it is different from everybody, I came from a poor family, we had nothing, there 
were 8 or 9 of us living in 3 rooms; so, when I was a child I learned how to provide for myself 
and take care of myself just about…I guess my daddy made about $8 a week, mother made about 
$3 a week, so I grew up learning not to worry about things…I just keep on living, I just never let 
it bother me. I do what I am supposed to do. (a man).  
I feel to myself that depression can mean self-pity, it is like feeling sorry for what you have and 
then again thinking about the things you were able to do before you had diabetes. (a participant) 
 
When they first put me on the pills [for diabetes], I used to think I don’t feel like taking these 
pills, you know, just seem like it started getting on my nerves at one point because I had to take 
those pills every day, … and it was just like taking a pain killer … Yeah, it was what started me 
to get depressed, but then I had to shake it off. Because, I remember, I had to shake it off…I just 
shook it off. (a woman). 
I regret the chronic use of antidepressants. I only took them because I had this fear of being 
ill…I don’t want to get sick. That’s all. I am trying to keep it down for now. Because I know how 
it gets, I know it will put me in the hospital. That’s some place I don’t like to be. I don’t like to go 
in there. So, that is why I do what I do…to stop me from having depression. (a woman).   
Diabetes can destroy you and depression can destroy you, both of them can do it to you. (a 
participant). 
My son was stressed out,…it was not warranted. He was up for promotion, they put somebody 
else in his place, and he didn’t get it. He got stressed out. And the doctor put him on stress pills, 
and he was all right. He had the same mind you got, he said: ‘I don’t need this.’ And he took 
himself off of them [the medications], and every time he took himself off it he would have to get 
back on them. But it was all because he didn’t have a strong mind. (a man). 
I just hope I never get depressed. I’ve got two people with depression, I’ve got a sister and a 
brother, and they both have a little nerve condition and I know through dealing with them and 
371 
 
seeing them, how it works. And you know, I just hope I never have to get to that point. (a 
participant). 
If I feel like I need to talk to somebody, I am not going to go to them saying I am depressed, you 
know. I may be depressed, but I ain’t taking no medicine. Yeah, you know, I…sometimes…I need 
to go lean on somebody’s chest… Yes, I do, so somebody can hear me, you know, hear how I am 
feeling. (a woman). 
Medications are only acceptable if prescribed for a short time. (a medication advocate). 
If just based on what’s on a piece of paper you are going to tell me that I’m depressed, and 
you’re just going to sell me some medication, no. It’s not going to work like that. You know, you 
have enough evidence, you know, over a period of time, and then it’s going to be on a trial basis. 
For me, I need to know you for 6 months. (a man). 
With depression, I just call it a sickness, and as she said [referring to anothr participant’s 
comment], I just need somebody to talk to…And you can get depression that makes you feel 
bad…make you feel real old, but I won’d take them, I won’d take the depression medicine. (a 
woman). 
[T]his is what I say. They’re no medication that can help depression. Not to me, it is all within 
yourself, your mind. (a man). 
Excuse me, I am not saying you smoke cigarettes because you are depressed, but it actually 
relieves the stress, calms your mind. The medication for depression does the same thing. What I 
am saying is if you smoke a cigarette, you do it to calm yourself. Depression is just relaxation 
backwards. So, what is the difference? (participant). 
Would I tell anyone that I am depressed? Well, maybe my friends or people like that. I would 
probably let them know what I am going through but I would not allow people who don’t care 
for me or might want to do me harm to know. (participant). 
 
This is the best confidence right here because it is only fellows. I am not saying that I am 
knocking the women out, but I mean most men will not discuss certain things in front of a woman 
[referring to emotional issues such as depression]. (a male participant). 
A woman on antidepressant medications talked about the shame and pain she felt because people 
made fun of depression. She began to cry, saying, [w]ell, they talk about you, laughing, and 
thinking, you’re crazy. Something went bad for me. I raised 5 children and I think I did good. I 
didn’t recognize it [depression] until I went and talked to my doctor; my doctor told me I have a 
little probem.    
If I am really depressed I know I’m not going to take one doctor’s opinion on that because I 
might not be that depressed like he said I am. If the doctor said he is going to give me some 
medicine for depression, I will tell him no. (participant).    
I think, he might tell you to take this for depression, and all he might be doing is giving you 
aspirin to make you think in your mind that he is giving you something to help your depression. 
But he ain’t giving you nothing really, but a little confidence to build yourself up inside to get 
over the depression…so you can deal with it then. (participant). 
I try to, you know, do positive things, and I control things, that, you know, that I can control. If 
he [the physician] says I am depressed, that’s just his opinion, but I’m not going to let him get 
me on medication or anything because that’s more depressing. (male participant). 
 
16 Fosgerau and Davidsen 2014 




GP: did you at all talk about what one could do about it or what is sort of treatment? 
Patient: well they urged me to start medication as fast as possible to use their expression. To me 
that request was both a little shocking and also kind of a relief. Because it is like a hope about 
sometjing that could give me a little help  
Extract 7: 
GP: But what about your friends? Are they there for you? 
PA: They are, they are.. 
PA: It is just my friend Petra who knows that I get depression tablets [right] and then my family 
and no one else knows. It is not something that I am advertising. Because it is not something that 
I like… 
PA: You do not need to.. 
GP: You are the one deciding who you want to share your problems with 
Extract 8:  
GP: What do you think about the effect of the medication Peter? Now you have a little more 
experience with them 
Patient: well.: I believe I have been lucky that I have not had any side effects. 
GP: exactly… but four months..you have been taking them for four to five months 
PA: yes, but actually I think that it is like..that it in one way or the other hmm..how I describe 
this that I go up and down and at least it cuts off the lowest part 
PA: so…when I ..the third time I got depressed and chose to stay in bed and started a vicious 
circle then .I get out of bed every day, I get from my bed every day.. 
GP: so, it puts such a safety net underneath you 
PA: Well…it..takes me up to a place from where I can push myself further ahead and then comes 
the snowball effect right and that is what I would like to get started so that I never get to the 
opposite lying three days in bed 
Extract 9: 
Psychiatrist: what about medicine? Do you really have like – do you feel uncomfortable taking 
medicine or has it just become such a:.. 
Patient: It took a ridiculous amount of time before I accepted it to begin with. But I – I think it is 
okay now because what I am getting now…I do not feel there are any side effects and I feel that 
it works so I am really not as angry about the medication any more as I have been.. 
PS: So, you have like integrated or accepted it? 
Patient: Yes, I have accepted them pretty well. 
 
17 Frank et al., 2007 
Symptom descriptions 
… it started out with a sleeping problem where I would only be sleeping maybe 4 hours a night, 
and in that 4 hours, I would wake up even, and then it got to be where I didn’t even want to get 
out of bed, I didn’t want to put on makeup, I didn’t want to do housework, I wanted to do 
absolutely nothing. (Female S) 
Low mood, low energy, lack of motivation, lack of focus/concentration, feelings of guilt, self-
critical thoughts, feeling overwhelmed, lack of enjoyment, hypersomnia, restlessness, anger, and 
irritability. 
I became more defensive … feel like people are picking at me; having a hard time enjoying 
things you used to enjoy; Anger was a big one. 
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Most bothersome symptoms 
Fear and fear of the future; anxiety fear that makes me want to completely draw in; the severity 
of the experience attacking through multiple symptoms; want to die … afraid to die; want to 
withdraw … You just want to live in a cave … esteem is gone, self-conscious and self-aware, 
over-analyze everything …; Forgetful … and then I am agitated and I’m mad at the world and 
I’m frustrated. Then, all of a sudden, you’re barking at your children and your wife. Functional 
impairment that is prominent among most bothersome symptoms; It got to the point to where … 
especially at work, my performance just kept going downhill. Depressed mood, fatigue, and 
feelings of worthlessness… 
 
Improvement with drug treatment and first symptoms to remit 
- Irritability 
A male patient: Irritability is probably the key thing; grumpy, cranky; hypersensitivity and 
reactivity to describe this symptom: ‘being overly sensitive to everything’, and easily set off; 
‘anger’ along with irritability; irritability subsiding in social situations with close friends or 
family members: ‘Not being as cranky and angry with him over every little thing. I wasn't as 
easily set off. I used to snap at my mom, bite her head off.’  
A male patient: medication helped me have ‘better impulse control at home—my first reaction 
wasn't I am going to smack you’; the medication helped me stop ‘yelling’.  
A father: the medication helped me stop ‘being short with my children.’ 
A female participant: My internal experience of reduced irritability was strong: ‘I went from 
being overly sensitive to everything, to finally I can let some of the things go, roll off my back.’  
All Participants: irritability was the first symptom to improve.  
- Energy/Motivation 
The second most common symptom to remit early in treatment was a lack of energy or 
motivation. Female participant: I’ve noticed medication-related improvement when I actually got 
out of bed.  
Participant related interest level to functioning: I have more interest in my husband, more 
interest in taking care of my house, bathing and putting on makeup …  
Participant: Increased motivation leads to other improvements that follow: If you're motivated, 
then you allow yourself the ability to enjoy some things, but if you have no motivation, there is no 
way to enjoy it. 
Woman: My family noticed I was able to maintain more organization in our house.  
The increased energy was linked to my experience of irritability: The first was I had more energy 
and I was less irritable. By ‘irritable’ I mean like in a home situation, I had better impulse 
control. What I noticed was energy, I was less irritable and less fidgety. 
- Sad Mood 
Several participants: a sad mood was the first symptom they noticed improving.   
Female participant: I was happy, my mood; I was happy for no reason, was just happy; I also felt 
very carefree and did not have the negative thought pattern, and then my energy started to come 
back. 
Male participant: Happiness, that was my first thing; all of a sudden, I realized that I am walking 
around work whistling. 
Others: ‘lifting of the cloud or feeling’ ‘lighter’. Anhedonia was relieved as mood improved. 
Participants: other people frequently noticed improvements in their mood.  
Mother: My daughter told me ‘I was less miserable than I used to be.’  
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Several patients said their psychiatrists commented that they appeared “brighter.” 
- Anxiety 
Patients: symptoms of anxiety were among the first to improve with antidepressant treatment. 
Words and phrases used by patients to describe this anxiety included “worry,” “fear,” and 
“nervousness.” Most of the patients appeared to perceive symptoms of anxiety and depression as 
being interrelated. 
Other Symptoms: Coping, Decisiveness, Negative Thoughts 
Patients: the first characteristics to improve with treatment was an ‘ability to cope.’ 
Patient: The ability to cope was a feeling of being ‘not quite so overwhelmed—I felt like I had 
more control of things that I was doing.’  
Participant: The ‘ability to make decisions’ was the first characteristic to improve.  
Two participants: said they quickly noticed improvements in the negative thought patterns that 
tend to accompany depressive episodes, such as hopelessness. 
Patients also identified symptoms that were slower to improve: Sleep difficulties, problems 
concentrating, and feelings of social isolation were often cited as being more treatment-resistant. 
Several of the patients reported: significant improvement in mood, irritability, and energy level 
said that their ability to concentrate or focus had still not improved.  
Most subjects: indicated that sleep improvements took longer to establish. 
 
18 Fullagar, 2009 
Kaz (33 years, urban): I’m having my medication upped again. Which is to the level that I’m at 
now, which is fantastic. I’m not changing it. I’ve actually come to the conclusion, and one doctor 
… said this to me once, ‘If you’re a diabetic, would you stop taking your medication because you 
felt good?’ And I said ‘No.’ And she said, ‘Well, why would you, as a person who has a chemical 
imbalance in your brain, stop taking the medication, because you feel good?’ I went, ‘Because 
you’re not depressed any more.’ And she goes, ‘Yeah, but your chemical imbalance hasn’t gone 
though’ … if you’re on it because you’ve obviously got a shortage of serotonin or something, if 
you are on that, you could be on it for life as maintenance. 
Jasmin (37 years, urban): When I’m not on medication and I’m depressed, I feel like I’m already 
in deficit because my mind’s not working properly and my brain is not working properly, so at 
least on medication I feel like I’m on a level playing field … so I’m not at a disadvantage for 
working on life’s xperiences. 
Kaz (33 years, urban): Taking medication is a practice of ‘doing’ something to create the 
conditions for normality: ‘I’m not doing it to feel good, I’m doing it to feel normal. 
 
Sandy (53 years, rural): I am relieved that it was my brain not my ‘self’ that was the problem: 
For the first time in my life I actually thought, ‘There is something wrong with me.’ And that was 
a weight lifted off my shoulders. They explained it to me … in my case the serotonin was going 
across and going back quickly; not enough. 
Roslyn (43 years, urban): My depression arose in relation to this sense of failing to meet multiple 
gender expectations that culminated in a frightening panic attack: ‘I felt a failure … I’d failed 
my kids … pursued my career at the expense of my family. And now I’d failed in my career and 
I’d failed them. For me depression and anxiety … was always something that happened to 
malingerers and people … who weren’t strong.’ 
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Jasmin (37 years, urban): … that little pill is a reminder that there’s something not quite right, 
and that you’re a little bit dependent on something to keep you sane. So, I guess there’s an 
aspect of your life then that you don’t have control over? 
Irene (59 years, urban): You become two persons, two people in the one body, but there’s always 
the fear in the back of your mind that you are not standing hard enough on the other person 
(depressed self), and that other person is going to reappear, just when you don’t want them to. 
Difficult process of withdrawing  
Elisabeth (34 years, urban): It was quite a shock when I wanted to go off medication and that’s 
when I had terrible mood swings and I just kept crying and screaming. 
Roslyn (43 years, urban): my conflicting desires: … because they made such a difference, the 
medication, I’m just sort of a bit anxious about getting off them … [it’s] a bit of a safety net for 
me … I tried to get off them once and the side effects are just horrible … the doctor who first 
prescribed them for me … painted a pretty rosy picture, which I think was misleading because I 
have suffered signifi can’t side effects trying to withdraw from them … [also] I think it’s a 
psychological thing that I’m dependent on these …Am I dependent on these drugs to be well, or 
not? It will be interesting to see. 
Cathy (32 years, urban): You have to draw upon risk rationalities: I used medication to surveil 
my emotions as a prevention strategy: I thought as soon as I sense that something could be 
amiss, or that I’m at risk, like if there is a death in the family, I’ll start taking medication, even if 
I’m not too grieved by it because maybe I might develop something, I always sort of keep watch. 
 
19 Fullagar, Simone and O'Brien 2013 
Tayla (31 years) was initially prescribed anti-depressants after she had suicidal thoughts. She 
decided to stop taking anti-depressants after a conversation with another person who had a 
similar experience. Tayla reflected on her own experience,  
Nop, I’m not going to be on medication for five or six years. I just went cold turkey …I can beat 
this with (the help of) husband, kids, friends.  
Allie (69 years), who lived through the era when barbiturates were prescribed to treat depression, 
challenged this form of treatment by refusing to take medication because it sedated her too 
much: 
 I thought no, this is no good, there must be something, something else. But I didn’t know what 
the something else could be and it wasn’t until many, quite a few years later that I learnt, yeah 
how to deal with depression … And then it was a matter of dealing with it, I mean I learnt how to 
… live with it if you like, but it was many more years after that before I came through it. 
I mean I think you can’t go past exercise, but it’s not the only answer, it’s very complex, 
depression is complex and also the overcoming it is complex, so you try lots of things until you 
find what works for you. 
Renata (38 years): I changed my relation to ‘self’, because I notice that I haven’t done exercise, 
or something for myself, or a massage, or something like that; that’s when I start to go off the 
rails. And so what I do is, just say knowing my signs, is I kick in the self-care. So … I mentioned 
the massage … or I cut my workload down. 
 
20 Gammel and Stoppard, 1999 
How did you come to be diagnosed as depressed? What forms of treatment have you received? 




I was afraid that she [her physician] was going to say that I didn’t need an anti-depressant drug 
… I think I would fight tooth and nail if anybody refused to prescribe it for me. (Ann) 
Taking medication…It made me feel weak, like, yeah. Like to have to take a chemical … And 
then I got thinking about like the medication, I was just like, so what does this mean if I have to 
take this medication in order to be, in order to be normal? Like it just felt so weird … I haven’t 
told my doctors but I’m, I have stopped taking my medication. (Susan) 
And I’m not really, at this point I’m still deciding … I think partly it’s fear of the drugs 
themselves. Like I’m not really sure what, in terms of side effects and in terms of sort of like and 
addiction. And just, I guess the idea of needing, whatever drug to feel okay is a really, I don’t 
know, it’s kind of a nasty idea. (Tracy) 
I felt I couldn’t talk to my psychiatrist. You’re in five minutes and okay we’ll try you on this pill. 
We’ll try you on that pill and there was no counselling. And I’d come home and there was no 
counselling, like there was no, there was nowhere to go. And um, so I, Dr. [name of psychiatrist] 
said I’ll put you in touch with a clinical psychologist and he did, and he put me in touch with a 
clinical psychologist and that was the best thing that ever happened. (Sarah) 
I think, um, counselling has helped probably the, the most though. Yeah, yeah, taking time to to 
look back and go over, you know, things that should have been dealt with … When I started 
going through all the healing for, my sexual abuse, the depression started lifting. (Debbie) 
It was good to be there [the psychiatric unit]. It was a safe place, a good time to get away and 
think … you get to know people, I got to know some really good people in there. (Debbie) 
Life After Diagnosis with Depression 
I mean even after all this, I really I don’t consider myself to be depressed just because I hate that 
classification … I don’t think about myself as depressed because I don’t want to be, kind of … 
Right now, like I don’t consider myself to be depressed. I don’t think I’m depressed right now. 
But I know I am. If that makes sense. They tell me I am. (Susan) 
I still did my daily activities of daily living. You know, had supper ready, had dinner ready, had 
their lunches ready. Did the wash. But none of that had ceased, you know … (Sarah) 
But I just let go and went with the illness. I thought to hell with other people, I’m not going to. If 
I want to lay on this couch, I’m going to lay on this couch. (Jane) 
I want to go to law school like and that’s another seven years and I just think, if I can’t handle 
second year Arts, how in the hell am I supposed to be able to deal with this? (Susan) 
I’m hoping I won’t have any recurrence … I’ll never say that it’ll never happen again, but I’m 
hoping that with each time and with my experience, I’m hoping that I can minimize you know … 
I hate this feeling, you know, it’s but you know that you can overcome it and you know that it’s 
going to get better. (Sarah) 
I don’t think it’s something that can ever be permanently fixed. Um, I think it’s something that 
you can um, deal with better, I think it’s something you can learn how to live with. But I don’t 
think it’s something you can ever um, you know, cure. (Kelly) 
Medicalization and Women’s Experiences of Depression 
There was always something wrong, a lot of physical you know, couldn’t sleep, always tired, 
didn’t want to eat and things like that. Um, the big one was the insomnia. I just couldn’t sleep. 
(Kelly) 
I’ve got a small group of friends who are all suffering from various mental illnesses and we all, 
you know, joke about it, you know how we’re all, we use the term crazy but we don’t use it in a 
derogatory sense you know. But I mean there’s still that you know, when someone tells you your 
brain chemistry’s all messed up you’re sort of like ooh. (Kelly) 
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I’m not ashamed of it [depression], I mean it was something that’s, it was natural, it was a 
natural occurrence … People aren’t ashamed to walk around with diabetes or a heart attack … 
people get cancer, it’s not something you’re going to hide. It’s the same thing. (Debbie) 
It’s a chemical imbalance and, to me it just happened, it may have had something to do with my 
menopause … (Gloria) 
… you do need your medication or I felt I needed my medication to alter that, the thought 
process … (Sarah) 
I think counselling probably was the best thing. You know, more so than the Paxil [an anti-
depressant drug] … I don’t know, I shouldn’t say that. But I think I probably could have healed 
without the Paxil too, but the Paxil’s like an aid … giving you your you know, your ability to you 
know, calm down or to. It takes awhile for it to work though, I I think it helped, initially. 
(Debbie) 
Well, just if I get a medication that works for me. (Gloria) 
And I know I do need medication … we’ve tried three, well four different drugs now and this is 
the one that seems to be working, you know, the best. (Sarah) 
… you’re going to have to acknowledge that sometimes you know it [depression] is going to 
invade in your life and you know, and at that time, times like that you have to ride it out you 
know. (Kelly) 
… if I had something that brought it [depression] on or something to keep it here, ah with me, ah 
but like I said there’s nothing. I have a really good life with my family. And I have my car to 
drive and no problems. If I want to go shopping and buy something I can go shopping and buy 
something so it’s it’s, there’s nothing, not a thing. (Gloria) 
Dr. [name of psychologist] knows so much more because I see him more often. He knows all 
about [male acquaintances], and he knows all about [situation with a relative] and he knows all 
about you, the anxiety and stuff so I’d I’d say I talk more with him than I do with the psychiatrist. 
(Susan) 
But it may have a bearing, the stress of that, work, on the genetic … But I was always one to 
strive like I’ve always had many irons in the pot. And whether I just let myself get overwhelmed 
by too many things going on at the same time. (Sarah) 
I still have to limit myself um and that’s the hardest thing I do find is trying to limit. And, you 
know, take time for [Jane], take that bubble bath. (Jane) 
Like, I went into hospital, he [husband] had to take over the budget. He’d never once looked at 
the budget. (Jane) 
So therefore, they [family members] did not see a whole lot of change in me except that I 
couldn’t work [outside the home]. You know, because I worked around here [in the home]. 
(Sarah) 
… when I go to work I feel very comfortable there, very safe. I’d rather just work there forever. 
Um, I just work part-time as a sales person and as far as school, surprisingly it hasn’t affected 
as much as I thought it would. Um, I figured I’d just fall behind really bad. I dropped a course 
immediately and just said forget this. (Amy) 
Several women felt more positive and made positive changes in their lives since their diagnosis 
and treatment.  
I’ve been off medication for a year or so, um, I have managed to straighten out a lot of, a lot of 
things in my life … mean I’m doing much better in school now and ah, I’m enjoying it a lot more 
and so I mean for the most part I’m pretty, pretty happy you know … I didn’t know like 
happiness, how cool it could be, how great it could be. (Kelly) 
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Another young woman with a history of abuse and depression, admitted that her treatment had 
helped her become a stronger, more confident person. 
I feel so totally healed and so positive about myself and, oh gosh, it’s just like, like on top of the 
world. Really I just feel like I have a total grip on, on life and, a lot stronger than I used to be … 
Having to go through that, you know, depression, just to just to get where I am is worth it for 
sure. (Debbie) 
Susan: I am concerned that depression will negatively influence my life in the future. For 
instance, the implications of my diagnosis for my future relationships. 
 
21 Gibson, Cartwright and Read 2016 (a) 
Taking Charge or Giving up Control 
Taking antidepressants makes you feel like a failure . . . like giving in (Participant 1).  
I understand antidepressant use as a weakness: Maybe that’s also wrapped up in this idea about, 
you know, I should be able to cope with it without medication as well. It’s maybe it’s some sort 
of failing, maybe it’s some sort of sense of failure about having, you know, I’m not doing what I 
could do, I’m not achieving what I could achieve because I need medication, I should be able to 
manage these sorts of things. (Participant 13) 
Generally, men tend to think that they can overpower any situation with just pure physical-ness 
(Participant 20). 
We’ve always had people that used to talk about taking their happy pills and yeah I was never 
sure that they’d done enough themselves to try and fix things (Participant 4). 
It’s not a sign of weakness, it helps your own mental stability sort of get back on even keel again 
(Participant 5).  
You’ve got to help yourself . . . there’s only so much that people from the outside can do. It’s got 
to come from within (Participant 6). 
I’ve got pretty good at sitting back and analyzing what’s going on and looking back over a week 
I’m able to chop and dice and go “mm I’m going to stop those meds now, I’m going to monitor 
myself for a couple of days and if I don’t improve after those two days I’ll go back on the meds 
knowing that it’s something else. (Participant 10) 
 
I didn’t want to be bothered going to the GP. I told the GP after I had done it . . . I made up my 
mind I was going to do it, I didn’t want the doctor to say no, it’s bad. I don’t think he would 
have. But I thought I can control this myself. (Participant 16) 
What I felt it was the loss of control over my own life. ‘my brain belongs to Mr. Pfizer’ 
(Participant 12). 
Functioning in Life or in Sex 
The whole unpleasant thing, you know, your libido is absolutely stripped. I might as well live in a 
monastery because I’ve got no libido and when it does come then I have erectile problems and so 
it’s really, for something that’s supposed to stop depression, it causes me a lot of depression, you 
know. (Participant 12) 
There’s a stigma attached to, and particularly for a man, to be suffering from depression. So I 
kept wanting to get off [antidepressants] and so from time to time I would wean myself off. But I 
found that I couldn’t function under high pressure without them. (Participant 7) 
And so here they are, they give you functioning for day to day activities but possibly take away 
marriages for certain people. . . . It makes you feel good but you can then coast into a separation 
that perhaps might not have happened. (Participant 20) 
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Well I think getting rid of the depression probably is the most important thing of all because it 
affects everything whereas impotence only affects part of your life. . . . But then on the other 
hand as you say it’s like do you sacrifice your sexuality or do you sacrifice your life and that’s 
what it felt like. (Participant 19) 
Well it meant that I could never have another relationship. I mean how many people do you meet 
who might be interested in you for taking things further through a relationship once they know 
that you can’t perform a sex act. It would have to be a very special person. You can’t advertise 
on the net “this and this and this wonderful—but no sex. 
Having said that when you get to your 60s your sex life is not as active as it used to be anyhow. 
(Participant 7).  
I re-engaged. I became a loving and I think a better partner in the fact that it made me more 
facilitating, like I wasn’t sweating the small stuff. Now some people would say that’s 
disengagement again but for me it wasn’t. I actually re-engaged. (Participant 20) 
So I actually find the performance is actually great as well, because that means I can go for it 
quite a long time (Participant 9). 
Relieving Distress or Reducing Emotional Vitality 
Pretty much all the classic things . . . highly emotionally unstable I guess in the sense of bursting 
into tears at a moment’s notice (Participant 14).  
Well I’m quite a rational, stable sort of person but that would get me at times, in areas that were 
completely beyond my control. So, I was worried that I might be in the middle of a business 
presentation and suddenly crack up for no reason. (Participant 19) 
When you crack, you show the signs that you see in a woman, crying, not being able to cope, you 
know, just bursting into tears at the drop of a hat, and no one wants to go there. I guess that’s 
why we take the pills. (Participant 3) 
 [They] kind of take the edge off if you like (Participant 8).  
You can’t think about how you feel if you are too clouded by emotion. You can’t step back from 
it. And even though I hate to admit it that was a really beneficial part of it. (Participant 1) 
They’re terrible things because they take away, yeah they take away the lows, there’s no doubt 
about it, but they take away the highs and they put you in the ‘nothing zone.’ So, you don’t feel 
things (Participant 3).  
And then I found I wasn’t interested in movies. Oh, I can’t be bothered. Couldn’t be bothered 
going to Art Galleries. No pleasure in it. Um sense of taste, just sort of flat. . . . I would eat in a 
completely functional way. (Participant 11) 
Yeah I guess in one way [less emotion] is good. And in another way, it’s not going to be good if 
you want to, you know, become more empathetic, more compassionate, or learn how to be more 
relational with people. (Participant 1) 
I know in New Zealand, especially, I mean you know you’ve got to sort of man up and be a man 
and do everything else and all the rest of it. But I think a lot of people nowadays are sort of 
realizing that people do have feelings, whether you’re male or female. But you can still have 
feelings without degrading yourself or belittling yourself. (Participant 5) 
So, I was trusting someone because I had lost all confidence, so I didn’t know what to do. It’s an 
all new experience for me, and you know. (Participant 15). 
I can’t remember how many I cycled through with [my doctor] in that five months. There was 
always the question of we’ll give it a bit longer and see if it works. But I just got to the point 
where I said “Doc it’s not working. I’m not prepared to elongate the timeline because it makes 
no difference for me physiologically. It’s not going to help.” (Participant 10) 
380 
 
So you’ve just got to roll with it but I’m old enough and experienced enough now to know how to 
trust my own gut. This is telling me it’s not the thing for me then you know . . .  
There are times when you go well I don’t need to take the pills because I feel good. But of course 
you feel good because you are taking the pills. I’m like well I don’t think I’m depressed, but 
that’s because I am depressed, so I’m not thinking properly in terms of knowing whether I am 
depressed or not. (Participant 8) 
You are left feeling insecure in your own ability to understand what you are going to become 
like, what you could be like, what is the real you anymore? (Participant 20). 
Certainly, a lot of the symptoms of depression that I exhibit, you know, I wonder whether they’re 
actually symptoms of depression or it just so happens to be that that’s the way that I am, if you 
know what I mean. (Participant 8) 
No doubt there was an element of going along with it because I was in the relationship and I 
enjoyed that and she thought this would help and I thought well maybe it will. 
I’m sure there would have been [my partner’s] expectations of what she wanted or expected me 
to be like, that would have been some kind of force.  
My wife is very good obviously at now identifying where I am at and saying: ‘Hey come on, 
don’t you think you need to be taking your antidepressants again’ (Participant 14). 
I wasn’t aware of the depression myself but [my wife] tells me my mood was much further down 
[than I thought] (Participant 16).  
It’s because I can’t trust my judgement anymore and you’re my wife, you’re supposed to know 
that I’m not well (Participant 10). 
(Participant 16) My wife would “divorce” me if I stopped. 
My wife seemed to appreciate me more when I was taking antidepressants.   
And I understand partners’ encouragement to take antidepressants as sign that they were 
uncomfortable with the emotional vulnerability of someone who is depressed… 
It’s just it seems to be, [my wife] expects you to be a male and be the strong one, and she’s a 
pretty strong person herself, but she expects me to be, I can’t really show too much vulnerability, 
which is hard work. (Participant 7) 
For me it was a matter of my wife pointing out to me that I need to be responsible for my own 
behaviour and if you can’t control it you need to see somebody about it or do something about it, 
like “You are a complete asshole and I am not prepared to tolerate it, now are you prepared to 
do something about it.” (Participant 20) 
My wife was saying: “[Participant’s name] you have to do something. You’re depressed, you’ve 
changed. You’re not the man I knew.” And so, I found that each time. I discontinued it three 
times before I found a way off it. 
 
22 Gibson, Cartwright and Read, 2016 (b) 
Positive experiences of antidepressants 
[Its] just like diabetes – a chemical shortage…I need serotonin uptake inhibitors – simple!  
I would hope that one day I could stop taking them but realize that for me it is the same as taking 
heart pill for someone else. 
My GP said that if I had diabetes I would need to take insulin forever, so not to worry that I 
appear to need to continue to take anti-depressants forever. 




It was a life-saver in a real sense of the word. That medication had prevented me from 
committing suicide.  
I truly feel that I would not be alive if I had not taken them. 
[Antidepressants are] the sole reason I can now function as normally as possible as a human 
being and a participating member of my family and community.  
[they have been] very helpful, they have allowed me to be a better parent than I would have 
otherwise been, I believe. 
 [Antidepressants are] helpful in enabling me to manage the stresses of job loss and 
unemployment. I feel that I can cope better with job interviews on them. 
I have had such good therapy that I have been able to address the wider issues that had 
contributed to my mental state. …Without the medication though, I would never have had the 
ability to do this. 
Negative experiences of antidepressants 
They were a waste of time and did not help me.  
I get more benefit from mild to moderate exercise, or energy drinks, or spending quality time 
with friends.  
[They were] greatly disappointing. I wish I had never tried them, because before I tried them at 
least there was hope that something could have helped. 
Each one has had a worse effect than the previous…. I can’t remember them all. It started with 
memory loss then progressed to me becoming borderline catatonic staring at the wall for hours 
unable to stand up. Within a few weeks and genuinely terrified. It was a relief to go back to the 
misery of depression after these experiences. 
They don’t make the problems go away. They just make me numb enough to not give a shit.  
By taking the medication I felt alienated from others almost as though I was walking around like 
a zombie in a kind of bubble. 
In my life, antidepressants have been prescribed to me to cover up what was wrong, and to me 
were a fake fix. 
I believe that I stayed in a relationship that was unhealthy for me, because the antidepressants 
made me tolerate treatment that was unacceptable. 
[It’s] like smoking. When you smoke, you know it’s bad for you, but you also feel momentary 
relief and therefore can’t (or don’t want to stop) because you miss that feeling of being slightly 
more capable to handle situations. 
I felt bullied into keeping taking them and at times told I would not receive therapeutic treatment 
if I didn’t take them. There felt like no alternative and I felt very trapped into taking them. 
Mixed experiences of antidepressants 
It is a necessary evil, with very unfortunate side effects in terms of weight gain and sexual 
dysfunction which lead to me stopping the treatment despite its benefits for my mood. 
I know they do me good and I am better on them, but they do make me feel physically sick, and 
not like myself. I seem to be constantly trying life without them, but always go back to them in the 
end. 
Antidepressants have been a two-edged sword. I felt less affected by things that would normally 
distress me while on anti-depressants… [but] when I came off them, my head felt clear, I felt like 
I was waking up and that I was in touch with myself again. 
[Antidepressants were] helpful in making my depression less. However, the effects that they had 
on me as a person and how I treated others is the main reason I came off them. I am a 
considerate and selfless person and while on the antidepressants I was the complete opposite. 
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The thing is that I have been on them so long that I have no idea what it would be like not to be 
on them. I would love to come off them but they have become such a ‘normal’ part of my life 
since I was approximately 15 years old that I am not sure I would cope without them. 
They helped me get back on my feet when I was facing a difficult time. However I was never told 
when to go off them and …have not heard from the doctor who prescribed them to me in years. 
The withdrawal effects if I forget to take my pill are severe shakes, suicidal thoughts, a feeling of 
too much caffeine in my brain, electric shocks, hallucinations, insane mood swings. [I’m] kinda 
stuck on them now coz I’m too scared to come off it. 
I have been on MANY different antidepressants. None of them were helpful at all to me until I 
tried Fluoxetine 4 years ago. My life now is greatly improved by taking this medication and a 
quality of life has returned. 
I have tried almost all antidepressants available under prescription (including combinations), 
and most worked to varying amounts to start with, then stopped helping, then the dose was 
increased, then stopped working/made me worse, then dose increased to the maximum, then 
stopped working, then I was put on something else. I’ve wondered if I would have been better off 
never starting taking them at all. 
 
23 Givens et al., 2006 
I didn't want to start get myself hooked on a medication that I would have to be taking the rest of 
my life. 
I think sometimes medication is wonderful but I think you can't escape from your problems that 
way so I watch when I take it. I don't want to get dependent on it. 
I stopped taking it on my own … I felt that I didn't want to stay on the medication. I didn't want 
to become addicted to it, an antidepressant. 
I have (a) stressful time going, dealing with death in the family, losing my mother, losing my 
father a year ago. In fact, a year this February I lost six other family members in one year. And 
it just looked like it was just too much to cope with. 
It's not—I don't know whether it's the depression or not but I think when it changed why I feel 
that the death of my husband has changed me. He was the first man that I loved and I—even feel 
yet that a part of me is missing, that something—just something I feel that a part of me is missing 
because he is not around. … 
If you can't see and you feel like you're going to lose your eyesight, you know, it kinda gets you 
down. Especially when you don't have nobody. 
I do think that there's a reason for my depression. I don't think it's just there like a cloud because 
nothing's wrong. I think there are things that are wrong and that's why I kind of don't like to take 
medication for it because the medication doesn't change the basics. 
He prescribed Zoloft for me. Well I never took it. I mean, my feeling at the time was that I wasn't 
interested in the pill. I didn't want to do this because I couldn't just bury my husband and then go 
on and go out and party. 
I have to face reality and I think you have to feel some pain in life. 
I didn't want to stay on the medication … why should I be different than everybody else? 
I didn't want to take them … 'cause I had taken tranquilizers when I was young … A doctor 
recommended that … I don't think they knew about antidepressants then … I never thought it was 




I'm not interested in pills anymore. I get bad dreams. I mean, they gave me pills that left me 
waking up and not knowing where I was. I was still in a dream. 
 
24 Hanssen and Cabassa, 2012 
Treatment Initiation 
I was urged by my husband to talk to a female doctor in hopes this would help me feel 
comfortable discussing health concerns, which I struggled to do until that point. 
Like the doctor tells me “You have to accept your diabetes. You have to accept your high blood 
pressure. You have to accept….bad moods….like you accept your problems, you have to accept 
your illness”. And I now, that is what I am trying to do, accept. (Focus group) 
Adherence 
At times I take a half of the pill for depression…it’s what helps me, it’s what calms me…. I don’t 
take it every day, only when I get to the point of feeling a lot, a desire to cry, with anxiety… 
(Individual interview) 
Barriers to Care 
Look, in reality with the doctor here, I cannot communicate well, because he does not speak any 
Spanish. The doctor is informing me through an interpreter and so the interpreter does not tell 
us everything, because one very clearly sees… she is listening and in the whole time tells us two, 
three words. So realistically, you understand, that it is not everything that the doctor is saying. 
(Individual interview) 
Stigma  
Well, I heard that it makes you sick, like that is the medicine for when one is loco [crazy] and all 
that…Well, also because of that I didn’t want to take them, because I was scared they would 
make me ill in the head… (Individual interview) 
Barriers in accessing services  
Well, since they treat me every six months… we hardly have talked, I only come and they look me 
over, and they say to me “where does it hurt, if it hurts”. They only prescribe me the medication 
and that is it. 
Interviewer: You have never thought of talking to your doctor? 
Respondent: No, because almost it never lends itself to do so, or moreover, since I know there 
are many patients, they try to get them out fast. (Individual interview) 
 
25 Izquierdo et al., 2014 
Beliefs about the nature of depression and its treatments 
A 61-year old woman said: I’m not happy that my body just doesn’t want to behave itself and 
that I have to use medications to correct this. I used to hate that I had to depend on a medication 
to make me feel normal, but then I realized that I had an imbalance and I had to take care of it. 
 
IA 54-year old woman: You cannot control depression. Even if you discuss it with someone like a 
doc, by the time they finish medicating you and counseling you they didn’t cure it. It doesn’t stop. 




Some believed depression was a condition that would take care of itself, or did not require 
medical treatment. “My depression will heal naturally,” said a 52-year old woman. A 54-year 
old woman described, “I just have to let the depression run its course.” Participants who 
believed they had to manage depression on their own described reticence or refusal to use 
therapeutic treatments. “Though my doctor suggested counseling, it’s up to me myself to get 
better. I have to do it on my own. I don’t need any medication,” (a 71-year old woman). 
 
A 58-year old woman: “I was prescribed my medication to be taken twice a day but I only take it 
that way sometimes because I don’t want to get hooked on pills.”  
 
Participants also described antidepressant medications as unnatural or illicit substances; they 
referred to them as chemicals (“químicas”) and drugs (“drogas”). 
Prior experiences with mental illness and its treatments 
A 61-year old woman said, “My mother was a prescription addict, so I didn’t even want to take 
aspirin. But I came to realize there’s a difference between tranquilizers and the medications I 
take for depression.”  
 
A 54-year old woman” “Schizophrenia runs in the family and I don’t want to be in a looney-
tooney bin. I can’t talk to nobody about it, no professionals, because they want to lock you up.” 
 
“I’ve been taking them a long time. I don’t like to take them but they help,” said a 55-year old 
woman.  
 
A 57-year old woman stated, “I’ve tried to quite [my anti-depressant medication] twice by 
myself but my symptoms came back and I needed to go back on it. I know that if I stop taking it I 
will get sick and depressed and will be crying all the time.” In contrast, participants who 
previously experienced treatment side effects reported reluctance to re-start antidepressant 
medications. A 56-year old woman stated: 
 
I used to take antidepressants years ago, but they made me have headaches and made me 
nervous. I generally felt worse throughout the day so I stopped taking them. I have no interest in 
getting antidepressants again. 
 
26 Jaffray et al. 2014 
Initiation of treatment 
385 
 
…now that I’ve been to the doctor and the doctor said yeah you have a problem and 
everything…I can sort of go right, there is a bit of problems here I can do something about that. 
(continuer) 
 
I’ve a good friend who is a CPN [Community Psychiatric Nurse], she was supporting me and 
she said ‘I really think you should be going you know and speak to the doctor … I decided that 
yes I would go. (continuer) 
 
I didn’t ask to go on them but I had that in my head you know if she offered me to go on these, on 
something then I would, so she did offer them. (continuer) 
 
I felt quite embarrassed about it because I didn’t realise they were antidepressants she just said 
it was something to pick me up…like why do I need antidepressants? None of my family have 
ever needed antidepressants. (discontinuer) 
 
I suspect my depression was more reactive. (discontinuer) 
 
I just thought, well it’s a waste of time because they are not listening to me, they are not 
understanding what I’m saying. (discontinuer) 
 
I was quite open with my husband but I haven’t told my parents because my mum has depression. 
(continuer) 
    
Some of the employers,…one of them I spoke to was okay but the other one was probably 
thinking ‘get over it’. (continuer) 
 
When patients began to feel better 
I think it’s just sort of got me over the worst of it, I think, that’s how I was starting to think 
perhaps I can come off of them. (discontinuer) 
 
As long as I am feeling good, I know I shouldn’t question it but you start to wonder how will I 
feel if I come off them? (continuer) 
 
I just felt perhaps now is the time to wean me off a bit, I have come to terms with a lot 
(continuer) 
  
Although things were explained quite clearly at the beginning I think at this point [now I feel 
better] I would have benefitted from a bit more support or just knowing a bit more about what I 
am doing (continuer) 
Experiences of side effects 
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My sister said I had put on weight, she said you probably should stop your antidepressants. I 
said no. 
 
They just said that your moods will change, and you will have an upset tummy and your side 
effects. I thought, no, I am not going through that. (discontinuer) 
 
I just felt that I shouldn’t really be, well, always depending on tablets. (continuer) 
 
Latency period (perceieved lack of efficacy of antidepressants) 
 
Yeah, I was really, really surprised, although I did have my doubts, but no, I will persevere, and 
I’m glad I did actually. (continuer) 
 
No, I just, I actually felt more depressed, I just wanted to sleep, I just wanted to go to my bed and 
it [antidepressant] was encouraging me to do that…there was a spell that it wasn’t working. 
(discontinuer)  
  
If there’s just a little niggle, you can talk about it, a little peace of mind, and then as I said they 
monitor you, they don’t give you automatic prescriptions. (continuer)  
 
I’ve kind of been left to it, she said to make sure that I come back, I don’t know what would have 
happened if I had just stopped them, and not come back. (continuer) 
 
I will know myself, if it’s not working then to increase it again. (continuer) 
 
 27 Kadir and Bifulco 2010 
 
I think I’ve got this illness because I’ve many worrisome thoughts… I went to see my GP at first, 
then I was referred to mental hospital. I believe I will be normal again with modern treatment 
but I can’t affort to pay for this treatment… so I decided to see bomoh too. It will help me get rid 
of this illness. (Anisa) 
 
I never sought treatment, I was unaware of services offered. I though that mental hospitals offer 
treatment only for those people with serious mental illness who ‘run amok’. Depression is just a 
‘thought problem’ and can be cured with ‘willpower’. This is why I never sought help. I cannot 
talk to other people, either… (Salina) 
 
I did receive treatment for my depression and I was given an antidepressant medication and 
referred to a psychiatric unit at our community clinic. Then, I’ve decided to stop the medication 
due to the side effects: fatigue, being unable to sleep and nausea. I didn’t want to see the 
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psychiatrist for continuous treatment because of was afraid to be labeled as mentally ill. 
(Norma) 
 
I sought psychiatric treatment and was on medication for about a year, but stopped taking it 
because of the side effects: fatigue and memory loss. My parents decided I should seek 
alternative medicine.  The bomoh advised me to stop the medication and not to think or worry 
too much. 
The bomoh told me that evil spirits are happy if I feel depressed and do something stupid like 
attempting suicide.  
 
I think the bomoh can cure my illness. I talked to her a lot about my illness … what I’ve felt … 
my sorrow… my sadness… my loss of interest… I’ve no job. The bomoh encouraged me to share 
my entire problem with her. I share lots of things with her. She gave holy water so I drink it 
everyday. I feel more confident. She asked me to chant every time after I perform my prayer. I 
did it… I feel relief. (Miriam) 
 
I think my illness is normal. Not really severe compared to others. I can go to work. I can speak 
to people. I … sometimes feel unhappy and am not in a mood for doing things I like to do… but I 
still think I’m fine … I don’t go out and kill people as a few mad people do. Oh yeah … I was on 
medication … the GP gave me antidepressants … but I became worse day-by-day so I decided to 
stop. (Norma) 
 
I’ve seen a psychiatrist and a bomoh. I knew it was not right to see bomoh but I do believe 
bomoh will help me strengthen my faith. To make me feel close to God and to make me feel I’m 
not alone in this world. I wanted to be a good follower … a good believer … I will see the 
psychiatrist again when my illness becomes severe but I do believe the power of will inside me 
will help me against my illness … you see … sorrow and sadness are not good for us … I should 
not grieve about my fate … I know that. (Rokiah) 
 
 28 Knudsen et al. 2002 (a) 
 
Informant: Because you see yourself in the situation which you know is completely crazy. You see 
yourself and you can’t do anything ... That, that is what I think is really hard. Because you are 
thinking so clearly. Sometimes, I’m in such despair about myself … and you can’t keep that up in 
the long run.  
 
Informant: You just felt so lonely. And that you were just killing time. Yeah … the emptiness … 
The feeling you don’t have anything to live for. That is what typically triggers the thinking about 
suicide. Life is a piece of s[…] and all that. And you just sit and wallow in it, you know? And 




Informant: I’m not really sociable. My work requires me to be quite extroverted and social. And 
that really drains my energy. When I get home, well … I can’t really stand being together with 
anyone … And perhaps that is partly why we’re getting a divorce. I don’t really think I can live 
up to it. I’m the one who wants a divorce. I can’t live up to what you’re supposed to live up to 
when you’re married. I spend such an incredible amount of energy getting my workday to 
function … and that’s how things are these days. In the society we live in, you have to work to 
survive … that’s how it is. It’s hard for me.  
 
Conflicts about taking antidepressants 
And then when she [the doctor] mentiones the medicine, I just feel paralyzed. For me to take 
those pills. It was … but haevens I don’t feel that I have that kind of illness, you know? Well, it 
was really a shock. Really. I found it unpleasant in the extreme. 
 
It’s one thing to have a psychological illness, but if then you have to take medicine for it. Well, 
then, that’s twice as bad. To be down and have psychological problems. Lots of people can have 
them. So, okay, maybe we can accept that. You get over that by yourself. It’s just that you don’t 
quite mention that you didn’t in fact do that, but you had to take those pills. Double whammy. If 
you get those pills then people think “Well, so it was real”.   
 
And I have always … taken the stand that I wouldn’t take medicine. Because I … I have always 
believed that I could manage without it. So then I go see this psychiatrist and get a very positive 
impression of him. And he tells me that there is an imbalance in my brain that makes me get 
these depressions … and so after some major deliberations I start taking Seroxat [an SSRI]. 
 
It’s embarrassing, simply ... Yes, why it is embarrassing [laughs]. It just is. Because it’s not 
normal. You just aren’t ordinary, a person who can function without having to take something 
chemical [laughs]. [But what about your goiter, isn’t that also chemical?] Yes, okay, it is. But 
that’s allowed. It’s allowed because it’s a physical problem, you know? But the other thing, 
that’s in your head. It’s because [laughs] it doesn’t work too good. But that’s the thing. When he 
[her doctor] said that it was something chemical, then, then it was easier for me to handle it. 
 
SSRIs users’ accounts: 
I have much more energy for other people. Hmmm… I’m more open and … that means that I 
have started to believe more in myself. And be more. Not just say yes and well but really give 
something to people. Give something back to them. And not always be the … what should I say 
… the neutral person … I’ve blossomed.  
 
But when I’m taking the pills, then I have…Then I can function. I can. I can. I can go to work. 
Smile and be happy. And can enjoy things and I… can stay out of bed except when I have to 
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sleep… hmmm, and I can be sociable. I can do things together with my friends… but that’s all 
they do. 
Discontinuing the medication 
The reason I want to wean myself away from the medicine is simply because I will not conceive 
of myself as ill … I think that is very important to my conception of myself that I don’t think I’m 
some kind of therapeutic case. 
 
Cutting down wasn’t a problem I don’t think. So in that way you’re not dependent on them … not 
like with other types of medicine. You’re not that dependent on them. I’m not anyway [laughter]. 
I think it’s more the anxiety that makes you dependent. It’s a psychological that dependence. 
You’re afraid everything will go wrong if you don’t take your medicine.   
 
I hope it’s not something I’ll have to take the rest of my life. I’m not counting on that. I would be 
sorry about that. But if that’s what it takes for me to have a good life. Then I would be willing to 
do it. But right now I still hope that at some point I can manage without it.  
 
 




It was a validation that I had never had before and I had a name. It was like, you know, it’s a 
bad attitude, it’s not. I’m not … you know maladjusted, I’m not ill sociallyor whatever. It’s just 
I’m depressed. And that’s cool. Like it was really neat to have a name for it. (Kate) 
 
I was reading this book [which listed the diagnostic criteria of depression] and it was describing 
what I was going through […] and all of a sudden I said Geeze that’s what’s wrong. I’m 
depressed. That’s what it is. Just to be able to put a name on it? Because there are times when I 
thought I was different from everybody […] But what I found in that book, I found that when you 
have the symptoms I had, that the way I was feeling in my condition was normal. See? I wasn’t 
going crazy. (Dianne)   
 
Something in me made me go to the doctor and I went into her office and she sat down and she 
said: ‘What’s the matter?’ And I said: “How do you know if you’re depressed?’ And she said, 
‘OK, I have got ten questions to ask you’. And I was nine out of ten. […] So she said, you know, 
you’re depressed! There’s no way out of it’. […] So anyway, fine I said OK what do I have to 
do? 
I was so relieved! I was so relieved I thought thank God! There’s something wrong with me! I’m 
not- there-it’s got a name! Like it’s not that I am just a terrible, awful person who is unattractive 




It was kind of a relief to have somebody say, ‘Yes, you have something seriously wrong, you 
know, tis is what it is’ […] There’s something really wrong with me that they have even a name 
for it […] It’s a sense of relief that there is something there that people know about that you 
know you’re not the only person in the world that’s had it and you really do have something. 
You’re not just making this up, you know. And that’s kind of good because people do have a 
tendency to sort of look at you and say, well, you just want attention. Well no, attention’s nice, 
but no, that was not the plan here. If I wanted attention I could dance on the table, I don’t have 
to try and kill myself. (Joanne)        
I would like to see more women be honest about it and lose their shame because it doesn’t mean 
– And this is something that I’ve learned. I’m not a weak person because I have this, I’m not a 
bad person because I have this, I could just as easily have, you know diabetes or blond hair or 
red hair or long legs, I should be so lucky. You know it’s just, it’s one of those things and there’s 
no blame associated with it. (Kate) 
 
So it’s right down the line, my mother, my brother, myself, my nice, my son […] It certainly is 
hereditary. You know it’s … it is an illness the same as diabetes or a bad heart or anything like 
that, high blood pressure, it’s in the family. (Bea)     
 
Well I think I did suffer depression. Because, and again I say, if I was on Prozac way back then, 
like I say to my boys, I’d say, ‘I know I would have been a much better mother. Because I would 
have put you in your snowsuits, we could have gone for walks, we could have gone out and made 
snowmen (crying) I could have made cookies with you.’ You see? … I could have enjoyed them. 
But they were just work. Laundry and laundry and bedding and it was just, it was just work work 
work work work no enjoyment eh? (Bea) 
 
[I]f you suffer from migraine headaches or say if you were diabetic you could say to a person 
‘Oh, I’ve got a terrible migraine again’ or ‘My diabetes is acting up’. But with depression just to 
say ‘Oh, I’m depressed’, that doesn’t go with people. ‘Oh come on, come on you promised, 
you’re you’re well, ther’s nothing wrong with you, you promised, you can go, you can go’. See?   
   
Interviewer: What do you think is the difference between people being able to say ‘I’ve got a 
migraine or my diabetes or’ and  
 
Well, they accept that. But just to say, ‘Well I’m depressed, ah, they feel well … good kick in the 
butt. ‘You can do it, get up and you you can go. There’s nothing to prevent you from doing it. 





It’s a hell of a thing to have. It’s a really bad thing. I’d far sooner deal with any of my physical 
ailments than I would depression. Depression is hard.  
 
Interviewer: What makes it so much harder? 
 
Well I find it’s so personal. Nobody can understand how bad you’re feeling. And like you can go 
to a doctor, you got bad asthma, you can’t breathe? They can understand that. They can see it, 
they can feel bad for you and they can really try to help you without feeling sorry for you.  When 
you’re feeling depressed, people don’t understand they figure you’ve just got the blues and 
you’re not dealing with it. (Joanne)  
  
30 Lafrance 2014 
Terrible. Wellbutrin makes it so you’re jumpy. I got palpitations from it, I could feel my heart 
going whoop, whoop, whoop, and it made me dizzy. I couldn’t sleep at night, so that’s why he 
gave me Ativan. Ativan? I don’t want to get addicted to this stuff. But I couldn’t relax, so I said, 
‘No, this is not the way to go, I just don’t want to do this anymore.’  (Barb) 
I was given Luvox and it made my heart flutter. And I would get very angry a lot and one day I 
forgot to eat […] I did some really strange things like, just being angry and short tempered and 
my sleeping was way of whack. I was staying up all night, sleeping during the day. It was very 
difficult to do anything because I was tired all the time and then when it was time for me to go to 
sleep I couldn’t sleep. And it was just a bad experience and they said, ‘Oh well we’ll just put you 
on another kind’ and I was like ‘I don’t want to go through a whole, you know, test all these 
drugs’. I didn’t want to do that so I stopped thaking that eventually just cold. (Shelly) 
Whenever I read about it [depression], it was always like ‘Go see your doctor, they will give you 
Prozac […] And I especially found that with my doctor because the second it came up she’s like 
‘Here is a prescription’. And that kind of makes me mad. When I read about it because and like a 
lot of pressures that women have to face, family and work and you know there’s a lot of different 
other things that affect it too that can make it worse. (Shelly) 
When I went to the doctor and explained I was depressed, Prozac, right away. And I really had a 
problem with that because I knew there was a lot of stuff wrong and I wanted to get to the bottom 
of what was wrong and not just simply take the Prozac. (Joan) 
 
31 Lavender, Khondoker and Jones 2006  
Coping with depression:  
Friends 
And that evening a friend rang and I told her, and she said ‘have you had anything to eat?’ And I 
realized I hadn’t had a thing to eat for about three days, not a thing. She said ‘you must have 
something to eat, you must do’. (White British) 
If it is this country the only way [is] … to go to the doctor, but in Nigeria the people will tend to 
think of so many ways of helping out, according to individuals’ beliefs. (Yoruba) 
 
Doctors involving the family 
My own advice to doctors … if it is a woman, they should try to invite the husband … and tell 
him that look, the wife got a depression. So what’s going on? And they should, you know, try to 
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advise them that he is the right person to help the woman out, because that woman is only with 
the doctor for a few minutes. (Yoruba) 
Antidepressants 
I think they are good, but not for a long period of time … because after a long time of it, your 
body is immune to them. I’ve took them … I think it’s only me that can make myself get better. 
(White British) 
In this situation medicine will not benefit. This is mind matter, unrest of mind. So doctors’ 
medicine can not work. (Bangladeshi) 
So I decided to take [the antidepressant] even though I don’t feel good in taking it. Actually, it 
doesn’t help me much. I think going to my church for counselling has helped me a lot. (Yoruba) 
Taking medicine can change the mind … So medicine can make the brain normal and can make 
the heart normal …medicine can make him better. (Bangladeshi)  
Depression as an illness 
If she is ill, there should be effect on her body, maybe stomach ache, or headache or some other 
effect on her body. Because there is no effect on her body, therefore with my little knowledge I 
think she is not ill. Perhaps she has a mental problem. (Bangladeshi) 
 
32 Lawrence et al. 2006 
Self-help 
I think the main helping with depression, any kind of depression, physical, mental, it’s self-help. 
If you help yourself the way you want to do it, you will get over the depression 100%, I am that 
sure. But if you don’t want to do it, there’s nothing you can do. Treat yourself. (South Asian, not 
depressed) 
Cognitive techniques 
It’s a mental attitude, mental attitude. If you change the mental attitude and all that and you 
become cheerful and start activities it will go. (South Asian/depressed & not treated) 
Avoidance/not to dwell on things 
It’s easier said than done, not to concentrate on one particular thing, especially bad things. 
Don’t concentrate on it a lot. Let it go away as quickly as you possibly can. (Black 
Caribbean/not depressed) 
 
Taking your mind off 
You think a bit differently you know with the way you think about things, it’s different but I don’t 
keep it in my mind. I like to read, I’m really interested in reading, papers, books, so then I forget 
everything. I kind of do it myself. (South Asian/not depressed) 
Getting out of the house helps me enormously. I have been paying someone to take me out 
usually once a week, at the weekend, but she’s moving to Norfolk and that’s been sort of my life-
saver because I thought I would go mad if I didn’t get out the house…Yes, it’s the one thing that 
is guaranteed to help. (White British/depressed & treated) 
The first thing is communicating, that somebody is listening to what I am going through. You are 
pouring out your heart to that person and you feel a bit better that you have passed on your 
worries and problems to another person. (Black Caribbean/depressed & not treated) 
You’ve got to try aand keep cheerful when you are with people, it’s difficult, you want them to 
know but no I put on a brave face and make out I’ve got no troubles. If they ask me how I am, 
‘I’m all right, I’m fine, I don’t best to look on the bright side I find otherwise people get fed up, 




But of course, religion means that you are in talk with God and if God can’t help you what else 
will help you? (Black Caribbean/not depressed) 
General practitioners 
You see the GPs are so tied up with so much work they don’t have time to talk to their patients 
and they find a lot of people don’t get the necessary benefit that they would get from the GP if 
the GP talked to them. Even give them less medication and have a talk because it makes them 
feel good within themselves is like a self-healing power you know. That builds them up. (Black 
Caribbean/depressed & not treated) 
There’s so much to say and so little time. So you always feel like you haven’t got enough time 
with the doctor. Yes so then you think to yourself, ah well, the important thing, first, cure your 
pains and then think about the depression later on. (Black Caribbean/depressed & treated) 
Medication 
I mean you hear of people taking these drugs for years and years and they got so dependent on 
them. (White British/depressed & not treated) 
Psychiatrist 
I would feel that if someone was to say we are ging to make an appointment for you to see a 
psychiatrist, straight away I would think oh I am going off me rocker kind of thing. (White 
British/depressed & not treated)  
Counselling 
When you get a counsellor to talk to you, what the persn says to you is encouraging, strengthen 
your body, strengthen your mind and whatever is there, it come right out. (Black 
Caribbean/depressed & treated) 
Counsellors would be able to spend more time with them, to chat with them, to make them feel at 
home and things like that you know. Whereas a GP, tey would be considered to be an official, 
authority, while these counsellors are normal people who gve their time in counsel. I suppose 
that’s what it is, so that would help them, the counsellors would be more helpful. (South 
Asian/not depressed) 
 
33 Malpas et al. 2011 
I was dreading going and saying I don’t feel better … that was getting me down … the pressure 
of having to tell someone ‘no I still feel terrible’; I want to say ‘this is really working’. I didn’t 
want her to panic and suddenly think ‘oh things have got so much worse’ …I felt I was in control 
of it, I didn’t want her to change my medication because of it’. (female patient) 
I tend not to like to tell doctors what to do…I want someone to tell me what to do…I have always 
sort of thought, ‘right, a doctor just tells me what I have and I just say thanks and go’. (female 
patient) 
I have this panic that there’s not going to be anything else to help me so I’m trying to kid myself, 
‘it’s alright, it’s quite contained, just tell her everything’s fine’, and I haven’t, I mean I’ve gone 
along and said ‘it’s been a difficult month’. (female patient) 
As a doctor she really asks, she doesn’t just ask ‘Is the medication okay?’ she really asks how I 
am and how I am coping with things. (female patient) 
[sighs] she wasn’t very…sympathetic, and I just burst into tears as soon as I says [sic!] that I 
was sent over by the, health visitor [sighs]. I suppose some people you click with, some people 
you don’t and she just seemed a bit distant … I know she’s following procedures … it’s just I 
expected someone to be oh, you know, and she was ‘right, let’s start with … sleeping tablets first 
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and then see how’... maybe she was in a hurry … I probably felt guilty for taking up the time, I 
was just crying, so she couldn’t get the information out of me because I was in a bit of a state’. 
(female patient) 
I thought I’d come away with antidepressants and came away with sleeping tablets … perhaps 
she felt that I needed to have a decent sleep and see how I felt after that, so maybe she didn’t 
want to jump into things too quickly … In some ways that was good, but at the time I think I just 
wanted something to make me feel better’. (patient) 
… he was just on your side because he’s sort of with you … He can empathise …I was quite 
determined tat I’ll go in and talk to him, tell him how I’m feeling …  I did explain I don’t want 
anything too heavy but I’d like something to lift my spirits a bit …I felt like I’d got the goods 
[laughter]. I felt like mission accomplished. (patient) 
 
…there is one person saying it’s a good idea to take them and somebody saying no, you should 
not take them; I was in the middle and I couldn’t make my mind up, I was really confused, I 
think, I’m worse at the minute; I just can’t make my own mind up’. (patient)   
What can they say to me if I go back and say ‘I haven’t taken the tablets but I still feel 
down’…they’ll probably say ‘Take the tablets’ [laughter] …they might just think why am I back 
in the surgery…will I look a fool if I go back? I don’t know … the feeling I’ve got is that they 
happily give you tablets but they won’t recommend things like counselling. (patient) 
She kept sort of going through the various options and kept avoiding going up dosage and I kept 
thinking ‘Well I think I need to’, but then I always have something my mother’s instilled in me 
“Don’t tell a doctor what to do”. (patient) 
  But I don’t know…if there’s an issue on dosage or not? …So shall I just carry on with this 
[dosage]?  
GP: Well at the end of the day it’s up to you, but yes, I’d say carry on a bit longer and I think it 
will help answer your questions [about latency in the recovery process].   
I want that guidance really which I don’t necessarily get … I want someone to say, ‘this is what 
you need, this will make you feel better.’ (patient) 
 
34 Murawiec 2008    
Case study. Patient’s report. Treatment with citalopram and later fluoxetine for a year 
Before starting the treatment I had experienced a continually increasing feeling of helplessness 
towards the course of life and a progressive loss, or at least a significant limitation of 
intellectual properties necessary for me to deal with my problems. I have noticed incread 
problems with concentration, memory, making association (deduction) and motivation for effort. 
I associated these symptoms with aging, although it seemed unusual, that at the age of 40 they 
were so intensive. These symptoms were accompanied by a decreasing self-esteem, poignant 
frustration and lack of success, and an increasing need of self-control unsuccessfully aiming to 
turn around this unfavourable situation. I realised that I needed medical help. 
 The medication started to be effective surprisingly quickly and in the right direction. In the first 
months of treatment its effect was even a little too strong. I could burst out laughing at my 
thoughts or speak to myself in the street. I started acting spontaneously, which was funny both 
for me and my surrounding: I would make frivolous remarks toward others, I paid complements 
to my female work colleagues; overstepping not so much the bounds of customs and morale, but 
my own psychologica boundaries.  
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With a good effect, I have gone back to spending my free time enjoying myself, and all the time 
being able to return to my duties (controlling everything). Having control over life is the key 
aspect for mental wellness here: it relates to i.e. drinking alcohol. I have successfully started to 
spend more time enjoying myself being sober than being drunk. As the mood functions as a 
background for emotional experiences, which are made gloomy by the alcohol, I decided that in 
this respect it has a negative influence and it is worth avoiding it. 
At work I am able to impose discipline on myself, but at the same time I know when to stop an 
arduous activity, at least for a few minutes, to regenerate my strength.  
Surprisingly, this self-centred attitude towards myself, allows me to develop altruism: this 
inclination, in turn, I define as a luxury of a person with a well-balanced self-esteem, who does 
not have to confirm his/her image perceived by other people, and in this way is able to step 
beyond his/her own needs. During the last 2 years, I have started many acquaintances, most of 
which go back to my school years, forgotten for the last 20 years and renewed with a great 
effort. Therefore I have a large circle of friends (my wife’s and mine) with whom I stay in touch. 
Some of them are my close friends, some I contact only occasionally. My present intensive social 
life reveals the loneliness I felt for the last few years and is a way of compensation for it. It is 
especially visible when one looks at my position in the professional circles. 
If I were to name other areas in which I have become active recently, it is necessary to mention 
many sublimations (there are artistic and literary projects which I had abandoned in my adult 
years, and to which I have returned now, as well as social and scientific projects). The high 
number of engagements may suggest that I have fallen in a state of exaltation. Using an album of 
photographs of Camposanto, a necropolis in Genoa, publishe before the war, and being inspired 
by the whiteness of the walls in my living room, I have painted of both sides of the entrance 
natural size figures of Adam and Eve. By painting these figures I have dealth with getting used to 
the anonymous space, time giving it, at the same, intimate and universal dimensions. The figures 
live in various circumstances: I am socially praised by friends visiting our house, but in the 
lonely evenings I contemplate with pleasure these figures, laughing at the irritating insufficiency 
of my skills. 
Considering that I am in the course of treatment and that I have wanted to get out of the magic 
circle of incapability, and do something useful (as opposed to professional activities undertaken 
in recent years, which di not give me any satisfaction), I believe that this state reflects my needs 
and inclinations, and that it represents the emanation of my mental health.                
 
35 Patel et al. 2013 
… that’s one more stress on top of every stress you’ve been put under and sort of, one of them 
must have been the straw that broke the camel’s back. But which one?There are just so many 
straws…(P7) 
I found it difficult to distinguish between what was just complete exhaustion and maybe what was 
the depression really and I still think that they are still linked. (P3) 
I think it’s harder to grasp because it’s all to do with feelings and emotions and it’s hard to sort 
of try and understand that it’s a chemical that’s causing that. (P11) 
 




…but I was adamant that I was fine and that it was just a lack of sleep and this, that and the 
other and I would not let her refer me to anybody because I was fine, I was just blocking it out 
…(P3)  
 I just can’t bring myself to say it. Fear of ridicule I suppose … and I don’t want people to feel 
that I can’t look after my children because I can …and I love them …(P2) 
Antidepressants: ‘the lesser of two evils’ 
People will think she needs to be on meds to be a normal mother …(P2) 
…if you are not taking the drugs you can kind of pretend you haven’t got it but when you are 
taking drugs, you can’t hide behind anything, you have a mental illness that you are taking drugs 
for and therefore, you’ve got that stigma. (P7)  
 I’d rather not, but it’s the lesser of two evils I guess. (P4) 
I’m not the sort of person who easily gives into things. If I can possibly do it without the drugs, 
then I must be a stronger person. (P3) 
I am quite happy to take it forever if it maks me feel like I can get up in the morning …but …I 
would like to think I could stop taking it and go back to my normal self but I don’t know whether 
I would want to for fear of going back to that crazed fool. (P2) 
You can’t really put a timescale on it; you just need to keep working towards it.  (P6) 
 
36 Ridge et al. 2015  
My general experience of antidepressants has been very positive in terms of all the horrible 
things that people talk about that can happen with them. (Tony) 
…we have just a bit of a pill culture, take a pill for that, take a pill for a headache, that kind of 
thing, it's easy. (Michael) 
…part of me feels like a failure for not being able to manage my life without chemicals. 
(Samantha) 
[It] felt harder going back [on antidepressants] the second time because you sort of feel as if it 
should be sorted and you feel as if you're taking this antidepressant and it should be fine…(Paul) 
… the doctor didn't think there was something wrong with me… I felt like I was just being a 
drain on my doctor. I was given antidepressants at one point, I think it was Prozac, and I was on 
those for about eighteen months or so. But I was never given a particular explanation of what 
they were to do with, other than they might help - have a side-effect of weight loss. Well that's 
[laughs] I don't think that's a particularly good thing...(Rosey) 
 
I Ieft them on my top shelf for ages and I just didn't want to take them because I was a bit 
confused as why I; he's prescribed me that after like a really short chat, just me saying I was 
down and maybe at the time they were handing them out left right and center, I don't know. 
(George, UK) 
Isn't that strange… I don't tell them [children] that I am taking antidepressants. I never have told 
them that I was diagnosed with depression. (Liza) 
For me medication was a means to an end…but I wasn't going around shouting from the roof-
tops…(Catherine) 
There is a stigma definitely attached to them... absolutely, I mean well of course there is you're 
doing something wrong if you're on antidepressants…(Steve) 




And I think I'm quite afraid of the thought of ever not having it, because I know how awful I feel 
if I stop taking it for a couple of days. I wish I didn't have to always go back and get those damn 
prescriptions. I wish I could just have the drugs - just hand them [over] - because each time I go 
back I think oh, maybe this time that doctor's going to fuss…(Charlotte) 
They gave a bit of hope… I didn't have any negative feelings about the drugs, I was very happy 
to take them because they were a straw to clutch at I guess. (Spencer) 
[I'm] certainly not one of these people who thinks Oh God, some kind of poison in my body. It's 
like no, it makes me feel better… some people are diabetic, they take drugs, you know. And I 
know people say, “Oh, it's not the same”. But I'm afraid it bloody well is! (Matthew) 
...the more people talk about antidepressants as a positive thing, the better it is that people don't 
end up, you know, people don't end up not taking something they need because of the stigma. 
(Layla) 
I would like 100% take them [antidepressants] again… I'm not saying it's suitable for everyone 
but for me it is and so I'm not going to feel ashamed that I need them. Because like it's just an 
illness like anything else. (Lilly) 
It was like being on really strong drugs… made your pupils dilate. (Peter) 
I found it quite scary… I wasn't really ready for taking drugs of that strength. (Gary) 
… it was amazing…within two hours I could feel different. (Christina) 
I think between 24 and 48 hours I felt so different that I rang the doctor and I said, look do I 
have to go up to a full dose, because this is amazing. (George) 
People call them like happy pills and stuff, that's f[…]g crap…. you don't feel spaced out, drunk, 
stoned, whatever you want to call it. You just sort of feel yeah, this is the way life is supposed to 
be…(Matthew) 
 
Actually I just don't see any bad in them other than potentially the stigma… you don't have to 
share it with the world, you can do it yourself, it's a tiny little pill that you take and nobody ever 
needs to know about [it]. (Sean) 
[I feared it was] going to lead to drug addiction in a sense. (Gabriel) 
One of my friends was like “Oh well we've got to get you off them straight away,” and I sort of 
went “Well no because I've only just been on them and I need them for a bit,” …I think he was 
acting like I'd told him I'd got addicted or something…(Val) 
[I did not take them] …she [doctor] said “they're not addictive anyway” but I was still scared. 
(Sasha) 
I overdosed on everything I had, including Seroxat. I took all the rest of the tablets, [um] which, 
it turns out hasn't had any bad effect on me. (Nicola) 
I think I might well be on this medication for life… They seem to suit me very well…. and for the 
next four and a half years from now I am quite safe. I can still continue taking that. But in five 
years time, do I have to go back [to the doctor] and sort of plead my case again? (Liza) 
Zoloft, yeah, and I couldn't think and I took myself off it when [son] was about six months old 
and just went cold turkey. And I wouldn't recommend that. Never ever do that. [laughs] I had the 
zapping - you get this zapping in your tongue… it was just awful. I had the shakes, I had dry 
mouth, it was just horrendous…(Catherine) 
was full of anxiety around [um] becoming addicted to them… however they did help and they 
helped me to find what I would call the equilibrium… so my experience of kind of 
antidepressants have gone from kind of the very first ones that I got that were fantastic I lost 
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weight but I would never want to take them again because I think they're now banned [um]…they 
messed with my mind. (Catherine) 
Anyway, I can say, here we are, it is April, 29th 2010 and I am proudly still on one capsule of 
Lovan (fluoxetine). It gives me confidence, it is like a security blanket and I think it is 
fine...(Miho) 
 
37 Simon et al. 2007 
For a long time I used every occasion as a reason and excuse for my problems and tried to live 
with it before I finally realized that I needed to look for some kind of treatment (male, age 33). 
 
I would have liked to know more about how to cope with a severe depression and how to 
continue with my life, but all my GP said was that I have to accept the fact that I am depressive. 
It took several weeks until I received more information in the hospital (female, age 48). 
 
When I was told that in-patient treatment would be necessary all that came to my mind was that I 
would be completely isolated from the world outside. I could not think of anything positive a 
psychiatric hospital could have to offer (female, age 56) 
I went to see my GP and said: I can’t go on anymore. I don’t know what to do. Please help me 
and 
do something (female, age 39). 
 
I was not in a mood to feel anything or to be satisfied. Now I would say that the decision was 
alright but at that time I did not really care about what had happened (male, age 51). 
 
38 Smardon 2007 
[A]nd I like, I have to tell you that I like taking something that’s not Prozac or Zoloft; it’s just 
this thing that nobody knows about. Umm so…I didn’t attach it to anything in particular… it’s 
just enigmatic enough that I wouldn’t… you know like if somebody looked in my medicine 
cabinet they 
wouldn’t know. Not like anybody would look in my medicine cabinet. (Celexa consumer) 
 
author: What kind of antidepressant did they give you? 
Helena: Um a serotonin reuptake inhibitor. 
author: Prozac? 
Helena: No, it was Celexa. Which is a European antidepressant and I had really good results. 
And I wasn’t too keen on taking... I’d rather not take Prozac. Just because of all the stuff 
attached to that. So… 
author: Did you think that anything bad would happen if you took Prozac?Were you afraid of it? 
Helena: No, I wasn’t afraid of it, I just, you know if there were another one that could be 
effective that didn’t have this mystique about it. 
Helena: He takes antidepressants. 
author: Really? 
Helena: It is very interesting how people … I was getting a prescription filled at the drug store 
and there were a lot of people there and there was this guy in front of me. And she said do you 
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have any questions about taking Celexa and he said no. But I was like, hey he’s taking 
antidepressants, you know when you become aware of something it’s like … 
author: And you might not have known what Celexa was before you started taking it? 
Helena: Right yeah right … and I like, I have to tell you that I like taking something that’s not 
Prozac or Zoloft; it’s just like this thing that nobody knows about. Um so … 
author: What does the word make you think of? 
Helena: I didn’t attach it to anything in particular … it’s just enigmatic enough that I wouldn’t 
… you know like if somebody looked in my medicine cabinet (author: Right.) they wouldn’t know. 
(author: mmm) Not like anyone would look in my medicine cabinet. (Helena laughs) 
Author: Did you discuss your decision about taking the antidepressants with anybody besides 
your doctor? 
Mary: Um well, I think I talked about it with Annie, with um my boyfriend, um I think I just told 
my mom. I don’t think she really understood. I was just like, ‘well, this is what they’re doing’. I 
just sort of announced it. Um, … well there was an Ally McBeal show and she was prescribed 
Prozac and the character that played the psychiatrist said happiness does not come in church, a 
man, love, church any of these things, she listed off a lot of different things, it comes in a pill. It 
was really sort of depressing. And in the end Ally flushed away the Prozac. And I was thinking 
oh boy tomorrow I’m supposed to be starting my Klonopin, that’s when I started Klonopin which 
is an anti-anxiety … 
Author: Mmhmm. 
Mary: And it worked to help me fall asleep, temporarily … 
Author: What did you think about the Ally McBeal show at the time? 
Mary: I thought Ally needs it more than me (laughs); the character Ally needs it more than me. I 
think she should try it, I think also that the show generally addressed everything and like you 
know she’s not gonna take Prozac, sounds like a great thing, but I think if they were to do it a 
more believable thing I think she should have tried it. 
Well I guess I questioned it first of all. And second of all I was seconded by my therapist. She 
said yeah I think you’ve had a low grade depression for a while. And um and actually now that I 
remember, she had said that two years ago. Maybe a year prior to my going on the 
antidepressant. And I went to a psychiatrist and the psychiatrist said no you’re not depressed. 
And I was like ha ha 
ha I’m not depressed, you’re wrong and I’m just you know … So I knew that it wasn’t normal 
when I was questioning it and then through talking about it to her.And the resilience that I used 
to have wasn’t there. (Helena) 
 
I didn’t like the word depression. I thought it was terrible. In my hyperliterary state I thought it 
was an awful word, you know, I preferred melancholy you know. Because that had more of a 
literary history too it, so I thought OK. But I was very resistant to the idea that what I had was 
clinical depression. So to me what I had was hypersensitivity to the side of life that ... the dark 
side, the void, that life was just a painful experience. That’s what I had, I didn’t have depression. 
I didn’t really admit that I had depression for a few years. Even when I was in the hospital I 
wasn’t willing to admit that I was just one of many many people that suffered from this. 
(Thomas) 
 
39 Stanners et al. 2014 
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I started to get depressed because I couldn’t do the things that I was always doing. You know, 
looking after my family, cooking, things like that because I was told I had to get off my feet, I 
wasn’t allowed to walk… So my life sort of just, you know, from being a normal mother, wife and 
that, running around and doing my thing, to doing nothing at all. (Female aged 59, 10 chronic 
conditions) 
Every day’s so hard, you know, to cope, well that’s with-- the [morphine] pump’s good, but all it 
does is take the edge off, you still have severe, you still have severe pain. (Male aged 49, 7 
chronic conditions) 
I guess initially it sort of shocked me, because I thought that I wasn’t sort of in that category… 
(Male aged 65, 10 chronic conditions).  
…I’m very strong person, and I don’t allow myself, you know, to be how shall I say, overcome, 
you know, by emotions… Well, I was surprised. (Female aged 80, 8 chronic conditions) 
See, on TV now there’s adverts about depression with young people, and that type of thing? So I 
haven’t felt like that, just maybe down for a little while”. (Female aged 61, 5 chronic conditions) 
But because I know why I’m like that and I feel that it’s justified, I don’t think that I’m clinically 
depressed, do you know what I mean? Because I feel that my condition justifies my feelings”. 
(Female aged 75, 12 chronic conditions) 
I had no reasons for being in this [state] (Male aged 62, 5 chronic conditions) 
…here I go, I’m nutsville.’ And I didn’t agree with it. At first I fought the idea of being on 
antidepressants, but then realized I couldn’t cope the way I was going, and then went on 
antidepressants. . . . But at first I thought, oh no, here I go, I’m a nutcase, nobody’s going to take 
me seriously, and you know, it was embarrassing. (Female aged 48, 8 chronic conditions) 
So there’s highs and lows, but I wouldn’t say, like, great depression. (Female aged 61, 5 chronic 
conditions). 
Yeah yeah, it [psychotherapy] was helpful, unfortunately it doesn’t last forever. . . You get it off 
your chest. But as I said it doesn’t last forever. (Male aged 65, 10 chronic conditions) 
I was pretty down on myself in all respects, and couldn’t understand how I f[…]d up my life, 
excuse me and I just didn’t think a tablet could take that away”. (Male aged 62, 5 chronic 
conditions) 
 
40 Stanton and Randal 2016 
And I suspect it was a thoroughly horrible situation for [psychiatrist] as well. (DP 6) 
I didn't want to appear too assertive and too knowledgeable and too threatening. (DP 3) 
It [training] keeps you away from a feeling state…allows you to stay even more in your head. 
(DP 4) 
You end up talking about brain biochemistry to your doctor which doesn't fix the problem at all 
(DP 7) 
I wasn't listening to the cry of my heart, I wasn't listening to my pain, I wasn't listening to the 
truth I knew about what had happened and who I was. (DP 3) 
[Psychiatrist] immediately made up his/her mind that it was clearly biological cause which I 
totally disagreed with and that was fine, let him/her talk and ramble on. (DP 7) 
I'm actually not going back now, that's me, I'll just get your okay to increase my prescription and 
say, I'm just going to go now and I'll go to my GP. (DP 6) 
Doctors don't want to know if their patients are angry with them. Doctors want to feel really 
good and helpful and wonderful. (DP 3) 
I said I want another option. I have no bipolar disorder…I was very clear about it. (DP 8) 
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[Psychiatrist] just said ‘you're depressed’ and started me on [medication]…it was just again 
that huge sense of relief that I just, I'm unwell and I'm doing something proper about it. (DP 5) 
I went because I thought I was having a few problems. And [psychiatrist] told me I was 
depressed and that I needed antidepressants and I was devastated (DP 4) 
I just take it and I don't give it much thought really. Except I know they keep me well and I don't 
stop. I mean I realized very quickly that they worked. (DP 9) 
I didn't want to be a doctor. I didn't want to be a diagnosis. I didn't want to be on medication. I 
wanted and needed to be me…as I learned to live with myself, then I kind of…this illness thing 
evaporated. (DP 4) 
I'd never talked to anyone about it before in my life. I didn't know you could, thinking back, I just 
didn't know you could do that… (DP 10) 
Not bound by ‘I’ve got to fill in my risk assessment documents and I've got to give you a 
diagnosis’. It just felt like, actually ‘I’m here and I'm listening to you and I’m going to do 
whatever I need to.’ (DP 6) 
I'm a doctor and I care about doctors, yeah, part of it's about treating your own kind, like 
helping people in your own family. (TP 2) 
Ranged from being extremely enjoyable, rewarding, interesting, worthwhile to being one of those 
things I had to do but wanted to get out of (TP 2) 
They're either being good patients or being really difficult and foul and revolting. (TP 6) 
It's brilliant, I really love the fact that I've been depressed….It stinks as an illness but it's a great 
extra dimension as a psychiatrist. (TP 5) 
I feel really comfortable to talk about [taking time off work] because it's part of my experience 
and I talk about how I push myself to work, even though I know probably that it would be better 
for me to take some time out…I find that easier really because there's a bit of a connection yeah. 
(TP 5) 
 
41 van Geffen et al. 2011 
I felt very depressed and down. I was unable to settle down and do something. I started getting 
upset easily, even with my children. I felt fatigued and tense all the time; I didn't have the energy. 
(patient 3, discontinuer) 
For quite a while already I was suffering from anxiety and panic attacks. At some point it got out 
of control; I couldn't suppress it any more. I was truly afraid of my fears and wasn't looking 
forward to anything. Even opening the mailbox felt like it was too much to handle. (patient 13, 
continuer) 
What I would usually get done in a day now took me three days. That, in turn, made me feel 
guilty, and even more depressed. It felt as if I had failed; I just couldn't do it. (patient 15, 
continuer) 
Until, at some point, you reach your limit, and then cross it. Just to avoid the constant thinking, 
the feeling of fear. That's when I realised this is it, I have to stop this. (patient 13, continuer) 
I didn't believe it would work, as with the other antidepressant I hadn't noticed any improvement 
either. I reluctantly went along; now it has become very clear to me that it actually works. I was 
truly surprised by its effect. (patient 10, continuer) 
I started getting specific symptoms that I recognised from before. It didn't seem like a good idea 
to let it get much worse, so I went back to our GP. Having used it before definitely helped; it 
makes it easier to explain certain side effects you might experience. You know it will all be just 
fine, if you give it some time. (patient 16, continuer) 
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I had used paroxetine before, several years ago. That had made me feel so much better. This time 
I again felt weird and awful, so I went to our GP. He said that since I had experience with using 
this medication, and it went well before, I got it again this time. (patient 17, continuer) 
I'm not the kind of person that takes a lot of medication, but if I have to, I will. Our GP is 
knowledgeable, and he recommends this to me, so I will take it. (patient 11, continuer) 
He told me “This is better for you,” so then I went ahead and started using it. Not really a 
conscious decision. You don't really know why, or for how long; you don't really know anything. 
(patient 3, discontinuer) 
I did know a bit about antidepressants and I definitely didn't want any of that. The doctor 
suggested it to me three times, and all three times I pushed it off. Eventually, when the situation 
got quite desperate, I gave in. (patient 7, discontinuer) 
My GP explained that your brain produces certain chemicals that have to be in balance. That 
balance may be what I'm missing. If this pill makes me get my balance back then I would sell 
myself short if I don't take it, according to him. (patient 8, discontinuer) 
The doctor had first prescribed a “Benzo,” but that made me feel quite groggy. There had to be 
a better alternative. That's when I read about Prozac, and brought it up myself. I felt the doctor 
was taking me seriously. (patient 13, continuer) 
I don't have a problem with it and don't feel weird about this kind of medication. Obviously I'd 
rather be healthy without medication, but if you can't live without then you have to take them. If 
the medication was bad then the GP wouldn't have prescribed if to me. (patient 17, continuer) 
To me it's quite simple: a person with heart problems takes heart medication, so if there's a 
short-circuit in your brain which causes you to have too little serotonin, then you take fluoxetine. 
(patient 13, continuer) 
I actually wanted to fix it myself. If you can resolve it without medication then you're part of the 
regular people, but now I no longer belong to that group. Taking medication means admitting 
failure. (patient 10, continuer) 
To me, cholesterol reducers are something different; that you can't really do anything about. In 
this you can't really either, but still … it's something that's in your brain. That's what makes it 
difficult for me to take medication. (patient 3, discontinuer) 
I'm afraid to get labeled unstable. You generally get told to just get off you’re a[…] and do 
something about it, then it will be just fine. (patient 12, continuer) 
You can get dependent on SSRIs. When you stop using it the depression can return even worse. I 
believe you should use an antidepressant only temporarily. (patient 7, discontinuer) 
I always want to maintain control over my own life, but the medication dominates. The problem 
doesn't get treated. You become depressed for various reasons, and you have to do something 
about it. (patient 7, discontinuer) 
I was actually quite relieved when I got the medication. You are really sick and you're not just 
pretending. Your behavior is no longer strange; it's okay now. If you have a broken leg, then 
everyone accepts that you can't move around. But if they can't tell what your problem is, then 
you're just weak, lazy, or egocentric, then you're just not right. (patient 10, continuer) 
I kept insisting it wasn't a depression I was feeling, and I still don't like it. (patient 12, continuer) 
I was glad this guy on the radio explained it this way, that when you're depressed your brain has 
too little of a certain chemical. I had heard that before and realise there are contradicting 




For me it's quite difficult to take medication for this. That's because I don't know what exactly 
I'm using it for. Perhaps if they had told me there's a certain chemical that my body doesn't 
produce by itself, then I'd be okay with it. (patient 3, discontinuer) 
The GP told me that the medication can take a little while to work, and what side effects might 
occur. He also said that I have to use it for at least six months, plus that I can't quit all of a 
sudden, but rather reduce the dose over time. (patient 11, continuer) 
The doctor didn't discuss any side effects. That's what I had indicated, because when they tell 
you, then you'll probably get them. I don't ask any questions, I don't need to know everything. 
(patient 18, continuer) 
I don't remember what the GP said. From the conversation I had with him I only remember how 
it made me feel at the time. (patient 12, continuer) 
 
I was told by the GP that in the beginning I might feel rushed. I'm glad I learned about that, 
because I did suffer from that in the beginning. So when that happened I knew it was part of the 
process and would soon pass. (patient 3, discontinuer) 
When I started with this medication, I didn't receive any information whatsoever, not even about 
side effects. They did tell me in passing that it could take a while before I would notice the 
intended effect. The doctors should be much keener about this. It would be so easy to just give 
the main messages, and refer to the information leaflet for more information. When I asked my 
doctor whether this medication has any side effects, he just grabbed a big book and said “If you 
like I can read them for you.” (patient 6, discontinuer) 
The first time the GP said it's not addictive. I had reduced the dose over time, but yet from the 
way I was walking it seemed like I was drunk. I had a headache all the time. I believe it actually 
is addictive. The doctors better stop telling that story. (patient 16, continuer) 
My GP had consulted the gynaecologist and said there appeared to be something wrong with my 
hormone balance. I trusted him. I didn't know then that it was an antidepressant until later when 
I read the information leaflet. If a doctor can't explain why you need it, then you won't accept the 
medication as easily either. (patient 3, discontinuer) 
The first four weeks were really difficult. You don't feel too great to start with, and on top of that 
these side effects. The stomach aches were the worst part. I couldn't keep any food down, just tea 
I was able to manage. I was shaking a lot, felt nervous and restless. I had the feeling there was 
so much I was supposed to be doing, but I didn't have the energy to get to it. (patient 12, 
continuer) 
I was rather apathetic. Temporarily, perhaps that's a good thing, but not over a long period of 
time. I no longer had the energy to take any initiative; it seemed as if I lived in a bell jar. (patient 
7, discontinuer) 
I'm a lot less tense now, and more relaxed. I can take setbacks a lot better, and don't let things 
get to me as much. I enjoy moving around and started picking up basic things like making coffee. 
The household is back in operation. (patient 10, continuer) 
I no longer have panic attacks, and I'm not as scared. I'm noticing that the negative feelings are 
diminishing. I am more open now to positive aspects, which helps me focus on my inner self. 
(patient 16, continuer) 
My emotions in general are more subdued. Some things I don't care about any more; I've 
become more egocentric. (patient 10, continuer) 
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My head feels calmer now; it's not churning thoughts as much any more. It doesn't feel as heavy, 
though it's not stable yet. I still have days of much doubt, of not being my true self. (patient 15, 
continuer) 
I received a medication that didn't do anything; the situation got worse. I kept sliding down 
further and further. (patient 6, discontinuer) 
 
My disease is a so-called “self-finishing process.” I feel better now, but I don't know if it's 
thanks to the medication or just because of time passing. If you don't take anything, you'll also 
get better. I started biking again; that may have actually helped me more than the Efexor. 
(patient 6, discontinuer) 
My relationship with our GP is really good. He is always willing to listen to my side of the story. 
He understands my situation; I think that's important. (patient 16, continuer) 
My previous doctors never really counseled me. They just wrote out a prescription, opened a 
drawer, and before I knew it I was back outside. My current doctor is willing to admit he doesn't 
know everything. He's just trying to get things started again. He explains everything, and I feel 
comfortable discussing my doubts with him. (patient 6, discontinuer) 
[SSRI]: The first four weeks I felt really lousy: heart palpitations, perspiring often, ear drums 
closing, and headaches. It was as if I was having a heart attack. I called the doctor at least six 
times because I thought it wasn't normal. The doctor kept telling me that these were common 
side effects, that I had just had to bite the bullet. I thought that was quite limited. (patient 7, 
discontinuer) 
I did tell my GP about the bruising, but he wasn't too concerned. It's not about craving for 
attention, or making up stories; it just worries me. (patient 10, continuer) 
I've discussed the medication with my GP, a psychologist, and a psychiatrist. They each have a 
different opinion, that's annoying. I was always told to avoid alcohol when taking an 
antidepressant. Then the psychiatrist told me: sure, that's what we're saying, but in principle 
there's no such correlation. (patient 7, discontinuer) 
Some people probably think it's crazy that I'm taking this medication. Only my family knows, and 
my friend. I use it and it helps me, and I don't care what anyone else says. (patient 17, continuer) 
My family knows I use medication, but what for they don't know. I believe they think it's just 
some relaxation pills, nothing more. I'd rather not tell anyone. I'm afraid to get labeled mentally 
unsound, and not being able to get rid of it. When I get back to work I want to have all of my 
job's responsibilities; no special treatments because of what happened to me. (patient 12, 
continuer) 
When I talk about it with other people they're often wondering if taking this kind of medication is 
a wise thing to do. You hear a lot of negative stories about these medicines. That's a shame 
because I'm sure there are people who benefit from it. (patient 7, discontinuer) 
My wife thinks this medication is scary since it's affecting your brain. That doesn't bother me. 
The list of side effects on the information leaflet was quite shocking to her. So we talked about it, 
and then asked our GP if I could stop using it. I am doing okay now, but the deepest fears haven't 
gone away yet. (patient 1, discontinuer) 
Moment of discontinuation 
In my case the benefits outweigh the downsides, as far as I can tell. Obviously, I'm worried about 
the bruising and the muscle aches; what does that mean about what's happening in your body? 
Perhaps if I knew more about that I would decide to quit. But I had thought long and hard on 
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whether I should start with it, so you don't quit just like that. After all, my quality of life did 
improve (patient 10, continuer) 
The weather was fine, and I was doing okay. I was tired of being dependent on medication any 
longer, so I just quit. I thought I could do without; others also can. (patient 3, discontinuer) 
I don't believe I could do without my medication yet. I'm still feeling too unstable. Once I can 
quit I will do so, but I'm afraid I'll slide back to my previous conditions. I update the GP on how 
I feel and leave the decision when to quit to him. After all, he's the expert. (patient 11, continuer) 
I don't want to take any pills if it's not absolutely necessary. I had called the doctor to start 
reducing the dose. I thought, if I don't speak up, a year from now I would still be taking these 
pills. But he thought it was too soon, so I'll continue for a little while longer, which is fine. 
(patient 15, continuer) 
I felt much better and was not sure whether this was due to the fact that I started dancing and 
sporting again, or due to the medicine. That's what I wanted to find out, and that's why I stopped 
taking the medicine. (patient 6, discontinuer) 
Considerations for continuation 
I'd like to try quitting one more time. If I still get the symptoms back even after this third time, 
then I'll accept that I just have to take this pill. Then it would no longer bother me. (patient 8, 
discontinuer) 
Reasons for discontinuation and consequences of it 
To me, quitting was a very positive experience. I did suffer from side effects, but with every day I 
felt I was becoming more “me.” I felt a boost in energy and started picking up activities. I do 
worry about the depression returning, knowing that I quit too soon. However, I would never take 
an antidepressant again. The cure is worse than the disease! (patient 7, discontinuer) 
I just couldn't go on any longer. So I started again; I have arranged it all myself. I just know by 
now that it's better for me to take this medicine. (patient 3, discontinuer) 
 
42 van Grieken et al. 2014 
I felt that I was more held back than that there was a connection to what I was experiencing. So 
the [treatment] method was leading more than I was. It was also really the method that didn׳t 
work for me. (ID26) 
Everybody was in the same process and at the same courses… I think it was primarily the people 
who were taking a lot of antipsychotic medication, and were sometimes suddenly screaming 
loudly or demanding a lot of attention, and were physically very slow at the time that we were 
doing an activity, interfering more than that they were able to participate. I sometimes found that 
horrible, I really had trouble with that. (ID28) 
 
The lack of a framework has a very negative impact: what are you working on, where are you 
headed, how long will it take? If I know what his or her perspective is, I can speak more easily. 
Then I know what׳s being measured, and in what direction someone wants to take me. It also has 
to be clear, I really missed that. You see, of course there is an end. At a certain moment you׳ll be 
discharged. And that doesn׳t mean that you׳ll be 100% recovered and healthy, but it׳s nice to 
know that in advance.’ (ID23) 
There must be a plan, a beginning and an end, and you have to have goals. I found that lacking 
very much. … What you were working towards and what you wanted. (ID4) 
Because then if I went into therapy, very frequently I had to go through my whole childhood, 
family, and work, whereas that׳s not where the problem was. It lay primarily with the way I was 
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thinking and incorrectly reacting to situations. You don׳t solve that directly by discussing your 
marriage, parents, or childhood, that in fact had nothing to do with it. (ID4) 
Then I was referred to a psychologist for [therapy] sessions. And I thought, I׳d also find 
medication perfectly fine. But I thought, they׳ll know… I would have preferred to think along and 
be involved in the decision-making. … So, we weren׳t making any progress, we were only talking 
about my past and meanwhile I was not recovering from my depression. … I experienced several 
times that in hindsight I thought: why are we doing it this way? (ID19) 
If, for example, every psychiatrist would tell a client: we׳re going to work together for four 
sessions, and after those four sessions, you can say whether you think it׳s working or not. I׳ve 
never experienced a psychiatrist who evaluates. (ID15) 
The only reason why I am on medication now, is because friends and family have given me 
incredible support with this. Otherwise I wouldn׳t have taken pills. Thirty minutes with my 
psychiatrist was not enough to convince me. He didn׳t take enough time for that. I had a very 
serious fear that was not being recognised. And it was also not taken seriously. And that has a 
very large influence on adherence. (ID11) 
I don׳t think that the confidence was really there to just talk about myself over there. It׳s just very 
important that there is a click in order to move forward together. (ID16) 
Hope is incredibly important. That always has been a tremendously important basis for me. 
Therapists who have the balls to say that everything will be all right: that requires courage. 
Because there are also therapists who do not dare to say that, because they don׳t know whether 
that׳s true and they think it׳s not right to say it then. (ID20) 
‘I had a very good psychiatrist, but then I couldn׳t go to him anymore and I had to go to someone 
else. And then you feel you need to start all over again. (ID2) 
What doesn׳t work: someone who doesn׳t take you seriously. He wasn׳t warm, he didn׳t show any 
compassion…. Apparently I felt ‘you׳re not going to help me’. No, I didn׳t even start with him.’ 
(ID20) 
 
There has to be a good mix between a professional attitude and not too much distance, And also 
not someone who sits across from or next to me and will continuously say ‘oh yeah, that׳s 
horrible’… yes, who will only commiserate. So also there will have to be a balance actually. 
That I have someone who confronts me with things, but where I also feel, whenever there is a 
confrontation, that he understands me.’ (ID9) 
You also feel very dependent. I actually felt growing smaller and smaller during that 
conversation. I absolutely did not have a good feeling then. (ID16) 
‘I would rather have someone who knows better than I do. That׳s what you need. There are 
certain phases where you really need to be told what to do. If that doesn׳t happen then, that 
works badly.’ (ID23) 
‘A three month-waiting list! And one week afterwards I attempted suicide. Exactly because 
you׳re going there to ask for help because you can׳t deal with it anymore.’ (ID21) 
What can be worse for someone with a depression than to be abandoned? I attempted suicide, 
amongst others because I could not get a hold of my therapist… who was just not available. Then 
I thought now I׳m done…. What I really find heart-warming, I now have an agreement with my 
psychiatrist: ‘I will never call you. And if I call you, all alarms are on red. Then I want you to 
directly intervene, to put me on medication, and to set me up with a specialist.’ That kind of 
agreements has a very high value for me. (ID20) 
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At a certain point you׳re not sure who your primary contact person is. I also found that to be 
something very difficult. I never had the feeling that there was one person who I could always 
contact. (ID28) 
You end therapy and after a while, you relapse again. Aftercare, that was not available. I think 
that it׳s better if you follow-up on people, that you let them return every month or every two 
months, and that you just go through those check-lists, like how is this going, how is that going, 
how is the other thing going? Because that׳s my experience, you yourself do not ring an alarm 
bell. Because you׳re already so fed up and you׳re ashamed that you failed again, and then you 
think, tomorrow things will be better again. (ID4) 
To involve the significant other is important, not in the least for the significant other him/herself. 
Also that attention be paid to the possibilities of the partner to be supportive or to need support 
themselves. That should be part of treatment, as at least for me, one of the success factors has 
been my system. (ID20) 
 
43 Vargas et al. 2015  
Many participants said their depression could be treated by medication that “helps to regularize 
the nerves (ayuda a regularizar los nervios).” 
Labels because of their depression: Close associates, such as relatives, friends, or 
acquaintances, viewed participants’ depression as a sign of personal weakness or lack of drive 
to feel better, as if, “you want to feel [depressed]…  [and] that with just a little extra effort, you 
can get out of it.” 
Other people viewed depression as something which “does not exist, something that you cause 
yourself,” through excessive investment in your own dilemmas (“believing in your own crap”), 
dwelling on problems, attending too strongly to negative circumstances, or apathy about 
negative emotive states (“you let yourself fall and let it happen”). 
María explained that her family and friends said depressed people need to “put forth effort 
(poner de su parte), that it is not an illness … that depression is cured  … by oneself putting forth 
effort … and going to church.” 
Silvia described, “I have always been depressive … but with strong will (fuerza de voluntad) I 
have prevailed, but not now. The other [times I’ve used] the remedy of ‘I won’t pay attention,’ of 
patching up the problem …  and now … my mind says no.” 
Diego described his father’s attitude toward antidepressants as follows: “My father …  doesn’t 
agree with this … he says I can get better on my own, but it’s not as easy as he thinks.” 
Gabriela described her preference for natural medicine, like tea, but explained how it did not 
address her mental health needs: “I have always liked natural medicine, but you know … it is 
very delayed and … too mild (suave) for what I have,” indicating her depression was too severe 
for alternate treatments. 
One participant expressed her frustration at not being located on this gradient: “so far  … they 
haven’t told me what class of depression I have.” 
“[My psychiatrist] would give me tests similar to this one and I never knew what came of those 
tests.” He eventually dropped out of that treatment. 
Many participants described delaying psychiatric treatment by trying first to “keep fighting with 
my problems and control myself.” 
Pamela explained why she avoided treatment in the past: “I thought … I am going to take 
medicine and my nerves are going to become unwell (voy a estar mala de los nervios), I will 
have to start seeing a psychiatrist—the psychiatrist is for crazy people.”  
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Daniela stated that her family thought antidepressants could also precipitate the onset of 
madness. Seeing a psychiatrist could be construed as a pathway to madness.  
Miguel explained how seeing a psychiatrist could yield further stigmatization: “[People say 
about a depressed person] that he is crazy  … And if he sees a psychiatrist or something, they 
say, no, that one really becomes crazier every day. Because psychiatrists, they say …  make 
people crazy.” 
Ricardo explained this difficulty: “It took a lot from me to come [to the clinic] because of all the 
myths, the negative aspects … [attributed to] a person with depression … who sees a 
psychiatrist.” 
Most sought help only when completely unable to cope: “If I were to find a solution … I would 
not look for help. But … this is overtaking me [me está rebasando]. And each time it’s … more 
so.” 
Gabriela explained that she stopped going to a previous treatment because she at that point 
“thought I could … help myself without needing the medication.” 
Other concerns with bodily effects included fluctuations in weight, sleeping habits, sexual 
function, dizziness, and “the way they [medications] can alter my brain.” 
Elena described, “if … they need to remove my liver because I have hepatitis as a result of the 
medications, my depression will get worse, it will get stronger.” 
Margarita said she worried over feeling “abobada” (befuddled) as a result of taking the 
medication, and that “other people could do with me whatever they want  … that I would not be 
aware of what was happening.” 
[I]f I stop taking it … you can feel more down, more depressed, a greater sense of guilt or a 
desire to kill yourself … if I don’t feel that way now, and by ceasing medication treatment I’d feel 
that way, well then I say things are just going to get worse. 
[Using medication for a long time] would be  … relying entirely on the pill to feel well. And the 
pills only, in my opinion, [should be used for] a limited time to help the person return to their 
normal state. 
Carolina said, “I have heard that if you take it every day, they are addictive every day. But I 
think that … if the doctor says you must take it, you must take it. He will know when to stop it.” 
Carmen explained, “If I go to the gym, I feel better as well, but right now I feel so impotent, so 
bad, that I can’t find the way to go exercise.” 
Elena explained that while others thought visiting a psychiatrist was “a thing crazy people do 
(cosa de loco),” she thought treatment was meant “to help everyone, crazy people and those who 
are not crazy.” 
 
44 Vilhelmson, Svensson and Meeuwisse 2013 
In fact, my so-called ‘depression’ was a normal reaction to crisis following separation, 
homelessness, loss of two jobs within three years, and death in the family. (Woman, 63 years 
old). 
Went to see a doctor because I was exhausted. Could not sleep, could not think, had stopped 
working. The doctor said it was depression, but I was hesitant. I did not feel depressed, just tired 
and sad about the terrible situation I was in…He stated all symptoms of fatigue to be the same as 
depression. (Woman, 41 years old). 
I have had a very severe, lonely, and anxious childhood (not because of incest or physical 
violence) and as an adult have had more and more frequent and deeper periods of apathy and 
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depression. My memory works poorly, and I have had big blackouts in the past and have needed 
therapy to make out what is missing. (Woman, 34 years old). 
I was not feeling well after my second breast cancer and was offered psychiatric help and 
thought that it would be useful to talk to someone, but after twenty minutes, first consultation, I 
was offered ‘happy pills’. (Woman, 50 years old). 
I do not like taking pills and told this to the doctor. Then she proposed Valium [Swedish 
benzodiazepine brand name (substance: Diazepam) – author’s not] so I would feel more relaxed 
in taking Seroxat [Swedish antidepressant brand name, substance: Paroxetine – author’s note]. 
(Woman, 50 years old). 
The doctor has told me to continue in order to feel better and that I shall understand it as a 
‘vitamin boost’. (Woman, 36 years old). 
Maybe the root cause is not a chemical imbalance in the brain! (Woman, 38 years old). 
I along with my doctors know that I have low levels of serotonin and one doctor told me that I 
probably will have to take Cipramil [Swedish antidepressant brand name (substance: 
Citalopram – author’s note] for the rest of my life (Woman, 38 years old). 
I have felt that the reason for doctors to prescribe antidepressant medication is that it is the only 
help they can offer, and that this is why the doctor can be frustrated if you reject this help. 
(Woman, 38 years old). 
All I wanted was someone to talk to, some sort of therapy. (Woman, 22 years old). 
The first doctor I visited barely looked at me when I told her about my symptoms. (Woman, 42 
years old). 
I have the ‘luck’ nowadays of having ongoing contact with psychiatrists with solid knowledge of 
the field and who also order laboratory tests to ensure that the right medicine is prescribed. 
(Woman, 49 years old). 
After a couple of months of being sick-listed because of severe burnout, the doctor decided to 
issue an ultimatum: either I started with Fluoxetine [Generic antidepressant, substance: 
Fluoxetine – author’s note], or he would not continue my sick-listing. (Woman, 26 years old). 
…I refused despite threats of ending my sick-listing, since I ‘apparently did not want to get better 
as I was avoiding work’, as he [the doctor] concluded. (Woman, 34 years old). 
While I have been medicating, my doctor and I have not spoken. (Man, 56 years old). 
This one [the doctor] after I ended drug treatment has have been malicious and unpleasant and 
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Appendix F. Step 3 of study selection. Summary of screened qualitative, quantitative, and mixed method studies (n=426) 
Year Author/s Title Country 






Focus of the study Results/Conclusion 
Recommendation for 
future studies/actions 














The moderately to severely 
depressed group reported 
significantly more masochistic 
dreams than the non-depressed 
group.  
 
Psychoanalytic interview with 
focus on the verbal and 
nonverbal behavior of the 





The depressed patient Canada Commentary Depression Depressed patients 
demand attention 
and sympathy. They 
can drain nurses 
emotionally. 
In patients who are prevented 
from externalizing their feelings, 
it is more than likely, their anger 
will be internalized with 
consequent prolongation of the 
depression. 
The nurse can be guided by 
the knowledge that it takes 
time for anyone to work 
through a depression.  
1965 Ayd, Frank J. The chemical assault 
on mental illness: 
The antidepressants 




their adverse effects 
Although the progress made  
from 1953 to 1963 can rightfully 
be called unprecedented, the fact 
remains that much needs to be 
accomplished. 
To discover more effective, 
safer drugs for the mind. 
Equally necessary are more 
nurses prepared to care for 
psychiatric patient 













DSM III, DAS, 
HRS-D 
amitryptyline 75-
120 mg + 
benzodiazepine 
Positive effects of the tricyclic 
antidepressants on depressive 
symptomatology are 
accompanied by changes in 
cognitive patterns  
Role of persistent irrational 
beliefs in people prone to 














DSM III R& 
ICD 10-DCR 
tricyclic AD or 
similar; MOI; 
benzodiazepine & 
'other'; 100 mg of 
Amitriptyline 
Treatment is not effectively 
deployed 
Systematic research on 
the effectiveness of 
services for depressed 
patients 
1992 Karp, D.  Illness ambiguity and 
the search for 
meaning 







the illness, reliance 
on medical experts, 
efficacy of ADs 
 
Group discussions provided 
plausible explanations for shared 
difficulties. Group talk implied 
an antipsychiatry ideology that 
questioned medical dominance  
 
Examine a variety of 
personal troubles and 
learn the timing and let 
the circumstances 















Depression To explore the 
symbolic meanings 
attached to taking 
antidepressant 
medications 
However long it took the 
respondents to recognize and 
label their difficulty as 
depression, their eventual 
treatment by physicians involved 
use of prescribed medication. An 
individual’s response to 
medication can be described as 
process of unfolding 
consciousness and identity 
change consisting of: resistance, 
trial commitment, conversion, 
and disenchantment. 
Not found 
1994 Flare Personality by 
prescription 
Canada GREY LIT 
    

















Shared features of the depression 
experience found; living with 
depression varies  
How gender, marital status, 
occupation, race and ethnicity 
influence the meaning of 
being depressed  
1995 Bech, Per Quality-of-life 
measurements for 
patients taking which 
drugs? The clinical 
PCASEE perspective 










stressors or negative 




Patients with primary depression 
are less reliable than doctors or 
their relatives in giving reliable 
assessments of their cognitive 
and affective symptoms when 
they are ill.   
Health-related QOL 
measurements are 
recommended as they have an 
impact on doctor-patient 
relationship and involve a 
holistic approach to drug 
treatment by checking all 





experiences as a side 












Suggested increases in central 
serotogenic neuronal activity as a 
probable cause of orgasmic 
sexual experiences 
Experience with fluoxetine 
to understand the 




1995 Lewis, S. E. A search for 
meaning: Making 




























Depression is a different 
experience for everybody 
Looking at how clinicians 
understand the concept of 
depression and how far this is 
consistent with their patients' 
understanding of depression 
1995 North et al. Patient responses to 
benzodiazepine 
medication: a 
typology of adaptive 
repertoires developed 








s users  
In all cases, 
benzodiazepines 
were initially 
prescribed during a 
high-stress 





were given a high 
degree of autonomy 
to manage their own 
use 
Type and dosage of the regime 
was established by the users's 
doctor, but the community-based 
participants in the study 
were granted considerable 
autonomy in the management of 
their regime and had generally 
developed an understanding of 
mutual trust with their doctor. 
Emergent concepts of this 
kind can serve to sustain 
patterns of patient self-
regulation and active 
management, rather than 
merely to extend the reach of 





















rating & the 
GP general 
assessment 




The use of low doses, long 
duration of treatment and 
uncertainty are important 
features. Also, discrepancy btw. 
The use of ADs in GP and the 
scientifically-based 





& Frodi, A. 
Gender differences in 













gender and eliciting 
factors of 
depression, marital 
status, age, season 
of hospital 
admission, type of 
medication 
Significant gender differences re. 
eliciting factors, marital status 
and age. 
Results concerning type of 
medication and season of 
hospitalization need to be 






1996 Barter & 
Cormack 














This study found 
that the participants 
had no knowledge 
of what their 
doctors thought of 
their use of 
benzodiazepines 
Participants perceived 'giving up' 
their drugs as problematic, 
indicating that research is 
needed to examine the 
conceptions long-term users hold 
about discontinuing their drugs 
Doctors need to be informed 
on how to introduce the idea 
of discontinuation to their 
patients without evoking 
distress, disappointment, fear 
and failure. 









1996 Priest et al. Lay people's attitudes 
to treatment of 
depression: results of 
opinion poll for 
Defeat Depression 
Campaign just before 
its launch 










lay beliefs &public 
opinions 
Counselling favoured; 
antidepressants and tranquillisers 
believed to be addictive; 
tranquillisers found affective in 
depression 
This survey was carried out 
in December 1991, before 
the launch of the Defeat 
Depression Campaign in 
January 1992. Findings of a 
further survey at the end of 
this campaign are expected 
1997 Bosc, Dubini, 
& Polin 
Development and 
validation of a social 




















with placebo and/or 
fluoxetine 
The SASS scale represents a 
useful additional tool for the 
evaluation of social functioning 
in depression 
The SASS scale will facilitate 
the development of new 
antidepressants with 
differential effects in this 
domain in depressed patients 
1997 Cooper-
Patrick et al. 
Identification of 




USA focus groups Depression Patient experiences 
and concerns re. 
treatment in 
depression 
Identified a wide range of patient 
attitudes and preferences 
Incorporate the range of 
factors  identified by patients 














4 BPD; 12 











A large number of patients did 
not receive adequate treatment 
before hospitalization  
Pay more attention to the 
training of physicians in 








of recurrent major 
depressive episodes: 












People entering a 
major depressive 









characteristics of the prodromal 
phase of recurrent depression 
and patient responses, and 
toward a more comprehensive 
phenomenological description 
of the experience and 
characteristics of this phase 
Specific clinical interventions 
should be developed to 
identify early warning signs 
and initiate actions that can 
help minimize or prevent a 
major depressive episode.  
This study can inform further 
investigations of the course 
of recurrent depression 








Study of Beliefs and 
Outcomes.  
USA Dissertation 
    
1998 Lewis & 
Nicolson 
Talking about early 
motherhood: 
Recognizing loss and 
reconstructing 
depression 












Deconstructed experience of 
depression as part of women's 




History of modern 
psychopharmacology: 
a personal view with 
an emphasis on 
antidepressants 




Depression Provided the 
chemical basis for 
the molecular 
modification of H1 
antihistamines in 




Molecular manipulation can 
produce new therapeutic leads  
Increase research efforts in 
all branches of 
psychosomatic medicine 
1999 Gammel & 
Stoppard 
Women's experiences 













readily co-exist with 
personal 
empowerment 
Medicalization of depression has 
disempowering consequences 
Develop strategies for 






2000 Boyle & 
Chambers 
Medication 
compliance in older 
individuals with 
depression: gaining 
the views of family 
carers 










Number of key issues identified 
with carers acting as advisors 
Explore methods to develop 
enhanced relationships btw 
caregivers and older 
patients 
2000 Bultman & 
Svarstad 
Effects of physician 
communication style 
on client medication 



















Mapping the ways the providers' 
communication influences 
patients' treatment adherence  
Determine if physicians' 
collaborative style directly  or 
indirectly effects treatment 
outcomes 
2000 Churchil et 
al. 
Treating depression 







square tests and 
logistic 
regression 
Depression Patients' preferences 





Counselling preferred over drug 
treatment (3 times); negative 
association of depression caused 
by problems in ppl's lives; no 
association btw a preference for 
counselling and age 
Results of studies evaluating 
effectiveness of counselling 
for depression in primary 
care  
2000 Cooper et al.  Primary care patients’ 
opinions regarding 
the importance of 
various aspects of 












ability to restore 
patients to their 




is particularly important and 
should be considered in 
decisions affecting health policy 
for patients with depression. 
Explore how patient 
attitudes and ratings of care 
differ across demographic 
groups and determine how 
patient attitudes influence 
their preferences for 
treatment, receipt of 
guideline-concordant care, 


































Most depressed primary care 
patients desire treatment, 
preferably counselling. 
Treatment preferences vary by 
ethnicity, gender, income, and 
knowledge about treatment 
Examine the extent to 
which patient treatment 
preferences are honored; 
whether educational 
interventions shift patient 
preferences, and whether 
providing preferred 
treatments leads to 
improved treatment 


























Study provided new insights into 
possible mechanisms for non-
compliance 
The need for other more 
objective methods other than 
pill counting and patient 
questioning in controlled 
clinical studies 
2000 Jorm et al. Public belief system 
about the helpfulness 
of interventions for 
depression: 
associations with 



















of depression and 
seeking professional 
help 
Analysis of reasonable and less 
reasonable public beliefs 
detected limited knowledge. The 
study forms part around the 
concept of mental health literacy.  
Awareness of such belief 
systems is helpful in 
individual treatment 
programs and in health 
promotion campaigns that 
improve mental health 
literacy 
2000 Lin et al. Low-Intensity 
treatment of 
depression in primary 
care: is it 
problematic? 















 Patients demonstrated poor 
adherence to pharmacotherapy 
and inconsistent follow-up visits  
Systematic and pro-active 
monitoring of patient 




2000 Williams et 
al. 
New drugs for old 
folks: the evidence 
based argument for 
newer antidepressants 
USA Review of data 













SNRIs and St. 
John's wort) 
The newer agents are superior to 
placebo for MD and dysthymia 
but their absolute superiority 
over the second generation 
tricyclic nortriptyline is not 
supported.  
Application of newer agents 
for the treatment of mood 
disorders beyond MD and 
among more representative 
clinical populations; data on 
the options not responding to 
initial treatment; benefits of 








Belgium Commentary  Depression Antidepressants  Poor acceptance of, and non-
adherence to antidepressants  
continues to hinder effective 
treatment in MDD 
Explore patients' 
beliefs and attitudes 
and their origin 





USA Review Depression Recurrent 
depression 
Understanding the chronic nature 
of this illness is key to the 
development of a more 
informed, longitudinal 
perspective on the diagnosis and 
treatment of depression. 
Re-conceptualizing major 
depression from this 
longitudinal and 
multidimensional perspective 
is crucial to providing an 
effective response to this 
critical public health 
challenge 
 
2001 Kadam et al. A qualitative study of 

















Patients' views are central to 
informing the debate on the 
management of affective 
disorders 
1) Explore the degree to 
which patients perceive the 
GP as the main source of 
help; 2) Check how 
counselling services are 
delivered; 3) Explore 
patients' perceptions and 








exploration of the 
woman's experience 
USA Dissertation 
    
424 
 
2001 Mundt et al. Effectiveness of 
antidepressant 
pharmacotherapy: the 





















Effective treatment with 
pharmacotherapy; medication 
compliance is critical to 
effectiveness 
Additional efforts at program 
improvement  
2001 Schaub et al. What do patients in a 
lithium outpatient 





















Lithium Negative correlation with age; no 
correlation with duration of 
treatment, sex, education and 
diagnosis 
Patient education about 
lithium should be intensified 
to adverse effects, especially 
in older patients  
2001 Sirey et al. (a) Perceived stigma and 
patient-rated severity 


























mixed age,  
Antidepressant 
medication 
1)Treatment adherence  
correlates with lower perceived 
stigma, higher self-rated severity 
of illness, age over 60 years, and 
absence of personality pathology 
2) Patients' views are important 
in explaining treatment 
behaviors   
Deepen understanding of the 
individualized impact of 





2001 Sirey et al. (b) Perceived stigma as a 
predictor of treatment 
discontinuation in 




















MDD Perception of 
stigma was greater 
in younger patients. 
Stigma negatively 
influenced treatment 
only in older adults. 
Patient stigma is a useful target 
for intervention to improve 
treatment adherence out 
outcomes in depression 
Stigma is an appropriate 
target for intervention aimed 
at improving treatment 
adherence and outcomes 
 2002 Andersson, 
Lindberg, & 
Troein 
What shapes GP's 







Depression GPs discussing 
doctor-patient 
relationship 
GPs preference for individual 
'tacit knowledge' 
GPs should make optimal 
use of available treatment 
options and be more critical 








and coping strategies 
preceding 
schizophrenic and 

















symptoms + related 
coping strategies 
Schizophrenic patients showed a 
more increased emotional 
reactivity whereas depressive 
patients reported an increased 
emotional reactivity, certain 
perception and thought 
disturbances  
Confirm these findings in 
first episode or initial 
prodromal state to use them 
for early diagnosis and 
intervention 
2002 Bull et al. (a) Discontinuation of 





USA Mixed method: 
Tel. interviews; 















contact may increase treatment 
adherence. The study captures 
information from the 
perspectives of both patient and 
physician 
Precise instructions about 
pharmacological treatment 
and possible adverse effects 
may improve adherence 
426 
 




USA Mixed method: 
Telephone 
surveys at 3 and 
6 mos after 









disorder; ICD 9 
SSRIs Adverse effects are the main 
reason for treatment 
discontinuation. Suggestion of 
possible adverse effects appears 
to induce such effects 
Physicians and pharmacists 
should inform patients about 
possible adverse effects. 
Future research should 
address development of 






















The vast majority were receiving 
antipsychotic medication; a 
substantial proportion were also 
on antidepressant and mood 
stabilizing agents. Atypical 
antipsychotics tended to be 
associated with lower levels of 
psychotic and affective 
symptomatology, and a generally 
lower side-effect burden. 
Determine the optimal 
medication regime for each 
individual patient, and in 
exploring psychosocial 
treatments which can 
augment medications 
in the holistic care of 




Beliefs and Attitudes 
of African Americans 
with type 2 diabetes 











Depression The beliefs & 







as a barrier to 
effective treatment  
Despite knowledge of depression 
and of effective treatment, 
multiple barriers and false beliefs 
may negatively influence 
adherence 
Need to compare the beliefs of 
African Americans diabetics 
with such patients from other 
ethnic groups. Need for 
studies on the relationship btw 
beliefs & attitudes in 
depressed diabetics and 
treatment outcomes in ethnic 
minorities  
2002 Hensley & 
Nurnberg 
SSRI sexual 
dysfunction: a female 
perspective 







SSRIs and treatment 
with sildenafil  
Sexual dysfunction is a common 
side effect of many ADs from 
different classes  
Double-blind placebo-
controlled trials of SSRIs-
induced sexual dysfunctions 







awareness of attitudes 















Lay beliefs and 
general attitudes in 
an Australian 
community 
Depression was perceived to 
have the greatest impact on 
quality of life (QoL). Attitudes 
toward ADs were less negative 
than in the past.    
The goal is to change 
critical attitudes and 
health behaviors. Future 
mental health campaigns 
need to be of significant 
intensity and duration 
2002 Katona & 
Livingston 
How well do 
antidepressant work 
in older people? A 
systematic review of 























trials in older 
patients 
The analysis supports the 
preferential use of SSRIs(exc. 
Fluoxetine) and of venlafaxine in 
depression treatment in older ppl 
 
The authors urge that 
regulatory authorities consider 
requiring NNT & NNH data 
in future trials as one 
clinically relevant and 
understandable measure 
2002 Knudsen et 
al.  (a) 
Changes in self-











SSRIs Emotional problems 
vs. emotional illness 
Findings in this study showed, 
the women’s self-concept was 
closely related to their social 
lives 
Further studies be made with 
other age groups and for men, 
and in other contexts and 
cultures, to analyze 
experiences with regard to the 





Perceptions of young 
women using SSRI 











their daily lives 
 
The young women using SSRIs 
felt stigmatized 
Further studies should be 
conducted with other 
population groups of users of 
SSRIs to analyse perceptions 






Just keep taking the 
tablets': adherence to 
antidepressant 
treatment in older 
people in primary 
care.  















Prevalence or the 
associates of 
adherence to ADs in 
older ppl  
1/3 of primary care patients who 
are thought to be adherent to 
ADs are not; a 'concordance 
therapy' & using medications 
that minimize side effects  
Test the effectiveness of an 
intervention based on 
findings from this study 
2002 Pampallona 
et al. 
Patient adherence in 











1973 to 1999. 









adherence factors  
1) confirmation that adherence is 
a major problem in the treatment 
of depression; 2) adherence has 
rarely been the specific research 
subject; 3) quantitative studies 
on adherence are neither reliable 
nor consistent  
Carefully designed clinical 
trials are needed to clarify 
effects of single and 
combined interventions on 
adherence 
2002 Posternak & 
Zimmerman 
The effectiveness of 
switching 
antidepressants 
during remission: a 

















Patients were followed for 8 to 
110 weeks. Preliminary 
evidence: switching ADs while 
in remission eliminated 
intolerable adverse effects in all 
patients (n=9)  
The results of this study need 

























treatment   
2/3 of the patients felt that ADs 
were helpful, 1/3 felt that they 
were not effective. Almost 2/3 of 
participants experienced 
moderate or severe adverse 
effects of ADs 
Maximize efforts to reduce 





Clinical databases of 
patients receiving 
antidepressants. The 
missing link between 
research and 
practice? 
Italy Brief report Clinical 
pharmacology 
Clinical databases 
for patients treated 
with ADs 
Clinical databases should be 
developed, organized and 
utilized in avoidance of the gap 
between research and practice 
Developing and maintaining 
clinical databases could 
ultimately constitute a 
permanent link btw. routine 
clinical practice and research 
429 
 
2003 Bitner et al. Subjective effects of 
antidepressants. A 















A pilot study of 
subjective effects of 
ADs on meditators; 
combined SSRIs 
and 'other 
medication groups'  
Meditation might be a helpful 
strategy in depression treatment, 
combined with ADs 
Investigate the effects of 












taken for depression 
USA Dissertation 








USA Review MDD and 
persistent pain 





patients who are at 
risk for depression 




Early pain management might be 
especially useful for 
patients who are at risk for 
depression who are not yet 
exhibiting significant depressive 
symptoms. 
To elucidate cultural 
contributions to the 
experience of pain and 
depression, much more 
research is needed across a 





The paradoxical role 
of antidepressant 
medication - 
returning to normal 
functioning while 








To identify factors 





Adverse drug reactions were 
of importance to respondents 
because of their direct effects 
and because they increased the 
stigma attached to taking 
antidepressant medication 
 
Patients may find it 
beneficial if doctors 
talk about the number of 
similar people that they treat 
for depression each day, 
thereby normalising the 
condition. 
 
2003 Gask et al. Qualitative study of 
patients' perceptions 
of the quality of care 








Depression To explore patients' 
actual experiences 
with the primary 
mental health care 
and quality of their 
services   
Quality of care in depression 
depends on good communication 
btw doctors and patients. People 
tend to accept non-professional 
help because of low expectations 
toward the health care and low 
self-worth   
A model of health care is 
advocated, in which patients 
with depression are followed 
up systematically  
430 
 
2003 Geddes et al. Relapse prevention 
with antidepressant 
drug treatment in 













trials until 2000 in 
which continued 
AD therapy was 
compared with 
placebo in patients 
who responded to 
acute treatment with 
ADs 
Prolonged treatment with ADs is 
recommended in patients who 
responded well to ADs in the 
acute phase  
Further trials are needed to 
establish the optimum 
duration of therapy. These 
studies need to also include 
patients with low risk of 
relapse 
2003 Knudsen et 
al. 
Leading ordinary 
lives: a qualitative 

















SSRIs Patients experienced relief from 
depressive symptoms while on 
SSRIs. The AD gave them 
resources to lead active lives and 
function on psychological and 
social level 
It is imperative for health 
professionals to explore 
users' views on 
pharmacological treatment 
and to gain insight beyond 
the knowledge derived from 
RTCs 
2003 Kwon et al.  Antidepressant use: 
Concordance 
between self-report 






Depression Adherence to 
antidepressant 
medications 
Self-report and claims showed 
good concordance, but they 
revealed different aspects and 
discrepant responses 
Percentage adherence with 
medications, especially 
among depressed patients, 
may be best assessed 
through multiple sources 
2003 Lin et al. Enhancing adherence 
to prevent depression 
relapse in primary 
care 
USA RCT, n= 386 
primary care 






Depression Pragmatic & 
biopsychosocial 
program to prevent 
relapse: patients 
randomized to 








This depression relapse 
prevention program showed 
significant increase in: positive 
attitudes towards ADs, self-
confidence in managing adverse 
effects, depressive symptoms 
monitoring, checking for early 
warning signs, and coping 
Addressing patients' 
attitudes and concerns about 
the use and side-effects of 
ADs is useful in improving 
adherence to long-term 
treatment in primary care  
2003 Manning & 
Marr 
'Real-life burden of 
depression' surveys - 













A large proportion 
of depression 
sufferers experience 
repeated episodes of 
depression. 
A majority of patients had made 
a lifestyle change to manage 
their depression or avoid relapse. 
GPs may benefit from 
educational programmes 
that promote awareness of 







adherence issues in 
antidepressant 
therapy 
USA Lit. review, 
Commentary   
Depression Factors contributing 
to nonadherence, 









represent obstacles to successful 
treatment in depression   
Combination of: adequate 
treatment duration, realistic 
patient expectations, and the 
right dose of medication 




The impact of 
antidepressant use on 
self-efficacy and 
athletic performance 
in female student 
athletes 
USA Dissertation 
    
2003 Posternak & 
Zimmerman 
How accurate are 
patients in reporting 
their antidepressant 
treatment history? 
USA Diagnosis of 











An assessment of 
trial adequacy being 
an important 
element in any 
evaluation of 
treatment history 
Patients were able to recall about 
80% of their treatment history. 
They were unable to recall 
situations where two ADs were 
administered together 
(augmentation trials)  
not found 
2003 Roeloffs et al. Stigma and 
depression among 
primary care patients 














Stigma is a major problem in 
primary care patients. The 
relationship btw. stigma and 
perceived unmet needs of 
depressed patients indicate there 
may be some unmeasured illness 
burden  
Further research should 
document effects of stigma 
in different communities and 
treatment settings and 
determine strategies to 
decrease its negative impact   
2003 Scheibe et al. Are there gender 
differences in major 
















SNRIs, MAOIs, & 
RIMAs) 
Women experience more 
vegetative and atypical 
symptoms, anxiety, and anger 
than men, and reported higher 
severity of depressive symptoms. 
No differences were found in the 


















Depression Available and 






AD on treatment 
adherence 
Patients listed pharmacists, 
primary care physicians, and 
mental health specialists as 
sources of information. 
Health care providers should 
give all patients chance to 
inquire about their AD 
medication and educate 


















Depression Hispanic patients 
respond and adhere 
to AD treatment 
differently than non-
Hispanic people 
Primary care doctors asked only 
one of five patients on continued 
therapy how well the AD was 
working and only one in 10 
patients if they were 
experiencing side effects 
Future research needs to be 
conducted in other parts of 
the US to examine if 
Hispanic patients are treated 
differently and how 
Hispanic ethnicity impacts 
antidepressant adherence in 
larger samples 
2003 Solberg et al. When depression is 
the diagnosis, what 
happens to patients 




















A much larger share of 
depression is chronic than 
usually assumed and depressed 
patients have a significantly 
lower quality of life 
Primary care physicians 
need to improve depression 
care 
2003 Sullivan et al. Patient beliefs predict 
response to 
paroxetine among 
primary care patients 
with dysthymia and 
minor depression 























Patients' beliefs about their 
health and depression add to 
depression type and age 
predicting responsiveness to 
ADs. No need to believe in own 
depression as a biological illness 
to adhere to treatment was 
demonstrated as well.  
Patients with milder types of 
depression should be 
scheduled for a return 
appointment after 1 or 2 
months of watchful waiting 
in place of immediate 
medication 
2003 Wiens Juliana Depression and 
decision making: a 
material-discursive 
analysis of 
antidepressant use in 
women 
Canada MA THESIS 
    
433 
 
2004 Bann et al. Assessing patient 
beliefs in a clinical 
trial of hipericum 
















data models     
MDD Patients' beliefs 
about the causes of 
their depression and 
the helpfulness of 
certain treatment 
options can have 
impact on their 
adherence; trial of 
hypericum, 
sertraline, or 
placebo treatment  
The results support the role of 
patients' beliefs in their recovery: 
people who believe in causes of 
their depression being outside of 
their control will less likely 
improve over time 
Future studies should 
explore if patients' beliefs 
have an even greater impact 
if supported by patients' 
knowledge about the 
treatment and accept it as in 
accordance with their beliefs 
2004 Bhugra & 
Hsiao-Rei 
Hicks 














doctors to be 
applied in real-
world situations  
Depression and 
suicidality 
South Asian women 
suffer 
disproportionately 








Pattern of significant 
improvement: large proportion 
of women reading the pamphlet 
remonstrated a help-seeking 
attitude; 51 % agreed at baseline 
that AD were efficient in 
depression treatment 
Verification of findings 
would require a large, 
prospective study 
2004 E Boath, E 
Bradley & C 
Henshaw 
Women's views of 
antidepressants in the 








value assessed  
Postnatal 
depression 
Women are likely to 




may be clinically 
ineffective 
The majority of women in this 
study did not take their AD as 
prescribed, and were self-
regulating or discontinuing 
treatment.  
Women need ongoing 
support and monitoring from 
their GPs. Communication 
and information about 
treatment is necessary. Fears 
of dependence and stigma 
may dictate the women's 
decisions     
2004 Bollini et al. Understanding 
treatment adherence 
in affective disorders: 
a qualitative study 
Italy Qualitative; 8 
separate focus 
groups 
Depression Patients' models of  
depression, 







The study highlighted several 
themes which should be 
considered when designing 
specific interventions to improve 
adherence with treatment  
Need to address stigma and 
discrimination which were 
brought up in this study but 




2004 Dinos et al.  Stigma; the feelings 
and experiences of 46 







own reports of 
their diagnoses 
as the most 
relevant 
description of 
their illnesses  
Experiencing 
stigma, forms of 
stigma and forms of 
mental illness, types 




lack of stigma  
Perceptions of depressive illness 
and stigma were not always 
negative. Some participants 
denied feelings of stigma and 
discrimination and showed 
positive attitude towards their 
treatment   
Data collected through this 
study is being used to 
develop a quantitative 
measure of felt and enacted 
stigma that is hoped to be 
applied in evaluations of 
mental health services and 
treatments  
2004 Frankenberg


















depression and its 
treatment accessible 
to college students; 
influence of general 
perceptions  
Several conclusions. One of 
them is that college students 
should be presented with 
effective methods to reduce or 
cope with stress before they are 
diagnosed with depression and 
placed on AD.   
Further research, using an 
appropriate sample of men, 
should be conducted on the 


















coded to allow 
qualitative 
analysis 
Depression Work on a 
concordant 
approach responsive 
to the patients' 
needs 
Large amount of information 
was needed to support 
individuals beginning courses of 
AD medications. Current health 
services did not provide patients 
with sufficient information about 
their AD treatment 
Developing and evaluating 
intervention that would 
provide verbal and written 
information by healthcare 
professionals to patients 
who start treatment with 
ADs.   




comparison of an 
information leaflet on 
antidepressants with 











Depression 6 commonly asked 
questions about AD 
in the Depression 
Alliance leaflet 
were used as a 
framework for 
analysis  
There is a gap btw. the 
professional representation of 
depression as a physical illness 
and patients' own experience of 
depression 
Improving the leaflet to 
accommodate patient's 
knowledge would encourage 
the public to consult the 
professionals, making them 
aware of views and attitudes 
435 
 
2004 Halter M J The stigma of 






Help Scale & 
Attribution 
Questionnaire 
Depression Seeking help in 
depression hindered 
by the mechanisms 
of the disorder. 
Stigmatization is a 
leading cause of 
under-diagnosis and 
under-treatment 
The belief that depression was 
under personal control associated 
with not seeking care, and 
greater anger toward persons 
with depression. Pity involved. 
There is still the perception that 
depression is a sign of weakness 
of evidence of a flaw.  
National focus on mental 
health should get the 
attention of policy makers. 
Researchers should study 
and develop successful 
interventions to minimize 
stigma and change general 
views on depression.  
2004 Haslam et al. Patients’ experiences 
of medication for 
anxiety and 
depression: effects on 
working life 
UK Qualitative: 
focus groups,   
Depression Prevalence of 
anxiety and 
depression has 
increased, leading to 
extensive use of 
medication 
Non-compliance was widespread 
due to adverse effects, lack of 
improvement in symptoms and 
fear of dependence. Patients 
were not well informed by their 
physicians about the medication.   
Providing information and 
careful patient monitoring 
may improve compliance. 
Development and evaluation 
of accessible patient 
information leaflets a high 
priority for primary care 





an intervention to 
help older people 
take antidepressants 
UK RTC Depression in 
older people 
Concordance 
Therapy over 3-4 
sessions; 9 patients 
received treatment 
as usual; Main 
outcome measure: 
adherence at 1 
month. 
The therapy was acceptable to 
patients. The cases had less 
depressive symptoms; beliefs 
about ADs were more positive in 
this group. Concordance Therapy 
for older patients taking ADs is 
acceptable and feasible.    
It is suggested that 
Concordance Therapy be 
tested with a larger, 
statistically robust trial and 
also test economic 
feasibility of the tool 
2004 Rabheru 
Kiran 
Special Issues in the 
management of 










treatment in older 
patients often 





Depression in older patients can 
impact comorbid medical 
conditions. Rates of strokes and 
cardio-vascular events are higher 
in depressed older patients than 
in others.  
More trials should examine 
the long-term efficacy and 
safety of AD treatment in 
older patients. More data are 
needed on the effects of 
ADs on comorbid medical 
conditions 

























findings of a 
national survey of 
primary care 
patients who were 
selected specifically 
for chronic and 
recurrent depression 
The patients were not treated to 
full remission, complete 
wellness and full life function. 
Almost half of participants 
complained about adverse effects 
of ADs.  
Patient-physician 
communication needs 
improvement. An important 
area of such improvement is 
the way in which treatment 
decisions are made 
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2004 Swan et al.  "Coping with 
depression": an open 
study of the efficacy 




refractory depression  











II, BSI, global 
severity index, 
EQ  
The CWD course 










recommended for the chronically 
depressed patients. Baseline 
assessments confirmed 
chronicity and treatment 
resistance, high symptom burden 
and poor QOL in the study 
cohort. 
There is a need to evaluate 
the efficacy of CWD in a 
formal RCT and to 
determine if the course 
should be modified to 
improve patients' adherence 
2004 van Schaik et 
al.  
Patients' preferences 
in the treatment of 









Patients' choice and 
autonomy should be 
respected. These 
preferences can be 
supported by 
primary health care  
Providing information and 
discussing concerns and 
assumptions underlying 
preferences is necessary before 
starting therapy. Involvement of 
family and friends is 
recommended. 
Attention should be paid to 
the validation of preference 
measures, making 
comparability btw. Studies 
feasible;    
2005 Aikens et al. Adherence to 
maintenance-phase 
antidepressant 
medication as a 
function of patient 
beliefs about 
medication 




Depression Maintenance phase 




During the maintenance phase, 
patients' demonstrate various 
adherence. It is caused by their 
perception of need and 
harmfulness of AD. 4 attitudes 
toward ADs: skepticism, 
indifference, ambivalence, and 
acceptance   
Determine whether patients' 
perceptions about 
medication determine 
treatment outcome, to 
improve clinical 
management of depression  




compliance: results of 
a patient survey 
USA Survey Depression The impact of 
adverse effects on 
compliance and 
quality of life 
This survey of patients with mild 
to severe depression suggest that 
compliance /efficacy can be 
promoted  
Future studies to confirm 
this hypothesis may provide 
physicians with suggestions 
for making treatments more 
acceptable to patients. 




Perceptions of people 











of attribution of 
recovery are largely 
absent from the 
literature 
Ppl with depression consider 
their recovery multifactorial. 




acknowledge and support a 
variety of approaches to 










among Hispanics and 
African Americans 
USA Mixed: Survey 
of random 












There is an urgent 







The perception of discrimination 
and racism is significantly 
correlated with depression status 
in Hispanics and African 
Americans 
Explore how race/ethnicity, 
culture, beliefs, and patient 
preferences influence the 
expression of depressive 
symptoms vs the 
interpretation of these 
symptoms by health care 
providers. Strategies needed 
to make the therapies more 
acceptable to minorities 
2005 Beck Cynthia 
et al.  
Psychotropic 
















Antidepressant use may be 
higher and antipsychotic use 
may be lower in Canada than in 
recent European and American 
reports. SSRIs and venlafaxine 
are mostly used. 
Data collection of treatment 
quality, icl. dosage and 
duration of 
pharmacotherapy and 
indication for use   
2005 Brown et al. Beliefs about 
antidepressant 
medications in 










Depression Beliefs about 
medicines in 192 
primary care 
patients 
Patients believe that their current 
or future health depends on ADs. 
Still, concerns about ADs were 
expressed: long term use and 
dependency and overuse of 
medication 
Medication beliefs are 
important attitudinal 
variables that should be 
incorporated into self-
regulatory models such as 
Leventhal's when studying 
adherence to ADs. 
2005 Chao et al. The mediating role of 















8 derived from 
PHQ-9. 
Morisky's and 
Horne's scales  
How depression 
effects medication 
adherence and other 
self-care behaviors 
in diabetes 
Subjects with greater depressive 
symptoms had lower adherence 
to their diabetes medication 
regimens 
The findings from this study 
would benefit from 
development of strategies to 
improve the self-
management of diabetes 
2005 Gonzales et 
al. 
Adherence to mental 
health treatment in a 










Depression This is said to be 




Nonadherence to mental health 
treatments in primary care is of 
significant concern. Early 
identification of patients likely to 
be non-adherent to mental health 
treatment is one of the most 
urgent issues to be addressed 
Adherence to AD 
medications and to mental 
health referrals should be 




2005 Haslam et al. Perceptions of the 
impact of depression 
and anxiety and the 
medication for these 
conditions on safety 















detection of mental 
health problems in 
workplaces is 
fundamental 
Workers reported that symptoms 
and medication's adverse effects 
impacted their work 
performance. 
Future quantitative studies 
in this area might focus on 
reported accidents at 





Belief in the 
harmfulness of 
antidepressants: 
Results from a 













about: causes and 
alternative treatment 
and long-term 
outcomes with and 
without treatment; 
stigma  
About a quarter of Australians 
believe in harmfulness of ADs if 
the persons suffers from 
depression and is suicidal. A 
common belief is that depression 
is a sign of weakness and is 
under the person's control  
It is recommended to 
increase public awareness of 
depression and reduce 

















Depression Why do SA and 
individuals from 
other traditional 
societies rarely seek 
treatment for 
depression? 
Depressive emotional symptoms 
do not constitute depression-as-
disease in the SA context but 
rather reflect painful and 
threatening real-life problems. 
"Treatment" involves: solving 
the problem or avoiding thinking 
about it  
Future analyses of data 
collected in a larger study 
will address questions such 
as: what constitutes 
depression-as-disease in 
South Asian population 
2005 Kessing et al. Depressive and 
bipolar disorders: 


















older patients (aged 
above 40 years) had 
more negative views   
Lack of knowledge about 
affective disorder and its 
effective treatment is a critical 
attitude, especially among older 
patients, and may add to poor 
prognosis of depressive and 
bipolar disorders      
Suggested is a need to carry 
out further investigations to 







Lay beliefs about 
treatments for people 
with mental illness 
















Research on public 
attitudes. Tel. 
interviews. 
Attitudes should not 
be mistaken for 
actual interpersonal 
behavior, but should 
be acknowledged as 
proxy measures of 
social behavior 
 
Treatment suggestions included: 
psychologist, GP, getting outside 
and becoming active, 
psychiatrist; 
psychopharmacology, 
psychiatric hospitalization and 
ECT, were less favoured. 
Respondents especially warned 
of hypnotics and, to a lower 
extent, antidepressants and 
antipsychotics 
More research is needed to 
clarify the relation btw. 
social distance and 
knowledge about treatment 







professionals and the 
general population on 
how to treat mental 
disorders 





Mental health Mental health 
professionals must 
be aware of their 
shortcomings, i.e. 










To improve treatment of mental 
disorders, various strategies must 
be considered: continuous 
education of all mental health 
professionals, especially nurses 
and other therapists    
A special focus must be 
given to the treatment of 
affective disorders and to 
potential (over-) treatment 
of normal behavior without 
appropriate symptomatology 
2005 Lin et al. The influence of 
patient preference on 
depression treatment 

















72% of participants were 
matched with their treatment 
preference; matched participants 
demonstrated more rapid 
improvement in depression 
symptomatology 
An ongoing study of 
stakeholders values in 
collaborative care for 
depression would provide 
more information on the 
ways in which decision 
makers view the issue 
2005 Maxwell, M. Women's and doctors' 
accounts of their 
experiences of 
depression in primary 
care: the influence of 
social and moral 
reasoning on patients' 







& Strauss)  
Depression For both doctors 
and patients, the 
recognition and 
diagnosis of 
depression is a 
complex process 
involving social and 
moral reasoning 
The women's perceptions of their 
ability to function within their 
social roles played a large part in 
their accounts of help-seeking, 
thus help-seeking was portrayed 
as a sense of duty   
A broader understanding of 
the range of emotional 
problems that GPs 
encounter, and the 
development of a broader 
range of options for GPs in 
caring for their patients   
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2005 Ozmen et al. Public opinions and 
beliefs about the 
treatment of 
depression in urban 
Turkey 
Turkey Public survey Depression Opinions and 






and causality of 
depression on 
people’s perception 
The beliefs that "psychological 
and social interventions are more 
effective than pharmacotherapy" 
and "antidepressants are harmful 
and addictive" must be taken into 
account in clinical practice and 
in anti-stigma campaigns 
Studies are needed to 
understand the public's 
tendency to conceptualize 
depression as a psychosocial 
problem 
2005 Pound et al. Resisting medicines: 
a synthesis of 
qualitative studies of 
medicine taking 
UK Synthesis of 
qualitative 
studies on 
medicine taking  
6 studies on 
psychotropic 
medications 
The significance of 
the lay evaluation of 
medicines lies 
not simply in the 
fact that it occurs, 
but in the reasons 
why it occurs 
A person’s experience of 
medicines is likely to differ 
according to the medicine in 
question and the nature of the 
illness for which it is taken. 
There is a need to accept 
that people are unlikely to 
stop resisting their 
medicines. Safer ways need 
to be found to administer 
medicines, and to monitor 
their effectiveness and 
acceptability to individual 
patients 












and clinical data 






The degree of QoL-
impairment across 
depressive and 
anxiety disorders is 







duration of illness, 
and demographic 
features   
 
Patients with affective or anxiety 
disorders who enter clinical trials 
demonstrate significant quality-
of-life impairment, although the 
degree of dysfunction varies 
Individual perception of 
quality of life is an 
additional factor that should 







Mental disorders - 
who and what might 
help? Help seeking 
and treatment 
preferences of the lay 
public 






A ranking approach 
permits for the 
preferences of the 
lay public to be 
introduced with the 
aim to reflect the 
real-life decision 
making process  
Public expectations differ from 
evidence-based psychiatric 
treatment 
More effort should be put 
into psychoeducation; public 
knowledge about mental 
disorders and their treatment 




2005 Sher et al. Effects of caregivers' 
perceived stigma and 
causal beliefs on 













The findings stress the 
importance of patients' social 
environment in determining 
treatment adherence and the 
necessity of education caregivers 
about the impact that their causal 
attribution have on patients 
It is recommended to 
involve caregivers in 
treatment to improve their 
attitude toward persons with 
depression and with it, 
enhance patients' adherence 
and treatment outcome 
2005 Singh, Reshmi College students' 
depression treatment 
decision-making: A 
narrative of the 
trajectory of their 




    
2005 Tatano Beck 
& Indman 







from an earlier 
psychometric 








in this sample 
support anxiety and 
irritability as major 
symptoms in PD  
 
Scores on all seven dimensions 
of PD: sleeping/eating 
disturbances, anxiety/insecurity, 
emotional lability, mental 
confusion, loss of self, 
guilt/shame, and suicidal 
thoughts, were elevated. 
Emotional lability was the 
highest reported dimension   
Clinician who treat new 
mothers need to be alert to 
the range of possible 
depressive symptoms so 
these mothers do not suffer 
in silence 
2005 Van Vorhees 
et al. 
Beliefs and attitudes 
associated with the 
intention to not 
accept the diagnosis 













attitudes, views on 





biological causes,  
embarrassment  
Negative beliefs and attitudes, 
subjective social norms and lack 
of successful treatment history 
are linked with non-acceptance 
of diagnosis and refusal of 
treatment in young people  
Policy makers should 
consider increased monetary 
value of physician's time 
and efforts in the process of 
detection, correct diagnosis 
and effective treatment of 
depression 





























complicated by the 
stigma of 
depression and the 
non-recognition of 
its symptoms 
Patients' illness characteristics 
were found to be the strongest 
predictor of patients' 
expectations and doctor's 
recommendations  
Clinicians should make use 
of resource lists of books or 
websites that provide 
information for patients and 





2006 Backenstrass Preferences for 
treatment in primary 





Germany the German 




















Psychotherapy is clearly 
preferred over pharmacological 
treatment <20% of primary care 
patients accepted both therapy 
options and ca 12% refused both 
treatment options 
The group of depressive 
patients  could be 
differentiated from patients 
without the disorder 








Canada Survey using 
data from the 
Alberta Mental 





failure to fill a 
prescription, to take 
the medication, 
dropout, and failure 
to regularly take 
prescribed dosages  
The study replicates prior reports 
indicating that noncompliance is 
common with AD treatment 
To confirm generalizability, 
a Canada-wide study would 
need to be conducted  












Depression Depression as most 
common mental 
health problem in 
elderly people and 
continues to be 
underdiagnosed and 
undertreated 
The study highlights the 
complicated nature of the 
diagnosis and management of 
late-life depression 
There is a need for the 
development of evidence-
based provision for older 
patients with depression, 
and for motivating older 
patients to report depressive 
symptoms to their doctors 
2006 Chur-Hansen 
& Zion 
Let's fix the chemical 
imbalance first, and 
then we can work on 
the problems second': 
an exploration of 
ethical implications 
of prescribing an 












The increasing use of SSRIs 
meaning that depression is 
viewed as biological illness 
challenges the evidence that its 
etiology is still unknown 
A quantitative study could 
address the question of the 
relative incidence of both 
positive and negative 
experiences with SSRIs. 
2006 Cohen et al. Relapse of major 
depression during 
pregnancy in women 





















43% of women experienced 
relapse of MD during pregnancy. 
While some women may 
experience affective well-being 
during pregnancy, the pregnancy 
is not protective against the risk 
of relapse in MD. 
Several limitations of this 
study give directions to 
improved research 
strategies, i.e. it is possible 
that participants' depressive 
illness was of highly 
recurrent nature  
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2006 de Groot et 
al. 
Depression treatment 
and satisfaction in a 
multicultural sample 












Depression is two 
times greater in 
patients with 
diabetes than in 
regular population. 
Cost of comorbid 
depression and 
diabetes is high. 
The majority of people reporting 
high levels of depressive 
symptoms reported some form of 
depression treatment in their 
lifetime.  
Longitudinal studies are 
needed to evaluate 
effectiveness of depression 
treatment in community 
samples 









Depression Fear of dependence; 
resistance to view 
depression as 
illness; concerns 





AD medications  
Many older patients resisted the 
use of ADs. Concerns reflected 
their concepts of depression and 
ADs.  
Concerns expressed by older 
patients may be 
representative of larger 
groups. Larger studies 
utilizing survey methods 
may determine if these 
views are common  
2006 Granger et al. An assessment of 
patient preference 
and adherence to 
treatment with 
Wellbutrin SR  





Depression Wellbutrin SR twice 
a day. The most 
common reason 
reported for missing 
a dose of Wellbutrin 
SR was simply 
forgetting to take it. 
Users were 
interested in a once-
daily formula  
 
Reduction in dosing frequency is 
favored by Wellbutrin users. 
Such adjustment is likely to 
improve adherence to treatment 
Associations btw. 
nonadherence and other 
variables, such as age, 
gender, and concomitant AD 
use 
2006 Gum et al. Depression treatment 
preferences in older 
primary care patients 
USA Multisite RCT 
comparing 


















after 12 months 
More patients preferred 
counselling to medication 
 Discussion about treatment 
preferences should include 
an assessment of prior 
treatment experiences. A 
collaborative care model is 
recommended as it increases 
collaboration btw. primary 
care and mental health 
professionals and can 




2006 Hanley & 
Long 







questionnaire   
Postnatal 
depression 
Mothers had little 
knowledge of the 
effects of postnatal 
depression before 
becoming pregnant 
The findings suggest that, to 
some extent, postnatal 
depression is a consequence of 
social deterioration rather than a 
purely physiological reaction to 
motherhood. 
A greater understanding of 
the emotional and social 
effects of childbirth could 
help mothers overcome the 
feelings of isolation  
2006 Karasz & 
Watkins 










Depression Tricyclic AD, 
SSRIs 
More than half of the 
participants viewed medical 
consultation and treatment as 
helpful. Almost all considered 
psychotherapy helpful and found 
anxiolytic and sedative effects of 
medications helpful 
More research is needed on 
actual experiences of 
patients currently in 




Attitudes and beliefs 
among patients 
treated with mood 
stabilizers 




was mailed to a 








treatment raises a 
doubt whether the 




of drugs and that 
medication can alter 
personality.   
The majority of participants had 
incorrect views on the effects of 
mood stabilizers; older patients 
had negative views on doctor-
patient relations  
There is a need of improving 
knowledge and attitudes 
toward diagnosis and 
treatment especially among 
elder patients 

















distress with the 
social meaning 
of identity 
Participants’ accounts of their 
depressive and recovery 
experiences point to their 
lives as women as central to their 
distress 
A further direction for 
research involves 
the analysis of naturally 






interview study of 
Yoruba, Bangladeshi, 






ti software used 
to organize the 
data 
Depression Cultural models of 






cultural groups.  
 
Diverse views on causes and 
cures for depression. Magic & 
religion played a role.  Coping 
methods and help-seeking 
behaviors included religion, 
family, friends and neighbors, 
and becoming more active 
Implications for strategies 
that are successful and 
beneficial for the patient: 
provision of culturally 
specific information, 
cultural beliefs to minimize 




2006 Lawrence et 
al. (a) 
Coping with 
depression in later 
life: A qualitative 
study of help-seeking 
in three ethnic groups 






There was wide 
variation in how 
older adults 
construed the role of 
the general 
practitioner 
Participants felt that the 
responsibility for combating 
depression was an internal and 
individual task with support 
considered secondary. 
Efforts to socialize and 
remain active may provide a 
useful and acceptable 
adjunct to clinical 
interventions 





cultural study of the 
beliefs of older adults 
UK Qualitative: In 
depth separate 
interviews 
Depression A multicultural 




South Asian, and 
White British older 
adults 
Depression was often viewed as 
an illness arising from adverse 
personal and social 
circumstances in old age. 
Health and social care 
professionals need to be 
sensitive to language in 
depression in various ethnic 
groups  
2006 Lynch et al.  Patients' beliefs about 
depression and how 
they relate to duration 
of antidepressant 
treatment. Use of a 









Depression ADs taken longer 
by older patients 
and those who 




ADs taken for a 
shorter time by 
people who were in 
stable relationships 
or believed in 
alternative treatment 
Beliefs seem to be related to 
duration of treatment 
Longitudinal research is 




The strategy of 
combining 
antidepressants in the 
treatment of Major 
Depression: clinical 
experience in Spanish 
outpatients 








SSRIs + TCAs The strategy of combining AD 
medication seems to be dictated 
by trends and tendencies in 
prescription patterns 
Further efforts to evaluate 
this strategy are required 
2006 McKay, Bill The use of 
antidepressants and 
counselling for 
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that patients decide 







Significant influences upon self-
medication habits are prior 
health beliefs, medication 
attitudes, adverse effects and 
adequacy of communication 
from the health care professional 
The self-medication 
hypothesis with prescribed 
psychotropic medication 
should assist clinicians in 
improving adherence by 
taking a patient centred 
approach and where possible 
promoting patient autonomy 





UK Commentary Depression The reason why 
most people 
discontinue 
treatment with ADs 
remains unclear 
Collaborative communication by 
the clinician enhances the 
patient's knowledge of the 
medication  and treatment 
options, improves patients 
satisfaction and increases 
adherence  
Recommendations about the 
long-term benefit of ADs 
are not explained by doctors 
in a way that is convincing 
to patients. This 
phenomenon requires more 
attention. 
2006 Moncrieff & 
Cohen 
Do antidepressants 
cure or create 
abnormal brain 
states? 
UK Review and 
summary of 
findings 
Depression The term AD refers 
to a drug that helps 
to rectify specific 
biological 
abnormalities that 
give rise to the 
symptoms of 
depression. 
There are no specific 
antidepressant drugs that most of 
the short-term effects of 
antidepressants are shared by 
many other drugs, and that long-
term drug treatment with 
antidepressants or any other 
drugs has not been shown to lead 
to long-term elevation of mood. 
The term “antidepressant” 
should be abandoned. 
2006 Morgan et al. Difficulty taking 
medications, 
depression, and 






















and poor quality of 
life 
 
Among outpatients with heart 
failure, nonadherence to AD 
medication relates to worse 
health status. This association 
can be explained in part by 
comorbid depression 
Future studies should 
evaluate interventions such 
as depression treatment to 
improve medication 




2006 Naeem et al. Stigma and 
psychiatric illness. A 
survey of attitude of 
medical students and 
doctors in Lahore, 
Pakistan 
Pakistan Survey + 
statistical 
analyses (SPSS) 
mental illness Exploring stigma  a) 
well spoken English 






reduction of mental 
health stigma 
Attitudes of doctors and medical 
students were not very different. 
Doctors were less likely to have 
negative attitudes toward mental 
illness compared with medical 
students 
The authors plan to further 
this work, by exploring 
attitudes of the lay public.   
2006 Olfson et al. Continuity of 
antidepressant 
treatment for adults 
with depression in the 
United States 
USA Data were 












likely to continue 
with AD treatment 
beyond 30 days; 
self-perceived 
physical and mental 
health status and 
limitations in 
cognitive and social 
function were not 
significantly related 
to continue drug 
treatment beyond 30 
days  
Patients treated with SSRIs and 
SNRIs are significantly more 
likely to continue the therapy 
than are patients treated with 
tricyclic ADs or other older ADs 
In efforts to improve 
adherence of AD 
medications, priority should 
be given to the 
socioeconomically 
disadvantaged populations 





sertraline in patients 
with schizophrenia - 
own experience 










The authors found that both 
drugs sertraline and imipramine 
were effective but sertaline 
proved better than imipramine 
not found 
















The study suggests 
a need for greater 
focus on etiological 
factors and 
subtyping. 
Patients can distinguish btw. 
differing causes for depression 
and patients’ beliefs about their 
non-melancholic depression 
concur with the clinical 
subtyping diagnosis. 
Continue to investigate 
patients’ views about the 
causes of depression, as well 
as other aspects of mental 
health literacy, such as 
beliefs about help-seeking 
and treatment efficacy.  
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2006 Van Vorhees 
et al. 
Attitudes and illness 
factors associated 
with low perceived 
need for depression 
treatment among 
young adults 
USA A cross- 
sectional study; 
n= 10, 962; 
statistical 
analysis  
Depression Low perceived need 
for treatment leads 
many young adults 
not to seek care for 
their depression  
Low perceived need for therapy 
can be viewed as an "intention" 
not to seek treatment. Negative 
beliefs and attitudes, social 
norms and past treatment 
experiences, rather than low 
levels of depressive symptoms, 
accounted for the majority of 
model variance  
Policy makers should 




education of the public  
required to deepen 
knowledge of treatment 
options to increase the rate 





Better safe than sorry 
- why patients prefer 
to stop using SSRI 
antidepressants but 
are afraid to do so: 














and back pain 
SSRIs, 
benzodiazepines, 
Continuing SSRIs, has a 
tendency to give experienced 
users the idea that this is a 
chronic condition, which cannot 
be cured but can be managed by 
medication  
Research is needed about 
people who were successful 
after stopping the 
medications. Also, addiction 
and withdrawal effects of 
AD, if any, should be 
explored 
2006 Wang, JianLi Perceived barriers to 
mental health service 
use among 
individuals with 
mental disorders in 


















health services in 
Canada are publicly 
funded, barriers due 
to accessibility and 
availability were not 
significant 
The percentage of perceived 
barriers due to acceptability was 
higher than barriers due to 
accessibility and availability. 
Clinical characteristics play a 
role in perceiving barriers to 
mental health care 
Future effort should pay 
focused attention to the 
needs of individuals with 
chronic and severe mental 
health problems and focus 
on improving the 





experience with the 
mental health system: 
A focus on integrated 
care solutions 
USA Commentary Depression From the 
perspective of 
patients, there are 
multiple barriers to 
treatment in 
depression  
According to patients and their 
families, stigma is the primary 
barrier hindering treatment of 
depression, Working with a 
recovery model-"You are not 
alone, treatment works, recovery 
is possible, and there is hope", 
NAMI brings treatment closer to 
the patients 
With future innovations and 
programs in place, hope 
might be realized for all 
patients with mental illness 


















Constructs that are 
determining 
whether a patient’s 
depressive episode 
is in remission 
include 
the ability to cope 
with stress, a sense 
of well-being, 
quality of life, and 
feeling like one’s 
normal self 
 
Depressed patients consider 
symptom resolution as only one 
factor in determining the state of 
remission. Presence of positive 
features of mental health such as 
optimism, vigor, and self-
confidence was a better indicator 
of remission than the absence of 
the symptoms of depression 
Recommended that studies 
comparing the respective 
validity of alternative 
conceptualizations of 
remission focus on 
prognosis. 


















with poor adherence 
in a privately 
insured population 
using medical and 
pharmacy claims 
Alcohol and other substance 
abuse increase risk of poor 
depression treatment outcomes 
More research needed to 
clarify responsible 
mechanisms for adherence 
2007 Badger F. & 
Nolan P. (a) 
Use of self-chosen 
therapies by 

















treatments might be 
beneficial 
 
Health practitioners need to be 
aware that people with mental 
problems are using a range of 
self-chosen therapies and might 
consider initiation of discussions 
on self-chosen treatments with 
patients 
The findings of this study 
require a larger debate and 
identification of appropriate 
knowledge elements 




Perceptions of people 
cared for in primary 
care 







Depression Identifying and 
understanding 
people's accounts of 







Depressive patients regard their 
recovery as multifactorial and 
are keen to have their own roles 
in recovery acknowledged. 
Doctors must aim to explore 
patients' beliefs about 
treatments and recovery. 
Addressing these can 

























Escitalopram showed a lower 
number of discontinuation 
symptoms than paroxetine or 
venlafaxine XR, confirming that 
discontinuation symptom 
profiles differ btw. 
antidepressants and btw. SSRIs.  
This study did not examine 
whether tapering might 
demonstrate advantages 
compared to abrupt 
discontinuation. Further 
studies may focus on the 
effect of tapering 
2007 Bennett et al. Becoming the best 








Depression When confronted 







For many women, the idea of 
becoming depressed during 
pregnancy was unethical to the 
concept of the pregnant self. The 
challenge for a pregnant woman 
diagnosed with depression is that 
medical treatment can be 
harmful to the baby. 
Improved awareness of 
depression during pregnancy 
is needed in health care 
professionals. Further 
qualitative research is 
needed to determine the 
specific aspects to be 
addressed. 








A group of mood-
disorder outpatients 
(n=80) were 





High levels of adherence were 
reported. Forgetting or a change 
in the routine were the most 
frequently identified reasons for 
nonadherence. Patient did not 
adhere to treatment if they were: 
female, had not completed post-
secondary education, and 
experienced sexual side-effects 
of ADs. 
Doctors should be aware of 
this complexity and address 
issues not only related to 
efficacy and tolerability, but 
also social mediators and 
health beliefs when 
prescribing Ads 
2007 Buultjens & 
Liamputtong 
When giving life 
starts to take the life 










is a complex illness 
with varying 
degrees, reasons for 
onset and medical 
treatments. 
Emotions and feelings of women 
were captured and it is hoped 
that health-care practitioners will 
gain a deeper understanding of 
this debilitating condition 
It is hoped, in making the 
wider community aware of 
depression after childbirth, 






















Depression The study examined 
how demographics, 
acculturation, 





Hispanic immigrants perceived 
depression as a serious condition 
caused by interpersonal and 
social factors. Most patients 
demonstrated positive attitudes 
toward treatments but were 
apprehensive toward 
antidepressants 
The study emphasizes the 
need to incorporate Hispanic 
immigrants' perceptions and 




2007 Cooper et al. Why people do not 
take their 
psychotropic drugs as 
prescribed: results of 
the 2000 National 
Psychiatric Morbidity 
Survey 














because they did not 
want it or did not 
think the treatment 
was necessary 
34.2% of participants reported 
incomplete adherence to their 
psychiatric medication. Reasons 
given: forgetting, losing, running 
out, reluctance to taking drugs 
and side effects 
About 1 in 10 people 
reported over-medicating 
themselves, people with 
diagnosed depression. The 
reason given: to control the 
symptoms and perceived 
need for sedation an 
important factor. This is 
common and should be 
asked about routinely in 
clinical practice 
2007 Cornford, 
Hill & Reilly 
How patients with 
depressive symptoms 
view their condition: 
a qualitative study 
UK Semi-structured 
interviews 







Differentiating depression from 
understandable reactions to life 
adversity was difficult for 
patients. Negative images of 
depression, i.e. depression is a 
20-centrury phenomenon, were 
pervasive. Views about 
medication varied 
The wide employment of 
techniques patients use to 
control their disorders, such 
as support from others, 
engagement in activities an 
working on relationships, 
doctors may recommend as 





preferences of VA 
primary care patients 









Half of the veterans 






The results document depression 
treatment preferences of veterans 
and suggest that receiving 
treatment and clinical response 
do not relate to having particular 
preferences  
Further study involving 
observation of actual clinical 
interactions and use of more 
sensitive measures of 
treatment to better clarify 
the relationships among 
preferences, treatment 
offered and received, and 





access to mental 
health care in a 
university student 
population 










in student mental 
health services may 
be necessary 
Effective mechanisms to identify 
students with the most serious 
needs are crucial; health 
insurance plans and primary care 
clinics could help improve 
access to care 
Investigate the roles of 
institution-level factors, 
such as policies and 
perceptions related to 
confidentiality and 
repercussions for being 
known to have a mental 
disorder    
2007 Ellen, Steven Depression and 
anxiety. 
Pharmacological 
treatment in general 
practice 
Australia GREY LIT. 
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based both on the 
semi-structured 
interview and on the 
review of the group 
discussion.  
The most bothersome symptoms 
were depressed mood, fatigue, 
and feelings of worthlessness. 
More women than men included 
diminished interest and 
hypersomnia on the list of most 
bothersome symptoms. Suicidal 
ideation and insomnia were 
among the least bothersome 
symptoms for this sample. 
A comprehensive measure 
of early symptom remission 
should include the following 
constructs: irritability, 
sadness/depressed mood, 
negative thoughts, low 
energy/motivation, interest, 
and agitation. 
2007 Gardner et 
al.  
A comparison of 
factors used by 
physicians and 








Depression Patients and 





compare in terms of 
risks  
Patient participation in AD 
decision will lead to improved 
acceptance of the AD in the long 
term, which should offer better 
treatment outcomes, such as 
improved symptoms response 
and better QOL  
Follow-up interventional 
studies are required  
2007 Gilchrist & 
Gunn 
Observational studies 
of depression in 






Depression To determine: the 




quality of the 
studies; identified 
recovery and risk 
factors for persistent 
depression;  
treatment and health 
service use patterns 
among patients 
Risk factors for persistence of 
depression identified in this 
review were: severity and 
chronicity of the depressive 
episode, the presence of suicidal 
thoughts, AD use, poorer self-
reported QOL, lower self-
reported social support, 
experiencing key life events, 
lower education level and 
unemployment 
 
Future research should be 
large enough to investigate 
risk factors for chronicity 
and relapse 










Depression The study utilized a 




users to access an 
online assessment. 
Racial and ethnic minorities 
prefer counseling for depression 
more than whites. Beliefs about 
the effects of antidepressants, 
prayer, and counseling partially 
mediate preferences for 
expression treatment 
Future studies should focus 
on identifying the most cost-
effective approaches to the 
training of health 
professionals in patient-
centered communication and 
cultural competence  
453 
 





Denmark Review Depression Misperceptions 
regarding 
depression and 
medication; there is 





Adherence is essential for 
obtaining full efficacy of the 
treatment, and awareness of the 
importance of adherence is 
mandatory for improving 
treatment results  
Results from qualitative and 
other studies should in the 
future be tested in RCTs 
investigating the effect on 
adherence to treatment and 
acute and long-term 
outcomes 
2007 Hickie et al.  Perspectives of young 













young people is 




awareness and early 
intervention 
 
Small but continuous 
improvements in knowledge and 
beliefs were occurring over time 
in younger persons 
Further education 
on the risks and benefits of 
using antidepressant 
medication appears 
warranted given the 
substantial proportion of 
young people who consider 
them harmful. 



















Those receiving MMT or ADs 
appreciated the beneficial effects 
of these treatments, aligning 
themselves with treatment goals. 
If clients cannot be convinced of 
the need for medication or its 
efficacy, they will continue to 
modify or refuse treatment 
regiments  
Instead of positioning clients 
as 'non-compliant', treatment 
providers could do much 
better by recognizing clients' 
investment in their own 
"well-being" 
2007 Hunot et al. A cohort study of 
adherence to 
antidepressants in 










Depression This article provides 
the first longitudinal 
evidence for the 
strength of 
independent 




on adherence to 
ADs in primary care 
 
Findings highlight the central 
role of the patient-physician 
partnership in exploring and 
addressing treatment concerns 
and in providing support in 
treatment 
Possible overconsumption 
or misuse of ADs is of 
clinical importance and, 
being an under investigated 
area of nonadherence, would 
be worthy of further study   
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2007 Iacoviello et 
al. 
Treatment 















randomized to their 
preferred mode of 
treatment would 
develop a stronger 
alliance over the 
early phase of 
therapy than 
patients who did not 
receive their 
preferred treatment 
Because treatment preference 
was assessed with a forced-
choice format, the strength of 
patient preference cannot be 
determined. 
Future studies that use a 
format that measures the 
absolute strength of a 
preference (a Likert scale 
for each treatment option) 
may better illustrate 
preferences and their effect 
on alliance development 
2007 Interian et al. A qualitative analysis 









Depression Perceptions of 
stigma related to 
both the diagnosis 
of depression and 
use of ADs. ADs 
use seen as 
implying more 
severe illness, 
weakness or failure 
to cope with 
problems, and being 
under the effect of 
drugs    
Stigma was a prominent concern 
among Latinos treated with AD 
medications. Stigma often 
affected adherence. The 
perceived negative attributes of 
AD use were at odds with self-
perceived cultural values. 
Employ hypothesis-driven, 
quantitative or mixed-
methods studies to confirm 
these findings. Interventions 
for treatment adherence may 
benefit from considering 
issues explored in this study 
2007 Johnston et 
al. 







Depression Constructing and 
resisting boundaries 
btw. depression, the 
self, and the normal 





and the failure of 
GPs  
The majority of participants who 
considered management 
strategies in depression, wanted 
to 'get out' of their condition. 
The importance of GPs listening 
to their patients was identified, 
but patients felt that this did not 
happen very often 
These findings highlight the 
potential relevance of 
narrative medicine which 
emphasizes listening to 
patients' individual stories. 
Approaches that emphasize 
drug or psychological 
treatments may fail to 
engage many patients    




depression in primary 
care: A summary of 
the current literature 
and implications for 
practice 
Canada Review of 
RCTs 
Depression Primary care 
practices need to be 
able to regularly 
monitor patients 
during and after 
treatment of a 
depressive episode 
There is conclusive evidence for 
the benefits of changing systems 
of care delivery to support a 
more effective management of 
depression in primary care  
Primary care practices need 
to examine how they can 
incorporate different 
concepts and models for 
managing depression.  
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2007 Lader, M. Pharmacotherapy of 
mood disorders and 
treatment 
discontinuation 
UK Review and 
commentary 
Depression In many countries, 
the public regards 




symptoms can occur 
in almost all classes 
of ADs, including 
SSRIs. 
  
More resources should be 
devoted to establishing how 
various forms of therapy in 
depression can be combined and 
include a discontinuation phase 
for all these treatments. 
Physicians should educate 
themselves and the public 
about discontinuation and 
withdrawal, so that these 
clinical features can be put 
in a realistic context   
2007 Lafrance, 
Michelle N. 
A bitter pill: A 









Depression Through talk of 










By examining medicalized 
accounts of depression, this 
analysis simultaneously explored 
how stigma and de-legitimation 
are worked up and resisted in 
sufferers' talk. 
This analysis reinforces the 
importance of community-
based research and activism 
aimed at disrupting the 

















loss of control  
Treatment options for mothers 
with postnatal depression require 
consideration of the severity of 
depression and mothers' 
preferences for treatment 
An up-to-date systematic 
review is recommended to 
establish current prevalence 
rates. Further research on 
psychosocial and support 
systems and their relation to 





A qualitative study of 
patient views on 
discontinuing long-
term SSRIs 
UK Qualitative Depression SSRIs. There is 
concern that patients 
may be remaining 
on SSRIs longer 
than it is clinically 
indicated 
Patients need to be reassured 
that, thinking about or, actually 
stopping medication is a task that 
will be managed with the 
professional help. 
Research highlights the 
importance of GPs contact 
when deciding to start 
treatment and it is likely that 
the same holds true when 
deciding to stop. 
2007 Leykin et al. The relation of 
patients' treatment 
preferences to 













The study examined whether 
matching patients to treatments 
according to their preferences 
produces positive results. No 
significance was detected. 
Much larger studies with 
many more dropouts would 
need to be conducted in 


















medication at least 








When considering the patients' 
perspective in medication 
adherence, it is useful to consider 
the self-medication hypothesis. 
People appear to prefer to take 
medication "as required" 
(symptomatically) rather than 
prophylactically. 
Not found 
2007 Mitchell & 
Selmes 
Why don't patients 








Over the course of a 
year, three-quarters 






Before prescribing medication 
clinicians should acknowledge to 
the patient the difficulties taking 
ADs, outline realistic benefits 
and discuss possible adverse 
effects and consideration of 
treatment alternatives  
It is suggested that methods 
are developed that help 
patients who have adherence 
difficulties. New research is 
required to discover which 
methods are effective 





























A partial support for the 
hypothesis found that a 
combination of psychotherapy 
and pharmacotherapy would 
show more effect in relieving 
depressive symptoms and 
improving social functioning 
than drugs alone 
In a future article, the 
authors hope to clarify the 
issue about the long-term 
effects of combined 
treatment on social 
functioning  
2007 Okuyama et 
al. 
Mental health literacy 
in Japanese cancer 
patients: ability to 
recognize depression 
and preferences of 
treatment- 
comparison with 













ability to recognize 
depression and their 
preferences of its 
treatments 
The results indicated that cancer 
patients’ knowledge about 
mental illness and its treatment 
were insufficient. 
Psychological education 
may reduce patient-related 
barriers to seek and to utilize 
optimal mental health care 
in cancer patients. 





strategies by those 
with clinical 
depression 












higher than SSRIs 
with fluvoxamine 
rated lowest in the 
SSRI class; TCA 
dothiepin superior 
to other TCAs 
Many self-help strategies rated 
as strongly as professionally 
recommended strategies, with 
exercise being rated extremely 
highly.  
It might be useful to study 
the highly rated alternative 
therapeutic strategies more 
closely: exercise, 




2007 Prins et al. Health beliefs and 
perceived need for 







Depression A majority of 
people view Ad as 
addictive and many 
perceive stigma and 
see practical and 
economic barriers to 
care 
People who suffer from 
depression have more positive 
beliefs about biological etiology 
and medication treatment than 
healthy people. All patients 
prefer psychological treatment 
forms to medication. 
More research is required 
into the specific needs of 
anxiety and depression 
patients. Open 
communication btw. Patient 
and health care provider 
could lead to valuable 





depression: The role 
of beliefs, attitudes 
and mood 












Results showed lower thresholds 
for professional help-seeking in 
those who had previously 
received psychological treatment 
than in those treated with ADs 
only and non-clinical controls  
Further research should 
clarify the extent to which 
help-seeking co-varies with 
depressed mood. More work 
is needed to reduce the 
stigma  


















depression severity  
Patients' lack of insights re. 
depression severity substantially 
delayed patient engagement in 
treatment seeking and decision-
making. Patients expected GPs 
to be the source of objective 
information and provide 
emotional support 
Shared-treatment decision 
making (SDM) approaches 
for depression treatment 
should be adapted based on 
depression severity and 
patient-identified needs 
2007 Slingsby et al. Physician strategies 




medications in Japan: 










Depression Physicians across 







Physicians believed SSRIs 
decrease rather than reinforce 
patients' resistance. Participants 
believed that patients resisted the 
use of ADs because of held 
misperceptions  
Given the efficacy of 
advanced communication 
and patient education 
strategies for treatment 
adherence in other countries, 
similar strategies deserve 
formal assessment in Japan. 
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study of illness 
narratives, the 
meaning of 
medicine and the 






cultural patterns of 
consumption  
 
Tragically, the limited images of 
mental illness, healing and 
medicine that are circulated in 
the media tend to misrepresent 
the experiences of the mentally 
ill and distort the effectiveness of 
antidepressants. 
Future research on 
pharmaceutical consumption 
ought to take seriously 
how antidepressant 
consumers incorporate 
media representations to tell 
their antidepressant 
narratives 
2007 Tentler et al. Factors affecting 
physicians' responses 
to patients' requests 
for antidepressants: 
focus group study  





not found Patients' requests 







   
The most common affective 
responses to patients' requests 
are annoyance, empathy and 
frustration with time lost 
discussing the pros and cons of 
the DTCA-recommended drugs 
Developing a model that 
includes relevant clinician, 
patient and contextual 
features can provide a 








Depression More than 20 ADs 
have been approved 
by the FDA for the 
treatment of 
depression in older 
adults  
Patients with depression that 
persists after one or more trails 
of medication for 8 to 12 weeks, 
and suicidal patients, who have 
had previous manic symptoms 
while on AD, or who have 
psychotic symptoms, should be 






American Association for 
Geriatric Psychiatry 
(www.aagpgpa.org), and the 










reported by means of 















not found Relevance of side 
effects was assessed 
by comparing the 
proportion of 
adverse effects that 
cause 
discontinuation of 
the initial AD use, 
incl. categories 
"discontinuation" 
and "switching to 
other treatment 
 
Patients report the 
ineffectiveness and side effects 
of AD therapy as negative and 
leading to treatment 
discontinuation. Patients and 
HCPs differ n the nature of the 
reported side effects.  
Patient experiences should 
be included in the evaluation 
of AD treatment in clinical 
practice 
2007 Wang et al. Gender specific 
correlates of stigma 
toward depression in 









analysis   
Depression Generalizing the 






be made cautiously  
In multivariate linear regression 
models, correct identification of 
depression in a case description 
and agreement with health 
professionals bout treatments 
were associated with low stigma 
scores, regardless of gender  
Improving mental health 
literacy may be one of the 
promising ways to reduce 
stigma associated with 
depression. 
2007 Weich et al. Attitudes to 
depression and its 




History of an 
ICD-10 
depressive 
episode in the 
year preceding 
the episode    
Experience of 
moderate and severe 
depressive episodes 
1) depression is a disabling, 
permanent state; 2) it is a 
medical condition responsive to 
support; 3) ADs are addictive 
and ineffective 
People with moderate or 
severe depressive episodes 
have subtle and divergent 
views about this condition, 
its outcome, and appropriate 
help. Such beliefs should be 
considered in primary care 
as they may have a 
significant impact on help 
seeking and adherence to 
treatment  
2007 Winkler et al. Escitalopram in a 
working population: 
results fom an 
observational study 
of 2378 outpatients in 
Austria 












Most of the patients 
in this study were 
treated with 10 
mg/day of 
escitalopram 
The results suggest that 
escitalopram is an efficacious 
and overall well-tolerated 
treatment in a naturalistic sample 
of working patients. A decrease 
in the days on sick leave is 
indicative of indirect cost-
effectiveness of this treatment 
Future observational trials 
should investigate, if 
escitalopram possesses 
similar efficacy in the 
continuation and long-term 
treatment of affective and 

























Young people view 
their depressive 
symptoms as mild 
and transient and 
feel unclear about 
the factors affecting 
their depression 
Scepticism about ADs is 
strongest among younger 
patients who have never taken 
ADs 
The present patient sample 
from this trial will be 
followed through the entire 
treatment course. The 
resulting data will help 
reveal how these key beliefs 
evolve during treatment and 
indicate which variables 
should be targeted to 
enhance adherence and 
outcome  
2008 An, S. Antidepressant 
direct-to-consumer 
advertising and social 
perception of the 
prevalence of 
depression: 






Depression DTCA - Zoloft, 
Paxil, Prozac and 
Wellbutrin 
The results of this study provide 
some cause for concern: it is 
possible for those with 
heightened perceived prevalence 
to self-diagnose and strongly 
insist on the prescription of the 
advertised drug from the 
physician 
This study calls for more 
scholarly attention to the 
cognitive effects of DTCA 










groups, in depth 
semi-structured 
interviews; 
Data analysis:  
grounded 
theory   
Depression Depression was 
perceived as a 
serious condition 
linked to the 
accumulation of 
social stressors 
Somatic and anxiety-like 
symptoms and the cultural idiom 
of 'nervios' were central themes 
in low-income Hispanics' 
explanatory models of 
depression. Perceived reciprocal 
relationship btw depression and 
diabetes illustrated multiple 
ways by which these two 
illnesses impact each other 
More studies are needed to 
examine how low-income 
Hispanics and other 
underserved communities 
conceptualize and cope with 
these illnesses in order to 
develop better patient-
centered interventions aimed 


















It is important to 
increase insight into 
patients' decision 
making regarding 
the use of ADs 
It is not so important whether 
ADs are really effective or 
discontinuation really leads to 
withdrawal effects; rather, it is 
important whether patients think 
the AD is effective or think that 
they will experience withdrawal 
symptoms 
 
Data from this study 
increase our understanding 
of patient decision making, 
thereby empowering health 
care professionals to further 
offer services that are best 
for the patient 
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Depression AD treatment in 
older patients is not 
necessarily their 
preference. 
Participants rated a combination 
of treatment consisting of CT 
and AM as more acceptable for 
treating depression than either 
treatment alone 
Further studies examining 
depression treatment 
preferences in older adults 
would be useful, as 
acceptability attitudes may 
affect treatment adherence  
2008 Harmer, C.J. Serotonin and 
emotional processing: 
Does it help explain 
antidepressant drug 
action? 













and their treatment. 
Antidepressant drug 
administration affects aspects of 
emotional processing thought to 
be important in depression and 
anxiety. Such effects can be seen 
very early on following drug 
administration and 
independently from mood 
change.  
 
The challenge remains 
to fully assess the relevance 
of these early shifts to 
antidepressant drug action in 
depression and anxiety and 
the contribution of different 
neurochemical systems and 
neural circuitry to these 
changes. 
2008 Hwang et al. A conceptual 
paradigm for 
understanding 
culture's impact on 
mental health: The 
cultural influences on 
mental health 
(CIMH) model 
USA Review and 
commentary 
Depression  This review offers a 




issues and their 
impact on mental 
health 
Mental health researchers, 
practitioners, and teachers can 
contribute to greater cultural 
awareness and competence.   
Mental health providers 
need to develop a more 
sophisticated understanding 
of how culture affects 




"Feeling blue" in 
Spanish: A 
qualitative inquiry of 
depression among 
Mexican immigrants 
















Depression appears as familiar 
and valid. Reporting of somatic 
symptoms did occur, but 
interpersonal problems and 
depressed affect symptoms are 
among the most salient in 
identifying someone as 
depressed 
Future qualitative studies 
examining illness 
perceptions and healing 
behaviors are recommended, 
but these must be 
approached with care and 
sensitivity about 




2008 Levin et al. Life-threatening 




report and discussion 








secondary to a 
citalopram-
fluconazole drug 
interaction is an 
uncommon case of 
delirium. Two cases 
are presented  
Although case report 
methodology has intrinsic 
limitations on generalizability, 
the citalopram-fluconazole drug 
interaction is predictable  
Because the use of 
fluconazole is common in 
oncology treatment, it is 
recommended that 
precautions be taken in the 
setting of concurrent 
citalopram treatment  
2008 Löwe et al.  Depression, anxiety 





















contributed to a 
similar extent to 
disability days, 
somatization was 
the only disorder 
without mental 
health impairment. 
In over 50% of cases, 
comorbidities existed btw. 
depression, anxiety and somatic 
symptoms. The contribution of 
the commonalities of depression, 
anxiety and somatization to 
functional impairment 
substantially exceeded the 
contribution of their independent 
parts. 
 
Describe basic diagnostic 
criteria for a single 
overreaching disorder and 
optionally code additional 
diagnostic features that 
allow a more detailed 
classification into specific 
depressive, anxiety, and 








    
2008  Murawiec S. Symbolic function of 
medication – a case 
report 





Pharmacotherapy is usually seen 
in the context of the biological 
action of the medication use. The 
action of the medication can be 
also discussed on many other 
levels, i.e. on the level of the 
transformation of this action into 
universal symbols experienced 
individually in the patient’s 
mind. 
Not found 












pharmacists is an 





depressed patients.  
 
Patients with depression appear 
very eager to receive additional 
drug information. These results 
provided further evidence that 
leaflets and counselling should 
be widely used  
Specialized educational 
interventions by pharmacists 
may improve patients' 


























AD medication use is 
confounded with symptoms 
severity. Observational studies 
are subject to bias as result 
Randomization may be an 
essential design feature in 
studies assessing AD 
effectiveness 







treatment in patients 
with chronic 
depression 











Patients with both high 
perceived stress and high 
dysfunctional attitudes prior to 
treatment reported more 
depressive symptoms at the end 
of treatment than patients with 
high perceived stress and lower 
dysfunctional attitudes. 
Priority for future RCTs 
would be to investigate 
whether these patients may 
benefit from treatments that 
directly address 
dysfunctional attitudes and 
teach ways to cope with 
stress 
2008 Politis et al. Combination therapy 
with amisulpride and 
antidepressants: 
clinical observations 
in case series of 
elderly patients with 
psychotic depression  
Greece RCT Psychotic 
depression, 
DSM-IV-TR 





Combination of amisulpride and 
ADs improved psychotic 
symptoms. This is the first report 
of such combination therapy 
Further controlled studies 
should help in verifying the 
positive results of the 
combination of amisulpride 
and AD medications 
2008 Prins et al. Health beliefs and 
perceived need for 














depression and see 
both psychological 
and medication 
treatment as helpful 
 
People who suffer from 
depression have more positive 
beliefs about biological etiology 
and medication treatment than 
healthy people, or those with less 
severe symptoms 
More research is required 
into the specific needs of 





Benefits of consumer 
psychoeducation: A 









Depression paroxetine and other 
SSRIs 
Improved adherence attributed to 
an increased understanding of 
depression and the need to take 
medication, realization that 
patient is not alone, and a better 
understanding and acceptance of 
possible side-effects 
As drop-out rates in South 
Africa are unacceptably 
high, psychoeducational 
programs may prove 
valuable in increasing 
adherence to treatment 
464 
 




An internet based 
study 
Japan Online survey, 
statistical 
analysis: SPSS  
MDD ADs: fluvoxamine, 
milnacipran, 
paroxetine, TCA 
Those on single medication 
perceived greater drug 
satisfaction with treatment than 
those on polypharmacy 
Further studies should be 
conducted to better 
understand the variables 
related to AD satisfaction to 






Public views on 
antidepressant 
treatment: Lessons 






Depression It appears that ADs 
are so widely used 
in Iceland because 
of their perceived 
effectiveness by 
users and owing to 
limited access to 




Most Icelanders are willing to 
use ADs to treat depression and 
factor influencing this view is 
their own experience or that 
experience of close friends or 
relatives  
The greatest challenge will 
remain to educate and 
motivate ppl who commonly 
lack motivation to seek 
treatment  
2008 Soudry et al.  Factors associated 
with antidepressant 
use in depressed and 
non-depressed 
community-dwelling 












In a large community-based 
elderly population, the influence 
of socio-demographic factors 
and general health characteristics 
on AD use varied with increased 
severity of depressive symptoms  
Further studies are needed to 
clarify the relationship btw 
gender and cognition and 
AD use 
2008 Turner et al.  Women's views and 
experiences of 
antidepressants as a 
treatment for 
postnatal depression: 
a qualitative study 







had negative views 
on ADs at the time 
of randomization 
Women's views changed in 
response to their treatment 
options and experiences, views 
of relatives and friends and 
contact with health professionals  
GPs should be aware that 
patients' views of ADs can 
change and that by listening 
and providing information, 
they could play a key role in 
this process 
2008 Vanelli & 
Coca-
Perraillon 

























Prior AD treatment rather than 
the use of a particular medication 
was associated with AD 
adherence. Patients without 
previous experience with ADs 
faced twice the risk of 
nonadherence 
Further study may explore 
the effects on adherence 
results in newly diagnosed 
patients who received short-
term prescriptions  
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2008 Wang & Lai The relationship 
between mental 
health literacy, 













Depression The findings may be 
affected by recall 
and reporting 
biases; lack of 
evidence that 
improving mental 
health literacy and 
personal contact 
with depression will 
reduce stigma 
In the highly educated 
population, attitudes toward 
individuals with depression were 
that these people and 
unpredictable and dangerous.  
Educational campaigns may 
have some positive effects 
on stigma of depression, but 
could be carefully designed 
2008 Wittkampf et 
al. 
Patients' view on 
screening for 









with MAXqda2   
MDD All patients 
appreciated being 
approached for 
screening, but some 
did not accept the 
diagnosis 
Some patients with undisclosed 
depression felt aversion to being 
diagnosed as having depression 
In the context of screening 
for depression, it is 
recommended that that 
patients' view on depression 
be elicited before diagnosing 
and offering treatment 
2008 Zivin & Kales Adherence to 
depression treatment 
in older adults 
USA A narrative 
review 
Depression Adherence to 
depression 
treatment in older 
adults is associated 
with multiple 
factors 
There is a pressing need to 
understand the characteristics of 
older depressed patients that lead 
to optimal treatment adherence, 
as well as understand the barriers 
to adherence  
Strategies to improve patient 
adherence need to be 
multidimensional, including 
consideration of age-related 
cognitive and co-morbidity 
factors, environmental and 
social factors, functional 
status and belief systems.   
2009 Chakraborty 
et al. 
Attitudes and beliefs 




their adherence to 
treatment 








MINI, BDI, ADCQ 
Most of the people value the 
doctor-patient relationship & 
their partners are also supportive 
re. diagnosis and treatment of 
depression; most ppl have 
erroneous beliefs re. ADs per se 
which influence the drug 
adherence 
It is important to study the 
attitudes and beliefs of 
patients in various cultures, 
as identification and 
clarification of erroneous 
beliefs may help in 
treatment adherence    
2009 Cipriani et al. Depression in adults: 




Depression Information relating 
to the effectiveness 
and safety of the 
following: AD 
drugs (TCAs), 
SSRIs, MOI, or 
venlafaxine 
Information relating to the 
effectiveness and safety of the 
following: AD drugs (TCAs), 
SSRIs, MOI, or venlafaxine; 
continuing prescription AD 
drugs, electroconvulsive therapy, 
exercise, lithium augmentation, 

















common, and it is 
the greatest barrier 
to effective 
treatment of MDD 
Non-compliance, either through 
treatment discontinuation or 
variation in the frequency and 
intensity of dosing, is associated 
with incomplete symptom 
resolution or relapse, adverse 
effects and treatment 
discontinuation syndromes  
Doctors should actively seek 
to address these 






















is frequent and a 
potential risk of 
recurrence 
 
Non-adherence ranged from 
39.7% to 52.7%. 20.9 5 were 
always non-adherent, 48.4% 
were intermittently non-adherent 
and 30.8% were always 
adherent.   
Doctors continuously have 
to be aware of this problem 
and should keep on 












used to code 
and analyse 
comments  
Depression The biomedical 
consumer is 
motivated not by a 
simple belief in 
biomedicine but by 
affective investment 
of self in the power 




Despite the dominance of 
biomedical accounts, very few 
women attributed their recovery 
solely to medication or 
understood depression as caused 
by chemical imbalance only 
In relation to health, patients 
are no longer passive 
recipients of others' 
expertise; they are urged to 
become active responsible 
consumers of medical 
services, products and 





perceived barriers to 
treatment for 
perinatal depression 
USA Questionnaire Perinatal 
depression 
Perinatal depression 





Understanding what prevents 
women from seeking or 
obtaining help for depression 
and determining their 
preferences for treatment may 
lead to better outcomes  
Overall efforts to improve 
treatment rates for perinatal 
depression are needed 
2009 Hodges et al. Patient and general 
practitioner 
preferences for the 
treatment of 
depression in patients 
with cancer: How, 
who, and where?  
UK Questionnaire depression & 
cancer 
Options for how 
depression should 
be treated, who 
should deliver the 
treatment and where 
treatment should 
occur 
Patients preferred talking 
treatment alone, whereas GPs 
preferred combination of drug 
and talking therapy. Both patient 
and GP preferred treatment to be 
given by GPs,  
A model of service that 
allows a choice of the initial 
treatment modality and 
collaborative care btw 
primary care and cancer 




2009 R. Liebert & 
N. Gavey 
"There are always 
two sides to these 
things": Managing 
the dilemma of 
serious adverse 






Depression SSRIs The article brings us to the 
assertion that SSRIs are linked to 
Two conflicting claims": that 
they may either increase or 
decrease harm 
Deepen the knowledge 
about SSRIs to be able to 
engage in fuller and more 
meaningful dialogue about 
























Patients that rate 
their doctor as more 
collaborative will 
report greater AD 
adherence than 
those who view 
their provider as 
less collaborative 
The results suggest that the most 
relevant patient choice may be 
that of preferred role in the 
treatment regardless if more or 
less participative 
Future studies in this area 
are necessary to determine if 
these findings can be 
generalized to other settings, 
particularly to primary care 
2009 Malpass et al. "Medication career" 
or "Moral career"? 
The two sides of 
managing 
antidepressants 













One obstacle to 
qualitative synthesis 
is the challenge of 
bringing together 





This synthesis tried to 
conceptualize the interplay of the 
moral and medication careers of 
AD use 
This requires further 
exploration through 
empirical work if we want to 
understand the processes by 
which the decision-making 
is negotiated 


















GPs in this study 








If depression is not treatable as 
its causes are outside the medical 
domain, the GP appears 
powerless in consultations for 
depression, with the medical 
discourse failing in providing 
explanations or treatment cures. 
Not found 
2009 Ööpik & 
Maaroos 
The preferences and 












SSRIs, SNRIs,   The most important factors 
influencing drug selection were 
good effect, ease of 
administration, presence of 
specific clinical symptoms, 
speed of effect, and presence of 






How and why do 
people with 
depression access and 









opinion and verify 
information 
provided by leaflets 
to learn about 
somebody's 
experiences, 
preparing for a 
doctor's visit  
 
Internet is an important source of 
drug information, especially 
when fear of stigmatization or 
depression related symptoms 
limited information seeking from 
other sources  
Health professionals should 
design online services and 
direct their clients to 
accurate and reliable sources 
of online drug information   
2009 Price, Cole, & 
Goodwin  
Emotional side-












Some people taking 
SSRIs, report that 
their experience of 
emotions is 
'blunted'.  
Robust evidence that some 
patients taking SSRIs experience 
significant emotional symptoms 
strongly attributed to AD 
medications 
Clinicians should add 
emotional side-effects of 
ADs to the common adverse 
effects that they usually 
mention to patients 
2009 Prins et al. Primary care patients 
with anxiety and 
depression: Need for 














in professional help 
and their evaluation 







Most patients with depression or 
anxiety expressed a need for 
counselling or information. 
Medication, practical support, 
skills training and referrals were 
less needed  
Health professionals should 
be aware of the fact that 
there are differences in 
perceived needs for care 
between subgroups of 
patients 
2009 Sawada et al. Persistence and 
compliance to 
antidepressant 



















treatment might be 
subject to patients' 
social and cultural 
background  
 
Low persistence and poor 
compliance to AD treatment 
were found to be problematic in 
patients with depression  
Further investigations are 
needed to evaluate the 




2009 Sinokki et al.  The association of 
social support at 
work and in private 
life with mental 
health and 
antidepressant use: 
The health 2000 
study  












Antidepressants Low social support at work and 
in private life was associated 
with a 12-mos prevalence of 
depressive or anxiety disorders; 
low social support at work was 
linked with subsequent ADs use  
To promote mental health 
at workplaces social support 
from supervisors and from 
colleagues should be 
regarded as an important 
resource for work. Practices 
for its utilization should be 
regarded as a target worth of 
priority. 
2009 de Toledo 
Piza Peluso & 
Blay  
Public stigma in 

















in relation to the 
case introduced in 
vignette 
This study indicated that persons 
with depression face a great 
amount of public stigma 
Need to gain in-depth 
knowledge about the impact 
of stigma on the experiences 
of persons suffering from 
depression and implement 
anti-stigma programs in 
Brazil 




therapy: do patient 





study linking a 
general practice 




initiate /or not/ 
drug taking is 
influenced by 










received a first-time 
an AD prescription 




fillers and patients 
who filled at least 2 
consecutive 
prescriptions 
Over 1 in 4 patients who receive 
first-time AD prescription 
decline the treatment; they either 
do not initiate the treatment at all 
or stop taking the drugs after the 
first 2 weeks 
More research is needed into 
the implications of declining 
AD treatment 





primary care: A 
cluster-RTC of the 
effect of a Depression 













SSRI The depression care program 
ameliorates beliefs about ADs in 
primary care  
The study results encourage 
the implementation of 
depression care programs in 
order to improve beliefs 
about AD medications 
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2009 Yen et al. Predictive value of 
self-stigma, insight, 
and perceived 
adverse effects of 
medication for the 
clinical outcomes in 
patients with 
depressive disorders  

















Adverse effects of 
medication 
Perceiving more severe adverse 
effects of medication increased 
the risk of non-remission of 
depressive symptoms; degrees of 
self -stigma and insight did not 
predict the severity of depressive 
symptoms, suicidal risk, or the 
level of drug adherence   
It is important for clinicians 
to prevent the occurrence of 
and to help patients manage 
the adverse effects of 
medication 
2010 Amey, C.  Suspected anti-
depressant-induced 
switch to mania in 
unipolar depression: a 
first-person narrative   









More understanding of AD-
induced mania is needed in 
unipolar depression 
Need for prompt specialist 
care for patients with 
depression reporting even 
mild, sub-threshold 
symptoms of mania 
2010 Aselton, P.  The lived experience 
of college students 
who have been 
medicated with 
antidepressants. 
USA Dissertation     
2010 Bennett et al. Pregnancy-related 
discontinuation of 
antidepressants and 
depression care visits 
among Medicaid 
Recipients 















compared to non- 
pregnant controls 
Pre-pregnancy, the AD use rate 
was 66%. During pregnancy, AD 
use dropped to 27% . Pregnancy 
was associated with 
discontinuation of any 
depression care among women 
receiving Medicare 
Efforts are needed to 
mitigate these reductions 
2010 Birnbaum et 
al. 
Employer burden of 














MDD Cost effectiveness 
of MDD treatment: 
prevalence of mild 
depression and its 
potential to become 
more severe 




Projected to the US-workforce, 
monthly depression-related 
worker productivity losses had 
human capital costs of nearly $2 
billion.  
Need for overall 
improvement of treatment 
quality, specifically in 
regard to MDD severity to 
improve care and better 




2010 Bob et al. Traumatic stress, 
dissociation, and 
limbic irritability in 
patients with unipolar 
depression being 


















criteria to identify 
unipolar depressive 
patients with high 
seizure-like 
symptoms which 
may respond to 
anticonvulsant 
treatment 
Seizure-like symptoms in 
depressive patients have 
significant association with 
depression, symptoms of 


















qualitative studies of 
medicine-taking  











update of work by 
2005 Pound et al) 
Cumulative evidence from 
qualitative studies indicates that 
patients’ non-adherence to 
antidepressants is often a 
purposeful action.  
Evidence of patients’ active 
engagement with their 
medicines and the 
difficulties they often 
experienced identifies a 
need for greater support 




medications in the 
general population  















A high frequency of 
non-adherence was 




The reported reasons for non-
adherence vary between 
medication types, forgetting 
being especially prevalent for 
antidepressants, mood stabilizers 
and antipsychotics. 
The cognitive impairment in 
depression may introduce 
misclassification bias that 
would tend to underestimate 
the degree of non-
compliance for respondents 
with some psychiatric 
diagnoses. 
2010 Carpenter et 
al. 
Ethno-cultural 
variations in the 
experience and 
meaning of mental 
illness and treatment: 
Implications for 


















Knowledge concerning the 
nature, course, and consequences 
of problems is produced in a 
personal, familial, and 
sociocultural context. 
Participants across the sample 
indicated the presence of 
psychiatric stigma. 
Clinical alliances should 
take such existential 
struggles to heart, by 
expanding clinical discourse 









antidepressants in the 
older population 









the benefits of ADs; 
understanding of 




GPs feel limited when 
considering alternative 
treatments for older patients with 
depression. 
Exploring experiences of 
depression and recovery; 
identifying future goals with 
patients can be helpful. Age 
is no barrier to plans for 
discontinuation of 
medications. 




immigrant women in 












Depression  Women described 
depression as 
affecting others and 
not them. Women’s 
perception: the 
clergy was preferred 
for treatment 
of depression rather 
than health care 
professionals 
The findings from the present 
study revealed that depression is 
not acceptable according to 
Nigerian-born immigrant women 
living in the US. The women 
described depression as craziness 
and being associated with evil 
spirits or a curse. 
Increase the awareness of 
nurses and other health care 
professionals of the need to 
focus on evidence-based, 
culturally specific research, 
and illuminate issues 
surrounding depression in 
this population. 
2010 Gabriel & 
Violato 













Depression Non-adherence to 
treatment can result 
from forgetting, 
carelessness, 
adverse effects, or 
stopping the drug 
when feeling better. 
There is a relationship btw. poor 
adherence and the lack of 
knowledge about depression and 
its treatment, and the negative 
attitude to antidepressants, 
providing validity for AAS 
instrument. 
Future research should 
include larger, more 
heterogeneous sample from 
various community clinics.  
2010 Holma et al. Treatment attitudes 
and adherence of 
psychiatric patients 









and good adherence 
Among psychiatric MDD 
patients in long-term, follow-up, 
treatment attitudes and 
adherence to pharmacotherapy  
mostly positive, significantly 
predicted by personality features 
and social support. 
Attention to patients with 
cluster B personality 
disorder, or poor social 
support, may be needed.  








USA Focus groups, 
preliminary, 






Depression Poor AD adherence 
is a significant issue 
in depression 
treatment, and it 
tends to be more 
common among 
Latinos. 
Qualitative methods helped 
generate data directly from 
participants’ experiences. The 
focus of this study was the 
adaptation of a MI intervention. 
Future design should focus 
on recruitment methods that 
can bring higher enrollment 
rates. The strategy calls for 
quantitative methods that 
confirm results of this study. 
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Depression To explore 
depression 




The women gave full and open 
descriptions of their emotional 
symptoms, easily recognizable 
by standard symptom categories; 
somatic symptoms were 
included, and the spiritual 
context to understanding 
depression was prevalent. 
Attention to such views of 
depression can help develop 
services in Malaysia. 
2010 Keers et al. Stressful life events, 
cognitive symptoms 




















the occurrence of 
stressful life events    
SLEs occurring prior to 
treatment may predict response 
to ADs, but the effects are both 
symptoms and drug specific. The 
association btw SLEs and the 
cognitive symptoms of 
depression may have important 
implications for treatment. 
Those reporting stress and 
therefore higher cognitive 
symptoms may benefit more 
from treatment with SSRIs 

















MDD AD, paroxetine, 
HRSD-17, BDI-II; 
ETI; WAI; CT 
A mismatch btw. preferred and 
actual treatment was associated 
with greater attrition, fewer 
expected visits attended, and a 
less positive working alliance. 
Significant indirect effect of 
preference match on depression 
outcomes. 
These findings highlight the 
importance of addressing 
patient preferences in the 
treatment of MDD. 




in a naturalistic 
setting 








The incidence of sexual 
dysfunction was substantially 
high during AD treatment. Of 
the ADs, the mirtazapine group’s 
total ASEX score was 
significantly lower than the 
scores of citalopram, fluoxetine, 
and paroxetine groups.  
The study suggests the need 
for clinicians to consider the 
impact of pharmacotherapy 
on patients’ sexual 
functioning. 
2010 Malpass et al. Concordance 
between PHQ-9 
scores and patients' 
experiences of 
depression 














and reducing their 
sense of stigma 
Evidence of patients ‘gaming’ 
when completing severity 
questionnaires, either to avoid 
unwanted treatment outcomes 
(stigma) or to achieve their 
desired outcome, is relevant to 
these findings. 
The potential therapeutic 
value of PHQ-9 may be 
dependent upon the GP’s 
willingness to openly 
discuss the results and what 
they mean for the patient. 
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2010 Mendel et al. 'What would you do 
if you were me, 
doctor?': Randomised 

















To study whether 
this question really 
leads psychiatrists 
to 
reveal their personal 
preferences. 
Psychiatrists chose 
distinctly different therapies 
when deciding in the self role 
compared with the regular 
recommendation role and the 
question ‘What would you do if 
you were me, doctor?’ 
apparently did not motivate 
psychiatrists to reveal their true 
personal preferences. 
Psychiatrists should try to 
find out why individuals are 
asking this question and, 
together with the individual, 
identify the most appropriate 
treatment option. 
2010 Ragan & 
Kane 
Meaningful Lives: 









Elders in treatment 








The major themes identified 
were independence, spirituality, 
family, depression, medical 
comorbidities, and motivation. 
Potential treatment strategies 
were derived from these themes 
Developing the role of the 
clinician as 
coordinator of health care 
and the appropriateness 
of motivational interviewing 
as a treatment strategy  
 
2010 Serna et al. Duration and 
adherence of 
antidepressant 
treatment (2003 to 






Depression To estimate the 
duration of AD 
treatment and to 
analyse the factors: 
age, sex, 
polypharmacy and 
the type of drug 
Only one out of five patients 
complied with treatment for over 
four months. Treatment periods 
were shorter in men. In chronic 
illnesses, patients with 
polypharmacy presented the best 
compliance. 
Knowledge of the factors 
involved in good 
compliance with treatment 
in polypharmacy patients 
may help in clinical practice 
to implement strategies for 
other patients.  











To identify the 
psychosocial/pharm
acological 
predictors of AD 
adherence 
Nearly 1/3 of participants 
reported low adherence. LA was 
predicted by lower age, worker 
or student status, 
neutral/negative doctor-patient 
relationship, and higher daily 
dose. 
This study is unique in 
Japan. Further studies would 
be helpful in estimating AD 
adherence. 
2010 Vega et al. Addressing stigma of 
depression in Latino 









Depression To develop a 
validated stigma 
checklist to assist 
physicians in 
addressing 
depression in Latino 
patients 
Patients reporting higher levels 
of perceived stigma were less 
likely to disclose their 
depression diagnosis to their 
family and friends and less likely 
to take the AD medication. They 
were not able to manage their 
depression.  
 
Doctors should be aware of 
the strong relation btw 
stigma and treatment for 
depression and address 







treatment and cultural 
differences - a survey 
of the attitudes of 
physicians and 























depression can be 
influenced by 
cultural differences.  
Presenting symptoms differed 
btw. Sweden and Turkey, with 
Turkish patients presenting more 
physical symptoms. After 8 
weeks of AD treatment, the 
improvement from baseline was 
greater in Turkish patients. 
In countries populated by 
diverse ethnic groups, it is 
important that physicians are 
aware of cultural differences 
in patients’ presentations 
and expectations.  
2011 Abdullah & 
Brown 
 
Mental illness stigma 
and ethno-cultural 
beliefs, values and 
norms: an integrative 
review 
USA An integrative 
review 
Mental illness To examine the 
relationship btw. 
mental illness 
stigma and culture 







Researchers may be disinclined 
to study culture as it is difficult 
to measure however, when 
culture is ignored, over-
generalizations occur.  
Better organize and more 
explore of the role of 
cultural history and values 
as they relate to mental 
illness stigma. A detailed, 
systematic approach to 
future research in the area is 
proposed. 
2011 Ballon, Diana Fear of falling, fear 
of failing. 
Antidepressant users 
- and prescribers - 
need more guidance 
around withdrawal 
Canada GREY LIT. 
    
2011 Cohen & 
Hughes 
How do people 
taking psychiatric 























The most frequent explanation 
for believing that one had an 
imbalance was that medication 
changed or relieved distressful 
symptoms. 
It remains unclear who will 
expose laypersons and 
professionals to messages 
that encourage critical 
thinking about psychoactive 
drug effects and the origin 




2011 Cook & 
Wang 














Depression This study focused 
on 3 depression 
etiologies: a 
biological model, a 
psychosocial model, 
and a medical 
model. 
Endorsing un-related cause of 
depression (allergy, virus, “being 
a nervous person”, weakness of 
character) was associated with 
increased stigma.   
Importance of mental health 
education and promotion 
with appropriate language 
discourse. 
2011 Griffiths et 
al.  
Does stigma predict a 
belief in dealing with 
depression alone? 







Depression Higher levels of 
personal stigma 
predicted belief in 
the helpfulness of 
dealing alone with 
depression and 
suicidal ideation. 
Personal stigma is associated 
with the belief in the helpfulness 
of self-reliance in coping with 
depression. 
Public health programs 
should acknowledge the 
importance of providing 
evidence-based self-help 
programs for those who 





Patients' beliefs about 





analysis of the 
results 
Depression Patients’ beliefs 







The analysis of patients’ beliefs 
emerged into 16 different 
categories of explanation. 
Primary care patients often gave 
multi-causal explanations of 
their depression. Biological 
explanations were rare.  
Patients’ beliefs about their 
illness are important in the 
patient-doctor encounter 
when developing treatment 
strategies. 
 
2011 Kikuchi et al.  Subjective 
recognition of 


















adverse effects  
It is still challenging to exactly 
tell adverse effects from 
symptoms of depression itself. 
Evaluation of multiple 
longitudinal assessment 
points is needed to better 
elucidate the interaction of 
btw. severity of depression 
and bias in subjective 
attribution of AEs to ADs. 
























Depression  Leventhal’s theory 
postulates that there 
are six underlying 
dimensions on 
which health beliefs 
are based. 
Beliefs about depression are 
multifactorial but there are 
reproducible underlying 
dimensions, which allow them to 
be reliably measured and 
classified.  
It is important to determine 
whether the beliefs affect 
the treatment choices and 
outcome. Comparisons of 
different questionnaires 
within one population would 
give more information on 








Users Perception of 










There are still many 
concerns related to 
the continuity of 
treatment and 
efficacy of ADs: 
major questions 
about the problem 
of continuing the 
treatment longer 
than recommended 
and, the issue of 
premature dropouts. 
The review provides some 
explanations how and why 
patients make decisions about 
AD medicine taking. Health care 
professionals need to take into 
account the personal beliefs, 
fears and motivations for taking 
or refusing ADs.  
Future research efforts 
should be directed towards 
how health care 
professionals should 
contribute in supporting 
patients who need mood 
modifying drugs and how to 
make social changes to 
reduce stigma surrounding 
mental health problems.  
2011 Malpass et al. I didn't want her to 
panic': unvoiced 










Depression The study aimed to 
recruit patients with 




for depression, and 
to include patients 




The concept of the ‘good patient’ 
is problematic for patients 
presenting with depression, 
whose low self-esteem and 
indecision may make 
contributing as an active partner 
challenging. 
It is important for GPs to 
explore the degree to which 
patients wish to be involved 
in decision making, 
discriminating between 
passivity as preference and 
passivity as a symptom. 
2011 Mergl et al.  Are treatment 
preferences relevant 
in response to 
serotogenic 
antidepressants and 
CBT in depressed 
primary care 
patients? Results 
from a RCT 










than those who did 
not receive their 
preferred therapy. 
Patients’ relative preference for 
medication vs. psychotherapy 
should be considered when 
offering a treatment because 
receiving the preferred treatment 
conveys an additional and 
clinically relevant benefit.  
Account for mediating 
factors such as treatment 
satisfaction  
2011 Mounce, S.  The lived experiences 
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2011 Rizo et al. A rapid, Web-based 
method for obtaining 




Canada Report of 
systematic 
search of many 
URLs 
Depression There are several 
reasons for 











Given the increasing number of 
patient narratives about drug 
experiences on open access 
forums, this rapid novel method 
will have increasing utility in 
post-marketing surveillance and 
in comparing the effects of 
psychiatric medications. 
Self-reported off-label use 
of ADs (i.e. for pain) could 
have biased the results of 
this study as compared to 
RCTs. 
2011 Sanyal et al.  The utilization of 
antidepressants and 
benzodiazepines 
among people with 
MD in Canada 
















remains an issue. 
The overall prevalence of AD 
and BDZ utilization was 49.3% 
in respondents who experienced 
a MDE in the previous year. 
To better understand patient-
and physician-based factors 
associated with the 
combined use of ADs and 
BDZs. 
2011 Schofield et 
al.  
Patients' views of 
antidepressants: from 










A wide range of 
factors that helped 
shape patients’ 
decisions about 
whether or not to 
take, and continue 
with AD medication  
Patients becoming experts 
through a process or trial and 
error in taking AD medications  
To address how patients can 
best be encouraged to take a 
more self-determining role 
in their use of medication in 
their collaboration with GPs 
2011 Sennfeld et 
al.  
Bupropion in the 





MDD Bupropion is a 
second generation 
AD drug that 
inhibits reuptake of 
dopamine and 
norepinephrine and 
has no direct 
serotogenic effects 
The 3 cases reported here 
demonstrate the efficacy of 
bupropion in patients with 
varying presentations of MDD 
In patients with MDD it is 
fundamental to make the 
distinction btw. patients who 
have comorbid anxiety 
disorder anxiety and patients 
whose anxiety is part of 
MDD, in order to choose the 
AD correctly. 
2011 Sun et al. Mediating roles of 
adherence attitude 
and patient education 
on antidepressant use 




Depression To examine the role 
of adherence 
attitude to ADs and 
patients’ education 
as mediators 
Attitudes towards ADs were 
positively associated with AD 
use, association explained by the 
mediating variable, patients 
education about ADs 
Adequate patient education 
and an understanding of 
patients’ adherence attitude 
to AD use 
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2011 Sundell et al. Antidepressant 
utilization patterns 
and mortality in 
Swedish men and 
women aged 24-30 
years 








Depression To compare AD 
utilization patterns 
and mortality in 
relation to AD use 
in patients aged 20-
34 years 
Almost twice as many Swedish 
women than men aged 20-34 
purchased ADs in 2006. 
Discontinuation rates were high, 
mortality rates were elevated in 
those using mood stabilizers and 
antipsychotics 
Health care providers need 
to acquire an increased 
awareness of attitudes to 
treatment. 
2011 Tallon et al. Involving patients 
with depression in 
research: survey of 
patients' attitudes to 
participation 








Depression Recruitment to 
RCTs is often 





Participants benefited from the 
enhanced support and feedback 
they received as part of the trial 
Understanding both GP and 
patient attitudes to 
participating in mental 
health research is crucial to 
finding effective strategies 
for improving recruitment to 
such trials. 
2011 van Geffen et 
al. 





beliefs of users of 












To explore the 
experiences and 
beliefs of SSRI 




Feelings of psychological 
dependency on the AD and 
denial of the disease, rather than 
side effects, were seen as the 
underlying reasons for 
nonadherence 
Health care professionals 
should be more supportive 
at the start and during the 
first months of SSRI 
treatment by eliciting 
patients’ considerations to 
either continue or 
discontinue treatment  
2011 Vlahiotis et 
al. 
Discontinuation rates 
and health care costs 
in adult patients 
starting generic 
versus brand SSRI or 
SNRI antidepressants 
in commercial health 
plans. 










that some generic 
antidepressants are 
not as safe or 
effective as the 
brand 
alternatives 
Comparing patients initiating 
antidepressant therapy with a 
brand versus generic medication: 
no significant difference in the 
likelihood of discontinuation of 
medication during the first 180 
days of SSRI or SNRI 
therapy 
Specific implications for 
cost management strategies 
like step therapy, and are 
important for health care 
payers who have 
investments in patient 
health. 
2012 Aikens & 
Klinkman 
Changes in patients' 
beliefs about their 
antidepressant during 









in relation to 
adherence, side 
effects, and 
response during the 
acute phase of 
treatment 
 
Patients’ medication perceptions 
became more pro-adherence as 
treatment proceeds 
Future interventions should 
focus on the association btw. 




2012 Al-Jumah & 
Qureshi 
Impact of pharmacist 
interventions on 











To explore different 
types of pharmacists 
interventions used 
in order to enhance 
patients’ adherence 
to ADs  
Pharmacists’ interventions can 
improve patient adherence to AD 
medication  
To assess the clinical 
outcomes of innovative 
pharmacists’ interventions  





with chronic physical 











Patient beliefs have implications 
for engagement with depression 
screening 
To understand fully how 
people comprehend 
depression associated with a 
physical illness and how this 
influences help-seeking and 







in patients with 
subthreshold to mild 
depression: Time for 








continue to judge 
the prescription of 
ADs for sub-
threshold and mild 
depression as 
adequate treatment 
Clinicians favor well 
merchandised, easy to prescribe 
AD drugs for patients with sub-
threshold to mild depression 
which is no different than 
placebo 
Need for a more 
differentiated, evidence-
based clinical and research 
practice  






USA RCT Depression Both, personal past 






Patients with vicarious 
experiences of depression 
express more acceptance of 
pharmacotherapy 
Focus on strategies that 
utilize knowledge of patient 





















Depression To gain detailed 
insight into patients’ 
personal accounts of 
depression 
The patients’ reasons for 
adhering to ADs included a 
range of diverse psychosocial 
issues. Increasing number of 
informants were in doubt about 
the effects of their ADs   
Clinicians should engage 
with patients who do not 
profit from antidepressant 
medications and collaborate 
toward finding alternative 
forms of treatment 
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populations in Spain: 






Mental illness Cultural identities 
of immigrant 
patients and their 
previous 
experiences of 
mental illness affect 
their ability to 
understand, accept 
and believe in the 
benefits of treatment 
 
Immigrants of all origins present 
higher percentages of early 
discontinuation of AD treatment 
The need to investigate the 
causes in greater depth to 
introduce new strategies. 
Need of qualitative studies 
assisting the quantitative 
research 
2012 Dunlop et al. Depression beliefs, 
treatment preference, 
and outcomes in a 
randomized trial for 
MDD 
USA RCT; statistical 
analysis 
MDD CBT; escitalopram; 
tested associations 
btw. beliefs and 
preferences, beliefs 
and outcomes, and 
preferences and 
outcomes 
The only study that has 
evaluated both beliefs about 
depression and treatment 
preferences as predictor of 
outcome. Conceptualizations of 
illness and treatment appear to 
be unrelated to treatment 
response  
Studies with other scales 
that could more fully 
capture belief structures that 
may more adequately 
predict preference, and 
treatment outcomes. 
2012 Fawzi et al. Beliefs about 
medications predict 
adherence in older 
adults 








To investigate the 
variables associated 
with adherence to 
ADs in older 
Egyptians 
Specific beliefs about ADs can 
predict adherence. 
Understanding cultural 
variations in medication 
adherence has great 
potential usefulness for 
clinicians 






income Latinos with 
diabetes and 
depression 




aspects of care, 
evaluated symptom 
relief, and improved 
functioning.  
Community outreach and 
education on the risk factors and 
symptoms of depression can 
increase awareness and promote 
treatment initiation. 
Inform future research that 
allows for hypothesis 
generation and theory 
development of the 
psychosocial and cultural 
influences of Latinos with 





What made me feel 
better? Patients' own 
explanations for the 








Depression To investigate 
previously 
depressed patients’ 
beliefs about the 
cause of their 
improvement  
Believing in the helpfulness of 
professional help correlated with 
a better treatment outcome; the 
coping strategy to rest and relax 
correlated with a worse outcome 
Patients’ beliefs, knowledge 
and enrolment in the 
diagnostics and treatment 




2012 Himmerich & 
Wranik 
Choice of treatment 
with antidepressants: 
Influencing factors 





The challenge of 
efficacious 
treatment lies in 
matching of the 
individual patients  
The choice of treatment is based 
on the variety of factors: illness 
and treatment characteristics, 
patient, physician and settings 
characteristics, decision supports 
and pharmaco-economic aspects.  
Hypothesis that clinical, 
individual and contextual 
factors are the three major 
groups of factors influencing 
AD treatment decision has 
to be evaluated in future 
studies. 
2012 Houle et al.  Treatment 
preferences in 








Depression The first study  
examining treatment 
preferences of 
persons with newly 
diagnosed first 
episode 
Study revealed an association 
btw. level of education and 
treatment preference. 
Physicians should make 
every effort to discuss 
treatment options with 
patients presenting mild to 
moderate symptoms. 
2012 Jylhä et al. Do antidepressants 
change personality? - 









variety of ADs 
were used 
No evidence found 
for a clinically 
significant 
covariation of AD 
pharmacotherapy 
with neuroticism or 
extraversion scores 
Scores of neuroticism decreased 
and those of extraversion 
increased as scores of depression 
decreased. 
Investigate the possibility of 
a single drug having a drug-
specific pattern of 
covariation (suggested by 
U.P). Authors’ indications 
not found here 
2012 Kikuchi et al.  Coping strategies for 
antidepressant side 




















trazodone   
Patients use various ways in 
alleviating ADs side effects. 
Some effects such as sexual 
dysfunction and fatigue may not 
be amenable to subjective coping 
efforts.  
Future studies are advised to 
disentangle various elements 
involved in subjective 
perception of side effects 
and coping strategies 
2012 Knudsen et 
al. 
Changes in self-






Depression SSRIs The extent to which the findings 
can be generalized cannot be 
concluded. The women’s self-
concept during the use of SSRI 
was closely related to their social 
lives 
 
Further studies be made 
with other age groups and 








young adult identity 
USA Dissertation 
    
2012 Liekens, S. Patients’ Beliefs 
Towards 
Antidepressants: 
Narrative Review of 
the Literature 
[Doctoral Thesis] 
Belgium Dissertation     
2012 Littrell, J.L. Taking the 




Implications for the 
use of antidepressants 
USA Review Depression The possibility that 
inflammation 
creates depression 
by blocking cell 
division in 
astrocytes in the 
PFC remains a 
possibility 
Systemic inflammation does 
contribute to depression. Over 
the long run, antidepressants 
contribute to inflammation. 
The recognition that 
depression is an 
inflammatory disease ushers 
in a wealth of new 
possibilities for treating and 
preventing mood disorders. 
























The incidence of 
side effects with 
ADs may be a risk 
factor for AD non-
adherence 
Patients with melancholic 
depression were significantly 
more non-adherent with AD 
medication than patients with 
other types of depression 
Pharmacist adherence 







acceptability of using 











Most members of the public 
found ADs acceptable in 
treatment of depression, but were 
much less positive toward the 
use of drugs for ADHD 
Qualitative studies could 
explore why drug treatment 
was found unacceptable in 
ADHD 
2012 Reavley & 
Jorm 









Depression Overall belief in the 
harmfulness of ADs 
for depression 
decreased between 
1995 and 2011 
Greater knowledge of the 
characteristics of those who 
believe in the harmfulness of 
ADs may assist clinicians in 
their efforts to engage and 
counsel patients with depression.  
Education about the role of 
ADs in the treatment of 
depression should focus on 





2012 Seekles et al. Personality and 
perceived need for 
mental health care 













Patients with higher 
level of openness to 
experience were 
more likely to seek 
help 
Personality traits are important 
in help-seeking behavior. These 
new findings suggest that people 
with different traits need 
different types of treatment. 
It is important to investigate 
the association btw. 
personality traits, common 
mental health disorders and 
mental health care 
utilization. 
2012 Singh et al. Antidepressant use 
amongst college 








Depression Students wanted to 
be the ‘player’ in 
their treatment 
decisions and 
needed to be 
acknowledged as 
such by their care 
providers 
 
Overall, the underlying essential 
theme of ‘autonomy’ was 
portrayed by the students in their 
accounts of depression treatment 
and treatment decision making. 
Recommended 
individualized and effective 
mental health care for 
college students 
2012 Vega et al. Differences in 
depressed oncologic 
patients' narratives 
















appeared to be 
frequent, with little 
understanding of 
how the drugs work; 
patients took ADs 
when they feeling 
down 
Qualitative analysis is an 
efficient method of examining 
the meaning of quantitative 
results in depth, particularly 
patients’ perspectives on quality 
of life. 
Further studies with 
different types of samples 
are needed for a better 
understanding of the 
psychological mechanisms 







who are in remission 
according to the 
HAMD who do not 
consider themselves 








perception of their 
remission status 
impacts their desire 
for a modification in 
their treatment. 
High rates of residual symptoms 
were found in patients who were 
considered to be in remission. 
Generalizability to samples 
with different demographic 






depression and its 
treatments: 
Associated variables 
and the influence of 
beliefs on adherence 
to treatment 
 




should be evaluated 
in all patients. 
Given that beliefs and attitudes 
are changeable, influenced by 
various factors, they should be 
assessed throughout the progress 
of the illness. 
The search for the best 
possible adherence strategy 
should take place in the 
context of a good 



























This is the first 
study to report 
implementation 
barriers to the 




This paper points to new 
research directions based on 
clinically applied medical 
anthropology and cultural 
psychiatry.  
By triangulating views of 
patients, clinicians, and 
experts, studies will 
contribute to qualitative 
research and improved 





management of major 
depression with 
comorbid alcohol use 
disorder-a review of 
the literature 





Depression  and  
AUD  co-occur  at  
levels  greater  than   
expected by chance 




Treatment must involve multiple 
interventions, including the use  
of  antidepressants  and  other  
adjunctive  pharmacological  and  
psychological  therapies.  
 
 
Provide better  
understanding of  the  
etiological relationship 
between the two disorders, 
determine the efficacy and  
safety of AD drugs use in  
dual disorder; new strategies  
2013 Anderson & 
Roy 








analysis of 80 
in-depth 
interviews  
Depression ADs appear to 
occupy a central 
place in many 
people’s lives 
People’s experiences with ADs 
use have a major impact on 
treatment continuation and 
treatment outcome 
Studies needed on depressed 
patients’ beliefs about their 
depression and treatment; 
how they relate to different 
stages of illness; their 
interactions with health care 


























results in a patient-clinician 
interaction that is more patient-
centered, collaborative, and 
personalized than standard 
psycho-pharmacology.  
The complete treatment 





2013 Bet et al. Side effects of 
antidepressants 
during long-term use 












Side effects are 
usually 
underreported in 
clinical trials and 
large scale 
naturalistic studies 
are restricted to 6 
months of use  
During long-term use, side 
effects to ADs are common  
Clinicians should be aware 
that antidepressant-induced 
side effects are persistent. 




and help-seeking in 
four European 
countries baseline 










Depression Findings indicate a 
moderate degree of 
personal stigma 
toward depression 
and help-seeking.  
Several country differences in 
attitudes were found. It is 
important to improve public 
mental health literacy in Europe 
in order to enhance the use of 
depression care. 
Public media campaigns 
aiming to improve mental 
health literacy are essential 
to enhance depression care. 






sleep and emotional 
experiences in 











severe MDE in 






Agomelatine and escitalopram 
had similar, high antidepressant 
efficacy. 2 ADs with different 
mechanisms of action can affect 
emotional processing in different 
ways; therefore, it may be 
associated with more or less 
risks of residual emotional 
problems 
Not found 
2013 DeJean et al. Patient experiences of 
depression and 
anxiety with chronic 
















anxiety as separate 
condition 
The relationship btw. chronic 
conditions and depression or 
anxiety can be experienced as 
independent or inter-related 
(with either one causing the 
other) 
More qualitative research is 
needed to specifically 
address screening for 
depression or anxiety, and 
their effects on the chronic 
diseases and their outcomes 







The limits of 
biomedical 














recovery that ignore 
the social conditions 
that enable the self 
to change 
 
This research revealed the 
limitations of biomedical-
scientific rationalities that 
position drug therapies as a 
thinkable solution to the 
neurochemically deficient self 
that ‘is’ depressed 
This is a contribution to the 
growing number of critical 
discourses that question the 
normalization of  
psychopharmacology and 
search for alternatives in the 
areas of women’s health, the 
mental health consumer 










sedatives: The search 














such as beliefs, may 
improve adherence 
to mood disorder 
medications  
Latino respondents who 
perceived their antidepressant 
/sedative/anxiolytic medication 
to be only for non-mood reasons 
had higher adherence than those 
who perceived their medication 
to be for mood improvement 
Healthcare providers can 
discuss the non-mood 
benefits of medications for 
mood and anxiety disorders 







clinical trials of 
antidepressants 
versus psychotherapy 














trials of ADs vs. 




Patients reported greater overall 
acceptability for psychotherapy 
over ADs. Patients had 
significantly greater expectancies 
for symptom reduction compared 
with the placebo-controlled 
design 
Test expectancies for 
improvement and treatment 
preferences in studies of 
combined treatments and in 
studies with designs directly 
comparing psychotherapy 




Illness beliefs and 
treatment beliefs as 
predictors of short 












beliefs in people 
with depression 
might be less 
relevant because 
mood may influence 
illness and 
treatment beliefs  
 
The findings highlight the 
significance of illness beliefs and 
treatment beliefs  
Future studies should aim to 
implement those efforts into 
the context of mental 
illnesses (CSM, Leventhal et 
al., 1980, 2001) 
2013 Kales et al. Racial differences in 
adherence to 
antidepressant 












found in baseline 
function with the 
exception of the 
executive function. 
White subjects had 
less impairment 
The results demonstrate racial 
and gender differences in AD 
adherence in older adults 
Depression treatment 
interventions for older adults 
should take into account the 
potential impact of race and 


























It is feasible to integrate 
pharmacotherapy for MDD and 
motivational interviewing into a 
novel motivational 
pharmacotherapy approach 
Test if motivational 
pharmacotherapy is more 




2013 Liekens et al. Instructional design 


















Depression To measure the 




depression training day that 
involve consumer educators may 
improve the care delivered to 
people with depression.  
Advanced training in mental 
health care is essential in 
preparing pharmacists to 
provide pharmaceutical care 
for this population 
2013 Misri et al. Factors impacting 
decisions to decline 
or adhere to 
antidepressant 
medication in 
perinatal women with 














factors in decisions 
to adhere or decline 
ADs in antenatal 
women with 
moderate to severe 
mood disorders and 
anxiety 
Significantly different course of 
illness was observed in adherers 
vs. decliners. Pregnant women 
experienced significantly 
divergent illness trajectories 
depending on acceptance or 
rejection of ADs therapy. 
Replicate this study with a 
larger sample size and 
determine if some ADs are 
more likely to be continued 






effects of psychiatric 
medication: The 






the need of support 
for people wishing 
to withdraw from 
AD medications  
Use of psychiatric drugs is only 
worthwhile if the benefits 
outweigh the harms however, 
what is considered harmful or 
beneficial varies according to 
psychological symptoms in 
placebo-controlled trials. 
Extensive research is needed 
to clarify the range of acute 
and longer-term mental, 
behavioral, and physical 
effects induced by 
psychiatric drugs  
2013 Munizza et 
al. 
Public beliefs and 
attitudes towards 
depression in Italy: A 
national survey 




Depression Barriers to the 
disclosure of 
depressive 
symptoms linked to 
concerns about ADs 




Depression is seen as a reaction 
to significant life events and 
should be overcome with the 
support of significant others, 
help of health professionals 
(mainly psychologists) and a 
variety of strategies. 
 
A “shared decision making” 
approach to treatment 
selection should be adopted 
489 
 
2013 Ngo et al. A qualitative analysis 
of the effects of 
depression and 
antidepressants on 
physical and work 
functioning among 
antiretroviral therapy 
clients in Uganda 
 









from the interview 
transcripts used to 
illustrate the lived 
experience of the 
participants 
Respondents attribute their 
depression to health problems, 
inability to work, financial 
concerns, and lost relationships. 
More rigorous quantitative 
evaluation is coming a the next 
phase of this research 
It is critical that more 
research is conducted to 
develop effective strategies 
to integrate mental health 
treatment into HIV/AIDS 
care. 
2013 Nitzan et al. Consenting not to be 
informed. A survey 
on the acceptability 








Depression Investigation of 
opinions of healthy 
students regarding 
acceptability of 
placebo treatment if 
they were to 
experience 
depression 
70 % answered that they would 
agree to treatment with placebo 
as a first-line treatment if they 
were diagnosed with depression. 
This is the first survey to clarify 
the opinions of laypersons re.  
option of receiving placebo in 
the treatment. 
The results will hopefully 
promote further discourse 
among physicians and health 
care professionals re.  
legitimacy of placebo 
treatment. 






imbalance theory of 
depression: The 
moderating role of 
scepticism 
USA Survey online; 
statistical 
analysis  
Depression Exposure to direct-
to-consumer 
advertising of ADs 
may shape common 
misperceptions 
about the chemical 
imbalance theory  
The study revealed that 
consumers hold a few common 
misperceptions about the 
chemical imbalance theory 
Future studies may replicate 
these research findings with 
a nationally representative 
sample 
2013 Patel et al. An exploration of 

















Participants’ narratives were 
conflicting as mothers were torn 
btw. their desire to be good 
mothers and internal struggles 




need to try and improve 
accessibility to non-
pharmacological 
interventions when mothers 





public's beliefs about 
the causes of 
depression: 
Associated factors 
and changes over 16 
years 






of depression are 
increasingly 
prevalent 
Australian public largely 
believes in multifactorial 
causation; certain subgroups  
significantly attribute depression 
to the weakness of character 
Future efforts to improve 
public knowledge about the 
causes of depression need to 









across time, across 
different treatments 
and across diagnoses? 















Adherence behavior was most 
consistent within specific 
treatments, less consistent across 
depression treatment and even 
less consistent across treatment 
for different conditions.  
Examining the relative 
importance of provider-level 
and treatment-level 
influences on adherence is a 




Follow up of patients 













Depression AD prescription in 








The empirical identification of 
predictors of poorer adherence to 
medication will allow these 
predictors to be considered 
together with the patient during 
treatment, facilitating good 
compliance 
Devising a scale specifically 
designed to evaluate 
satisfaction with AD 
treatment could be of 
interest in healthcare 
outcome research 
2013 Treuer et al. Use of 
antidepressants in the 
treatment of 







the current use 
of AD treatment 







MDD Appropriate use of 
SSRIs in the 
personalized 
treatment of MDD 
Among the MDD treatment 
guidelines in Asian countries, 
some adopt relatively 
conservative strategies and major 
differences were found in their 
AD treatment approach 
Treatment guidelines need 
to evolve from being 





A pill for the ill? 
Patients' reports of 
their experience of 
the medical encounter 







content analysis  
Depression A biochemical 
understanding of 
mental ill health 
may win as it 
relieves people of 
responsibility for 
their circumstances; 
can result in a sense 
of powerlesness   
Dynamics happening in the 
medical encounter may still be 
highly affected by a medical 
dominance, instead of a patient-
oriented perspective. This may 




It is crucial to patrol the 
boundaries of 
medicalization and 
especially the ones of 
pharmaceuticalization 








Depression To describe and 
demonstrate a 
method to develop  
Values markers may provide a 
foundation for personalized 
medicine and emphasize patient-
centred care 
 
Next step should assess 
whether values markers are 
predictive of treatment 
initiation and adherence 
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SSRIs The findings suggest a faster and 
more evident response to 
pharmacotherapy in melancholia 
compared to other depressive 
syndromes, particularly with 
SSRIs 
Clinicians should take into 
account the growing 
knowledge of differences in 
pharmacokinetics, response 
rates, and functional 


















analysis   
DSM-IV MDD General patient 
overuse and harm 
beliefs showed a 
direct positive 
correlation with the 
side effects domain 
High treatment satisfaction 
scores among patients in Saudi 
Arabia with MDD, which 
correlated with adherence and 
patient beliefs about the 
necessity of treatment.  
Further research is 
recommended in order to 
investigate other factors that 
may influence treatment 
satisfaction 
















Searching for an 
inexpensive and 
easy method to 





Adherence to ADs during 
pregnancy using MEMS is 
86%.Pill counts is a good 
alternative  
Owing to the small number 
of patients in this study, 
further investigation is 
recommended as mandatory 
2014 Burnett-
Zeigler et al. 
The association 


















and beliefs with 
race/gender 
differences in AD 
adherence 
  
Attitudes are potentially 
modifiable through improved 
patient-provider communication, 
culturally sensitive psycho-
education and therapeutic 
interventions 
Further explore adherence in 
African-American women, 
other treatment attitudes and 
beliefs that may be related to 
poor adherence 

















Study of medicine 
taking is 
controversial as it 




advice and patients’ 
actual behavior. 
 
Healthcare professionals played 
a very peripheral role in most 
participants’ lives, and that 
unsatisfactory interactions often 
isolated participants and left 
them to solve their own problem.  
Healthcare professionals are 
challenged to expand their 
traditional role as therapists 
and accept and accompany 
patients who would 
otherwise be alone in their 
search for solutions 
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can also activate 
other clinicians’ 
biases, i.e. the 
unexamined 







Combination of perceived stigma 
and racism are critical targets for 
improving the primary health 
care of Hispanics with SMI 
Anti-stigma and cultural 
competence training 
programs can help raise 
providers’ awareness of 
these issues and help shift 
maladaptive attitudes and 
biases.  




Risk factors for non-
adherence to 
antidepressant 
treatment in patients 
with mood disorders 












relevant given that 
diagnosis of mental 
disorder is well 
established 
A new profile of patients 
emerges when all of the scores 
are put together. It correlates the 
adherence to medication to a 
positive attitude towards 
medication and a higher cultural 
level and the lack of adherence 
to higher personal perception of 
side-effects. 
Patients’ health beliefs and 
attitudes need to be assessed 








for depression.  
USA Dissertation 
    
2014 Elnazer & 
Baldwin 
Treatment with 
citalopram, but not 
with agomelatine, 
adversely affects 
sperm parameters: a 
case report and 
translational review 
















This case report indicates that 
citalopram treatment can be 
associated with impaired semen 
quality, with particular effects on 
motility and morphology, but 
agomelatine treatment was not 
associated with similar effects. 
Further pre-clinical and 
clinical studies of the effects 
of antidepressants on 
spermatogenesis 
  











Depression Patients were more 
likely to express 
their perspectives on 
medications in 
consultations with 
GPs than with 
psychiatrists. 
Patients’ perspectives on ADs 
were deeply affected by the way 
ADs were looked on by society 
at large. That means that a 
shared decision making could 
also involve a third voice 
(i.e.media) 
Physicians listen to and 
explore patients’ concerns 














Depression High rates of ADs 
prescribing in 
Western countries 




Studies reporting patients’ 
negative rather than positive 
experiences of ADs. Possibly 
there are fewer positive 
experiences or that those with 
negative experiences tend to be 
more active in reporting those to 
researchers.  
It would be important to 
have more studies that 
investigate the positive 
experiences in order to 
better understand the 
complex mixture of views 
2014 Hartley et al. Narratives reflecting 
the lived experiences 





UK First person 
narratives from 

















opportunity for the 
reader to empathise 
with people with 
brain disorders 
First-person narratives illustrate 
realities for people with brain 
disorders facilitating a deeper 
understanding of their every-day 
life experiences.  
Data from quantitative 
studies would also be 
valuable 




with primary care 







theory analysis  
Depression To describe the 
salient themes that 
emerged when older 
depressed Latinos 
discussed their 
experiences of their 
primary care visit 
for emotional, 
personal or mental 
health problems   
 
Distinctive results included the 
finding that caregiving was 
associated with difficulties 
accessing primary care for 
mental health problems 
The findings may have 
implications for primary 
care providers and support 
for older depressed Latinos 
in patient-centered care for 
chronic depression 
2014 Jaffray et al. Why do patients 
discontinue 
antidepressant 
therapy early? A 
qualitative study 





Depression Patients’ views on 
ADs are influenced 





Health care professionals would 
benefit from exploring patient 
knowledge and views on 
depression and ADs at an early 
stage of treatment 
Treatment adherence could 
be improved by intervention 
to address perception at the 
same time  
2014 Jumah et al. Factors associated 
with adherence to 
medication among 
depressed patients 










MDD Low adherence to 
AD medication and 
severity of 
depression had a 
negative correlation 
The study indicated that he 
majority of patients with MDD 
reported low adherence (52.9%) 
Examine the impact of 
interventions targeting 
factors that correlate with 







older people: What 
can we learn from the 
current evidence 
base? 
UK Review Depression  How effective are 
antidepressants in 
older people? 
The most consistent evidence is 
for the effectiveness of continued 
AD treatment in those depressed 
patients who respond well to 
acute treatment 
There remains a clear need 
for more research to identify 
effective treatments for 
resistant depression 
2014 Kirino, Eiji Escitalopram for the 
management of 
MDD: a review of its 
efficacy, safety, and 
patient acceptability 
Japan Review MDD SSRI, escitalopram Because MDD recurs readily, it 
is important to select AD drugs 
that allow high therapy 
continuity for pharmacological 
treatments. The effects of 
escitalopram indicate that this 




comparative studies that 
evaluate specific efficacy, 
tolerability, health-related 
quality of life, and economic 








in women's stories of 
sadness. 





2006 and 2007, 
2009 
Depression The superficiality of 
medication as 
solution, and the 
readiness with 
which ADs are 
prescribed, was 
described by several 
participants 
In highlighting and circulating 
counter-stories, we provide 
alternate ways of understanding 
and responding to women’s 
experiences of depression  
Not found 
2014 Lam & Sun Stigmatizing opinions 
of Chinese toward 
different types of 
mental illnesses: A 
qualitative study in 
Hong Kong 











For depression, it 
was usually 




suffered from in life 
While there are different 
stereotypes for different mental 
illnesses, the perceived risk of 
aggressive behaviors determine 
the public’s acceptance. 
Stigmatizing opinions do not 
generalize across different 
mental illnesses. 
 
Future interventions among 
Chinese should reduce the 
public’s exaggeration of the 
aggressive image of 






among people living 
with inflammatory 














bowel disease due 
to the widespread 




ADs found to be accepted by 
IBD respondents with co-morbid 
mental health symptoms. 
Disease activity improved in 
only 25% of AD users; 
improvement in psychological 
well-being reported by nearly 
90% of participants 
Future clinical trials on ADs 
will likely be accepted by 
people living with IBD and 
in need of mental health care 
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2014 Moradveisi et 
al. 






medication on the 











MDD In Iran, most 
patients have only 
access to AD 
medications, not to 
psychotherapy 
High scores on psychotherapy 
preference vs ADs attitude 
predicted dropout from ADs. 
Patients’ preferences and 
attitudes toward depression 
treatment influence dropout from 
ADs  
Investigate the effects of 
preference/attitude for BA 
(behavioral activation) and 





The revolting self: 
An interpretative 
phenomenological 
analysis of the 
experience of self-








Depression To obtain an 
informed 
understanding of 
self-disgust.   
Self-disgust is a consuming 
negative psychological 
phenomenon, associated with 
depression, problems with 
eating, physical appearance, 
interpersonal relationships, and 
self-persecution 
The ‘self’ is a psychological 
phenomenon that deserves 
further empirical and 
therapeutic considerations. 
2014 Ramirez & 
Badger 
Men navigating 







depression in men 
remains poor. 
Depression in men 
is underdiagnosed. 
This study advances our 
understanding of men and 
depression by providing 
meanings to the behaviors men 
express when depressed. 
Based on these findings, 
further research can lead to 
better screening tools and 
early diagnosis of 






effects reported by 











Depression This study aimed to 
survey the largest 
sample of AD 
recipients to date. It 
reports participants’ 






The adverse effects of ADs are 
many and varied and are 
experienced by very high 
percentages of ADs recipients. 
The overrepresentation of 
women (76. 6%) is not of great 
concern as women are prescribed 
ADs at approx. twice the rate as 
men internationally  
 
The ethical principle of 
informed choice suggests 
that patients should be 
informed about adverse 
effects prior to starting ADs. 
2014 Read et al. Beliefs of people 
taking 
antidepressants about 
causes of depression 
















Clinicians should consider 
exploring patients’ causal 
beliefs. The public, even when 
taking ADs, continues to hold a 
multi-factorial causal model of 
depression with a primary 
emphasis on psycho-social 
causes. 
Clinicians may want to 
consider spending a little 
time exploring their 
patients’ understandings of 




2014 Serrano et al. Therapeutic 









Depression Patients with a 
higher level of 
therapeutic 
adherence are those 
who have a better 
perception of the 





The analysis of factors 
associated with greater 
adherence to AD treatment 
shows that personality factors 
and beliefs surrounding 
medication do not influence 
therapeutic compliance 
It is important to make use 
of the relationship between 
the PC doctor and the 
patient in order to provide 
personalized information 
about medication, its effects 
and therapeutic response.  




and attitudes toward 


















All three biogenetic 
causal beliefs were 
associated with 
more fear in all 
three illnesses 
‘Chemical imbalance of the 
brain’ and ‘brain disease’ were 
both associated with a stronger 
desire for social distance in 
schizophrenia and depression, 
and with more social acceptance 
in alcohol dependence 
A discussion-based strategy 
targeting sharply defined 
groups of recipients could 
probably serve well the 
pressing need to de-
stigmatize mental illness. 

























subsequent to a life 
event that resulted 
in the loss of their 
identity 
Beliefs about depression, about 
themselves, and about symptom 
causation and treatment efficacy 
strongly affected the diagnostic 
and treatment process 
Suggesting that 
psychotherapy/which is 
rarely offered/may be 
beneficial in these 
circumstances   
2014 Tahirkheli et 
al. 
Postpartum 
depression on the 
neonatal 
intensive care unit: 
current perspectives 
USA Review Post-partum 
depression 
The diagnosis of 
PPD is complicated 
by not only a lack of 
understanding but 
also varying 
definitions of the 
diagnosis itself. 
By implementing regular 
screenings for PPD, we can 
target mothers who need 
intervention earlier and reduce 
their chances of developing PPD 
symptomatology. 
With larger and more 
diverse sample sizes, 
improved PPD assessment 
measures, and observations 
of mother–infant 
interactions, we will achieve 
more powerful results than 




2014 Van Grieken 
et al.  
Patients' perspectives 
on how treatment can 












analysis   











This study highlights the 
importance of clinicians taking a 
more exploring role in 
uncovering the patients׳ 
perspective to MDD treatment. 
More awareness of the patients׳ 
perspective may increase 
treatment adherence, motivation 
and finally success. 
Each individual patients׳ 
perspective is unique and 
clinicians may learn from 
this study about the 
importance of paying 
attention to ‘minimal cues’ 
concerning the patients׳ 
feelings about diagnosis, 







with depression and 
coping behaviors  
USA Qualitative: 
phenomenology 
Depression Older women 
believed they 
experienced a 
number of situations 





Findings suggested all of the 
women endorsed use of 
culturally sanctioned coping 
behaviors such as religious 
coping and resilience  
Research focusing on older 
African American women’s 
mental health is in an 
infancy stage; there is a need 
for more research in this 
area   
















Assessing a wide array of 
patients’ experiences and 
perceptions regarding the 
efficacy, side effects, and 
practical problems of ADs 
contributes to better 
understanding of nonadherence 
to ADs. 
Guiding physician –patient 
conversations about patient 
experiences and perceptions 
may reduce both intentional 
and unintentional 
nonadherence 
 2014 Wouters et al. Primary-care patients' 
trade-off preferences 







Depression TCAs, SSRIs, 
SNRIs, tetracyclic 
ADs 
Relapse prevention and symptom 
relief were on average equally 
important. Side effects were as 
important. For approx. one in 
five patients, the benefits of ADs 
do not outweigh their drawbacks.   
Longitudinal studies in 
which patients are enrolled 
at the start of the regimen 
are recommended. 
2014 Wu et al. Individual counseling 
is the preferred 
treatment for 









need to consider 
patient preference in 
the treatment of co-
morbid depression 
in women with 
cancer. 
 
Survivors preferred counseling 
for treatment of depression. 
Cancer centres should be 
prepared to provide 
preferred treatment methods, 
particularly as screening, 
and therefore management 




2014 Yau et al. Non-continuous use 
of antidepressant in 
adults with MDDs-a 
retrospective cohort 
study 




Depression Major reasons for 
non-continuous 






Non-continuous AD use is an 
important predictor of relapse 
and recurrence with significant 
implications for long-term 
prognosis. The results from this 
study highlighted high early 
recurrence rate.  
Collaborative 
multidisciplinary approach 
utilizing various health care 
professionals to provide 
systematic psychoeducation 
on depressive illness and 









the case of Sri Lanka 








DSM-IV MDD A majority of 
undergraduates 
recognized the 
problem as a mental 
health problem, 
only 17.4% 
recognized it as 
depression 
Undergraduates are likely to 
consider the help of informal 
options such as parents and 
friends more than the help of 
professionals. They might also 
seek religious help for their 
problem. 
Depression literacy 
initiatives must improve the 
depression literacy while 
also improving the 
undergraduates’ awareness 
of professional help, 
especially with regard to 
medications.  




antidepressant use in 
primary care? 










The study presents a 
comprehensive 
examination of the 
characteristics of 
long-term ADs 
users in primary 
care.  
Long-term ADs use of 2 years or 
more is not uncommon in 
primary care. It occurs within the 
context of complex mental, 
physical, and social morbidities. 
Whilst most long-term use is 
associated with a history of 
recurrent depression, there 
remains opportunity for 
treatment re-evaluation and 
timely discontinuation. 
There is evidence to suggest 
that GPs could be more 
actively involved in 
considering treatment 
discontinuation: this is an 
important focus for future 
research. 
2015 Anderson et 
al. 
Starting 
antidepressant use: a 
qualitative synthesis 
















people willing to 
talk about their 




themselves as being 
‘in recovery’ 
 
This is the first paper to explore 
in-depth patient existential 
concerns about start of ADs 
using multi-country data. People 
need additional support when 
they make decisions about 
starting ADs. Many feel 
intimidated by the prospect of 
taking ADs 
Health professional can use 
these findings to better 
understand and explore with 




2015 Arco, L. A case study in 
treating chronic 










DASS-S, BDI  
OCD is difficult to 




The study shows a successful 
application of behavioral 
activation and pharmacotherapy 
for chronic and comorbid OCD 
and depression 
Behavioral activation shows 
promise as a primary 
psychological treatment for 
comorbid disorders that 
include severe depression. 




for depression and 






Depression There were no 
significant 
differences in 
beliefs in the 
helpfulness of any 
of the types of 
treatments/interventi
ons for depression 
btw. those who 
were and who were 
not currently 
experiencing 
depression   
 
Use of treatment and lifetime 
experience of symptoms of 
depression were assessed 
through self-report. It would be 
recommended to access 
objective measures about 
diagnosis and treatment of 
depression. 
Campaigns or educational 
programs aimed at changing 
beliefs about treatments may 
be useful in older adults. 
More research is needed into 
ways to overcome barriers 
to help-seeking and 
treatment in elderly patients. 




medication and CBT 








Depression Systematic, socially 
situated account of 
people’s 
experiences of ADs 
and CBT 
Participants differed in how they 
experienced and evaluated the 
effects of medication. 
Medication was frequently 
perceived as an aid to surviving 
in crisis: “Mirtazapine probably 
saved my life”. 
It might be appropriate to 
conduct quantitative studies 
on this topic. Also, consider 
application of the current 
model to combined 
treatment of other 
difficulties (i.e. psychotic 
disorders, CBT and drugs) 
2015 Blandin et al. No evidence in favor 
of a more deleterious 
impact of a major 
depressive episode on 
verbal memory in 

















Any kind of 
antidepressant 
This study suggests 
that older patients who suffered 
from a depressive 
episode have equivalent odds of 
recovering from 
their memory impairment than 
younger patients 
Further studies should 
explore the immediate recall 
and use attention and 
executive tasks to further 
characterize the impact of a 
depressive episode on 





Bowers et al. 
Postpartum 
depression in refugee 
and asylum-seeking 













belief that diseases 
and symptoms are 
objective entities 





The authors emphasise the 
contribution that midwives can 
make to integrated partnerships 
with other care providers in the 
care of refugee and asylum-
seeking women with perinatal 
distress. 
Utilization of midwifery 
model will increase social 
support for migrant 
maternity care 























engaging in a wide 








Reported an array of symptoms: 
cognitive, emotional and 
physical. Each person’s 
experience of longer-term 
depression was unique.  
Mental health services may have 
failed to develop a systematic 
approach to supporting and 
facilitating self-management 
There is greater scope for 
improving the ability of 
services to engage with this. 
2015 Demyttenaere 
et al. 
What is important in 










Depression Physicians had been 
asked to include 
patients with a 
diagnosis of clinical 
depression ‘where 
treatment with AD 




lowest ranking, in 
physicians and in 
patients. 
 
Physicians differ significantly 
from patients in what they 
consider important for ‘being 
cured’ from depression: 
physicians mainly focus on 
alleviation of depressive 
symptoms while patients mainly 







What is important in 




patients matter? (2) 
Belgium Meta-regression 
analysis 
Depression Previous study (1) 
showed that what 
physicians and 
patients consider to 
be important in 
being cured from 
depression is 
different   
Outcomes with standard AD 
drugs are still suboptimal and 
discordance btw. what patients 
and physicians consider 
important in the definition of 
cure from depression 
significantly influences clinical 
outcomes at 6 months, mainly 
for anxiety, positive affect and 
social relationships in quality of 
life. 
Not found 
2015 Hudson et al. Reduction of patient-
reported 
antidepressant side 














This secondary data 
analysis tested the 
hypothesis that 
patient-reported AD 
side effects were 












Patients in the TBCC group 
reported fewer antidepressant-
related side effects, which may 
have contributed to improved 





Attitudes and beliefs 









Depression  Primary aim: to 
determine the 











It was observed that Malay 
patients had more positive 
attitudes and beliefs toward 
depression and ADs. Malaysia is 
a multiracial country made up of 
60% Malays, more than 20% 
Chinese, and less than 10% 
Indian. By constitutional law, all 
Malays are Muslims.  
Most patients had erroneous 
views with regard to 
perceived harmful effects of 
ADs. Patients’ beliefs and 
attitudes influence their 
adherence, preference for 






























treatment seem to 
create a barrier to 
proper care. 
A lack of adequate treatment of 
depressive disorders is an 
ongoing problem although the 
results on treatment among 
young adults are better than in 
most previous studies and 
encouraging.  
More efforts of future health 
care are needed to reach out 
to individuals with less 
education who present a 
higher risk of suicidality, 
complications and social 
exclusion. 















statistics, t-test  









First-generation KA’s feel a 
stigma toward seeking Western 
mental health treatment such as 
ADs and prefer lifestyle 
modifications, especially 
exercise. Within the Oriental 
medical model, depression is 
considered as an imbalance in 
the flow of Qi (energy), Yin 
(cold) and Yang (hot) within the 
person.  
Compare Hwa-byung to 
depression and test the 
effects of exercise on 
depression and Hwa-byung 
in the population of interest.  
2015 King et al. Role of patient 













text analysis  






gender, race, and 
current depression  
Patients who trusted their 
provider reported greater bond, 
openness and shared decision 
making.  
PC environments in which 
individuals feel safe sharing 
psychological distress are 
essential to early 
identification and treatment. 
Attentiveness and active 
listening may influence the 
effectiveness of depression 
intervention. 
2015 Lesen et al. Beliefs about 
antidepressants 
among persons aged 
70 years and older in 




for ADs were 





To assess beliefs 
about ADs in older 
persons in treatment 
one year after a 
suicide attempt. (Up 
to ¾ of those who 
commit suicide in 




Beliefs about ADs tended to be 
more positive than negative in 
older persons taking ADs in the 
aftermath of a suicide attempt. 
Studies using objective 









symptoms in chronic 













SSRI; SNRI The findings underscore the 
patients’ need to talk about the 
disease and its consequences 
within the context of their life – 
not only about subjects directly 
affecting their heart disease. 
Many patients have objections to 
ADs as they worry about adverse 
effects or negative medication 
interaction.  
Investigate if supportive 
talks over an extended 
period of time could reduce 
depressive symptoms (at 
least in minor depression) 
and ease the overall 
symptom-burden by treating 
CHF and depression 
simultaneously 
2015 McCarrier et 
al. 
Patient-centered 
research to support 
the development of 
















ATLAS ti  
DSM-IV-TR 
and DSM 5  
MDD, recent 
MDE, HAMD 




of SMDDS has 35 










The current version of SMDDS 
also assesses emotional, 
psychological, and somatic 
symptoms commonly 
experienced in MDD but not 
identified by the DSM-IV-TR or 
DSM-5: anger, frustration, 
irritability, loneliness, 
nervousness, shortness of breath, 
aches and pain, and self-dislike 
When finalized and 
qualified by the FDA, the 
SMDDS will be made 
publicly available and is 
intended to be suitable for 
implementation. Assessing 
treatment benefit from the 
patient perspective has the 
potential to support product 
labeling claims beyond 
currently available for 
MDD.  
2015 Mert et al. Perspectives on 























The leading factors for 
medication nonadherence: “not 
willing to use medication”, “not 
accepting the disease”, “being 
disturbed by side effects”, 
“feeling well” 
It is recommended to 
evaluate medication 
adherence in future studies 
through more specific 
methods such as pill 






The influence of 
patients' attributions 
of the immediate 
effects of treatment 



















Depression ADs are the first- 
choice treatment for 
severe MDD with or 
without psychiatric 
features. Little is 
known about the 
long-term 
effectiveness of 
ADs and how it 
compares to 
psychotherapy. 
Long-term effects are predicted 
by attributional factors. 
Attribution to increased coping 
capacities and giving credit to 
oneself appeared essential. 
One attribution waiting for 
further study is that offering 
BA (behavioral activation) 
helps them learn new skills 
and strategies in coping with 
problematic life events. 
Future studies should 
investigate the effects of 
attributions for BA and ADs 
in other clinical settings and 
in other cultures.  
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2015 Novick et al. Antidepressant 
medication treatment 
patterns in Asian 




















 Early discontinuation of ADs 
among Asian MDD patients was 
high. 25.6% of those who 
discontinued prematurely were 
experiencing an adequate 
response to ADs. Nonadherent 
patients had significantly higher 
disease severity, lower QoL 
ratings, lower response and 
lower remission rates. 
Not found 
2015 Read et al. Beliefs of people 
taking 
antidepressants about 







Depression beliefs about the 
causes of their own 
depression: 
chemical imbalance, 




distressing events in 
childhood 
Self-reported effectiveness of the 
ADs positively associated with 
bio-genetic causal beliefs. The 
quality of the relationship with 
the prescribing doctor was 
positively related to a belief in 
chemical imbalance. 
83% reported that the medication 
reduced their depression  
Exploring patients’ beliefs 
may enhance the doctor-
patient relationship and 
selection of appropriate 
treatment modality. 
2015 Read et al. Understanding the 
non-pharmacological 
correlates of self-








Depression 2 outcomes were 
measured: i) 
perceived reduction 
in depression, ii) 
perceived 
improvement in 
quality of life  
Listening carefully to 
someone’s story, rather than 
being too concerned about 
adherence to a single 
treatment modality, can, it 
seems, be curative all by itself.  
Prospective studies are 
essential as it is difficult to 
draw firm conclusions about 
the meanings of some 
findings, incl. causality. 


















(NVivo)   
Depression Experiences of ADs 







them influence lives 
of people with 
depression 
 
Many participants described 
ADs as powerful medications 
that could make them high, 
numb, or sedated, and/or 
suggested such opinions were 
widely held. In terms of 
discontinuing the medication, 
people talked about this being 
difficult but different from 
addiction. People with 
depression who could benefit 
from ADs may well be put off by 
the moral concerns 
Professionals might help 
patients make better choices 
by illuminating the moral 
issues as severely ill patients 
may over-look the live-
saving nature of the 
medications when distracted 
by moral concerns. 
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To examine the 





advice or approval. 
Physicians prescribing ADs need 
to clearly communicate the 
expected benefits of treatment, 
the minimum duration of use 
required to experience benefits, 
and the potential side effects.   
Need for improved quality 
of diagnosis and treatment 
of mental disorders, incl. 
improved adherence with 
medications. 













cal Analysis  
DSM-IV 
Depression 





4 themes were identified: 
substitution of rage for the 
feeling of shame and 
unworthiness, perfection struggle 
to overcompensate belief of 
being inadequate, feeling of 
shame for their own body and 
sexual acts, and need for 
individuation 
Not found 

















findings of the 
trials, clinicians find 
difficult to decide 
how to proceed if 
the patient does not 
improve or shows 
only a partial 
response to the 
initial AD 
treatment. 
Switching from TCA to another 
TCA provides only a modest 
advantage (response rate 9%-
27%), while switching from one 
SSRI to another SSRI is more 
advantageous (response rate up 
to 75%).The study identifies 
alternative effective treatment 
strategies for TRD. 
 
Further large observational 
multicenter studies are 
needed to compare the 
efficacy of different 
strategies in more 
homogeneous 
subpopulations. Double-
blind control study, directly 
comparing the efficacy of 
different pharmacological 
strategies, should be 
conducted, too.  
 
2015 Vargas et al.  Toward a cultural 
adaptation of 
pharmacotherapy: 



















were views about 
depression and AD 
treatment 
The study emphasizes the 
importance of understanding and 
addressing cultural views of 
depression and treatment with 
ADs. Latino patients attribute 
complex meanings to ADs. 
Integrating cultural views 
into psycho-
pharmacotherapy can help 
patients negotiate and 
address their views in order 

























Hispanics with  
rheumatoid arthritis, 
many do not 
disclose it or seek 
treatment.   
Depression was perceived as a 
long-term, severe problem 
leading to suicide. It was 
associated with weakness and 
character flaws, contributing to 
stigma and reduced likelihood of 
disclosure.  
Use, duration, and goals of 
AD therapy should be 
clarified. Providers should 
strive to establish trust and 
conduct in-person 
depression screening to 
facilitate disclosure.    
2016 Akioyamen et 
al. 
Effects of depression 
pharmacotherapy in 
fertility treatment on 
conception, birth, and 












re. benefits and 
harms to mothers 
and their offspring. 
  
Women receiving treatment for 
infertility are especially 
vulnerable to symptoms of 
depression and adverse perinatal 
outcomes. Currently, no studies 
address whether 
pharmacotherapy for the 
treatment of depression in 
women undergoing assisted 
reproduction affects their health 
or that of their off-spring long-
term.   
Decisions re, the treatment 
of depression should be 
made taking into account 
clinical presentation and 
illness severity. It appears 
that much like AD use in 
fertile women, there are risk 
associated with both AD use 
and untreated depression.   
2016 Barr et al. Competing priorities 
in treatment decision-
making: A US 
national survey of 
individuals with 
depression and 

















and assess shared 
decision-making 
(SDM) in routine 
depression care 
While clinicians know what 
information is important to 
consumers making depression 
treatment decision, they do not 
always address these concerns. 
This adversely affects the quality 
of depression care. 
Development of decision 
support interventions can 
improve levels of shared-
decision-making and provide 
clinicians and patients with a 
tool to address the existing 
misalignment in information 
priorities. 
2016 Bortolato et 
al.  
Cognitive remission: 
a novel objective for 
the treatment of 
major depression? 















The management of cognitive 
dysfunction remains an unmet 
need in the treatment of MDD. 
It is hoped that the 
development of novel 
therapeutic targets will 
contribute to ‘cognitive 
remission’, which may 




2016 Brinijah & 
Antoniades 







Depression It was explicated 
how people with 
depression came to 
self-manage their 
illness within a 
neoliberal setting  
Few would consider self-
medicating with alcohol and 
other drugs, adjusting 
prescription dosages without the 
input of a qualified health 
professional or reducing 
interactions with health services 
as optimal practiced for people 
with depression. 
   
Instead, such practices 
highlight that the self-
management within a 
neoliberal context, without 
giving sufficient 
acknowledgement to the 
importance of a therapeutic 
relationship, a feeling of being 
cared for, may do more harm 
than good to human health.  
2016 Castonguay, 
Filer, & Pitts 
Seeking Help for 
Depression: Applying 
the Health 















The analysis of 
depression 
narratives yielded 
insight about the 
path to seeking 





The main barrier preventing 
help-seeking was fear of the 
unknown treatment process. 
Interpersonal cues to action 
served to reduce uncertainty by 
providing guidance and 
confirmation that help was 
needed. 
Interventions should target 
friends and family of 
depressed individuals and 
provide information regarding 
the treatment process to 
effectively reduce uncertainty 
and drive help-seeking. 
2016 Chaitanaya et 
al. 
Reasons for poor 
medication adherence 




study, MMAS-8  
Depression  To assess the 
reasons contributing 
to non-adherence to 
anti-depressants in 
India  
The overall non-adherence rate 
to ADs found in this study was 
high 
Pharmacist instructions may 
improve adherence in 
depression.  



















Financial crisis has 
yielded adverse 
effects on the global 
population, as 
evidenced by 
elevated rates of 
major depression. 
Attitudes to psychiatric 
medications were found to be 
particularly negative and 
influenced help-seeking 
intentions.  
Research on mental health 
effects of the global recession 
should encompass studies 
investigating the stigma 
attached to mental disorders 















Depression While men’s 
experiences of 
depression and help 
seeking are shaped 
by gender, there is 
little research which 
examines their 
experience of using 
ADs  
  
This study has a number of 
implications for men using ADs, 
for those who prescribe ADs, or 
who work with men to 
facilitative their recovery from 
depression. Using ADs involves 
considerable conflict for men. 
Professionals who work in 
men’s mental health should 
have discussions about 
sources of conflict that men 
experience with ADs and to 
facilitate their better 







In my life 
antidepressants have 
been…': a qualitative 
analysis of users' 
diverse experiences 










Depression The study explores 
diversity in the 
experience of ADs 
users. 
Considerable diversity in 
participants’ responses incl. 
positive (54%), negative (16%), 
and mixed (28%) experiences 
with ADs. 
Mental health professionals 
need to recognize that ADs 
are not ‘one size fits all’ 
solution. 
2016 Hanson et al. Attitudes and 
preferences towards 
self-help treatments 





















Psychotherapy and guided help 
were found to be the most 
acceptable and preferred 
treatment options.  
Future research should focus 
on understanding why 
unguided self-help 
interventions are deemed to be 
less acceptable than guided 
self-help interventions. 






cognitive therapy for 
recurrent depression: 












reduce the risk of 
relapse in recurrent 
depression, but their 
combination has not 
been studied. 
Clinician who supports the 
process of discontinuation 
should be also trained in the 
mindfulness model to manage 
difficulties that come up. Many 
psychological factors may 
influence discontinuation, 
placebo-controlled studies may 
inform on psychological and 




research on the 
barriers and facilitators 
that patients 
experience during the 
discontinuation 
process might help 
better tailor 










Australia Case study and 
commentary 
Depression Knowledge of 
psychopharmacolog




anxiety are known 
to enhance the 
perception of pain. 
Several ADs are efficacious in 
the management of chronic pain. 
TCAs along with gabapentin and 
pregabalin are recommended by 
recent-evidence based guideline 
as the first choice of treatment 
and SNRIs (duloxetine, 
venlafaxine) as the second-
choice treatment in painful 
neuropathy. 
 
Controlled data to support 
the use of SSRIs as pain 








among older Chinese 












among people with 
depressive disorder 
is a major, ongoing 
public health issue. 
Also, the global 
increase in the 






Specific beliefs about ADs can 
predict adherence among 
Chinese elderly with depressive 
disorder.  
For better adherence 
behavior, special attention 
should be directed at elderly 
depressed patients with 
negative attitudes towards 
AD medication who have 
had previous episodes of 
depression.  





both people are 


















To better understand 
the complexities of 
developing an 
effective 
psychiatrist - patient 
relationship when 
both people 
involved are doctors 
When a psychiatrist has a doctor 
as a patient there is risk of 
adverse effects on the quality of 
care and even harm  
This study shows that when 
a doctor engages with a 
psychiatrist, extra care needs 
to be taken of the 
therapeutic relationship. The 
strategies also have the 
potential to be useful for 
regular non-doctor-patients 
